<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>PlatCOVID</title>
    <link>/</link>
      <atom:link href="/index.xml" rel="self" type="application/rss+xml" />
    <description>PlatCOVID</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><copyright>BioHub - UFPE</copyright><lastBuildDate>Thu, 28 Jun 2018 00:00:00 +0100</lastBuildDate>
    <image>
      <url>/images/icon_hu7e12209333f22d741aca7d462871821f_9877_512x512_fill_lanczos_center_2.png</url>
      <title>PlatCOVID</title>
      <link>/</link>
    </image>
    
    <item>
      <title>ACETAZOLAMIDE</title>
      <link>/drugpanel/acetazolamide/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/acetazolamide/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00819&#39; target=&#39;_blank&#39;&gt;db00819&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=acetazolamide&#34; target=&#34;_blank&#34;&gt;acetazolamide&lt;/a&gt; &lt;br&gt;
Synonymous :2-acetylamino-1,3,4-thiadiazole-5-sulfonamide | 5-acetamido-1,3,4-thiadiazole-2-sulfonamide | 5-acetylamino-1,3,4-thiadiazole-2-sulfonamide | acetazolamid | acetazolamida | acétazolamide | acetazolamide | acetazolamidum | n-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide | n-[5-(aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;acetazolamide&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32226695
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In light of this, a countermeasure that has been shown to be effective in the analogous condition of HAPE is Acetazolamide. […] Acetazolamide has a myriad of effects on different organ systems, potently reduces hypoxic pulmonary vasoconstriction, improves minute ventilation and expired vital capacity. […] Acetazolamide, Nifedipine and Phosphodiesterase inhibitors may be potential countermeasures.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ACYCLOVIR</title>
      <link>/drugpanel/acyclovir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/acyclovir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00787&#39; target=&#39;_blank&#39;&gt;db00787&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=acyclovir&#34; target=&#34;_blank&#34;&gt;acyclovir&lt;/a&gt; &lt;br&gt;
Synonymous :aciclovir | aciclovirum | acycloguanosine | acyclovir
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;acyclovir&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32023685
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>AD5-NCOV</title>
      <link>/drugpanel/ad5-ncov/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/ad5-ncov/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db15655&#39; target=&#39;_blank&#39;&gt;db15655&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=ad5-ncov&#34; target=&#34;_blank&#34;&gt;ad5-ncov&lt;/a&gt; &lt;br&gt;
Synonymous :recombinant novel coronavirus vaccine (adenovirus type 5 vector)
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;ad5-ncov&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32234130
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
One is named as Ad5-nCoV developed by the Chinese Institute of Biotechnology of the Academy of Military Medical Sciences and Tianjin Cansino Biotechnology Inc. […] Ad5-nCoV is based on the replication-defective adenovirus type 5 as the vector to express 2019-nCoV spike protein.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ADENINE</title>
      <link>/drugpanel/adenine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/adenine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00173&#39; target=&#39;_blank&#39;&gt;db00173&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=adenine&#34; target=&#34;_blank&#34;&gt;adenine&lt;/a&gt; &lt;br&gt;
Synonymous :6-aminopurine | adenin | vitamin b4
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;adenine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294562
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
It is also exciting to uncover that Flavin Adenine Dinucleotide (FAD) Adeflavin, B2 Deficiency medicine, and Coenzyme A, a coenzyme, may also be potentially used for the treatment of SARS-CoV-2 infections.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ADENOSINE</title>
      <link>/drugpanel/adenosine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/adenosine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00640&#39; target=&#39;_blank&#39;&gt;db00640&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=adenosine&#34; target=&#34;_blank&#34;&gt;adenosine&lt;/a&gt; &lt;br&gt;
Synonymous :(2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol | 6-amino-9-beta-d-ribofuranosyl-9h-purine | 9-beta-d-ribofuranosidoadenine | 9-beta-d-ribofuranosyl-9h-purin-6-amine | 9-β-d-ribofuranosyl-9h-purin-6-amine | ade-rib | adenin riboside | adenine deoxyribonucleoside | adenogesic | adenosin | adenosina | adénosine | adenosine | adenosinum | ado | beta-d-adenosine
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;adenosine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32171193
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
IL-37 performs its immunosuppressive activity by acting on mTOR and increasing the adenosine monophosphate (AMP) kinase.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32239125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among them, remdesivir, an analogue of adenosine, is what seems to have a more promising future.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253888
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
It is hoped that certain drugs, such as CoV-19 receptor blockers, anti-inflammatories (against rheumatic diseases), monoclonal antibodies, anti-IL-1 and anti-IL-6, the remdesevir drug (analogue adenosine, effective against ebola), hydroxychloroquine (for the treatment of malaria) and vaccines, will open up new strategies and new therapeutic ways to combat this terrible virus.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ALANINE</title>
      <link>/drugpanel/alanine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/alanine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00160&#39; target=&#39;_blank&#39;&gt;db00160&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=alanine&#34; target=&#34;_blank&#34;&gt;alanine&lt;/a&gt; &lt;br&gt;
Synonymous :(2s)-2-aminopropanoic acid | (s)-2-aminopropanoic acid | (s)-alanine | alanina | alanine | alaninum | l-2-aminopropionic acid | l-alanin | l-alanine | l-alpha-alanine | l-α-alanine
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;alanine&lt;/em&gt; gene in 14 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32026671
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (Tbil), serum creatinine (Scr) and other items showed no significant changes.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32077660
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The results of laboratory examination showed that the alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin (ALB), and total bilirubin (TBil) for entire cohort were 26.98 (16.88 ~ 46.09) U/L and 24.75 (18.71 ~ 31.79) U/L, 39.00 (36.20 ~ 44.20) g/L and 16.40 (11.34- ~ 21.15) mmol/L, respectively.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32153170
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) level was initially increased (4.4 to 3.5 times of the normal value) along with decrease of albumin in the second week, and the difference was statistically significant (&lt;i&gt;P&lt;/i&gt; &amp;lt; 0.001).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32196707
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The laboratory results showed that compared to the normal values, the patients’ lymphocytes were reduced (four [80%] patients), and liver functions alanine aminotransferase and aspartate aminotransferase (two [40%] patients and two [40%] patients) and C-reactive protein (four [80%] patients) were increased when admitted to hospital.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32209890
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Alanine transaminase (ALT) (22.00 [15.00, 34.00] U/L vs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32216803
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Higher temperature, blood leukocyte count, neutrophil count, neutrophil percentage, C-reactive protein level, D-dimer level, alanine aminotransferase activity, aspartate aminotransferase activity, α - hydroxybutyrate dehydrogenase activity, lactate dehydrogenase activity and creatine kinase activity were related to severe 2019 novel coronavirus pneumonia and composite endpoint, and so were lower lymphocyte count, lymphocyte percentage and total protein level.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32217556
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Concentrations of alanine aminotransferase, aspartate aminotransferase, creatinine, creatine kinase, lactate dehydrogenase, cardiac troponin I, N-terminal pro-brain natriuretic peptide, and D-dimer were markedly higher in deceased patients than in recovered patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32217835
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Compared with moderate cases, severe cases more frequently had dyspnea, lymphopenia, and hypoalbuminemia, with higher levels of alanine aminotransferase, lactate dehydrogenase, C-reactive protein, ferritin, and D-dimer as well as markedly higher levels of IL-2R, IL-6, IL-10, and TNF-α.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32239591
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
31.6%, 35.4% and 5.1% COVID-19 patients had elevated levels of alanine transaminase (ALT), aspartate aminotransferase (AST) and bilirubin respectively.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32249918
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Compared to the controls, COVID-19 pneumonia patients had lower counts of white blood cells (WBC), neutrophils, C-reactive protein (CRP), and alanine aminotransferase (ALT) on admission.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32259132
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Patients with positive RT-PCR had significantly higher neutrophil (NEU) count (p = 0.0001), and C-reactive protein (CRP) (p = 0.04), lactate dehydrogenase (LDH) (p = 0.0001), aspartate aminotransferase (AST) (p = 0.001), alanine aminotransferase (ALT) (p = 0.0001), and Urea (p = 0.001) levels in serum.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32270660
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), γ-glutamyl transferase (GGT), total bilirubin (TBil), albumin(ALB) and international normalized ratio (INR) of 324 cases at baseline were 27.86 ± 20.02 U/L, 29.33 ± 21.02 U/L, 59.93 ± 18.96 U / L, 39.00 ± 54.44 U/L, 9.46 ± 4.58 μmol / L, 40.64 ± 4.13 g / L and 1.02 ± 0.10.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32271456
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Blood biochemical indexes exhibited that the proportion of patients with abnormal alanine aminotransferase and aspartate aminotransferase in the test group were lower than the control group.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283325
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Abnormal liver function was defined as increased levels of alanine and aspartate aminotransferase, gamma glutamyltransferase, alkaline phosphatase, and total bilirubin.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>AMILORIDE</title>
      <link>/drugpanel/amiloride/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/amiloride/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00594&#39; target=&#39;_blank&#39;&gt;db00594&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=amiloride&#34; target=&#34;_blank&#34;&gt;amiloride&lt;/a&gt; &lt;br&gt;
Synonymous :3,5-diamino-n-carbamimidoyl-6-chloropyrazine-2-carboxamide | amilorid | amilorida | amiloride | amiloridum | amipramidin | amipramidine | amyloride | n-amidino-3,5-diamino-6-chloropyrazinecarboxamide
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;amiloride&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32266994
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In addition, we would like to mention that amiloride, which increases the cytosolic pH, can be used in the COVID-19 treatment.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ANAKINRA</title>
      <link>/drugpanel/anakinra/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/anakinra/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00026&#39; target=&#39;_blank&#39;&gt;db00026&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=anakinra&#34; target=&#34;_blank&#34;&gt;anakinra&lt;/a&gt; &lt;br&gt;
Synonymous :anakinra | il-1ra | interleukin-1 receptor antagonist anakinra
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;anakinra&lt;/em&gt; gene in 5 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32267081
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To report the benefit of a therapeutic approach consisting of intravenous continuous anakinra (recombinant human interleukin-1 receptor antagonist) infusions in treating severely ill adult patients with secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome (sHLH/MAS). […] Continuous IV anakinra infusions up to 2400 mg/day resulted in rapid serologic, then clinical response in 4/5 severely ill patients who were refractory to all other therapies including subcutaneous anakinra. […] Subsequently, 3/5 have been maintained on anakinra or canakinumab with no recurrence of MAS. […] Continuous infusion of IV anakinra may result in rapid serologic and subsequent clinical improvement in adult patients with MAS.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ARTEMISININ</title>
      <link>/drugpanel/artemisinin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/artemisinin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db13132&#39; target=&#39;_blank&#39;&gt;db13132&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=artemisinin&#34; target=&#34;_blank&#34;&gt;artemisinin&lt;/a&gt; &lt;br&gt;
Synonymous :artemisinin | artemisinina
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;artemisinin&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281695
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We identified many cheap, available, and safe medicines, such as diphenidol, quinine, chloroquine, artemisinin, chlorpheniramine, yohimbine, and dextromethorphan, which may target the most common symptoms caused by 2019-nCoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ATAZANAVIR</title>
      <link>/drugpanel/atazanavir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/atazanavir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01072&#39; target=&#39;_blank&#39;&gt;db01072&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=atazanavir&#34; target=&#34;_blank&#34;&gt;atazanavir&lt;/a&gt; &lt;br&gt;
Synonymous :atazanavir | atazanavirum | atz
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;atazanavir&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32280433
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The result showed that atazanavir, an antiretroviral medication used to treat and prevent the human immunodeficiency virus (HIV), is the best chemical compound, showing an inhibitory potency with &lt;i&gt;K&lt;sub&gt;d&lt;/sub&gt;&lt;/i&gt; of 94.94 nM against the SARS-CoV-2 3C-like proteinase, followed by remdesivir (113.13 nM), efavirenz (199.17 nM), ritonavir (204.05 nM), and dolutegravir (336.91 nM).
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ATP</title>
      <link>/drugpanel/atp/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/atp/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00171&#39; target=&#39;_blank&#39;&gt;db00171&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=atp&#34; target=&#34;_blank&#34;&gt;atp&lt;/a&gt; &lt;br&gt;
Synonymous :adenosine 5’-triphosphate | adenosine triphosphate | adenosine-5’-triphosphate | atp
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;atp&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32094225
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The triphosphate form of the inhibitor (RDV-TP) competes with its natural counterpart ATP. […] Of note, the selectivity value for RDV-TP obtained here with a steady-state approach suggests that it is more efficiently incorporated than ATP and two other nucleotide analogs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32284326
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A unique property of RDV-TP is its high selectivity over incorporation of its natural nucleotide counterpart ATP.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>AZITHROMYCIN</title>
      <link>/drugpanel/azithromycin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/azithromycin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00207&#39; target=&#39;_blank&#39;&gt;db00207&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=azithromycin&#34; target=&#34;_blank&#34;&gt;azithromycin&lt;/a&gt; &lt;br&gt;
Synonymous :azithromycin | azithromycine | azithromycinum | azitromicina
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;azithromycin&lt;/em&gt; gene in 8 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32031570
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%]).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32205204
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Depending on their clinical presentation, azithromycin was added to the treatment. […] Azithromycin added to hydroxychloroquine was significantly more efficient for virus elimination. […] Despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in COVID-19 patients and its effect is reinforced by azithromycin.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32229706
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Similarly, two proposed therapeutics for the treatment of COVID-19 infection are Azithromycin and Quercetin, both drugs with significant senolytic activity. […] As Azithromycin and Doxycycline are both commonly used antibiotics that inhibit viral replication and IL-6 production, we may want to consider this general class of antibiotics that functionally inhibits cellular protein synthesis as a side-effect, for the treatment and prevention of COVID-19 disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32249257
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Very recently, hydroxychloroquine in combination with azithromycin treatment was reported to be effective for COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32276453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Two of these senotherapeutics, azithromycin and ruxolitinib, are currently undergoing testing for their efficacy in treating COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282982
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Hydroxychloroquine (HCQ) was used by 78.1% of respondents; azithromycin by 46.9%; tocilizumab by 31.3%, and remdesivir by 25.0%.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32285930
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The data sources included were 1) longitudinal clinical, pharmacokinetic, and virologic data from patients with severe acute respiratory syndrome-2 (SARS-CoV-2) infection who received HCQ with or without azithromycin (n=116), 2) in vitro viral replication data and SARS-CoV-2 viral load inhibition by HCQ, 3) a population pharmacokinetic model of HCQ and 4) a model relating chloroquine pharmacokinetics to QTc prolongation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32289548
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We conducted an uncontrolled non-comparative observational study in a cohort of 80 relatively mildly infected inpatients treated with a combination of hydroxychloroquine and azithromycin over a period of at least three days, with three main measurements: clinical outcome, contagiousness as assessed by PCR and culture, and length of stay in infectious disease unit (IDU).
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>BAL</title>
      <link>/drugpanel/bal/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/bal/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=bal&#34; target=&#34;_blank&#34;&gt;bal&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;bal&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32004165
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We collected clinical data and bronchoalveolar lavage (BAL) specimens from five patients with severe pneumonia from Jin Yin-tan Hospital of Wuhan, Hubei province, China. […] Nucleic acids of the BAL were extracted and subjected to next-generation sequencing.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>BARICITINIB</title>
      <link>/drugpanel/baricitinib/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/baricitinib/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db11817&#39; target=&#39;_blank&#39;&gt;db11817&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=baricitinib&#34; target=&#34;_blank&#34;&gt;baricitinib&lt;/a&gt; &lt;br&gt;
Synonymous :baricitinib
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;baricitinib&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253068
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Baricitinib has both antiviral and anti-inflammatory properties.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>BENZALKONIUM</title>
      <link>/drugpanel/benzalkonium/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/benzalkonium/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db11105&#39; target=&#39;_blank&#39;&gt;db11105&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=benzalkonium&#34; target=&#34;_blank&#34;&gt;benzalkonium&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;benzalkonium&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32035997
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Other biocidal agents such as 0.05-0.2% benzalkonium chloride or 0.02% chlorhexidine digluconate are less effective.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>BENZIMIDAZOLE</title>
      <link>/drugpanel/benzimidazole/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/benzimidazole/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db02962&#39; target=&#39;_blank&#39;&gt;db02962&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=benzimidazole&#34; target=&#34;_blank&#34;&gt;benzimidazole&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;benzimidazole&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32218301
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Previously we developed a large variety of benzimidazole derivatives able to inhibit these viruses. […] Compounds &lt;b&gt;6&lt;/b&gt;, &lt;b&gt;8&lt;/b&gt;, &lt;b&gt;16&lt;/b&gt; and &lt;b&gt;17&lt;/b&gt;, bearing the 5-(thio)semicarbazone and 5-hydrazone functionalities in combination with the 2-benzyl ring on the benzimidazole core structure, acted as dual inhibitors of influenza A virus and human coronavirus. […] For respiratory syncytial virus (RSV), activity is limited to the 5-thiosemicarbazone (&lt;b&gt;25&lt;/b&gt;) and 5-hydrazone (&lt;b&gt;22&lt;/b&gt;) compounds carrying the 2-[(benzotriazol-1/2-yl)methyl]benzimidazole scaffold. […] The herein-investigated benzimidazole-based derivatives may represent valuable hit compounds, deserving subsequent structural improvements towards more efficient antiviral agents for the treatment of pathologies caused by these human respiratory viruses.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>BEVACIZUMAB</title>
      <link>/drugpanel/bevacizumab/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/bevacizumab/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00112&#39; target=&#39;_blank&#39;&gt;db00112&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=bevacizumab&#34; target=&#34;_blank&#34;&gt;bevacizumab&lt;/a&gt; &lt;br&gt;
Synonymous :anti-vegf humanized monoclonal antibody | anti-vegf monoclonal antibody | bevacizumab | bevacizumab-awwb | rhumab-vegf
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;bevacizumab&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32256547
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We identified 24 clinical trials, involving more than 20 medicines, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, methylprednisolone, bevacizumab, and traditional Chinese medicines (TCM). […] Se identificaron 24 ensayos clínicos relacionados con más de 20 medicamentos, como inmunoglobulina humana, interferones, cloroquina, hidroxicloroquina, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, metilprednisolona, bevacizumab y medicina tradicional china.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>BICTEGRAVIR</title>
      <link>/drugpanel/bictegravir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/bictegravir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db11799&#39; target=&#39;_blank&#39;&gt;db11799&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=bictegravir&#34; target=&#34;_blank&#34;&gt;bictegravir&lt;/a&gt; &lt;br&gt;
Synonymous :bictegravir
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;bictegravir&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32266873
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
From the virtual screening results, two drug molecules were selected for each drug target protein [Paritaprevir (ΔG= -9.8 kcal/mol) &amp;amp;Raltegravir (ΔG= -7.8 kcal/mol) for 3CLpro and Dolutegravir (ΔG= -9.4 kcal/mol) and Bictegravir (ΔG= -8.4 kcal/mol) for 2’-OMTase]. […] After the extensive computational analysis, we proposed that Raltegravir, Paritaprevir, Bictegravir and Dolutegravir are excellent lead candidates for these crucial proteins and they could become potential therapeutic drugs against SARS-CoV-2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CAMPTOTHECIN</title>
      <link>/drugpanel/camptothecin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/camptothecin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db04690&#39; target=&#39;_blank&#39;&gt;db04690&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=camptothecin&#34; target=&#34;_blank&#34;&gt;camptothecin&lt;/a&gt; &lt;br&gt;
Synonymous :(+)-camptothecin | (+)-camptothecine | (s)-(+)-camptothecin | 20(s)-camptothecine | 21,22-secocamptothecin-21-oic acid lactone | camptothecine | d-camptothecin
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;camptothecin&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32291351
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The four drugs with the highest total score are didanosine, benzyl-quinazolin-4-yl-amine, camptothecin, and RO-90-7501.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CANAKINUMAB</title>
      <link>/drugpanel/canakinumab/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/canakinumab/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db06168&#39; target=&#39;_blank&#39;&gt;db06168&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=canakinumab&#34; target=&#34;_blank&#34;&gt;canakinumab&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;canakinumab&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32267081
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Subsequently, 3/5 have been maintained on anakinra or canakinumab with no recurrence of MAS.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CARBETOCIN</title>
      <link>/drugpanel/carbetocin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/carbetocin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01282&#39; target=&#39;_blank&#39;&gt;db01282&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=carbetocin&#34; target=&#34;_blank&#34;&gt;carbetocin&lt;/a&gt; &lt;br&gt;
Synonymous :1-butanoic acid-2-(o-methyl-l-tyrosine)-1-carbaoxytocin | 1-butyric acid-2-(3-(p-methoxyphenyl)-l-alanine)oxytocin | carbetocin | carbetocina | carbetocino | carbetocinum | deamino-2-o-methyltyrosine-1-carbaoxytocin
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;carbetocin&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32145714
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;ol start=&#34;3&#34; style=&#34;list-style-type: decimal&#34;&gt;
&lt;li&gt;In the treatment of uterine contraction fatigue, carbetocin or carboprost tromethamine was used more in cesarean section for pregnant women with COVID-19 (1.3±0.6), compared with Non-COVID-19 group (0.5±0.7), the difference was statistically significant (&lt;i&gt;P&lt;/i&gt;=0.001). &lt;b&gt;Conclusions:&lt;/b&gt; If there is an indication for obstetric surgery or critical illness of COVID-19 in pregnant women, timely termination of pregnancy will not increase the risk of premature birth and asphyxia of the newborn, but it is beneficial to the treatment and rehabilitation of maternal pneumonia.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CEFTRIAXONE</title>
      <link>/drugpanel/ceftriaxone/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/ceftriaxone/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01212&#39; target=&#39;_blank&#39;&gt;db01212&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=ceftriaxone&#34; target=&#34;_blank&#34;&gt;ceftriaxone&lt;/a&gt; &lt;br&gt;
Synonymous :ceftriaxona | ceftriaxone | ceftriaxonum | rocephin
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;ceftriaxone&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32031570
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%]).
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CHLORHEXIDINE</title>
      <link>/drugpanel/chlorhexidine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/chlorhexidine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00878&#39; target=&#39;_blank&#39;&gt;db00878&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=chlorhexidine&#34; target=&#34;_blank&#34;&gt;chlorhexidine&lt;/a&gt; &lt;br&gt;
Synonymous :1,1’-hexamethylene bis(5-(p-chlorophenyl)biguanide) | chlorhexidin | chlorhexidine | chlorhexidinum | cloresidina | clorhexidina | n,n’-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;chlorhexidine&lt;/em&gt; gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32035997
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Other biocidal agents such as 0.05-0.2% benzalkonium chloride or 0.02% chlorhexidine digluconate are less effective.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32217947
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;ol start=&#34;3&#34; style=&#34;list-style-type: decimal&#34;&gt;
&lt;li&gt;Decolonize patients using pre-procedural chlorhexidine wipes, 2 doses of nasal povidone iodine within one hour of incision, and chlorhexidine mouth rinse.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CHLORINE</title>
      <link>/drugpanel/chlorine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/chlorine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db11109&#39; target=&#39;_blank&#39;&gt;db11109&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=chlorine&#34; target=&#34;_blank&#34;&gt;chlorine&lt;/a&gt; &lt;br&gt;
Synonymous :chlor | chlore | cloro | dichlorine
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;chlorine&lt;/em&gt; gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32107909
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;b&gt;Objective:&lt;/b&gt; To explorethe proper protective measures for pancreaticdiseases treatment during theoutbreak of 2019 coronavirus disease(COVID-19). &lt;b&gt;Method:&lt;/b&gt; Clinical data of four cases of patients that suffered COVID-19from February 2(nd), 2020 to February 9(th), 2020 in pancreatic surgery were reviewed.After the first patientscuffednosocomial infection of COVID-19, the general protective measures in our department wereupdated.Only one patient was admitted to each room alone, with no more than one caregiver.The body temperature of care givers was measuredtwice a day.Primary protections were applied to all staff.The floor was sterilized using disinfectant with an effective chlorine concentration of 1000 mg/L.The protective measures for interventional procedures were as follow.Primary protection was applied to the operators ofcentral venipuncture catheter, percutaneous abdominal/pleural drainage, percutaneous retroperitoneal drainage, percutaneous transhepatic cholangial drainage and other surgical procedures with local anesthesiaand epidural anesthesia.Secondary protection was applied to the operators of endoscopic retrograde cholangiopancreatography and surgical procedures with general anesthesia. &lt;b&gt;Results:&lt;/b&gt; During Feb 2(nd), 2020 to Feb 9(th), 2020, four patients in our department were diagnosed with COVID-19, of which one was died of COVID-19, two were cured, and one is still in hospital for COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32232986
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The results showed that instant hand wiping using a wet towel soaked in water containing 1.00% soap powder, 0.05% active chlorine, or 0.25% active chlorine from sodium hypochlorite removed 98.36%, 96.62%, and 99.98% of the virus from hands, respectively.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CHLOROQUINE</title>
      <link>/drugpanel/chloroquine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/chloroquine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00608&#39; target=&#39;_blank&#39;&gt;db00608&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=chloroquine&#34; target=&#34;_blank&#34;&gt;chloroquine&lt;/a&gt; &lt;br&gt;
Synonymous :chloraquine | chlorochin | chloroquina | chloroquine | chloroquinium | chloroquinum | cloroquina | n4-(7-chloro-4-quinolinyl)-n1,n1-diethyl-1,4-pentanediamine
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;chloroquine&lt;/em&gt; gene in 37 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32074550
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Chloroquine phosphate, an old drug for treatment of malaria, is shown to have apparent efficacy and acceptable safety against COVID-19 associated pneumonia in multicenter clinical trials conducted in China.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32075365
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Previous studies have shown that chloroquine phosphate (chloroquine) had a wide range of antiviral effects, including anti-coronavirus. […] Here we found that treating the patients diagnosed as novel coronavirus pneumonia with chloroquine might improve the success rate of treatment, shorten hospital stay and improve patient outcome. […] In order to guide and regulate the use of chloroquine in patients with novel coronavirus pneumonia, the multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia developed this expert consensus after extensive discussion. […] It recommended chloroquine phosphate tablet, 500mg twice per day for 10 days for patients diagnosed as mild, moderate and severe cases of novel coronavirus pneumonia and without contraindications to chloroquine.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32092748
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This issue has rapidly reviewed and published articles describing COVID-19, including the drug treatment options for SARS-CoV-2, its clinical characteristics, and therapies involving a combination of Chinese and Western medicine, the efficacy of chloroquine phosphate in the treatment of COVID-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32147496
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). […] The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32147628
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32150618
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Chloroquine has been sporadically used in treating SARS-CoV-2 infection. […] Hydroxychloroquine shares the same mechanism of action as chloroquine, but its more tolerable safety profile makes it the preferred drug to treat malaria and autoimmune conditions. […] The pharmacological activity of chloroquine and hydroxychloroquine was tested using SARS-CoV-2 infected Vero cells. […] Hydroxychloroquine (EC50=0.72 μM) was found to be more potent than chloroquine (EC50=5.47 μM) in vitro. […] Based on PBPK models results, a loading dose of 400 mg twice daily of hydroxychloroquine sulfate given orally, followed by a maintenance dose of 200 mg given twice daily for 4 days is recommended for SARS-CoV-2 infection, as it reached three times the potency of chloroquine phosphate when given 500 mg twice daily 5 days in advance. […] Hydroxychloroquine was found to be more potent than chloroquine to inhibit SARS-CoV-2 in vitro.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32171740
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In the absence of a known efficient therapy and because of the situation of a public-health emergency, it made sense to investigate the possible effect of chloroquine/hydroxychloroquine against SARS-CoV-2 since this molecule was previously described as a potent inhibitor of most coronaviruses, including SARS-CoV-1. […] Preliminary trials of chloroquine repurposing in the treatment of COVID-19 in China have been encouraging, leading to several new trials. […] Here we discuss the possible mechanisms of chloroquine interference with the SARS-CoV-2 replication cycle.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32173110
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The aim of this systematic review was to summarize the evidence regarding chloroquine for the treatment of COVID-19. […] PubMed, EMBASE, and three trial Registries were searched for studies on the use of chloroquine in patients with COVID-19. […] Chloroquine seems to be effective in limiting the replication of SARS-CoV-2 (virus causing COVID-19) in vitro. […] There is rationale, pre-clinical evidence of effectiveness and evidence of safety from long-time clinical use for other indications to justify clinical research on chloroquine in patients with COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32173241
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, effective treatment is lacking; however, clinical trials investigating the efficacy of several agents, including remdesivir and chloroquine, are underway in China.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32179150
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Chloroquine, remdesivir, lopinavir, ribavirin and ritonavir have shown efficacy to inhibit coronavirus in vitro.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32196083
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Chloroquine (CQ) exhibits a promising inhibitory effect.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32205204
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2, and reported to be efficient in Chinese COV-19 patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32217113
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We discuss the latest options in antiviral therapy and vaccine development, including the novel use of chloroquine in the management of COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32219357
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
She was treated with dobutamine, antiviral drugs (lopinavir/ritonavir), steroids, chloroquine, and medical treatment for heart failure, with progressive clinical and instrumental stabilization.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32219882
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To help understand the advantages and limitations of differential treatments, we provide a timely review and discuss the complications and corresponding major treatments, especially controversial ones such as antiviral therapy (remdesivir, ribavirin, and chloroquine), glucocorticoid therapy, extracorporeal support including an artificial liver system, and extracorporeal membrane oxygenation based on available evidence.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32229706
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Also, Chloroquine-related compounds inhibit the induction of the well-known senescence marker, Beta-galactosidase.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32234468
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Treatments, including antiviral agents, chloroquine and hydroxychloroquine, corticosteroids, antibodies, convalescent plasma transfusion and vaccines, are discussed in this article.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32241801
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Two antimalarial agents, chloroquine (CQ) and hydroxychloroquine (HCQ), have been trusted treatments for a range of rheumatic diseases over the past seventy years [1].
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243270
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This review summarizes the current evidence of potential therapeutic agents, such as lopinavir/ritonavir, remdesivir, favipiravir, chloroquine, hydroxychloroquine, interferon, ribavirin, tocilizumab and sarilumab.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32246834
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In addition to the recommended antiviral drugs such as interferon-ɑ, lopinavir/ritonavir, ribavirin, and chloroquine phosphate, some clinical trials focusing on virus RNA dependent RNA polymerase (RdRp) inhibitors have been registered and initiated.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247050
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Potential treatments included remdesivir, chloroquine, tocilizumab, convalescent plasma and vaccine immunization (when possible).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In view of recent studies and discussion on chloroquine and hydroxychloroquine (HCQ), we aimed to review existing literature and relevant websites regarding these drugs and COVID-19, adverse effects related to drugs, and related guidelines. […] We systematically searched the PubMed database up till March 21, 2020 and retrieved all the articles published on chloroquine and HCQ and COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247213
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Search terms were, COVID-19, treatment of coronavirus, COVID 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ACE-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease. […] We discuss evidence regarding role of chloroquine and hydroxychloroquine in treatment and prophylaxis, use of inhibitors of the renin angiotensin system, safety of ibuprofen, unusual clinical features like gastrointestinal symptoms and interpretation of tests for cardiac enzymes and biomarkers.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251731
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Using a combination of structural and molecular modelling approaches, this study showed that chloroquine (CLQ), one of the drugs currently under investigation for SARS-CoV-2 treatment, binds sialic acids and gangliosides with high affinity.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32256547
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We identified 24 clinical trials, involving more than 20 medicines, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, methylprednisolone, bevacizumab, and traditional Chinese medicines (TCM).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32265182
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In light of this, there has been growing interest in the use of existing medications, such as chloroquine (CQ) and hydroxychloroquine (HCQ), as potential treatments of this disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32274787
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Cases of chloroquine-related toxicity have been reported elsewhere, but have not been observed in our hospital so far.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277367
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Preliminary evidence suggests potential benefit with chloroquine or hydroxychloroquine.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32278764
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Caution should be taken to potential hypoglycemic events with the use of chloroquine in these subjects.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281213
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Different drugs for prophylaxis against COVID-19 including chloroquine (CQ) or hydroxychloroquine (HCQ) have been tried.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281268
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In light of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) pandemic and the possible widespread use of chloroquine (a member of the drug class 4-aminoquinoline primarily used to prevent and treat malaria and amebiasis) and its derivatives (e.g. hydroxychloroquine, a metabolite of chloroquine),&lt;sup&gt;1&lt;/sup&gt; a safety issue is addressed, concerning the selection of patients suitable to receive it.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281481
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Due to factors such as history of prescription for other infectious diseases, availability, and relatively low cost, the use of chloroquine (CQ) and hydroxychloroquine (HCQ) has been tested &lt;i&gt;in vivo&lt;/i&gt; and &lt;i&gt;in vitro&lt;/i&gt; for the ability to inhibit the causative virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281583
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Chloroquine and hydroxychloroquine have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19). […] Increasing evidence obtained from completed clinical studies indicates the prospects for chloroquine/hydroxychloroquine to treat COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281695
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We identified many cheap, available, and safe medicines, such as diphenidol, quinine, chloroquine, artemisinin, chlorpheniramine, yohimbine, and dextromethorphan, which may target the most common symptoms caused by 2019-nCoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282502
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
No established treatment is currently available; however, several therapies, including remdesivir, hydroxychloroquine and chloroquine, and interleukin (IL)-6 inhibitors, are being used off-label and evaluated in ongoing clinical trials.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32285930
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The data sources included were 1) longitudinal clinical, pharmacokinetic, and virologic data from patients with severe acute respiratory syndrome-2 (SARS-CoV-2) infection who received HCQ with or without azithromycin (n=116), 2) in vitro viral replication data and SARS-CoV-2 viral load inhibition by HCQ, 3) a population pharmacokinetic model of HCQ and 4) a model relating chloroquine pharmacokinetics to QTc prolongation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293834
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The most frequently used agents both in Turkey and all over the world including chloroquine, hydroxychloroquine, lopinavir/ritonavir, favipiravir and remdesivir will be reviewed here .
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CHLORPHENIRAMINE</title>
      <link>/drugpanel/chlorpheniramine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/chlorpheniramine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01114&#39; target=&#39;_blank&#39;&gt;db01114&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=chlorpheniramine&#34; target=&#34;_blank&#34;&gt;chlorpheniramine&lt;/a&gt; &lt;br&gt;
Synonymous :1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane | 1-(p-chlorophenyl)-1-(2-pyridyl)-3-n,n-dimethylpropylamine | 2-[p-chloro-α-[2-(dimethylamino)ethyl]benzyl]pyridine | 3-(p-chlorophenyl)-3-(2-pyridyl)-n,n-dimethylpropylamine | chlorophenylpyridamine | chlorphenamin | chlorphenamine | chlorphenaminum | chlorpheniramine | chlorpheniramine polistirex | chlorpheniraminum | clorfenamina | clorfeniramina | γ-(4-chlorophenyl)-n,n-dimethyl-2-pyridinepropanamine | γ-(4-chlorophenyl)-γ-(2-pyridyl)propyldimethylamine
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;chlorpheniramine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281695
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We identified many cheap, available, and safe medicines, such as diphenidol, quinine, chloroquine, artemisinin, chlorpheniramine, yohimbine, and dextromethorphan, which may target the most common symptoms caused by 2019-nCoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CHOLECALCIFEROL</title>
      <link>/drugpanel/cholecalciferol/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/cholecalciferol/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00169&#39; target=&#39;_blank&#39;&gt;db00169&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=cholecalciferol&#34; target=&#34;_blank&#34;&gt;cholecalciferol&lt;/a&gt; &lt;br&gt;
Synonymous :(+)-vitamin d3 | (3β,5z,7e)-9,10-secocholesta-5,7,10(19)-trien-3-ol | (5z,7e)-(3s)-9,10-secocholesta-5,7,10(19)-trien-3-ol | activated 7-dehydrocholesterol | calciol | cc | cholecalciferol | cholecalciferolum | colecalciferol | colecalciferolum | oleovitamin d3 | vitamin d-3 | vitamin d3
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;cholecalciferol&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32280058
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In the presence of 25-hydroxyvitamin D deficit, cholecalciferol is promptly supplied.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CHOLESTEROL</title>
      <link>/drugpanel/cholesterol/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/cholesterol/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db04540&#39; target=&#39;_blank&#39;&gt;db04540&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=cholesterol&#34; target=&#34;_blank&#34;&gt;cholesterol&lt;/a&gt; &lt;br&gt;
Synonymous :(3β,14β,17α)-cholest-5-en-3-ol | cholest-5-en-3beta-ol | cholesterin
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;cholesterol&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32191676
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We focus on the role of lipid structures, such as lipid rafts and cholesterol, involved in the process, mediated by endocytosis, by which viruses attach to and infect cells.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CLOZAPINE</title>
      <link>/drugpanel/clozapine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/clozapine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00363&#39; target=&#39;_blank&#39;&gt;db00363&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=clozapine&#34; target=&#34;_blank&#34;&gt;clozapine&lt;/a&gt; &lt;br&gt;
Synonymous :clozapin | clozapina | clozapine | clozapinum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;clozapine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32289791
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Using Richardson and Davidson’s model and the sciences of pharmacokinetics and clinical pharmacopsychology, this article reviewed the: (1) poor life expectancy associated with treatment-resistant schizophrenia (TRS), which may be improved in patients who adhere to clozapine; (2) findings that clozapine is the best treatment for TRS (according to efficacy, effectiveness and well-being); and (3) potential for clozapine to cause vulnerabilities, including potentially lethal adverse drug reactions such as agranulocytosis, pneumonia, and myocarditis. […] Rational use requires: (1) modification of the clozapine package insert worldwide to include lower doses for Asians and to avoid the lethality associated with pneumonia, (2) the use of clozapine levels for personalizing dosing, and (3) the use of slow and personalized titration. […] This may make clozapine as safe as possible and contribute to increased life expectancy and well-being. […] In the absence of data on COVID-19 in clozapine patients, clozapine possibly impairs immunological mechanisms and may increase pneumonia risk in infected patients. […] Psychiatrists should call their clozapine patients and families and explain to them that if the patient develops fever or flu-like symptoms, the psychiatrist should be called and should consider halving the clozapine dose. […] If the patient is hospitalized with pneumonia, the treating physician needs to assess for symptoms of clozapine intoxication since halving the dose may not be enough for all patients; consider decreasing it to one-third or even stopping it. […] Once the signs of inflammation and fever have disappeared, the clozapine dose can be slowly increased to the prior dosage level.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>COBICISTAT</title>
      <link>/drugpanel/cobicistat/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/cobicistat/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db09065&#39; target=&#39;_blank&#39;&gt;db09065&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=cobicistat&#34; target=&#34;_blank&#34;&gt;cobicistat&lt;/a&gt; &lt;br&gt;
Synonymous :1,3-thiazol-5-ylmethyl [(2r,5r)-5-{[(2s)-2-({&lt;a href=&#34;methyl&#34;&gt;(2-isopropyl-1,3-thiazol-4-yl)methyl&lt;/a&gt;carbamoyl}amino)-4-(morpholin-4-yl)butanoyl]amino}-1,6-diphenylhexan-2-yl]carbamate | cobicistat
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;cobicistat&lt;/em&gt; gene in 4 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277836
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Both patients were treated with darunavir/cobicistat and hydroxychloroquine.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32279418
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Hydroxychloroquine and lopinavir/ritonavir were started, and the antiviral drug was replaced with darunavir/cobicistat after two days for diarrhea.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292805
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In the absence of authorised pharmacological treatments, many antiretrovirals, including darunavir/cobicistat fixed combination, were used off-label in the hospital wards as life-treating medicines for COVID-19 patients. […] The data in this article indicate that darunavir/cobicistat suspensions compounded by pharmacists using as active ingredient a commercially available tablet can be stable at least for one week.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>COLCHICINE</title>
      <link>/drugpanel/colchicine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/colchicine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01394&#39; target=&#39;_blank&#39;&gt;db01394&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=colchicine&#34; target=&#34;_blank&#34;&gt;colchicine&lt;/a&gt; &lt;br&gt;
Synonymous :colchicin | colchicina | colchicine | colchicinum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;colchicine&lt;/em&gt; gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251729
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Colchicine has been utilized safely in a variety of cardiovascular clinical conditions. […] GRECCO-19 trial aims to identify whether colchicine may positively intervene in the clinical course of COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CREATINE</title>
      <link>/drugpanel/creatine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/creatine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00148&#39; target=&#39;_blank&#39;&gt;db00148&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=creatine&#34; target=&#34;_blank&#34;&gt;creatine&lt;/a&gt; &lt;br&gt;
Synonymous :((amino(imino)methyl)(methyl)amino)acetic acid | (alpha-methylguanido)acetic acid | (n-methylcarbamimidamido)acetic acid | (α-methylguanido)acetic acid | alpha-methylguanidino acetic acid | creatin | creatine | kreatin | methylglycocyamine | n-(aminoiminomethyl)-n-methylglycine | n-amidinosarcosine | n-carbamimidoyl-n-methylglycine | n-methyl-n-guanylglycine
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;creatine&lt;/em&gt; gene in 8 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32205284
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Higher rate of fever, cough, expectoration, and headache, lower lymphocytes, albumin, serum sodium levels and higher total bilirubin, creatine kinase, lactate dehydrogenase and C-reactive protein levels and lower oxygenation index were observed in pneumonia patients (all P &amp;lt; 0.05).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32216803
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Higher temperature, blood leukocyte count, neutrophil count, neutrophil percentage, C-reactive protein level, D-dimer level, alanine aminotransferase activity, aspartate aminotransferase activity, α - hydroxybutyrate dehydrogenase activity, lactate dehydrogenase activity and creatine kinase activity were related to severe 2019 novel coronavirus pneumonia and composite endpoint, and so were lower lymphocyte count, lymphocyte percentage and total protein level.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32217556
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Concentrations of alanine aminotransferase, aspartate aminotransferase, creatinine, creatine kinase, lactate dehydrogenase, cardiac troponin I, N-terminal pro-brain natriuretic peptide, and D-dimer were markedly higher in deceased patients than in recovered patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32220650
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Typical abnormal laboratory findings were elevated creatine kinase MB (11 [31%]), decreased lymphocytes (11 [31%]), leucopenia (seven [19%]), and elevated procalcitonin (six [17%]). […] Besides radiographic presentations, variables that were associated significantly with severity of COVID-19 were decreased lymphocytes, elevated body temperature, and high levels of procalcitonin, D-dimer, and creatine kinase MB.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32227274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
COVID-19 mRNA clearance ratio was identified significantly correlated with the decline of serum creatine kinase (CK) and lactate dehydrogenase (LDH) levels.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32232979
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this study, we detected and analyzed the main laboratory indicators related to heart injury, creatine kinase isoenzyme-MB (CK-MB), myohemoglobin (MYO), cardiac troponin I (ultra-TnI), and N-terminal pro-brain natriuretic peptide (NT-proBNP), in 273 patients with COVID-19 and investigated the correlation between heart injury and severity of the disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32249943
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A higher number of children had elevated creatine kinase isoenzyme (57.1% vs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32271459
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Compared with the non-severe group, the severe group showed statistical significance in older age, hypertension, bilateral lung plaque shadow, decrease in lymphocyte count, increase in C-reactive protein (CRP), aspartate aminotransferase (AST), lactate dehydrogenase, and creatine kinase. […] Age, combined hypertension, oxygenation index, double lung patch, decreased lymphocyte count, and elevated levels of C-reactive protein, aspartate aminotransferase, lactate dehydrogenase, and creatine kinase can be used as predictors of the disease severity.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CREATININE</title>
      <link>/drugpanel/creatinine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/creatinine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db11846&#39; target=&#39;_blank&#39;&gt;db11846&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=creatinine&#34; target=&#34;_blank&#34;&gt;creatinine&lt;/a&gt; &lt;br&gt;
Synonymous :creatinina
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;creatinine&lt;/em&gt; gene in 13 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32026671
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (Tbil), serum creatinine (Scr) and other items showed no significant changes.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32141280
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Both univariate and multivariate logistic regression were used to analyze the correlation of past medical history including hypertension, diabetes and coronary heart disease (CHD) , as well as the levels of serum NT-proBNP and cTnI to the disease severity of COVID-19 patients. &lt;b&gt;Results:&lt;/b&gt; Age, hypersensitive C-reactive protein(hs-CRP) and serum creatinine levels of the patients were higher in critical care cases than in mild cases(all &lt;i&gt;P&lt;/i&gt;&amp;lt;0.05). […] Univariate logistic regression analysis showed that age, male, elevated NT-proBNP, elevated cTnI, elevated hs-CRP, elevated serum creatinine, hypertension, and CHD were significantly correlated with critical disease status(all &lt;i&gt;P&lt;/i&gt;&amp;lt;0.05).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32205284
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Muscle ache, shortness of breath, nausea and vomiting, lower lymphocytes levels and higher serum creatinine and radiograph score at admission were predictive factors for severe/critical subtype.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32209890
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
22.00 [17.65, 31.75] U/L, Z = 7.308, P &amp;lt; 0.001), and creatinine levels (89.00 [72.00, 133.50] μmol/L vs.65.00 [54.60, 78.75] μmol/L, Z = 6.478, P &amp;lt; 0.001) were significantly higher in the death group that those in the recovered group.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32211816
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A total of 82 patients (19.7%) had cardiac injury, and compared with patients without cardiac injury, these patients were older (median [range] age, 74 [34-95] vs 60 [21-90] years; P &amp;lt; .001); had more comorbidities (eg, hypertension in 49 of 82 [59.8%] vs 78 of 334 [23.4%]; P &amp;lt; .001); had higher leukocyte counts (median [interquartile range (IQR)], 9400 [6900-13 800] vs 5500 [4200-7400] cells/μL) and levels of C-reactive protein (median [IQR], 10.2 [6.4-17.0] vs 3.7 [1.0-7.3] mg/dL), procalcitonin (median [IQR], 0.27 [0.10-1.22] vs 0.06 [0.03-0.10] ng/mL), creatinine kinase-myocardial band (median [IQR], 3.2 [1.8-6.2] vs 0.9 [0.6-1.3] ng/mL), myohemoglobin (median [IQR], 128 [68-305] vs 39 [27-65] μg/L), high-sensitivity troponin I (median [IQR], 0.19 [0.08-1.12] vs &amp;lt;0.006 [&amp;lt;0.006-0.009] μg/L), N-terminal pro-B-type natriuretic peptide (median [IQR], 1689 [698-3327] vs 139 [51-335] pg/mL), aspartate aminotransferase (median [IQR], 40 [27-60] vs 29 [21-40] U/L), and creatinine (median [IQR], 1.15 [0.72-1.92] vs 0.64 [0.54-0.78] mg/dL); and had a higher proportion of multiple mottling and ground-glass opacity in radiographic findings (53 of 82 patients [64.6%] vs 15 of 334 patients [4.5%]).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32216803
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Age below 40 or above 60 years old, male, higher Creatinine level, and lower platelet count also seemed related to severe 2019 novel coronavirus pneumonia and composite endpoint, however the P values were greater than 0.05, which mean under the same condition studies of larger samples are needed in the future.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32217556
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Concentrations of alanine aminotransferase, aspartate aminotransferase, creatinine, creatine kinase, lactate dehydrogenase, cardiac troponin I, N-terminal pro-brain natriuretic peptide, and D-dimer were markedly higher in deceased patients than in recovered patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32229732
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Twelve (10.8%) patients showed mild increase of blood urea nitrogen or creatinine (&amp;lt;26 μmol/L within 48 h), and 8 (7.2%) patients showed trace or 1+ albuminuria in 111 COVID-19-confirmed patients without chronic kidney disease (CKD).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32237148
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
There were 38.5% of control patients had higher procalcitonin (PCT) levels than 0.5ng/ml, which was significantly higher than that percentage of COVID-19 patients (X&lt;sup&gt;2&lt;/sup&gt; =22.636, P &amp;lt;0.05), and COVID-19 patients were also more likely to have decreased or normal urea and creatinine levels than control patients (X&lt;sup&gt;2&lt;/sup&gt; =24.930, 8.480, P &amp;lt;0.05). […] Younger age, exposure to Wuhan, fever, cough, and slight changes in routine blood work-up parameters, urea and creatinine were important features discriminating COVID-19 from control patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The prevalence of elevated serum creatinine, elevated blood urea nitrogen and estimated glomerular filtration under 60 ml/min/1.73m&lt;sup&gt;2&lt;/sup&gt; were 14.4, 13.1 and 13.1%, respectively. […] Cox proportional hazard regression confirmed that elevated baseline serum creatinine (hazard ratio: 2.10, 95% confidence interval: 1.36-3.26), elevated baseline blood urea nitrogen (3.97, 2.57-6.14), AKI stage 1 (1.90, 0.76-4.76), stage 2 (3.51, 1.49-8.26), stage 3 (4.38, 2.31-8.31), proteinuria 1+ (1.80, 0.81-4.00), 2+∼3+ (4.84, 2.00-11.70), and hematuria 1+ (2.99, 1.39-6.42), 2+∼3+ (5.56,2.58- 12.01) were independent risk factors for in-hospital death after adjusting for age, sex, disease severity, comorbidity and leukocyte count.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32249089
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The most common symptoms on admission to hospital were fever (five patients, 100%), cough (five patients, 100%), myalgia or fatigue (three patients, 60%), and sputum production (three patients, 60%); serum creatinine or urea nitrogen levels were slightly higher than those before symptom onset.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275643
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The parameters including homocysteine, urea, creatinine and serum cystatin C were significantly higher in imaging progression patients (all p &amp;lt; 0.05), while eGFR decreased (p &amp;lt; 0.001).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283217
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The laboratory investigations showed leukopenia and lymphopenia as well as increased creatinine and CRP levels.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CYCLOPHOSPHAMIDE</title>
      <link>/drugpanel/cyclophosphamide/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/cyclophosphamide/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00531&#39; target=&#39;_blank&#39;&gt;db00531&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=cyclophosphamide&#34; target=&#34;_blank&#34;&gt;cyclophosphamide&lt;/a&gt; &lt;br&gt;
Synonymous :(+-)-cyclophosphamide | (rs)-cyclophosphamide | 2-[bis(2-chloroethylamino)]-tetrahydro-2h-1,3,2-oxazaphosphorine-2-oxide | anhydrous cyclophosphamide | bis(2-chloroethyl)phosphoramide cyclic propanolamide ester | ciclofosfamida | ciclofosfamide | cyclophosphamid | cyclophosphamide | cyclophosphamide anhydrous | cyclophosphamidum | cytophosphane | n,n-bis(2-chloroethyl)tetrahydro-2h-1,3,2-oxazaphosphorin-2-amine 2-oxide
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;cyclophosphamide&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283185
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Post-transplant cyclophosphamide (ptCY), is an increasingly used approach for graft-versus-host disease (GVHD) prophylaxis but the impact of graft cryopreservation on the outcomes of allo-HCT using ptCY is not known.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CYSTEINE</title>
      <link>/drugpanel/cysteine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/cysteine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00151&#39; target=&#39;_blank&#39;&gt;db00151&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=cysteine&#34; target=&#34;_blank&#34;&gt;cysteine&lt;/a&gt; &lt;br&gt;
Synonymous :(2r)-2-amino-3-mercaptopropanoic acid | (2r)-2-amino-3-sulfanylpropanoic acid | (r)-2-amino-3-mercaptopropanoic acid | cisteina | cisteinum | cys | cysteine | cysteinum | free cysteine | l-2-amino-3-mercaptopropionic acid | l-cys | l-cystein | l-zystein
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;cysteine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32266873
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3CLpro is a cysteine protease responsible for the proteolysis of replicase polyproteins resulting in the formation of various functional proteins, whereas 2’-O-MTase methylates the ribose 2’-O position of the first and second nucleotide of viral mRNA, which sequesters it from the host immune system.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>DACTINOMYCIN</title>
      <link>/drugpanel/dactinomycin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/dactinomycin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00970&#39; target=&#39;_blank&#39;&gt;db00970&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=dactinomycin&#34; target=&#34;_blank&#34;&gt;dactinomycin&lt;/a&gt; &lt;br&gt;
Synonymous :2-amino-n,n’-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1h-pyrrolo(2,1-i)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3h-phenoxazine-1,9-dicarboxamide | actd | actinomycin c1 | actinomycin d | actinomycin iv | dactinomicina | dactinomycin | dactinomycine | dactinomycinum | meractinomycin
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;dactinomycin&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32194980
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We further identify three potential drug combinations (e.g., sirolimus plus dactinomycin, mercaptopurine plus melatonin, and toremifene plus emodin) captured by the “&lt;i&gt;Complementary Exposure&lt;/i&gt;” pattern: the targets of the drugs both hit the HCoV-host subnetwork, but target separate neighborhoods in the human interactome network.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>DARUNAVIR</title>
      <link>/drugpanel/darunavir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/darunavir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01264&#39; target=&#39;_blank&#39;&gt;db01264&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=darunavir&#34; target=&#34;_blank&#34;&gt;darunavir&lt;/a&gt; &lt;br&gt;
Synonymous :(3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl n-((1s,2r)-1-benzyl-2-hydroxy-3-(n1-isobutylsulfanilamido)propyl)carbamate | (3r,3as,6ar)-tetrahydro-2h-furo[2,3-b]furan-3-yl (2s,3r)-4-(4-amino-n-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate | (3r,3as,6ar)-tetrahydro-2h-furo[2,3-b]furan-3-yl (2s,3r)-4-(4-amino-n-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate | [(s)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((r)-phenylmethyl)-propyl]-carbamic acid (3r,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester | {(1s,2r)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3r,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester | darunavir | darunavirum | n-((1s,2r)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1s,2r,5r)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;darunavir&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32238094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
As a result three FDA approved drugs (Remdesivir, Saquinavir and Darunavir) and two natural compounds (. flavone and coumarine derivatives) were identified as promising hits.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277836
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Both patients were treated with darunavir/cobicistat and hydroxychloroquine.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32279418
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Hydroxychloroquine and lopinavir/ritonavir were started, and the antiviral drug was replaced with darunavir/cobicistat after two days for diarrhea.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32280433
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Interestingly, lopinavir, ritonavir, and darunavir are all designed to target viral proteinases.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292805
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In the absence of authorised pharmacological treatments, many antiretrovirals, including darunavir/cobicistat fixed combination, were used off-label in the hospital wards as life-treating medicines for COVID-19 patients. […] The data in this article indicate that darunavir/cobicistat suspensions compounded by pharmacists using as active ingredient a commercially available tablet can be stable at least for one week.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>DATE</title>
      <link>/drugpanel/date/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/date/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db10632&#39; target=&#39;_blank&#39;&gt;db10632&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=date&#34; target=&#34;_blank&#34;&gt;date&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;date&lt;/em&gt; gene in 96 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
31986261
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
No data on person-to-person or nosocomial transmission have been published to date.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
31997390
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To investigate the genetic diversity, time origin, and evolutionary history of the 2019-nCoV outbreak in China and Thailand, a total of 12 genome sequences of the virus with known sampling date (24 December 2019 and 13 January 2020) and geographic location (primarily Wuhan city, Hubei Province, China, but also Bangkok, Thailand) were analyzed.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32023775
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We reviewed the currently available literature to provide up-to-date guidance on control measures to be implemented by public health authorities.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32031570
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Retrospective, single-center case series of the 138 consecutive hospitalized patients with confirmed NCIP at Zhongnan Hospital of Wuhan University in Wuhan, China, from January 1 to January 28, 2020; final date of follow-up was February 3, 2020.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32037389
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The remaining patient with severe pneumonia had shown signs of improvement by the cutoff date for data collection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32056249
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Based on the advice of the International Health Regulations Emergency Committee and the fact that to date 24 other countries also reported cases, the WHO Director-General declared that the outbreak of 2019-nCoV constitutes a Public Health Emergency of International Concern on 30 January 2020.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32079150
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Using publicly available event-date data from the ongoing epidemic, the present study investigated the incubation period and other time intervals that govern the epidemiological dynamics of COVID-19 infections.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32083985
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, CT findings have been recommended as major evidence for clinical diagnosis of COVID-19 in Hubei, China.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32087334
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, there are no clinically approved vaccines or antiviral drugs available for these human coronavirus infections.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32105680
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Clinicians should continue to follow the Centers for Disease Control and Prevention website to stay up to date with the latest information (&lt;a href=&#34;https://www.cdc.gov/coronavirus/2019-nCoV/hcp/index.html&#34; class=&#34;uri&#34;&gt;https://www.cdc.gov/coronavirus/2019-nCoV/hcp/index.html&lt;/a&gt;).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32125362
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Descriptive case series of the first 18 patients diagnosed with polymerase chain reaction (PCR)-confirmed SARS-CoV-2 infection at 4 hospitals in Singapore from January 23 to February 3, 2020; final follow-up date was February 25, 2020.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32141588
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, the outbreak has spread to most provinces in China and 25 other countries within a relatively short period.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32143502
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Although the fatality rate of SARS-CoV-2 is currently lower than SARS-CoV, the virus seems to be highly contagious based on the number of infected cases to date.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32145719
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, the controlling of outbreak of corona virus disease 2019 (COVID-19) has entered into a critical period in China.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32155789
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Specific up-to-date and accurate health information (e.g., treatment, local outbreak situation) and particular precautionary measures (e.g., hand hygiene, wearing a mask) were associated with a lower psychological impact of the outbreak and lower levels of stress, anxiety, and depression (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05). &lt;i&gt;Conclusions:&lt;/i&gt; During the initial phase of the COVID-19 outbreak in China, more than half of the respondents rated the psychological impact as moderate-to-severe, and about one-third reported moderate-to-severe anxiety.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32166607
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
There have been around 96,000 reported cases of coronavirus disease 2019 (COVID-2019) and 3300 reported deaths to date (05/03/2020).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32167524
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The final date of follow-up was February 13, 2020.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32171059
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The four datasets we fitted to were: daily number of new internationally exported cases (or lack thereof), by date of onset, as of Jan 26, 2020; daily number of new cases in Wuhan with no market exposure, by date of onset, between Dec 1, 2019, and Jan 1, 2020; daily number of new cases in China, by date of onset, between Dec 29, 2019, and Jan 23, 2020; and proportion of infected passengers on evacuation flights between Jan 29, 2020, and Feb 4, 2020. […] We used an additional two datasets for comparison with model outputs: daily number of new exported cases from Wuhan (or lack thereof) in countries with high connectivity to Wuhan (ie, top 20 most at-risk countries), by date of confirmation, as of Feb 10, 2020; and data on new confirmed cases reported in Wuhan between Jan 16, 2020, and Feb 11, 2020.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32171869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Final date of follow-up was February 25, 2020.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32171872
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The primary endpoint was a negative conversion rate of coronavirus from the date of COVID-19 diagnosis(day7, day14), and assessed whether the pneumonia was progressing or improving by chest CT (day7).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32173241
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, effective treatment is lacking; however, clinical trials investigating the efficacy of several agents, including remdesivir and chloroquine, are underway in China.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32175421
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Several studies have been done to estimate the basic reproduction number in the early phase of this outbreak, yet there are no reliable estimates of case fatality rate (CFR) for COVID-19 to date.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32176772
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
All patients were confirmed to be infected with SARS-CoV-2 and the final date of follow-up was February 4, 2020.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32178768
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Contacts were people with exposure to a patient with COVID-19 on or after the patient’s symptom onset date.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32179124
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
No systematic reviews on COVID-19 have been published to date.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32180292
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
From reports of 32 women to date affected by COVID-19 in pregnancy, delivering 30 babies (one set of twins, three ongoing pregnancies), seven (22%) were asymptomatic and two (6%) were admitted to the intensive care unit (ICU), one of whom remained on extracorporeal membrane oxygenation. […] No maternal deaths have been reported to date. […] Compared with SARS and MERS, COVID-19 appears less lethal, acknowledging the limited number of cases reported to date and that one woman remains in a critical condition.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32183901
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, no specific antiviral treatment has proven effective; hence, infected people primarily rely on symptomatic treatment and supportive care.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32186952
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
However, to date, no licensed antiviral treatment or vaccine exists for MERS and SARS.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32196406
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
While these common sense points will always be helpful, it is important that you keep up to date with the advice being given by the &lt;b&gt;Centers for Disease Control and Prevention (CDC)&lt;/b&gt; and &lt;b&gt;NHS England&lt;/b&gt; and how it might affect you personally. […] These suggestions have been produced using the most up-to-date advice available to us from our Scientific and Medical Advisors and are not intended to replace or supersede advice you may have been given from your health care professional.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32196426
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Expected final online publication date for the &lt;i&gt;Annual Review of Virology&lt;/i&gt;, Volume 7 is September 29, 2020.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32205090
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Evidencing eTCB effectiveness is Taiwan’s success to date in containing and controlling the community-hospital-community transmission cycle.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32210236
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
All data are geo-coded and, where available, include symptoms, key dates (date of onset, admission, and confirmation), and travel history.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32211816
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This cohort study was conducted from January 20, 2020, to February 10, 2020, in a single center at Renmin Hospital of Wuhan University, Wuhan, China; the final date of follow-up was February 15, 2020.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32212779
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, there is no scientific guideline regarding management of cancer patients in a background of coronavirus outbreak.&amp;lt;br /&amp;gt;.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32213786
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
As the situation with COVID-19 rapidly unfolds, it is critical that obstetricians keep up to date.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32216717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The severity of CXR findings peaked at 10-12 days from the date of symptom onset.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32217113
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, the outcomes of 55 pregnant women infected with COVID-19 and 46 neonates have been reported in the literature, with no definite evidence of vertical transmission.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32219428
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The study was conducted at the infectious disease department, Shenzhen Third People’s Hospital in Shenzhen, China, from January 20, 2020, to March 25, 2020; final date of follow-up was March 25, 2020.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32220284
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The final date of follow-up was Feb 12, 2020.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32224151
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, the clinical characteristics of COVID-19-infected cancer patients are largely unknown.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32225133
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Assuming an arithmetical growth in the second variation of the data, we present a cubic adjustment model in which we estimate over 100 000 cases at 120 days consistent with the data recorded to date.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32232520
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Since our hospital received the first patient with COVID-19 in Singapore, our centre has managed 16 COVID-19 cases to date.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32232652
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
By the end of follow-up date (Mar. 3, 2020), there were 16 non-severe cases (64%) and 9 severe cases (36%), 5 cases were dead (20%).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32233034
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, multiple position statements and guidelines have been issued by various professional organizations to recommend practices in endoscopic procedures.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32234451
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Although related to the Severe Acute Respiratory Syndrome (SARS) and the Middle East Respiratory Syndrome (MERS), COVID-19 shows some peculiar pathogenetic, epidemiological and clinical features which have not been completely understood to date.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32234466
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Coronavirus disease 2019 (COVID-19) originated in the city of Wuhan, Hubei Province, Central China, and has spread quickly to 72 countries to date.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32234728
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Every month, DTB scans sources of information on treatments, disease management and other healthcare topics for key items to bring to our readers’ attention and help them keep up to date.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32235085
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
It spread rapidly and to date has killed 3,242 persons with more than 81,000 cases of infection in China and causing over 126,000 global cases and 5,414 deaths in 166 other countries around the world, especially Italy.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32240128
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among 23 (30%) residents with positive test results, 10 (43%) had symptoms on the date of testing, and 13 (57%) were asymptomatic.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32241244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, computed tomography (CT) findings have been recommended as major evidence for the clinical diagnosis of COVID-19 in Hubei, China.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32241328
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Following this date, attention quickly increased and has remained high over time.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32245904
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, no effective treatment has been identified and management for critically ill patients relies on management in intensive care units.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247050
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Based on recently published literatures, official documents and selected up-to-date preprint studies, we reviewed the virology and origin, epidemiology, clinical manifestations, pathology and treatment of 2019-nCoV infection, in comparison with severe acute respiratory syndrome coronavirus (SARS-CoV) and middle east respiratory syndrome coronavirus (MERS-CoV) infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247326
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We used the date of the fourth revision of the case definition (Jan 27) to divide the epidemic into two time periods (Dec 24 to Jan 27, and Jan 28 to Feb 17) as the date of symptom onset.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32250385
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Date of final follow-up was March 25, 2020.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32250958
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The aim of this paper is to describe the utilization of a dedicated mobile health (mHealth) platform to disseminate up-to-date and validated information about SARS-CoV-2 to all medical staff of the Children’s Hospital at the University Hospitals of Geneva.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251794
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, no specific treatment has been proven to be effective for SARS-CoV-2 infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251848
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This article delineates some of those challenges and the responses to them which are known, to date.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32252141
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The purpose of this review is to summarize known-to-date information about SARS-CoV-2, transmission of SARS-CoV-2, and clinical features.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32254064
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, there are no proven options for prophylaxis for those who have been exposed to SARS-CoV-2, nor therapy for those who develop COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32255382
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Demographic, clinical, laboratory, and treatment data were collected and analyzed, and final date of follow-up was February 24, 2020.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32258351
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
It is imperative for public health practitioners and the One Health community to stay up to date on the most promising potential therapeutic options that are under investigation. […] Thus, the purpose of this review is to synthesize the knowledge to date about remdesivir as a therapeutic option for coronaviruses, with a special focus on information relevant to the One Health community.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32259155
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The aim of this paper is to review all the up to date evidence, including experiences from China and Italy, to guide the safe management of such patients when undergoing gynaecological procedures.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32259279
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Unpublished reports, unspecified date and location of the study or suspicion of duplicate reporting, cases with suspected COVID-19 that were not confirmed by a laboratory test, and unreported maternal or perinatal outcomes were excluded.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32264957
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, we have found it is one of the greatest challenges to human beings in fighting against COVID-19 in the history, because SARS-CoV-2 is different from SARS-CoV and MERS-CoV in terms of biological features and transmissibility, and also found the containment strategies including the non-pharmaceutical public health measures implemented in China are effective and successful.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32265182
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, there are no medical treatments for COVID-19 with proven effectiveness.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32267098
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this review article, we summarized the published literatures to date concerning four different aspects: (a) gastrointestinal manifestations of COVID-19 infection; (b) microbiologic and virological investigations; (c) the role of fecal-oral transmission; and (d) prevention/control infection in the digestive endoscopy room.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32269177
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, only three centers have performed a catheterization on a confirmed COVID-19 positive patient.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32270371
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, there is no specific therapy for COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32270521
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This research statistically analyzed the effect of sex, region, infection reasons, birth year, and released or diseased date on the reported numbers of recovered and deceased cases.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32271458
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The proposed classifier used different seven variables, namely, country, infection reason, sex, group, confirmation date, birth year, and region.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32271722
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In the four clusters for which the date of exposure could be determined, presymptomatic transmission occurred 1-3 days before symptom onset in the presymptomatic source patient.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281052
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
However, no standard treatment for this disease has been discovered to date.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281213
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Although pre-clinical results are promising, till date, there is dearth of evidence to support the efficacy of CQ or HCQ in preventing COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281330
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Documents were screened following the inclusion criteria, and data were extracted in regard to registration date, study objective, type of design, sponsor, patient, sample size, intervention, and evaluation index.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282022
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
No therapies have been shown effective to date.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283052
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, considerable knowledge gaps remain regarding the chest CT imaging features of COVID-19. […] We performed a systematic review and meta-analysis of results from published studies to date to provide a summary of evidence on detection of COVID-19 by chest CT and the expected CT imaging manifestations.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283108
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, the most promising broad-spectrum class of viral RdRp inhibitors are nucleoside analogues (NAs), with over 25 approved for the treatment of several medically important viral diseases.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283185
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To ensure availability of donor cells on the scheduled date of infusion, many sites now collect cryopreserve grafts before the start of pretransplant conditioning.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32285338
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Few studies have been performed on viral transmission during surgery, but to date there is no study that demonstrates or can suggest the ability for a virus to be transmitted during surgical treatment whether open or laparoscopic.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32286607
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, SARS-CoV-2 is known to enter the host cells via the angiotensin-converting enzyme 2 protein.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32288415
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Furthermore, we propose the BAT model, which is composed of three parts: simulation of the return rush (Back), analytic hierarchy process (AHP) method, and technique for order preference by similarity to an ideal solution (TOPSIS) method, to figure out the best return date for university students.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32288418
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We also evaluate the effectiveness of the quarantine measures and schedule the date to reopen Hubei Province.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32289472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, COVID-19 has affected over 944,181 people worldwide, resulting in over 47,312 reported deaths. […] As new findings emerge, there is an urgent need for up-to-date management guidelines.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32291505
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date there is no specific treatment available-the main goal of supportive therapy is to ascertain adequate oxygenation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32291526
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Several hypotheses have been proposed to date regarding the net effect of ACEI/ARB on COVID-19 infections.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292517
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
No patient has died in our hospital to date.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292529
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
As the epicentre of the initial outbreak, China has been updating the National COVID-19 Diagnostic and Treatment Guideline with up-to-date information about the disease. […] Medical professionals should diagnose and treat patients according to up-to-date guidelines.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292686
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, there is no specific therapy for COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292697
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The Coronavirus disease 2019 (COVID-19) reminds us of the SARS outbreak in 2003, and up to date, corticosteroid is commonly administrated to severe patients with COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292826
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
While there is no intervention for the prevention or treatment of COVID-19 with proven clinical efficacy to date, tools to distil the current research landscape by intervention, level of evidence and those studies likely powered to address future research questions is essential.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292911
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Its accuracy has been 1.29% for the last day added and predicted by the 57 previous WHO situation reports (the date 18 March 2020).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293020
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Based on the evidence to date, there are several treatment options to consider for the relief of fever (acetaminophen, NSAID, oral glucocorticoids), cough (morphine), breathlessness (morphine, oxygen, fan), anxiety (benzodiazepines) and pain (NSAID, morphine).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293875
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Since the emergence of a novel coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was firstly reported from Wuhan, China, to date, neither a specific vaccine nor antiviral drug against SARS-CoV-2 is available.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294617
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Individuals should get the most up to date information from the CDC website.].
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294718
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, no case series have been published in Brazil.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>DEXTROMETHORPHAN</title>
      <link>/drugpanel/dextromethorphan/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/dextromethorphan/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00514&#39; target=&#39;_blank&#39;&gt;db00514&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=dextromethorphan&#34; target=&#34;_blank&#34;&gt;dextromethorphan&lt;/a&gt; &lt;br&gt;
Synonymous :(+)-dextromethorphan | d-methorphan | delta-methorphan | dex | dextromethorfan | dextromethorphan | dextrométhorphane | dextromethorphanum | dextrometorfano | dm
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;dextromethorphan&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281695
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We identified many cheap, available, and safe medicines, such as diphenidol, quinine, chloroquine, artemisinin, chlorpheniramine, yohimbine, and dextromethorphan, which may target the most common symptoms caused by 2019-nCoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>DIDANOSINE</title>
      <link>/drugpanel/didanosine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/didanosine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00900&#39; target=&#39;_blank&#39;&gt;db00900&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=didanosine&#34; target=&#34;_blank&#34;&gt;didanosine&lt;/a&gt; &lt;br&gt;
Synonymous :2,3-dideoxyinosine | 9-((2r,5s)-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-1h-purin-6(9h)-one | 9-((2r,5s)-5-hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one | 9-((2s,5r)-5-hydroxymethyl-tetrahydro-furan-2-yl)-9h-purin-6-ol | 9-[(2r,5s)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6h-purin-6-one | ddi | ddino | didanosina | didanosine | didanosinum | dideoxyinosine
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;didanosine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32268515
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among possible interesting drugs for Covid-19 treatment, we found Nimesulide, Fluticasone Propionate, Thiabendazole, Photofrin, Didanosine and Flutamide.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32291351
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The four drugs with the highest total score are didanosine, benzyl-quinazolin-4-yl-amine, camptothecin, and RO-90-7501.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>DIPHENIDOL</title>
      <link>/drugpanel/diphenidol/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/diphenidol/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01231&#39; target=&#39;_blank&#39;&gt;db01231&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=diphenidol&#34; target=&#34;_blank&#34;&gt;diphenidol&lt;/a&gt; &lt;br&gt;
Synonymous :alpha,alpha-diphenyl-1-piperidinebutanol | difenidol | difénidol | difenidolo | difenidolum | diphenidol | diphenyl(3-(1-piperidyl)propyl)carbinol
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;diphenidol&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281695
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We identified many cheap, available, and safe medicines, such as diphenidol, quinine, chloroquine, artemisinin, chlorpheniramine, yohimbine, and dextromethorphan, which may target the most common symptoms caused by 2019-nCoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>DOBUTAMINE</title>
      <link>/drugpanel/dobutamine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/dobutamine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00841&#39; target=&#39;_blank&#39;&gt;db00841&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=dobutamine&#34; target=&#34;_blank&#34;&gt;dobutamine&lt;/a&gt; &lt;br&gt;
Synonymous :(±)-4-(2-((3-(p-hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol | 3,4-dihydroxy-n-[3-(4-hydroxyphenyl)-1-methylpropyl]-β-phenylethylamine | 4-{2-[3-(4-hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol | dl-dobutamine | dobutamin | dobutamina | dobutamine | dobutaminum | rac-dobutamine | racemic-dobutamine
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;dobutamine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32219357
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
She was treated with dobutamine, antiviral drugs (lopinavir/ritonavir), steroids, chloroquine, and medical treatment for heart failure, with progressive clinical and instrumental stabilization.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>DOLUTEGRAVIR</title>
      <link>/drugpanel/dolutegravir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/dolutegravir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db08930&#39; target=&#39;_blank&#39;&gt;db08930&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=dolutegravir&#34; target=&#34;_blank&#34;&gt;dolutegravir&lt;/a&gt; &lt;br&gt;
Synonymous :dolutegravir
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;dolutegravir&lt;/em&gt; gene in 3 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32266873
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
From the virtual screening results, two drug molecules were selected for each drug target protein [Paritaprevir (ΔG= -9.8 kcal/mol) &amp;amp;Raltegravir (ΔG= -7.8 kcal/mol) for 3CLpro and Dolutegravir (ΔG= -9.4 kcal/mol) and Bictegravir (ΔG= -8.4 kcal/mol) for 2’-OMTase]. […] After the extensive computational analysis, we proposed that Raltegravir, Paritaprevir, Bictegravir and Dolutegravir are excellent lead candidates for these crucial proteins and they could become potential therapeutic drugs against SARS-CoV-2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32280433
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The result showed that atazanavir, an antiretroviral medication used to treat and prevent the human immunodeficiency virus (HIV), is the best chemical compound, showing an inhibitory potency with &lt;i&gt;K&lt;sub&gt;d&lt;/sub&gt;&lt;/i&gt; of 94.94 nM against the SARS-CoV-2 3C-like proteinase, followed by remdesivir (113.13 nM), efavirenz (199.17 nM), ritonavir (204.05 nM), and dolutegravir (336.91 nM).
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>DOXYCYCLINE</title>
      <link>/drugpanel/doxycycline/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/doxycycline/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00254&#39; target=&#39;_blank&#39;&gt;db00254&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=doxycycline&#34; target=&#34;_blank&#34;&gt;doxycycline&lt;/a&gt; &lt;br&gt;
Synonymous :5-hydroxy-α-6-deoxytetracycline | 6-alpha-deoxy-5-oxytetracycline | 6alpha-deoxy-5-oxytetracycline | 6α-deoxy-5-oxytetracycline | anhydrous doxycycline | doxiciclina | doxycyclin | doxycycline | doxycycline (anhydrous) | doxycycline anhydrous | doxycyclinum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;doxycycline&lt;/em&gt; gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32229706
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Other anti-aging drugs should also be considered, such as Rapamycin and Doxycycline, as they behave as inhibitors of protein synthesis, blocking both SASP and viral replication. […] As Azithromycin and Doxycycline are both commonly used antibiotics that inhibit viral replication and IL-6 production, we may want to consider this general class of antibiotics that functionally inhibits cellular protein synthesis as a side-effect, for the treatment and prevention of COVID-19 disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32267566
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Tetracyclines (e.g. tetracycline, doxycycline, and minocycline) are highly lipophilic antibiotics that are known to chelate zinc compounds on matrix metalloproteinases (MMPs)&lt;sup&gt;1&lt;/sup&gt; .
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>EBSELEN</title>
      <link>/drugpanel/ebselen/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/ebselen/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db12610&#39; target=&#39;_blank&#39;&gt;db12610&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=ebselen&#34; target=&#34;_blank&#34;&gt;ebselen&lt;/a&gt; &lt;br&gt;
Synonymous :ebselen | ebseleno
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;ebselen&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32272481
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Ebselen also exhibited promising antiviral activity in cell-based assays.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>EFAVIRENZ</title>
      <link>/drugpanel/efavirenz/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/efavirenz/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00625&#39; target=&#39;_blank&#39;&gt;db00625&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=efavirenz&#34; target=&#34;_blank&#34;&gt;efavirenz&lt;/a&gt; &lt;br&gt;
Synonymous :(s)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-(s)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2h-3,1-benzoxazin-2-one4-(trifluoromethyl)-2h-3,1-benzoxazin-2-one | (s)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one | 6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4s)-1,4-dihydro-2h-benzo[d][1,3]oxazin-2-one | efavirenz | éfavirenz | efavirenzum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;efavirenz&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32280433
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The result showed that atazanavir, an antiretroviral medication used to treat and prevent the human immunodeficiency virus (HIV), is the best chemical compound, showing an inhibitory potency with &lt;i&gt;K&lt;sub&gt;d&lt;/sub&gt;&lt;/i&gt; of 94.94 nM against the SARS-CoV-2 3C-like proteinase, followed by remdesivir (113.13 nM), efavirenz (199.17 nM), ritonavir (204.05 nM), and dolutegravir (336.91 nM).
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>EIDD-2801</title>
      <link>/drugpanel/eidd-2801/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/eidd-2801/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db15661&#39; target=&#39;_blank&#39;&gt;db15661&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=eidd-2801&#34; target=&#34;_blank&#34;&gt;eidd-2801&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;eidd-2801&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253226
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In mice infected with SARS-CoV or MERS-CoV, both prophylactic and therapeutic administration of EIDD-2801, an orally bioavailable NHC-prodrug (β-D-N&lt;sup&gt;4&lt;/sup&gt;-hydroxycytidine-5’-isopropyl ester), improved pulmonary function, and reduced virus titer and body weight loss. […] The potency of NHC/EIDD-2801 against multiple coronaviruses and oral bioavailability highlight its potential utility as an effective antiviral against SARS-CoV-2 and other future zoonotic coronaviruses.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ELLA</title>
      <link>/drugpanel/ella/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/ella/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=ella&#34; target=&#34;_blank&#34;&gt;ella&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;ella&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32238261
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Se sostiene que los medios de comunicación de masas en la Argentina tienen la oportunidad histórica de mostrar la relevancia de su aporte no sólo para que enfrentar esta coyuntura, sino también para que salgamos de ella como una sociedad mejor y más justa.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>EMETINE</title>
      <link>/drugpanel/emetine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/emetine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db13393&#39; target=&#39;_blank&#39;&gt;db13393&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=emetine&#34; target=&#34;_blank&#34;&gt;emetine&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;emetine&lt;/em&gt; gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32245264
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This article presents the rationale for potentially using old drugs (emetine, other ipecac alkaloids or analogues) that have been used to treat amoebiasis in the treatment of COVID-19. […] Emetine had amongst the lowest reported half-maximal effective concentration (EC&lt;sub&gt;50&lt;/sub&gt;) from over 290 agents screened for the Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS) coronaviruses. […] While EC&lt;sub&gt;50&lt;/sub&gt; concentrations of emetine are achievable in the blood, studies show that concentrations of emetine can be almost 300 times higher in the lungs. […] Furthermore, based on the relative EC&lt;sub&gt;50&lt;/sub&gt;s of emetine towards the coronaviruses compared with &lt;i&gt;Entamoeba histolytica&lt;/i&gt;, emetine could be much more effective as an anti-coronavirus agent than it is against amoebiasis. […] This paper also discusses the known side effects of emetine and related compounds, how those side effects can be managed, and the optimal method of administration for the potential treatment of COVID-19. […] Given the serious and immediate threat that the COVID-19 coronavirus poses, our long history with emetine and the likely ability of emetine to reach therapeutic concentrations within the lungs, ipecac, emetine, and other analogues should be considered as potential treatment options, especially if in vitro studies confirm viral sensitivity.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251767
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We report the antiviral effect of remdesivir, lopinavir, homorringtonine, and emetine against SARS-CoV-2 virus in Vero E6 cells with the estimated 50% effective concentration at 23.15 μM, 26.63 μM, 2.55 μM and 0.46 μM, respectively. […] Synergy between remdesivir and emetine was observed, and remdesivir at 6.25 μM in combination with emetine at 0.195 μM may achieve 64.9% inhibition in viral yield.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ENOXAPARIN</title>
      <link>/drugpanel/enoxaparin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/enoxaparin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01225&#39; target=&#39;_blank&#39;&gt;db01225&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=enoxaparin&#34; target=&#34;_blank&#34;&gt;enoxaparin&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;enoxaparin&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294289
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Of note, patients that received heparin in this study were mostly treated with enoxaparin, at the thromboprophylactic dose of 40-60 mg/day, for at least 7 days.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>EOSIN</title>
      <link>/drugpanel/eosin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/eosin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db13706&#39; target=&#39;_blank&#39;&gt;db13706&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=eosin&#34; target=&#34;_blank&#34;&gt;eosin&lt;/a&gt; &lt;br&gt;
Synonymous :acid red 87 | eosine yellowish
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;eosin&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32172546
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Hematoxylin and eosin staining (HE) and histochemical staining were performed to investigate the pathological changes of indicated organs or tissues.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>EPCLUSA</title>
      <link>/drugpanel/epclusa/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/epclusa/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=epclusa&#34; target=&#34;_blank&#34;&gt;epclusa&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;epclusa&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32194944
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The drugs Epclusa (velpatasvir/sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) could be very effective owing to their dual inhibitory actions on two viral enzymes.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ETHANOL</title>
      <link>/drugpanel/ethanol/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/ethanol/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00898&#39; target=&#39;_blank&#39;&gt;db00898&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=ethanol&#34; target=&#34;_blank&#34;&gt;ethanol&lt;/a&gt; &lt;br&gt;
Synonymous :1-hydroxyethane | alcohol | alcohol (ethyl) | alcohol anhydrous | alcohol denatured | alcohol etílico | alcohol, denatured | alcool éthylique | alkohol | äthanol | äthylalkohol | dehydrated ethanol | etanol | éthanol | ethyl alcohol | grain alcohol | hydroxyethane | methylcarbinol | spiritus vini
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;ethanol&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32035997
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The analysis of 22 studies reveals that human coronaviruses such as Severe Acute Respiratory Syndrome (SARS) coronavirus, Middle East Respiratory Syndrome (MERS) coronavirus or endemic human coronaviruses (HCoV) can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 62-71% ethanol, 0.5% hydrogen peroxide or 0.1% sodium hypochlorite within 1 minute.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32116147
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Using data obtained from similar coronaviruses, e.g. severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), experts are confident that 70% ethanol and 0.1% sodium hypochlorite should inactivate the virus.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>EVEROLIMUS</title>
      <link>/drugpanel/everolimus/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/everolimus/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01590&#39; target=&#39;_blank&#39;&gt;db01590&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=everolimus&#34; target=&#34;_blank&#34;&gt;everolimus&lt;/a&gt; &lt;br&gt;
Synonymous :40-o-(2-hydroxyethyl)-rapamycin | 42-o-(2-hydroxyethyl)rapamycin | everolimus | évérolimus
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;everolimus&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32229705
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Previous studies showed that postulated geroprotectors, such as sirolimus (rapamycin) and its close derivative rapalog everolimus (RAD001), decreased infection rates in a small sample of elderly patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>FAVIPIRAVIR</title>
      <link>/drugpanel/favipiravir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/favipiravir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db12466&#39; target=&#39;_blank&#39;&gt;db12466&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=favipiravir&#34; target=&#34;_blank&#34;&gt;favipiravir&lt;/a&gt; &lt;br&gt;
Synonymous :fapilavir | favilavir | favipiravir
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;favipiravir&lt;/em&gt; gene in 9 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32147628
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243270
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This review summarizes the current evidence of potential therapeutic agents, such as lopinavir/ritonavir, remdesivir, favipiravir, chloroquine, hydroxychloroquine, interferon, ribavirin, tocilizumab and sarilumab.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32246834
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Favipiravir, a purine nucleic acid analog and potent RdRp inhibitor approved for use in influenza, is also considered in several clinical trials. […] Herein, we summarized the pharmacokinetic characteristics of favipiravir and possible drug-drug interactions from the view of drug metabolism. […] We hope this will be helpful for the design of clinical trials for favipiravir in COVID-2019, as data regarding in vitro virus inhibition and efficacy in preclinical animal studies are still not available.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251767
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Ribavirin or favipiravir that are currently evaluated under clinical trials showed no inhibition at 100 μM.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32256547
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We identified 24 clinical trials, involving more than 20 medicines, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, methylprednisolone, bevacizumab, and traditional Chinese medicines (TCM). […] Se identificaron 24 ensayos clínicos relacionados con más de 20 medicamentos, como inmunoglobulina humana, interferones, cloroquina, hidroxicloroquina, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, metilprednisolona, bevacizumab y medicina tradicional china. […] Foram identificados 24 ensaios clínicos envolvendo mais de 20 medicamentos, tais como imunoglobulina humana, interferons, cloroquina, hidroxicloroquina, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, metilprednisolona, bevacizumabe e medicamentos chineses tradicionais.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277367
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Antiviral drugs like lopinavir/ritonavir, favipiravir and remdesivir are also being explored.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32284326
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this regard, the triphosphate forms of 2’-C-methylated compounds, including sofosbuvir, approved for the management of hepatitis C virus infection, and the broad-acting antivirals favipiravir and ribavirin, exhibited significant deficits.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32290293
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The initial clinical studies revealed the promising therapeutic potential of several of such drugs, including &lt;i&gt;favipiravir&lt;/i&gt;, a broad-spectrum antiviral drug that interferes with the viral replication, and &lt;i&gt;hydroxychloroquine&lt;/i&gt;, the repurposed antimalarial drug that interferes with the virus endosomal entry pathway.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293834
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The most frequently used agents both in Turkey and all over the world including chloroquine, hydroxychloroquine, lopinavir/ritonavir, favipiravir and remdesivir will be reviewed here .
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>FEDRATINIB</title>
      <link>/drugpanel/fedratinib/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/fedratinib/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db12500&#39; target=&#39;_blank&#39;&gt;db12500&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=fedratinib&#34; target=&#34;_blank&#34;&gt;fedratinib&lt;/a&gt; &lt;br&gt;
Synonymous :fedratinib
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;fedratinib&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32205092
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We reviewed TH17 responses in patients with SARS-CoV-2 and proposed an FDA approved JAK2 inhibitor Fedratinib for reducing mortality of patients with TH17 type immune profiles.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>FENTANYL</title>
      <link>/drugpanel/fentanyl/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/fentanyl/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00813&#39; target=&#39;_blank&#39;&gt;db00813&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=fentanyl&#34; target=&#34;_blank&#34;&gt;fentanyl&lt;/a&gt; &lt;br&gt;
Synonymous :1-phenethyl-4-(n-phenylpropionamido)piperidine | 1-phenethyl-4-n-propionylanilinopiperidine | fentanil | fentanila | fentanilo | fentanyl | fentanyl cii | fentanylum | n-(1-phenethyl-4-piperidinyl)-n-phenylpropionamide | n-(1-phenethyl-4-piperidyl)propionanilide | n-(1-phenethyl-piperidin-4-yl)-n-phenyl-propionamide | n-(1-phenethylpiperidin-4-yl)-n-phenylpropionamide | n-phenethyl-4-(n-propionylanilino)piperidine | n-phenyl-n-(1-(2-phenylethyl)-4-piperidinyl)propanamide | phentanyl
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;fentanyl&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32133829
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Midazolam, Propofol and Morphine or fentanyl were used for sedation and analgesia, avoiding patients cough and agitated during the procedure.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>FLAVONE</title>
      <link>/drugpanel/flavone/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/flavone/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db07776&#39; target=&#39;_blank&#39;&gt;db07776&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=flavone&#34; target=&#34;_blank&#34;&gt;flavone&lt;/a&gt; &lt;br&gt;
Synonymous :2-phenyl-4-benzopyron | 2-phenyl-4-chromone | 2-phenyl-4h-1-benzopyran-4-one | 2-phenyl-4h-benzopyran-4-one | 2-phenyl-γ-benzopyrone | 2-phenylbenzopyran-4-one | 2-phenylchromone | flavon
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;flavone&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32238094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
As a result three FDA approved drugs (Remdesivir, Saquinavir and Darunavir) and two natural compounds (. flavone and coumarine derivatives) were identified as promising hits.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>FLUORESCEIN</title>
      <link>/drugpanel/fluorescein/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/fluorescein/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00693&#39; target=&#39;_blank&#39;&gt;db00693&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=fluorescein&#34; target=&#34;_blank&#34;&gt;fluorescein&lt;/a&gt; &lt;br&gt;
Synonymous :3,6-fluorandiol | 3’,6’-dihydroxyfluoran | 9-(o-carboxyphenyl)-6-hydroxy-3-isoxanthenone | 9-(o-carboxyphenyl)-6-hydroxy-3h-xanthen-3-one | c.i. solvent yellow 94 | d and c yellow no. 7 | d&amp;amp;c yellow no. 7 | fluoresceina | fluoresceína | fluoresceine | fluoreszein | japan yellow 201 | resorcinolphthalein | solvent yellow 94 | yellow fluorescein
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;fluorescein&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243678
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Aerosolization was simulated in a cadaver using fluorescein solution (0.2mg/10ml) and quantified using a blue-light filter and digital image processing. […] Surgical aerosolization was simulated during non-powered instrumentation, suction microdebrider, and high-speed drilling following nasal fluorescein application.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>FLUTAMIDE</title>
      <link>/drugpanel/flutamide/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/flutamide/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00499&#39; target=&#39;_blank&#39;&gt;db00499&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=flutamide&#34; target=&#34;_blank&#34;&gt;flutamide&lt;/a&gt; &lt;br&gt;
Synonymous :4’-nitro-3’-trifluoromethylisobutyranilide | flutamid | flutamida | flutamide | flutamidum | fta | nfba | niftolid | niftolide | α,α,α-trifluoro-2-methyl-4’-nitro-m-propionotoluidide
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;flutamide&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32268515
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among possible interesting drugs for Covid-19 treatment, we found Nimesulide, Fluticasone Propionate, Thiabendazole, Photofrin, Didanosine and Flutamide.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>FLUTICASONE</title>
      <link>/drugpanel/fluticasone/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/fluticasone/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db13867&#39; target=&#39;_blank&#39;&gt;db13867&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=fluticasone&#34; target=&#34;_blank&#34;&gt;fluticasone&lt;/a&gt; &lt;br&gt;
Synonymous :fluticason | fluticasona | fluticasone | fluticasonum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;fluticasone&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32268515
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among possible interesting drugs for Covid-19 treatment, we found Nimesulide, Fluticasone Propionate, Thiabendazole, Photofrin, Didanosine and Flutamide.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>FULVESTRANT</title>
      <link>/drugpanel/fulvestrant/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/fulvestrant/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00947&#39; target=&#39;_blank&#39;&gt;db00947&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=fulvestrant&#34; target=&#34;_blank&#34;&gt;fulvestrant&lt;/a&gt; &lt;br&gt;
Synonymous :(7α,17β)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1(10),2,4-triene-3,17-diol | fulvestrant
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;fulvestrant&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277836
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The wife (patient 1) was partially immunocompromised as a consequence of a recently started chemotherapy with fulvestrant and abemaciclid for recurring breast cancer, her husband (patient 2) had been healthy except for a history of controlled arterial hypertension.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>GADOLINIUM</title>
      <link>/drugpanel/gadolinium/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/gadolinium/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db12091&#39; target=&#39;_blank&#39;&gt;db12091&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=gadolinium&#34; target=&#34;_blank&#34;&gt;gadolinium&lt;/a&gt; &lt;br&gt;
Synonymous :gadolinio
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;gadolinium&lt;/em&gt; gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32219357
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Detection of cardiac involvement with an increase in levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) and high-sensitivity troponin T, echocardiography changes, and diffuse biventricular myocardial edema and late gadolinium enhancement on cardiac magnetic resonance imaging. […] Short tau inversion recovery and T2-mapping sequences showed marked biventricular myocardial interstitial edema, and there was also diffuse late gadolinium enhancement involving the entire biventricular wall.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>GALIDESIVIR</title>
      <link>/drugpanel/galidesivir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/galidesivir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db11676&#39; target=&#39;_blank&#39;&gt;db11676&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=galidesivir&#34; target=&#34;_blank&#34;&gt;galidesivir&lt;/a&gt; &lt;br&gt;
Synonymous :galidesivir | galidésivir | galidesivirum | immucillin a | immucillin-a
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;galidesivir&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32222463
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The results suggest the effectiveness of Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir as potent drugs against SARS-CoV-2 since they tightly bind to its RdRp.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>GANCICLOVIR</title>
      <link>/drugpanel/ganciclovir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/ganciclovir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01004&#39; target=&#39;_blank&#39;&gt;db01004&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=ganciclovir&#34; target=&#34;_blank&#34;&gt;ganciclovir&lt;/a&gt; &lt;br&gt;
Synonymous :2-(6-amino-purin-9-ylmethoxy)-propane-1,3-diol | 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1h-purin-6(9h)-one | 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3h-purin-6(9h)-one | 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9h-purin-6-ol | 2-amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one | 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1h-6-purinone | 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine | 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine | ga2 | ganciclovir | ganciclovirum | gancyclovir
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;ganciclovir&lt;/em&gt; gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32023685
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>GINSENG</title>
      <link>/drugpanel/ginseng/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/ginseng/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01404&#39; target=&#39;_blank&#39;&gt;db01404&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=ginseng&#34; target=&#34;_blank&#34;&gt;ginseng&lt;/a&gt; &lt;br&gt;
Synonymous :aralia ginseng root | asian ginseng root | chinese ginseng root | ginseng (panax ginseng) | ginseng extract | ginseng, asian | hong shen root | insam root | korean ginseng | korean ginseng root | ninjin root | panax ginseng | panax ginseng root | panax ginseng root extract | panax schinseng root | panax verus root | red ginseng | ren seng root | ren shen | ren shen root | true ginseng root
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;ginseng&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281329
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The results showed that the hit components with the inhibitory effect on AA were magnolignan Ⅰ, lonicerin and physcion-8-O-β-D-glucopy-ranoside, which mostly extracted from Magnoliae Officinalis Cortex, Zingiberis Rhizoma Recens, Lonicerae Japonicae Flos, Rhei Radix et Rhizoma, Salviae Miltiorrhizae Radix et Rhizoma, Scutellariae Radix, Gardeniae Fructus, Ginseng Radix et Rhizoma, Arctii Fructus, Dryopteridis Crassirhizomatis Rhizoma, Paeoniaeradix Rubra, Dioscoreae Rhizoma.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>GLYCINE</title>
      <link>/drugpanel/glycine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/glycine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00145&#39; target=&#39;_blank&#39;&gt;db00145&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=glycine&#34; target=&#34;_blank&#34;&gt;glycine&lt;/a&gt; &lt;br&gt;
Synonymous :aminoacetic acid | aminoessigsäure | aminoethanoic acid | glicina | gly | glycin | glycine | glycocoll | glykokoll | glyzin | leimzucker
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;glycine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32083328
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Position 723 in the COVID-2019 has a serine instead a glycine residue, while at aminoacidic position 1010 a proline instead an isoleucine.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>GOLD</title>
      <link>/drugpanel/gold/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/gold/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db14154&#39; target=&#39;_blank&#39;&gt;db14154&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=gold&#34; target=&#34;_blank&#34;&gt;gold&lt;/a&gt; &lt;br&gt;
Synonymous :aurum metallicum | colloidal gold | gold flake | gold leaf | gold powder | gold, colloidal | gold, elemental
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;gold&lt;/em&gt; gene in 6 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32172228
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
As the current gold standard for the etiological diagnosis of SARS-CoV-2 infection is (real time) reverse transcription polymerase chain reaction (rRT-PCR) on respiratory tract specimens, the diagnostic accuracy of this technique shall be considered a foremost prerequisite.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32174053
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The nucleic acid test or genetic sequencing serves as the gold standard method for confirmation of infection, yet several recent studies have reported false-negative results of real-time reverse-transcriptase polymerase chain reaction (rRT-PCR).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32196430
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Newer laboratory methods are fast, highly sensitive and specific, and are gradually replacing the conventional gold standards.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277023
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;b&gt;Objective:&lt;/b&gt; To investigate the interference factors that lead to false-positive novel coronavirus (SARS-CoV-2) IgM detected using gold immunochromatography assay (GICA) and enzyme-linked immunosorbent assay (ELISA) and the corresponding solutions.&lt;b&gt;Methods:&lt;/b&gt; GICA and ELISA were used to detect SARS-CoV-2 IgM in 86 serum samples, including 5 influenza A virus (Flu A) IgM-positive sera, 5 influenza B virus (Flu B) IgM-positive sera, 5 &lt;i&gt;Mycoplasma pneumoniae&lt;/i&gt; IgM-positive sera, 5 &lt;i&gt;Legionella pneumophila&lt;/i&gt; IgM-positive sera, 6 sera of HIV infection patients, 36 rheumatoid factor IgM (RF-IgM)-positive sera, 5 sera from hypertensive patients, 5 sera from diabetes mellitus patients, and 14 sera from novel coronavirus infection disease (COVID-19) patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281785
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The two-dimensional gold nanoislands (AuNIs) functionalized with complementary DNA receptors can perform a sensitive detection of the selected sequences from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through nucleic acid hybridization.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283141
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Here, we presented the colloidal gold-based immunochromatographic (ICG) strip targeting viral IgM or IgG antibody and compared it with real-time RT-PCR.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292623
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Polymerase chain reaction (PCR) is regarded as a gold standard test for the molecular diagnosis of viral and bacterial infections with high sensitivity and specificity.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>GUANOSINE</title>
      <link>/drugpanel/guanosine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/guanosine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db02857&#39; target=&#39;_blank&#39;&gt;db02857&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=guanosine&#34; target=&#34;_blank&#34;&gt;guanosine&lt;/a&gt; &lt;br&gt;
Synonymous :2-amino-1,9-dihydro-9-β-d-ribofuranosyl-6h-purin-6-one | 2(3h)-imino-9-β-d-ribofuranosyl-9h-purin-6(1h)-one | 9-β-d-ribofuranosyl-guanine | guanine riboside | guanine-9-β-d-ribofuranoside | guanosin | guanosina | guo
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;guanosine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32222463
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In addition, the results suggest guanosine derivative (IDX-184), Setrobuvir, and YAK as top seeds for antiviral treatments with high potential to fight the SARS-CoV-2 strain specifically.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HARVONI</title>
      <link>/drugpanel/harvoni/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/harvoni/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=harvoni&#34; target=&#34;_blank&#34;&gt;harvoni&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;harvoni&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32194944
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The drugs Epclusa (velpatasvir/sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) could be very effective owing to their dual inhibitory actions on two viral enzymes.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HEMOGLOBIN</title>
      <link>/drugpanel/hemoglobin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/hemoglobin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db04945&#39; target=&#39;_blank&#39;&gt;db04945&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=hemoglobin&#34; target=&#34;_blank&#34;&gt;hemoglobin&lt;/a&gt; &lt;br&gt;
Synonymous :deoxyhemoglobin | haemoglobin | human hemoglobin
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;hemoglobin&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32270515
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
After 7 days of treatment, he was discharged with miraculous improvement in his symptoms and hemoglobin level.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HEPARIN</title>
      <link>/drugpanel/heparin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/heparin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01109&#39; target=&#39;_blank&#39;&gt;db01109&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=heparin&#34; target=&#34;_blank&#34;&gt;heparin&lt;/a&gt; &lt;br&gt;
Synonymous :eparina | heparina | heparine | heparinic acid | heparinum | unfractionated heparin
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;heparin&lt;/em&gt; gene in 12 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32196410
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Combined with the published literature, the potential pathogenesis of COVID-19 is inferred, and the treatment recommendations for giving high-doses intravenous immunoglobulin and low-molecular-weight heparin anticoagulant therapy to severe type patients are proposed.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32208840
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Furthermore, he observes the significant abnormality of coagulation function and proposes that the early intravenous immunoglobulin and low molecular weight heparin anticoagulation therapy are very important.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32220112
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A relatively high mortality of severe coronavirus disease 2019 (COVID-19) is worrying, the application of heparin in COVID-19 has been recommended by some expert consensus due to the risk of disseminated intravascular coagulation and venous thromboembolism. […] The 28-day mortality between heparin users and nonusers were compared, also in different risk of coagulopaphy which was stratified by the sepsis-induced coagulopathy (SIC) score or D-dimer result. […] There were 449 patients with severe COVID-19 enrolled into the study, 99 of them received heparin (mainly with low molecular weight heparin, LMWH) for 7 days or longer. […] No difference on 28-day mortality was found between heparin users and nonusers (30.3% vs 29.7%, P=0.910). […] But the 28-day mortality of heparin users were lower than nonusers In patients with SIC score ≥4 (40.0% vs 64.2%, P=0.029), or D-dimer &amp;gt; 6 fold of upper limit of normal (32.8% vs 52.4%, P=0.017).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32220276
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
D-dimer and FDP levels increased progressively when COVID-2019 exacerbated, and 4 patients were diagnosed with definite disseminated intravascular coagulation (DIC). 6 patients received low molecular weight heparin (LMWH) treatment, after which their D-dimer and FDP decreased, but there was no significant improvement in clinical symptoms. 5 patients died finally and the median time from acro-ischemia to death was 12 days. &lt;b&gt;Conclusions:&lt;/b&gt; The existence of hypercoagulation status in critical COVID-2019 patients should be monitored closely, and anticoagulation therapy can be considered in selected patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32239799
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Coagulopathy in corona virus infection has been shown to be associated with high mortality with high D-dimers being a particularly important marker for the coagulopathy.&lt;sup&gt;1&lt;/sup&gt; In the latest paper from the same group, the use of anticoagulant therapy with heparin was shown to decrease mortality as well. &lt;sup&gt;2&lt;/sup&gt; This is especially so in patients i) who have met the sepsis induced coagulopathy (SIC) criteria ≥4 (40.0% vs 64.2%, P=0.029) compared to those with SIC score &amp;lt;4 (29.0% vs 22.6%, P=0.419).or ii) with markedly elevated D-dimer (greater than six-fold at the upper limit of normal).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32246317
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The 28-day mortality of heparin users were lower than nonusers In COVID group with D-dimer &amp;gt; 3.0 μg/mL (32.8% vs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282949
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
COVID-19 infected patients whatever hospitalized or ambulatory are at high risk for VTE and an early and prolonged pharmacological thromboprophylaxis with low molecular weight heparin is highly recommended.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294289
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this retrospective analysis, conducted at the Tongji Hospital of Wuhan, China, it is reported that heparin treatment reduces mortality in subjects affected by severe COVID-19 who have “sepsis-induced coagulopathy”. […] The Authors of this study also reported that, among subjects not treated with heparin, mortality raised according with D-dimer levels. […] Of note, patients that received heparin in this study were mostly treated with enoxaparin, at the thromboprophylactic dose of 40-60 mg/day, for at least 7 days.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HMS</title>
      <link>/drugpanel/hms/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/hms/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=hms&#34; target=&#34;_blank&#34;&gt;hms&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;hms&lt;/em&gt; gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282373
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
At Harvard Medical School (HMS), student leaders created a COVID-19 Medical Student Response Team to: (1) develop a student-led organizational structure that would optimize students’ ability to efficiently mobilize interested peers in the COVID-19 response, both clinically and in the community, in a strategic, safe, smart, and resource-conscious way; and (2) serve as a liaison with the administration and hospital leaders to identify evolving needs and rapidly engage students in those efforts. […] Within a week of its inception, the COVID-19 Medical Student Response Team had more than 500 medical student volunteers from HMS and had shared the organizational framework of the response team with multiple medical schools across the country. […] The HMS student volunteers joined any of the 4 virtual committees to complete this work: Education for the Medical Community, Education for the Broader Community, Activism for Clinical Support, and Community Activism. […] The COVID-19 Medical Student Response Team helped to quickly mobilize hundreds of students and has been integrated into HMS’s daily workflow.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HOMOCYSTEINE</title>
      <link>/drugpanel/homocysteine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/homocysteine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db04422&#39; target=&#39;_blank&#39;&gt;db04422&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=homocysteine&#34; target=&#34;_blank&#34;&gt;homocysteine&lt;/a&gt; &lt;br&gt;
Synonymous :l-2-amino-4-mercaptobutyric acid | l-homocysteine
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;homocysteine&lt;/em&gt; gene in 3 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275643
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The parameters including homocysteine, urea, creatinine and serum cystatin C were significantly higher in imaging progression patients (all p &amp;lt; 0.05), while eGFR decreased (p &amp;lt; 0.001). […] Logistic models revealed that age, MLR, homocysteine and period from onset to admission were factors for predicting imaging progression on chest CT at first week from COVID-19 patients (all p &amp;lt; 0.05). […] Age, MLR, homocysteine and period from onset to admission could predict imaging progression on chest CT from COVID-19 patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HYDROGEN</title>
      <link>/drugpanel/hydrogen/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/hydrogen/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db15127&#39; target=&#39;_blank&#39;&gt;db15127&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=hydrogen&#34; target=&#34;_blank&#34;&gt;hydrogen&lt;/a&gt; &lt;br&gt;
Synonymous :molecular hydrogen
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;hydrogen&lt;/em&gt; gene in 7 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32022276
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Also, during simulations, the CTL epitopes were observed to be binding MHC class I peptide-binding grooves via multiple contacts, with continuous hydrogen bonds and salt bridge anchors, indicating their potential in generating immune responses.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32035997
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The analysis of 22 studies reveals that human coronaviruses such as Severe Acute Respiratory Syndrome (SARS) coronavirus, Middle East Respiratory Syndrome (MERS) coronavirus or endemic human coronaviruses (HCoV) can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 62-71% ethanol, 0.5% hydrogen peroxide or 0.1% sodium hypochlorite within 1 minute.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32167173
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Regarding contact modes, hydrophobic interactions contribute significantly in binding and additional hydrogen bonds were found between theaflavin and RdRp.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32228825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
One of the COVID-19 treatments involves inhaling a mixture of gaseous hydrogen and oxygen, obtaining better results than with oxygen alone.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32286242
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Results The positive rates of urine occult blood (BLOOD) and proteinuria (PRO) were higher in COVID-19 patients than in healthy controls (p &amp;lt; 0.05); the urine specific gravity (SG) value was lower in patients than in healthy controls (p &amp;lt; 0.05), and the urine potential of hydrogen (pH) value was higher in patients than in healthy controls (p &amp;lt; 0.01).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293875
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In addition, only ritonavir could interact with the oxyanion hole residues N142 and G143 via two hydrogen bond formations.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HYDROXYCHLOROQUINE</title>
      <link>/drugpanel/hydroxychloroquine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/hydroxychloroquine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01611&#39; target=&#39;_blank&#39;&gt;db01611&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=hydroxychloroquine&#34; target=&#34;_blank&#34;&gt;hydroxychloroquine&lt;/a&gt; &lt;br&gt;
Synonymous :(±)-hydroxychloroquine | 2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol | 2-(n-(4-(7-chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol | 7-chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline | 7-chloro-4-(4-(n-ethyl-n-β-hydroxyethylamino)-1-methylbutylamino)quinoline | 7-chloro-4-[4-(n-ethyl-n-β-hydroxyethylamino)-1-methylbutylamino]quinoline | 7-chloro-4-[5-(n-ethyl-n-2-hydroxyethylamino)-2-pentyl]aminoquinoline | hidroxicloroquina | hydroxychloroquine | hydroxychloroquinum | oxichlorochine | oxichloroquine
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;hydroxychloroquine&lt;/em&gt; gene in 38 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32150618
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Hydroxychloroquine shares the same mechanism of action as chloroquine, but its more tolerable safety profile makes it the preferred drug to treat malaria and autoimmune conditions. […] We propose that the immunomodulatory effect of hydroxychloroquine also may be useful in controlling the cytokine storm that occurs late-phase in critically ill SARS-CoV-2 infected patients. […] Currently, there is no evidence to support the use of hydroxychloroquine in SARS-CoV-2 infection. […] The pharmacological activity of chloroquine and hydroxychloroquine was tested using SARS-CoV-2 infected Vero cells. […] Using the PBPK models, hydroxychloroquine concentrations in lung fluid were simulated under 5 different dosing regimens to explore the most effective regimen whilst considering the drug’s safety profile. […] Hydroxychloroquine (EC50=0.72 μM) was found to be more potent than chloroquine (EC50=5.47 μM) in vitro. […] Based on PBPK models results, a loading dose of 400 mg twice daily of hydroxychloroquine sulfate given orally, followed by a maintenance dose of 200 mg given twice daily for 4 days is recommended for SARS-CoV-2 infection, as it reached three times the potency of chloroquine phosphate when given 500 mg twice daily 5 days in advance. […] Hydroxychloroquine was found to be more potent than chloroquine to inhibit SARS-CoV-2 in vitro.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32171740
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In the absence of a known efficient therapy and because of the situation of a public-health emergency, it made sense to investigate the possible effect of chloroquine/hydroxychloroquine against SARS-CoV-2 since this molecule was previously described as a potent inhibitor of most coronaviruses, including SARS-CoV-1.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32196083
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We propose that hydroxychloroquine (HCQ), which exhibits an antiviral effect highly similar to that of CQ, could serve as a better therapeutic approach.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32205204
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2, and reported to be efficient in Chinese COV-19 patients. […] We evaluate the role of hydroxychloroquine on respiratory viral loads. […] French Confirmed COVID-19 patients were included in a single arm protocol from early March to March 16&lt;sup&gt;th&lt;/sup&gt;, to receive 600mg of hydroxychloroquine daily and their viral load in nasopharyngeal swabs was tested daily in a hospital setting. […] Azithromycin added to hydroxychloroquine was significantly more efficient for virus elimination. […] Despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in COVID-19 patients and its effect is reinforced by azithromycin.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32214286
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
These include vaccines, medications Remdesivir and hydroxychloroquine and potentially combination therapy.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32222713
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
He remained in critical condition being treated with hydroxychloroquine and tocilizumab in addition to the standard medical management for septic shock and ARDS.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32234468
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Treatments, including antiviral agents, chloroquine and hydroxychloroquine, corticosteroids, antibodies, convalescent plasma transfusion and vaccines, are discussed in this article.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32241801
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Two antimalarial agents, chloroquine (CQ) and hydroxychloroquine (HCQ), have been trusted treatments for a range of rheumatic diseases over the past seventy years [1].
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243270
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This review summarizes the current evidence of potential therapeutic agents, such as lopinavir/ritonavir, remdesivir, favipiravir, chloroquine, hydroxychloroquine, interferon, ribavirin, tocilizumab and sarilumab.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In view of recent studies and discussion on chloroquine and hydroxychloroquine (HCQ), we aimed to review existing literature and relevant websites regarding these drugs and COVID-19, adverse effects related to drugs, and related guidelines.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247213
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Search terms were, COVID-19, treatment of coronavirus, COVID 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ACE-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease. […] We discuss evidence regarding role of chloroquine and hydroxychloroquine in treatment and prophylaxis, use of inhibitors of the renin angiotensin system, safety of ibuprofen, unusual clinical features like gastrointestinal symptoms and interpretation of tests for cardiac enzymes and biomarkers.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32249257
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Very recently, hydroxychloroquine in combination with azithromycin treatment was reported to be effective for COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251731
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This study showed that, in the presence of CLQ [or its more active derivative, hydroxychloroquine (CLQ-OH)], the viral S protein is no longer able to bind gangliosides.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253799
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A severe cutaneous drug reaction resembling acute generalized exanthematous pustulosis resulting from ingestion of hydroxychloroquine has been documented. […] Given the anticipated surge in the use of hydroxychloroquine due to its reported benefits in those with coronavirus disease 2019, specific recognition of this entity is pivotal.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253888
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
It is hoped that certain drugs, such as CoV-19 receptor blockers, anti-inflammatories (against rheumatic diseases), monoclonal antibodies, anti-IL-1 and anti-IL-6, the remdesevir drug (analogue adenosine, effective against ebola), hydroxychloroquine (for the treatment of malaria) and vaccines, will open up new strategies and new therapeutic ways to combat this terrible virus.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32255489
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Hydroxychloroquine (HCQ) appears to be a promising treatment for COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32256547
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We identified 24 clinical trials, involving more than 20 medicines, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, methylprednisolone, bevacizumab, and traditional Chinese medicines (TCM).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32265182
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In light of this, there has been growing interest in the use of existing medications, such as chloroquine (CQ) and hydroxychloroquine (HCQ), as potential treatments of this disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32268005
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
It has been reported that hydroxychloroquine (HCQ) is active against SARS-CoV-2 in vitro, and this finding was quickly supported by an open label non-randomized clinical trial that provided the first published clinical evidence HCQ may be a treatment option.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277367
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Preliminary evidence suggests potential benefit with chloroquine or hydroxychloroquine. […] • Although preliminary results may be encouraging, high-quality clinical trials are needed to better understand the role of drugs commonly used in rheumatology like hydroxychloroquine and tocilizumab in COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277836
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Both patients were treated with darunavir/cobicistat and hydroxychloroquine.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32279418
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Hydroxychloroquine and lopinavir/ritonavir were started, and the antiviral drug was replaced with darunavir/cobicistat after two days for diarrhea.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281114
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Supportive measures, in addition to a 5-day course of hydroxychloroquine, were maintained until remdesivir could be supplied on day 9 of hospitalization, 13 days after symptom onset.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281213
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Different drugs for prophylaxis against COVID-19 including chloroquine (CQ) or hydroxychloroquine (HCQ) have been tried.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281268
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In light of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) pandemic and the possible widespread use of chloroquine (a member of the drug class 4-aminoquinoline primarily used to prevent and treat malaria and amebiasis) and its derivatives (e.g. hydroxychloroquine, a metabolite of chloroquine),&lt;sup&gt;1&lt;/sup&gt; a safety issue is addressed, concerning the selection of patients suitable to receive it.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281481
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Due to factors such as history of prescription for other infectious diseases, availability, and relatively low cost, the use of chloroquine (CQ) and hydroxychloroquine (HCQ) has been tested &lt;i&gt;in vivo&lt;/i&gt; and &lt;i&gt;in vitro&lt;/i&gt; for the ability to inhibit the causative virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281583
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Chloroquine and hydroxychloroquine have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19). […] Increasing evidence obtained from completed clinical studies indicates the prospects for chloroquine/hydroxychloroquine to treat COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282502
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
No established treatment is currently available; however, several therapies, including remdesivir, hydroxychloroquine and chloroquine, and interleukin (IL)-6 inhibitors, are being used off-label and evaluated in ongoing clinical trials.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282982
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Hydroxychloroquine (HCQ) was used by 78.1% of respondents; azithromycin by 46.9%; tocilizumab by 31.3%, and remdesivir by 25.0%.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32285930
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Hydroxychloroquine (HCQ) is a promising candidate for Coronavirus Disease of 2019 (COVID-19) treatment.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32289548
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We conducted an uncontrolled non-comparative observational study in a cohort of 80 relatively mildly infected inpatients treated with a combination of hydroxychloroquine and azithromycin over a period of at least three days, with three main measurements: clinical outcome, contagiousness as assessed by PCR and culture, and length of stay in infectious disease unit (IDU).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32290293
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The initial clinical studies revealed the promising therapeutic potential of several of such drugs, including &lt;i&gt;favipiravir&lt;/i&gt;, a broad-spectrum antiviral drug that interferes with the viral replication, and &lt;i&gt;hydroxychloroquine&lt;/i&gt;, the repurposed antimalarial drug that interferes with the virus endosomal entry pathway.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292817
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Our coalition of public health experts, doctors, and scientists worldwide want to draw attention to the need for high-quality evaluation protocols of the potential beneficial effect of hydroxychloroquine (HCQ) as a post-exposure drug for exposed people, meaning people with close contact with positive tested patients, including home and medical caregivers.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292908
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;i&gt;This paper provides an overview of the current global market and manufacturing landscape for hydroxychloroquine (HCQ). &lt;/i&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292909
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
For this emergency, the FDA has approved Remdesivir and Hydroxychloroquine for treatment of COVID-19 as Emergency Use Authorization.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293710
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
It is also allows consideration of agents, such as hydroxychloroquine, which may interfere with this overly brisk macrophage inflammatory response and perhaps influence the course of the disease, in particular those that blunt but do not completely abrogate the M1 to M2 balance in macrophage polarization, as well as viral load, which in SARS appears to be temporally related to the onset of ARDS.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293834
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The most frequently used agents both in Turkey and all over the world including chloroquine, hydroxychloroquine, lopinavir/ritonavir, favipiravir and remdesivir will be reviewed here .
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294807
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
At present, there are no studies demonstrating the clinical efficacy of hydroxychloroquine for the prophylaxis or treatment of COVID-19 infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HYPOCHLORITE</title>
      <link>/drugpanel/hypochlorite/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/hypochlorite/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db11123&#39; target=&#39;_blank&#39;&gt;db11123&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=hypochlorite&#34; target=&#34;_blank&#34;&gt;hypochlorite&lt;/a&gt; &lt;br&gt;
Synonymous :hypochlorit
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;hypochlorite&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32035997
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The analysis of 22 studies reveals that human coronaviruses such as Severe Acute Respiratory Syndrome (SARS) coronavirus, Middle East Respiratory Syndrome (MERS) coronavirus or endemic human coronaviruses (HCoV) can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 62-71% ethanol, 0.5% hydrogen peroxide or 0.1% sodium hypochlorite within 1 minute.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32116147
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Using data obtained from similar coronaviruses, e.g. severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), experts are confident that 70% ethanol and 0.1% sodium hypochlorite should inactivate the virus.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32232986
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The results showed that instant hand wiping using a wet towel soaked in water containing 1.00% soap powder, 0.05% active chlorine, or 0.25% active chlorine from sodium hypochlorite removed 98.36%, 96.62%, and 99.98% of the virus from hands, respectively.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IBUPROFEN</title>
      <link>/drugpanel/ibuprofen/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/ibuprofen/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01050&#39; target=&#39;_blank&#39;&gt;db01050&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=ibuprofen&#34; target=&#34;_blank&#34;&gt;ibuprofen&lt;/a&gt; &lt;br&gt;
Synonymous :(±)-2-(p-isobutylphenyl)propionic acid | (±)-ibuprofen | (±)-p-isobutylhydratropic acid | (±)-α-methyl-4-(2-methylpropyl)benzeneacetic acid | (4-isobutylphenyl)-α-methylacetic acid | (rs)-ibuprofen | 2-(4-isobutylphenyl)propanoic acid | 4-isobutylhydratropic acid | ibuprofen | ibuprofene | ibuprofeno | ibuprofenum | ibuprophen | α-(4-isobutylphenyl)propionic acid | α-(p-isobutylphenyl)propionic acid
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;ibuprofen&lt;/em&gt; gene in 3 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247213
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Search terms were, COVID-19, treatment of coronavirus, COVID 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ACE-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease. […] We discuss evidence regarding role of chloroquine and hydroxychloroquine in treatment and prophylaxis, use of inhibitors of the renin angiotensin system, safety of ibuprofen, unusual clinical features like gastrointestinal symptoms and interpretation of tests for cardiac enzymes and biomarkers.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32269893
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lastly, the current scientific data and status of governing bodies such as the Center of Disease Control (CDC) and the WHO on the usage of controversial therapies such as angiotensin-converting enzyme (ACE) inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs) (Ibuprofen), and corticosteroids usage in COVID-19 are discussed.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277367
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Angiotensin converting enzyme 2 (ACE2) appears important for viral entry into pneumocytes; dysbalance in ACE2 as caused by ACE inhibitors or ibuprofen may predispose to severe disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>INDINAVIR</title>
      <link>/drugpanel/indinavir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/indinavir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00224&#39; target=&#39;_blank&#39;&gt;db00224&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=indinavir&#34; target=&#34;_blank&#34;&gt;indinavir&lt;/a&gt; &lt;br&gt;
Synonymous :(1(1s,2r),5(s))-2,3,5-trideoxy-n-(2,3-dihydro-2-hydroxy-1h-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-d-erythro-pentonamide | indinavir | indinavir anhydrous
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;indinavir&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294562
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Several antiviral medications: Zanamivir, Indinavir, Saquinavir, and Remdesivir show potential as and 3CL&lt;sup&gt;PRO&lt;/sup&gt; main proteinase inhibitors and as a treatment of COVID-19. […] Zanamivir, Indinavir, Saquinavir, and Remdesivir are among the exciting hits on the 3CL&lt;sup&gt;PRO&lt;/sup&gt; main proteinase.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>INDIRUBIN</title>
      <link>/drugpanel/indirubin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/indirubin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db12379&#39; target=&#39;_blank&#39;&gt;db12379&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=indirubin&#34; target=&#34;_blank&#34;&gt;indirubin&lt;/a&gt; &lt;br&gt;
Synonymous :couroupitine b | indirubin
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;indirubin&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32120929
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The methanol extract of &lt;i&gt;S. cusia&lt;/i&gt; leaf contains chemical components such as β-sitosterol, indirubin, tryptanthrin, betulin, indigodole A, and indigodole B that have diverse biological activities.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>INOSITOL</title>
      <link>/drugpanel/inositol/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/inositol/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db13178&#39; target=&#39;_blank&#39;&gt;db13178&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=inositol&#34; target=&#34;_blank&#34;&gt;inositol&lt;/a&gt; &lt;br&gt;
Synonymous :1,2,3,5/4,6-cyclohexanehexol | cis-1,2,3,5-trans-4,6-cyclohexanehexol | inositol | l-myo-inositol | meat sugar | meso-inositol | myo-inositol
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;inositol&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32271462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Here we assess the potential utility of myo-Inositol, a polyol already in use for treating the newborn Respiratory Distress Syndrome, in downregulating the inflammatory response upon Sars-CoV-2 infection. […] Myo-Inositol proved to reduce IL-6 levels in a number of conditions and to mitigate the inflammatory cascade, while being devoid of any significant side effects. […] It is tempting to speculate that inositol could be beneficial in managing the most dreadful effects of Sars-CoV-2 infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IODINE</title>
      <link>/drugpanel/iodine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/iodine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db05382&#39; target=&#39;_blank&#39;&gt;db05382&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=iodine&#34; target=&#34;_blank&#34;&gt;iodine&lt;/a&gt; &lt;br&gt;
Synonymous :diiodine | i2 | iodo | jod | molecular iodine
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;iodine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32217947
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;ol start=&#34;3&#34; style=&#34;list-style-type: decimal&#34;&gt;
&lt;li&gt;Decolonize patients using pre-procedural chlorhexidine wipes, 2 doses of nasal povidone iodine within one hour of incision, and chlorhexidine mouth rinse.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IPECAC</title>
      <link>/drugpanel/ipecac/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/ipecac/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db13293&#39; target=&#39;_blank&#39;&gt;db13293&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=ipecac&#34; target=&#34;_blank&#34;&gt;ipecac&lt;/a&gt; &lt;br&gt;
Synonymous :ipecac syrup | ipecacuanha | ipsatol
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;ipecac&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32245264
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This article presents the rationale for potentially using old drugs (emetine, other ipecac alkaloids or analogues) that have been used to treat amoebiasis in the treatment of COVID-19. […] Given the serious and immediate threat that the COVID-19 coronavirus poses, our long history with emetine and the likely ability of emetine to reach therapeutic concentrations within the lungs, ipecac, emetine, and other analogues should be considered as potential treatment options, especially if in vitro studies confirm viral sensitivity.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IRON</title>
      <link>/drugpanel/iron/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/iron/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01592&#39; target=&#39;_blank&#39;&gt;db01592&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=iron&#34; target=&#34;_blank&#34;&gt;iron&lt;/a&gt; &lt;br&gt;
Synonymous :carbonyl iron | eisen | electrolytic iron | fe | fer | ferrum | ferrum metallicum | hierro | iron powder | iron, carbonyl | iron, electrolytic | iron, elemental | iron, reduced | reduced iron
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;iron&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32270515
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We concluded that rhEPO could attenuate respiratory distress syndrome and confront the SARS-CoV-2 virus through multiple mechanisms including cytokine modulation, anti-apoptotic effects, leukocyte release from bone marrow, and iron redistribution away from the intracellular virus.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ISOLEUCINE</title>
      <link>/drugpanel/isoleucine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/isoleucine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00167&#39; target=&#39;_blank&#39;&gt;db00167&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=isoleucine&#34; target=&#34;_blank&#34;&gt;isoleucine&lt;/a&gt; &lt;br&gt;
Synonymous :(2s,3s)-2-amino-3-methylpentanoic acid | 2-amino-3-methylvaleric acid | alpha-amino-beta-methylvaleric acid | ile | isoleucina | isoleucine | isoleucinum | l-isoleucine | α-amino-β-methylvaleric acid
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;isoleucine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32083328
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Position 723 in the COVID-2019 has a serine instead a glycine residue, while at aminoacidic position 1010 a proline instead an isoleucine.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IVERMECTIN</title>
      <link>/drugpanel/ivermectin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/ivermectin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00602&#39; target=&#39;_blank&#39;&gt;db00602&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=ivermectin&#34; target=&#34;_blank&#34;&gt;ivermectin&lt;/a&gt; &lt;br&gt;
Synonymous :ivermectin | ivermectina | ivermectine | ivermectinum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;ivermectin&lt;/em&gt; gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251768
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM cells 2 hours post infection with SARS-CoV-2 able to effect ∼5000-fold reduction in viral RNA at 48 h. […] Ivermectin therefore warrants further investigation for possible benefits in humans.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293834
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Nitazoxanide and ivermectin were also included in this review as they have recently been reported to have an activity against SARS-CoV-2 in-vitro and are licensed for the treatment of some other human infections.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>KALETRA</title>
      <link>/drugpanel/kaletra/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/kaletra/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=kaletra&#34; target=&#34;_blank&#34;&gt;kaletra&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;kaletra&lt;/em&gt; gene in 3 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32037389
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
All the patients were given antiviral treatment including lopinavir/ritonavir (Kaletra&lt;sup&gt;®&lt;/sup&gt;), arbidol, and Shufeng Jiedu Capsule (SFJDC, a traditional Chinese medicine) and other necessary support care.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32056407
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Interestingly, after lopinavir/ritonavir (Kaletra, AbbVie) was administered, β-coronavirus viral loads significantly decreased and no or little coronavirus titers were observed.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32198776
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
All patients received antiviral therapy (135 [100%]) (Kaletra and interferon were both used), antibacterial therapy (59 [43.7%]), and corticosteroids (36 [26.7%]). […] It is suggested that patients should receive Kaletra early and should be treated by a combination of Western and Chinese medicines. […] Kaletra and TCM played an important role in the treatment of the viral pneumonia. […] Further studies are required to explore the role of Kaletra and TCM in the treatment of COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32280433
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In addition, we also found that several antiviral agents, such as Kaletra (lopinavir/ritonavir), could be used for the treatment of SARS-CoV-2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>LANINAMIVIR</title>
      <link>/drugpanel/laninamivir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/laninamivir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db12791&#39; target=&#39;_blank&#39;&gt;db12791&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=laninamivir&#34; target=&#34;_blank&#34;&gt;laninamivir&lt;/a&gt; &lt;br&gt;
Synonymous :laninamivir | laninamivirum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;laninamivir&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251791
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
He saw doctors nearby twice (day2 and 5) and was prescribed Laninamivir and antipyretic agents, His family visited his home and found that he was unconsciousness and lying on the floor in his vomit.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>LEDIPASVIR</title>
      <link>/drugpanel/ledipasvir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/ledipasvir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db09027&#39; target=&#39;_blank&#39;&gt;db09027&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=ledipasvir&#34; target=&#34;_blank&#34;&gt;ledipasvir&lt;/a&gt; &lt;br&gt;
Synonymous :ledipasvir | lédipasvir | ledipasvirum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;ledipasvir&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32194944
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among these, the antivirals ledipasvir or velpatasvir are particularly attractive as therapeutics to combat the new coronavirus with minimal side effects, commonly fatigue and headache. […] The drugs Epclusa (velpatasvir/sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) could be very effective owing to their dual inhibitory actions on two viral enzymes.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>LEUCINE</title>
      <link>/drugpanel/leucine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/leucine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00149&#39; target=&#39;_blank&#39;&gt;db00149&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=leucine&#34; target=&#34;_blank&#34;&gt;leucine&lt;/a&gt; &lt;br&gt;
Synonymous :(2s)-2-amino-4-methylpentanoic acid | (2s)-alpha-2-amino-4-methylvaleric acid | (2s)-alpha-leucine | (s)-(+)-leucine | (s)-leucine | 2-amino-4-methylvaleric acid | l | l-leucin | l-leucine | l-leuzin | leu | leucine
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;leucine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32027036
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Despite the low heterogeneity of the 2019-nCoV genomes, we could identify at least two hypervariable genomic hotspots, one of which is responsible for a Serine/Leucine variation in the viral ORF8-encoded protein.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>LEVOFLOXACIN</title>
      <link>/drugpanel/levofloxacin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/levofloxacin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01137&#39; target=&#39;_blank&#39;&gt;db01137&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=levofloxacin&#34; target=&#34;_blank&#34;&gt;levofloxacin&lt;/a&gt; &lt;br&gt;
Synonymous :(-)-ofloxacin | (3s)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid | (s)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid | (s)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid | (s)-ofloxacin | l-ofloxacin | levofloxacin | levofloxacin anhydrous | levofloxacine | levofloxacino | levofloxacinum | ofloxacin s-(-)-form
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;levofloxacin&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32157862
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Three days later, levofloxacin was started because the patient’s symptoms did not improve.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>LOPINAVIR</title>
      <link>/drugpanel/lopinavir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/lopinavir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01601&#39; target=&#39;_blank&#39;&gt;db01601&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=lopinavir&#34; target=&#34;_blank&#34;&gt;lopinavir&lt;/a&gt; &lt;br&gt;
Synonymous :lopinavir
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;lopinavir&lt;/em&gt; gene in 35 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
31996494
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lopinavir /Ritonavir, Nucleoside analogues, Neuraminidase inhibitors, Remdesivir, peptide (EK1), abidol, RNA synthesis inhibitors (such as TDF, 3TC), anti-inflammatory drugs (such as hormones and other molecules), Chinese traditional medicine, such ShuFengJieDu Capsules and Lianhuaqingwen Capsule, could be the drug treatment options for 2019-nCoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32023685
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32037389
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
All the patients were given antiviral treatment including lopinavir/ritonavir (Kaletra&lt;sup&gt;®&lt;/sup&gt;), arbidol, and Shufeng Jiedu Capsule (SFJDC, a traditional Chinese medicine) and other necessary support care. […] The efficacy of antiviral treatment including lopinavir/ritonavir, arbidol, and SFJDC warrants further verification in future study.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32056407
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Interestingly, after lopinavir/ritonavir (Kaletra, AbbVie) was administered, β-coronavirus viral loads significantly decreased and no or little coronavirus titers were observed.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32057209
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Combination of Ribavirin and Interferon-α is recommended by the 5(th) edition National Health Commission’s Regimen (Revised Edition) because of the effect on MERS (Middle East Respiratory Syndrome), and the effectiveness of Lopinavir/Ritonavir and Remdisivir needs to be confirmed by randomized controlled trial (RCT), given the situation of no specific antivirus drug on NCP is unavailable.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32062875
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Twenty patients were treated with lopinavir and ritonavir.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32096367
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Early antiviral treatment could alleviate disease severity and prevent illness progression, and we found lopinavir/ritonavir combined with abidol showed antiviraleffects in COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32104907
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lopinavir (LPV) is an effective agent that inhibits the protease activity of coronavirus.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32125362
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Clinical course was summarized, including requirement for supplemental oxygen and intensive care and use of empirical treatment with lopinavir-ritonavir. […] Five individuals requiring supplemental oxygen were treated with lopinavir-ritonavir. […] Four of the 5 patients treated with lopinavir-ritonavir developed nausea, vomiting, and/or diarrhea, and 3 developed abnormal liver function test results.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32138488
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Management is primarily supportive, with newer antivirals (lopinavir ritonavir and Remdesivir) under investigation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32152082
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In addition, a combination of the human immunodeficiency virus type 1 (HIV-1) protease inhibitors, lopinavir/ritonavir, and interferon beta (LPV/RTV-INFb) were shown to be effective in patients infected with SARS-CoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32164424
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Similar to outbreaks of other newly identified virus, there is no proven regimen from conventional medicine and most reports managed the patients with lopinavir/ritonavir, ribavirin, beta-interferon, glucocorticoid and supportive treatment with remdesivir undergoing clinical trial.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32171866
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The Lopinavir and Ritonavir Tablets, Chinese medicine, oxygen therapy, and mechanical ventilation were statistically different in the elderly group and the young and middle-aged group, and the P values were all &amp;lt;0.05.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32171872
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We aimed to compare arbidol and lopinavir/ritonavir(LPV/r) treatment for patients with COVID-19 with LPV/r only.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32173576
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To explore the epidemiological information, clinical characteristics, therapeutic outcomes and temporal progression of laboratory findings in 2019-coronavirus disease (COVID-19) patients exposed to lopinavir. […] All cases (three transferred, seven discharged) exposed to lopinavir on initial hospitalization. […] Three patients stopped lopinavir using because of adverse effect, two of them deteriorated, one hospitalized longer than others who with sustained lopinavir using. […] The COVID-19 patients may benefit from sustained lopinavir using.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32179150
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Chloroquine, remdesivir, lopinavir, ribavirin and ritonavir have shown efficacy to inhibit coronavirus in vitro.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32187464
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Patients were randomly assigned in a 1:1 ratio to receive either lopinavir-ritonavir (400 mg and 100 mg, respectively) twice a day for 14 days, in addition to standard care, or standard care alone. […] A total of 199 patients with laboratory-confirmed SARS-CoV-2 infection underwent randomization; 99 were assigned to the lopinavir-ritonavir group, and 100 to the standard-care group. […] Treatment with lopinavir-ritonavir was not associated with a difference from standard care in the time to clinical improvement (hazard ratio for clinical improvement, 1.24; 95% confidence interval [CI], 0.90 to 1.72). […] Mortality at 28 days was similar in the lopinavir-ritonavir group and the standard-care group (19.2% vs. […] In a modified intention-to-treat analysis, lopinavir-ritonavir led to a median time to clinical improvement that was shorter by 1 day than that observed with standard care (hazard ratio, 1.39; 95% CI, 1.00 to 1.91). […] Gastrointestinal adverse events were more common in the lopinavir-ritonavir group, but serious adverse events were more common in the standard-care group. […] Lopinavir-ritonavir treatment was stopped early in 13 patients (13.8%) because of adverse events. […] In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir-ritonavir treatment beyond standard care.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32202256
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In view of the earlier evidence about effectiveness of repurposed lopinavir/ritonavir against severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronavirus (CoV), as well as preliminary docking studies conducted by the ICMR-National Institute of Virology, Pune, the Central Drugs Standard Control Organization approved the restricted public health use of lopinavir/ritonavir combination amongst symptomatic COVID-19 patients detected in the country. […] Hospitalized adult patients with laboratory-confirmed SARS-CoV-2 infection with any one of the following criteria will be eligible to receive lopinavir/ritonavir for 14 days after obtaining written informed consent: (i) respiratory distress with respiratory rate ≥22/min or SpO2 of &amp;lt;94 per cent; (ii) lung parenchymal infiltrates on chest X-ray; (iii) hypotension defined as systolic blood pressure &amp;lt;90 mmHg or need for vasopressor/inotropic medication; (iv) new-onset organ dysfunction; and (v) high-risk groups - age &amp;gt;60 yr, diabetes mellitus, renal failure, chronic lung disease and immunocompromised persons.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32210741
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Our results showed that several HIV inhibitors such as lopinavir, ritonavir, and saquinavir produce strong interaction with the active site of SARS-CoV-2 main protease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32219357
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
She was treated with dobutamine, antiviral drugs (lopinavir/ritonavir), steroids, chloroquine, and medical treatment for heart failure, with progressive clinical and instrumental stabilization.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32220650
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
All children received interferon alfa by aerosolisation twice a day, 14 (39%) received lopinavir-ritonavir syrup twice a day, and six (17%) needed oxygen inhalation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32227274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Furthermore, COVID-19 mRNA clearance time was positively correlated with the length of hospital stay in patients treated with either IFN-α + lopinavir/ritonavir or IFN-α + lopinavir/ritonavir + ribavirin. […] Therapeutic regimens of IFN-α + lopinavir/ritonavir and IFN-α + lopinavir/ritonavir + ribavirin might be beneficial for treatment of COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243270
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This review summarizes the current evidence of potential therapeutic agents, such as lopinavir/ritonavir, remdesivir, favipiravir, chloroquine, hydroxychloroquine, interferon, ribavirin, tocilizumab and sarilumab.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32246834
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In addition to the recommended antiviral drugs such as interferon-ɑ, lopinavir/ritonavir, ribavirin, and chloroquine phosphate, some clinical trials focusing on virus RNA dependent RNA polymerase (RdRp) inhibitors have been registered and initiated.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251767
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We report the antiviral effect of remdesivir, lopinavir, homorringtonine, and emetine against SARS-CoV-2 virus in Vero E6 cells with the estimated 50% effective concentration at 23.15 μM, 26.63 μM, 2.55 μM and 0.46 μM, respectively.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32256547
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We identified 24 clinical trials, involving more than 20 medicines, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, methylprednisolone, bevacizumab, and traditional Chinese medicines (TCM). […] Se identificaron 24 ensayos clínicos relacionados con más de 20 medicamentos, como inmunoglobulina humana, interferones, cloroquina, hidroxicloroquina, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, metilprednisolona, bevacizumab y medicina tradicional china. […] Foram identificados 24 ensaios clínicos envolvendo mais de 20 medicamentos, tais como imunoglobulina humana, interferons, cloroquina, hidroxicloroquina, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, metilprednisolona, bevacizumabe e medicamentos chineses tradicionais.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32271456
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The study aimed to investigate whether lopinavir/ritonavir (LPV/r) in combination with other pneumonia-associated adjuvant drugs has a better therapeutic effect on COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277367
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Antiviral drugs like lopinavir/ritonavir, favipiravir and remdesivir are also being explored.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277555
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This case states the importance of close monitoring of the concentration of ciclosporin in patients treated with lopinavir/ritonavir, routine treatment of corticosteroid can be continued.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32279418
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Hydroxychloroquine and lopinavir/ritonavir were started, and the antiviral drug was replaced with darunavir/cobicistat after two days for diarrhea.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32280433
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Interestingly, lopinavir, ritonavir, and darunavir are all designed to target viral proteinases. […] In addition, we also found that several antiviral agents, such as Kaletra (lopinavir/ritonavir), could be used for the treatment of SARS-CoV-2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283143
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lopinavir/ritonavir and arbidol have been previously used to treat acute respiratory syndrome- coronavirus 2 (SARS-CoV-2) replication in clinical practice; nevertheless, their effectiveness remains controversial. […] In this study, we evaluated the antiviral effects and safety of lopinavir/ritonavir and arbidol in patients with the 2019-nCoV disease (COVID-19). […] Fifty patients with laboratory-confirmed COVID-19 were divided into two groups: including lopinavir/ritonavir group (34 cases) and arbidol group (16 cases). […] Lopinavir/ritonavir group received 400mg/100mg of Lopinavir/ritonavir, twice a day for a week, while the arbidol group was given 0.2g arbidol, three times a day. […] On day 14 after the admission, no viral load was detected in arbidol group, but the viral load was found in 15(44.1%) patients treated with lopinavir/ritonavir. […] Patients in the arbidol group had a shorter duration of positive RNA test compared to those in the lopinavir/ritonavir group (P&amp;lt;0.01). […] In conclusion, our data indicate that arbidol monotherapy may be superior to lopinavir/ritonavir in treating COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283325
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
There was no statistical difference between groups in medications taken before hospitalization; a significantly higher proportion of patients with abnormal liver function (57.8%) had received lopinavir/ritonavir after admission compared to patients with normal liver function (31.3%). […] A significantly higher proportion of patients with abnormal liver function had received lopinavir/ritonavir after admission; these drugs should be given with caution.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293834
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The most frequently used agents both in Turkey and all over the world including chloroquine, hydroxychloroquine, lopinavir/ritonavir, favipiravir and remdesivir will be reviewed here .
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293875
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
However, a combination of two HIV-1 protease inhibitors lopinavir and ritonavir has been found to be effective against SARS-CoV, and both drugs could bind well to the SARS-CoV 3C-like protease (SARS-CoV 3CL&lt;sup&gt;pro&lt;/sup&gt;). […] Ritonavir showed somewhat higher atomic contacts, binding efficiency and key binding residues than that of lopinavir in correspondence with slightly less water accessibility at the 3CL&lt;sup&gt;pro&lt;/sup&gt; active site.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>LOSARTAN</title>
      <link>/drugpanel/losartan/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/losartan/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00678&#39; target=&#39;_blank&#39;&gt;db00678&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=losartan&#34; target=&#34;_blank&#34;&gt;losartan&lt;/a&gt; &lt;br&gt;
Synonymous :(2-butyl-4-chloro-1-{[2’-(1h-tetrazol-5-yl)biphenyl-4-yl]methyl}-1h-imidazol-5-yl)methanol | 2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2’-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole | losartan
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;losartan&lt;/em&gt; gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32129518
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A tentative suggestion based on existing therapeutics, which would likely be resistant to new coronavirus mutations, is to use available angiotensin receptor 1 (AT1R) blockers, such as losartan, as therapeutics for reducing the aggressiveness and mortality from SARS-CoV-2 virus infections.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32213760
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensive drug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin II receptor blockers (e.g. losartan), many patients from South America, Central America or Spain, have stopped or intend to interrupt their treatments with these drugs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32222713
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
He has hypertension controlled with angiotensin receptor blocker losartan 100 mg/day and coronary artery disease status-post stent placement. […] Losartan was withheld due to hypotension and septic shock.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>MEFLOQUINE</title>
      <link>/drugpanel/mefloquine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/mefloquine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00358&#39; target=&#39;_blank&#39;&gt;db00358&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=mefloquine&#34; target=&#34;_blank&#34;&gt;mefloquine&lt;/a&gt; &lt;br&gt;
Synonymous :[(r&lt;em&gt;,s&lt;/em&gt;)-2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol | alpha-2-piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol | mefloquin | mefloquina | méfloquine | mefloquine | mefloquinum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;mefloquine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32149769
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Three drugs-cepharanthine (CEP), selamectin and mefloquine hydrochloride exhibited complete inhibition of cytopathic effects in cell culture at 10 μmol/L. […] CEP, selamectin and mefloquine hydrochloride are potential drugs for treating 2019-nCoV infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>MELATONIN</title>
      <link>/drugpanel/melatonin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/melatonin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01065&#39; target=&#39;_blank&#39;&gt;db01065&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=melatonin&#34; target=&#34;_blank&#34;&gt;melatonin&lt;/a&gt; &lt;br&gt;
Synonymous :5-methoxy-n-acetyltryptamine | melatonin | melatonina | mélatonine | n-[2-(5-methoxyindol-3-yl)ethyl]acetamide | n-acetyl-5-methoxytryptamine
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;melatonin&lt;/em&gt; gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32194980
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Using network proximity analyses of drug targets and HCoV-host interactions in the human interactome, we prioritize 16 potential anti-HCoV repurposable drugs (e.g., melatonin, mercaptopurine, and sirolimus) that are further validated by enrichment analyses of drug-gene signatures and HCoV-induced transcriptomics data in human cell lines. […] We further identify three potential drug combinations (e.g., sirolimus plus dactinomycin, mercaptopurine plus melatonin, and toremifene plus emodin) captured by the “&lt;i&gt;Complementary Exposure&lt;/i&gt;” pattern: the targets of the drugs both hit the HCoV-host subnetwork, but target separate neighborhoods in the human interactome network.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32217117
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This article summarizes the likely benefits of melatonin in the attenuation of COVID-19 based on its putative pathogenesis. […] Melatonin, a well-known anti-inflammatory and anti-oxidative molecule, is protective against ALI/ARDS caused by viral and other pathogens. […] Melatonin is effective in critical care patients by reducing vessel permeability, anxiety, sedation use, and improving sleeping quality, which might also be beneficial for better clinical outcomes for COVID-19 patients. […] Notably, melatonin has a high safety profile. […] There is significant data showing that melatonin limits virus-related diseases and would also likely be beneficial in COVID-19 patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>MERCAPTOPURINE</title>
      <link>/drugpanel/mercaptopurine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/mercaptopurine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01033&#39; target=&#39;_blank&#39;&gt;db01033&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=mercaptopurine&#34; target=&#34;_blank&#34;&gt;mercaptopurine&lt;/a&gt; &lt;br&gt;
Synonymous :6 mp | 6-mercaptopurine | 6-mp | 6-thiohypoxanthine | 6-thioxopurine | mercaptopurina | mercaptopurine | mercaptopurine anhydrous | mercaptopurinum | mercapurin
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;mercaptopurine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32194980
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Using network proximity analyses of drug targets and HCoV-host interactions in the human interactome, we prioritize 16 potential anti-HCoV repurposable drugs (e.g., melatonin, mercaptopurine, and sirolimus) that are further validated by enrichment analyses of drug-gene signatures and HCoV-induced transcriptomics data in human cell lines. […] We further identify three potential drug combinations (e.g., sirolimus plus dactinomycin, mercaptopurine plus melatonin, and toremifene plus emodin) captured by the “&lt;i&gt;Complementary Exposure&lt;/i&gt;” pattern: the targets of the drugs both hit the HCoV-host subnetwork, but target separate neighborhoods in the human interactome network.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>METHIONINE</title>
      <link>/drugpanel/methionine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/methionine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00134&#39; target=&#39;_blank&#39;&gt;db00134&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=methionine&#34; target=&#34;_blank&#34;&gt;methionine&lt;/a&gt; &lt;br&gt;
Synonymous :(2s)-2-amino-4-(methylsulfanyl)butanoic acid | (s)-2-amino-4-(methylthio)butanoic acid | (s)-2-amino-4-(methylthio)butyric acid | (s)-methionine | l-(−)-methionine | l-a-amino-g-methylthiobutyric acid | l-methionin | l-methionine | l-α-amino-γ-methylmercaptobutyric acid | m | met | methionine
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;methionine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32228827
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
All differentially expressed genes were introduced into the SREING online analysis website for protein interaction network analysis, and core genes such as signal transducer and activator of transcription 3, IL-10, IL17, TNF, interferon regulatory factor 9, 2’-5’-oligoadenylate synthetase 1, mitogen-activated protein kinase 3, radical s-adenosyl methionine domain containing 2, c-x-c motif chemokine ligand 10, caspase 3 and other genes were screened.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>METHOTREXATE</title>
      <link>/drugpanel/methotrexate/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/methotrexate/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00563&#39; target=&#39;_blank&#39;&gt;db00563&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=methotrexate&#34; target=&#34;_blank&#34;&gt;methotrexate&lt;/a&gt; &lt;br&gt;
Synonymous :4-amino-10-methylfolic acid | 4-amino-n(10)-methylpteroylglutamic acid | amethopterin | methotrexat | méthotrexate | methotrexate | methotrexatum | metotrexato | mtx | n-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-l-glutamic acid
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;methotrexate&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32256705
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
There is no definitive evidence that specific cytotoxic drugs, low-dose methotrexate for auto-immune disease, NSAIDs, JAK kinase inhibitors or anti-TNFα agents are contraindicated.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>METHYLPREDNISOLONE</title>
      <link>/drugpanel/methylprednisolone/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/methylprednisolone/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00959&#39; target=&#39;_blank&#39;&gt;db00959&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=methylprednisolone&#34; target=&#34;_blank&#34;&gt;methylprednisolone&lt;/a&gt; &lt;br&gt;
Synonymous :(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione | 1-dehydro-6α-methylhydrocortisone | 6α-methyl-11β,17α,21-triol-1,4-pregnadiene-3,20-dione | delta(1)-6alpha-methylhydrocortisone | methylprednisolon | methylprednisolone | methylprednisolonum | metilprednisolona
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;methylprednisolone&lt;/em&gt; gene in 11 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32149773
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Each eligible subject will be assigned to an intervention group (methylprednisolone via intravenous injection at a dose of 1-2mg/kg/day for 3 days) or a control group (no glucocorticoid use) randomly, at a 1:1 ratio.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32167524
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among patients with ARDS, treatment with methylprednisolone decreased the risk of death (HR, 0.38; 95% CI, 0.20-0.72). […] Moreover, treatment with methylprednisolone may be beneficial for patients who develop ARDS.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32181990
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Following a treatment regimen consisting of reduced immunosuppressant use and low dose methylprednisolone-based therapy, the COVID-19 pneumonia in this long-term immunosuppressive patient was successfully recovered.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32211844
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Finally, Higher rates of ICU admission (9.56% vs 1.38%, P&amp;lt;0.001) and methylprednisolone application (28.68% vs 9.36%, P&amp;lt;0.001) were also identified in older patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32219428
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
All 5 patients (age range, 36-65 years; 2 women) were receiving mechanical ventilation at the time of treatment and all had received antiviral agents and methylprednisolone.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32229257
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In severe COVID-19 patients, early and short-term use of low-dose methylprednisolone was beneficial and did not delay SARS-CoV-2 RNA clearance and influence IgG antibody production.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243690
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Based on the severity of clinical symptoms, chest computer tomography findings and SARS-Cov-2 RNA test results, we admitted the husband to the respiratory intensive care unit (RICU) and used a treatment consisting of immunosuppressant reduction/cessation and low dose methylprednisolone-based therapy, and his wife to the respiratory isolation ward.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243697
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
After the diagnosis of COVID-19, immunosuppressive agents were discontinued and methylprednisolone with prophylactic antibiotics were initiated, however, the lung injury progressed.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253759
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The TCZ was used in combination with methylprednisolone in eight patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32256547
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We identified 24 clinical trials, involving more than 20 medicines, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, methylprednisolone, bevacizumab, and traditional Chinese medicines (TCM).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282986
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Following a treatment regimen consisting of discontinued immunosuppressant use and low-dose methylprednisolone-based therapy, the patient developed acute rejection but eventually recovered.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>METRONIDAZOLE</title>
      <link>/drugpanel/metronidazole/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/metronidazole/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00916&#39; target=&#39;_blank&#39;&gt;db00916&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=metronidazole&#34; target=&#34;_blank&#34;&gt;metronidazole&lt;/a&gt; &lt;br&gt;
Synonymous :1-(2-hydroxy-1-ethyl)-2-methyl-5-nitroimidazole | 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole | 1-(β-ethylol)-2-methyl-5-nitro-3-azapyrrole | 1-(β-hydroxyethyl)-2-methyl-5-nitroimidazole | 1-(β-oxyethyl)-2-methyl-5-nitroimidazole | 2-methyl-1-(2-hydroxyethyl)-5-nitroimidazole | 2-methyl-3-(2-hydroxyethyl)-4-nitroimidazole | 2-methyl-5-nitroimidazole-1-ethanol | metronidazol | métronidazole | metronidazole | metronidazolum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;metronidazole&lt;/em&gt; gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32259129
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this context, both &lt;i&gt;in vitro&lt;/i&gt; and &lt;i&gt;in vivo&lt;/i&gt; studies have revealed that metronidazole could decrease the levels of several cytokines, which are known to increase during the COVID-19 infection, including interleukin (IL)8, IL6, IL1B, tumor necrosis factor (TNF)α, IL12, IL1α, and interferon (IFN)γ, as well as the levels of C-reactive protein (CRP) and neutrophil count. […] Metronidazole could counteract majority of the immunopathological manifestations of the COVID-19 infection. […] Therefore, studies with a large sample size are required to determine the efficacy of metronidazole in the treatment of COVID-19 infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>MIDAZOLAM</title>
      <link>/drugpanel/midazolam/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/midazolam/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00683&#39; target=&#39;_blank&#39;&gt;db00683&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=midazolam&#34; target=&#34;_blank&#34;&gt;midazolam&lt;/a&gt; &lt;br&gt;
Synonymous :midazolam | midazolamum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;midazolam&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32133829
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Midazolam, Propofol and Morphine or fentanyl were used for sedation and analgesia, avoiding patients cough and agitated during the procedure.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>MORPHINE</title>
      <link>/drugpanel/morphine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/morphine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00295&#39; target=&#39;_blank&#39;&gt;db00295&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=morphine&#34; target=&#34;_blank&#34;&gt;morphine&lt;/a&gt; &lt;br&gt;
Synonymous :(−)-morphine | (5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol | (5alpha,6alpha)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol | (5r,6s,9r,13s,14r)-4,5-epoxy-n-methyl-7-morphinen-3,6-diol | (5α,6α)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol | (5α,6α)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol | (7r,7as,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1h-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol | anhydrous morphine | morfina | morphia | morphin | morphine | morphinum | morphium
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;morphine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32133829
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Midazolam, Propofol and Morphine or fentanyl were used for sedation and analgesia, avoiding patients cough and agitated during the procedure.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293020
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Based on the evidence to date, there are several treatment options to consider for the relief of fever (acetaminophen, NSAID, oral glucocorticoids), cough (morphine), breathlessness (morphine, oxygen, fan), anxiety (benzodiazepines) and pain (NSAID, morphine).
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>MRNA-1273</title>
      <link>/drugpanel/mrna-1273/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/mrna-1273/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db15654&#39; target=&#39;_blank&#39;&gt;db15654&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=mrna-1273&#34; target=&#34;_blank&#34;&gt;mrna-1273&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;mrna-1273&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32234130
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The another vaccine is mRNA-1273 developed by the National Institute of Allergy and Infectious Diseases and Moderna, Inc..
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NICLOSAMIDE</title>
      <link>/drugpanel/niclosamide/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/niclosamide/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db06803&#39; target=&#39;_blank&#39;&gt;db06803&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=niclosamide&#34; target=&#34;_blank&#34;&gt;niclosamide&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;niclosamide&lt;/em&gt; gene in 3 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32125140
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Through a series of drug repurposing screening campaigns, niclosamide, an FDA-approved anthelminthic drug, was found to be effective against various viral infections with nanomolar to micromolar potency such as SARS-CoV, MERS-CoV, ZIKV, HCV, and human adenovirus, indicating its potential as an antiviral agent. […] In this brief review, we summarize the broad antiviral activity of niclosamide and highlight its potential clinical use in the treatment of COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NICOTINAMIDE</title>
      <link>/drugpanel/nicotinamide/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/nicotinamide/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db02701&#39; target=&#39;_blank&#39;&gt;db02701&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=nicotinamide&#34; target=&#34;_blank&#34;&gt;nicotinamide&lt;/a&gt; &lt;br&gt;
Synonymous :3-pyridinecarboxamide | niacinamide | nicotinamida | nicotinamide | nicotinamidum | nicotinic acid amide | nicotinic amide | β-pyridinecarboxamide
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;nicotinamide&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The top 20 drugs in the virtual screening studies comprised a broad-spectrum antiviral (ribavirin), anti-hepatitis B virus (telbivudine), two vitamins (vitamin B12 and nicotinamide) and other miscellaneous systemically acting drugs. […] Ribavirin, telbivudine, vitamin B12 and nicotinamide can be combined and used for COVID treatment.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NICOTINE</title>
      <link>/drugpanel/nicotine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/nicotine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00184&#39; target=&#39;_blank&#39;&gt;db00184&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=nicotine&#34; target=&#34;_blank&#34;&gt;nicotine&lt;/a&gt; &lt;br&gt;
Synonymous :(−)-nicotine | (s)-(−)-nicotine | (s)-3-(1-methylpyrrolidin-2-yl)pyridine | (s)-3-(n-methylpyrrolidin-2-yl)pyridine | (s)-nicotine | 3-(2-(n-methylpyrrolidinyl))pyridine | 3-(n-methylpyrollidino)pyridine | l(−)-nicotine | nicotina | nicotine betadex | nicotine polacrilex | nikotin | nikotyna
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;nicotine&lt;/em&gt; gene in 3 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32189428
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Here, we focus on those individuals who have been exposed to nicotine prior to their exposure to the virus. […] We predict that these individuals are ‘primed’ to be at higher risk because nicotine can directly impact the putative receptor for the virus (ACE2) and lead to deleterious signaling in lung epithelial cells.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32238438
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Moreover, we predict that nicotine exposure through various kinds of smoking (cigarettes, e-cigarettes, or vape) can increase the risk for COVID19 neuroinfection based on known functional interactions between the nicotinic receptor and ACE2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NIFEDIPINE</title>
      <link>/drugpanel/nifedipine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/nifedipine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01115&#39; target=&#39;_blank&#39;&gt;db01115&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=nifedipine&#34; target=&#34;_blank&#34;&gt;nifedipine&lt;/a&gt; &lt;br&gt;
Synonymous :4-(2’-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredimethylester | nifedipine | nifedipino | nifedipinum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;nifedipine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32226695
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Other therapeutics to consider that are also directed towards decreased pulmonary pressure include Nifedipine and Phosphodiesterase inhibitors. […] Acetazolamide, Nifedipine and Phosphodiesterase inhibitors may be potential countermeasures.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NIMESULIDE</title>
      <link>/drugpanel/nimesulide/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/nimesulide/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db04743&#39; target=&#39;_blank&#39;&gt;db04743&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=nimesulide&#34; target=&#34;_blank&#34;&gt;nimesulide&lt;/a&gt; &lt;br&gt;
Synonymous :nimesulida | nimesulide | nimesulidum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;nimesulide&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32268515
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among possible interesting drugs for Covid-19 treatment, we found Nimesulide, Fluticasone Propionate, Thiabendazole, Photofrin, Didanosine and Flutamide.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NITAZOXANIDE</title>
      <link>/drugpanel/nitazoxanide/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/nitazoxanide/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00507&#39; target=&#39;_blank&#39;&gt;db00507&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=nitazoxanide&#34; target=&#34;_blank&#34;&gt;nitazoxanide&lt;/a&gt; &lt;br&gt;
Synonymous :nitaxozanid | nitaxozanide | nitazoxanida | nitazoxanide | nitazoxanidum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;nitazoxanide&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293834
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Nitazoxanide and ivermectin were also included in this review as they have recently been reported to have an activity against SARS-CoV-2 in-vitro and are licensed for the treatment of some other human infections.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NITROGEN</title>
      <link>/drugpanel/nitrogen/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/nitrogen/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db09152&#39; target=&#39;_blank&#39;&gt;db09152&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=nitrogen&#34; target=&#34;_blank&#34;&gt;nitrogen&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;nitrogen&lt;/em&gt; gene in 7 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32229732
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Twelve (10.8%) patients showed mild increase of blood urea nitrogen or creatinine (&amp;lt;26 μmol/L within 48 h), and 8 (7.2%) patients showed trace or 1+ albuminuria in 111 COVID-19-confirmed patients without chronic kidney disease (CKD).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The prevalence of elevated serum creatinine, elevated blood urea nitrogen and estimated glomerular filtration under 60 ml/min/1.73m&lt;sup&gt;2&lt;/sup&gt; were 14.4, 13.1 and 13.1%, respectively. […] Cox proportional hazard regression confirmed that elevated baseline serum creatinine (hazard ratio: 2.10, 95% confidence interval: 1.36-3.26), elevated baseline blood urea nitrogen (3.97, 2.57-6.14), AKI stage 1 (1.90, 0.76-4.76), stage 2 (3.51, 1.49-8.26), stage 3 (4.38, 2.31-8.31), proteinuria 1+ (1.80, 0.81-4.00), 2+∼3+ (4.84, 2.00-11.70), and hematuria 1+ (2.99, 1.39-6.42), 2+∼3+ (5.56,2.58- 12.01) were independent risk factors for in-hospital death after adjusting for age, sex, disease severity, comorbidity and leukocyte count.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32249089
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The most common symptoms on admission to hospital were fever (five patients, 100%), cough (five patients, 100%), myalgia or fatigue (three patients, 60%), and sputum production (three patients, 60%); serum creatinine or urea nitrogen levels were slightly higher than those before symptom onset.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>OSELTAMIVIR</title>
      <link>/drugpanel/oseltamivir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/oseltamivir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00198&#39; target=&#39;_blank&#39;&gt;db00198&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=oseltamivir&#34; target=&#34;_blank&#34;&gt;oseltamivir&lt;/a&gt; &lt;br&gt;
Synonymous :(−)-oseltamivir | 1-cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3r-(3alpha,4beta,5alpha))- | ethyl (3r,4r,5s)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate | oseltamivir | oséltamivir | oseltamivirum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;oseltamivir&lt;/em&gt; gene in 3 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32023685
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32031570
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%]).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32040667
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Oseltamivir is the most widely used neuraminidase inhibitor for treatment of influenza; data suggest that early use is associated with reduced mortality in critically ill patients with influenza.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32196707
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
All patients were given antiviral therapy (including oseltamivir), oxygen inhalation, and antibiotics.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32256547
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We identified 24 clinical trials, involving more than 20 medicines, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, methylprednisolone, bevacizumab, and traditional Chinese medicines (TCM). […] Se identificaron 24 ensayos clínicos relacionados con más de 20 medicamentos, como inmunoglobulina humana, interferones, cloroquina, hidroxicloroquina, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, metilprednisolona, bevacizumab y medicina tradicional china. […] Foram identificados 24 ensaios clínicos envolvendo mais de 20 medicamentos, tais como imunoglobulina humana, interferons, cloroquina, hidroxicloroquina, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, metilprednisolona, bevacizumabe e medicamentos chineses tradicionais.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281114
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Late initiation of remdesivir may be effective in treating SARS-CoV-2, unlike antivirals utilized for different disease states, such as oseltamivir, which are most effective when started as soon as possible following symptom onset.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282022
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Oseltamivir has not been shown to have efficacy, and corticosteroids are currently not recommended.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>OUABAIN</title>
      <link>/drugpanel/ouabain/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/ouabain/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01092&#39; target=&#39;_blank&#39;&gt;db01092&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=ouabain&#34; target=&#34;_blank&#34;&gt;ouabain&lt;/a&gt; &lt;br&gt;
Synonymous :3-(α-l-rhamnopyranosyloxy)-1β,5β,11α,14,19-pentahydroxy-5β-card-20(22)-enolide | g-strophanthin | ouabagenin l-rhamnoside | ouabagenin-l-rhamnosid | ouabain anhydrous | ouabaine | oubain
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;ouabain&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32248575
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this context, some of the natural products have antiviral activity in the nanomolar concentration (e.g., lycorine, homoharringtonine, silvestrol, ouabain, tylophorine and 7-methoxycryptopleurine), and could be leads for further drug development on their own or as a template for drug design.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>OXYGEN</title>
      <link>/drugpanel/oxygen/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/oxygen/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db09140&#39; target=&#39;_blank&#39;&gt;db09140&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=oxygen&#34; target=&#34;_blank&#34;&gt;oxygen&lt;/a&gt; &lt;br&gt;
Synonymous :dioxygen | molecular oxygen | oxigeno gaseoso | oxygen usp | pure oxygen
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;oxygen&lt;/em&gt; gene in 47 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32031570
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Of the 36 cases in the ICU, 4 (11.1%) received high-flow oxygen therapy, 15 (41.7%) received noninvasive ventilation, and 17 (47.2%) received invasive ventilation (4 were switched to extracorporeal membrane oxygenation).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32053470
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Patients with severe respiratory distress and/ or oxygen requirement at any time during the disease course were excluded.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32096367
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Conservative oxygen therapy was preferred and noninvasive ventilation was not recommended.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32105680
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Principles of management of coronavirus disease 2019 in pregnancy include early isolation, aggressive infection control procedures, oxygen therapy, avoidance of fluid overload, consideration of empiric antibiotics (secondary to bacterial infection risk), laboratory testing for the virus and coinfection, fetal and uterine contraction monitoring, early mechanical ventilation for progressive respiratory failure, individualized delivery planning, and a team-based approach with multispecialty consultations.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32112884
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Fever, cough and expectoration were the most common symptoms, 14 patients had decreased oxygen saturation, 33 had leukopenia, 53 had lymphopenia, and 82 had elevated C-reactive protein.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32125362
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Clinical course was summarized, including requirement for supplemental oxygen and intensive care and use of empirical treatment with lopinavir-ritonavir. […] Six individuals (33%) required supplemental oxygen; of these, 2 required intensive care. […] Five individuals requiring supplemental oxygen were treated with lopinavir-ritonavir. […] For 3 of the 5 patients, fever resolved and supplemental oxygen requirement was reduced within 3 days, whereas 2 deteriorated with progressive respiratory failure. […] Some patients required supplemental oxygen and had variable clinical outcomes following treatment with an antiretroviral agent.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32171866
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The Lopinavir and Ritonavir Tablets, Chinese medicine, oxygen therapy, and mechanical ventilation were statistically different in the elderly group and the young and middle-aged group, and the P values were all &amp;lt;0.05.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32173725
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Refractory COVID-19 patients were more likely to receive oxygen, mechanical ventilation, expectorant, and adjunctive treatment including corticosteroid, antiviral drugs and immune enhancer (P&amp;lt;0.05). […] After adjustment, those with refractory COVID-19 were also more likely to have a male sex and manifestations of anorexia and fever on admission, and receive oxygen, expectorant and adjunctive agents (P&amp;lt;0.05) when considering the factors of disease severity on admission, mechanical ventilation, and ICU transfer.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32186172
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Close monitoring of oxygenation, reducing patients’ oxygen consumption, active psychological intervention, and rapidly dealing with severe hypoxemia events are the key factors for the successful treatment of NIV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32187464
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We conducted a randomized, controlled, open-label trial involving hospitalized adult patients with confirmed SARS-CoV-2 infection, which causes the respiratory illness Covid-19, and an oxygen saturation (Sao&lt;sub&gt;2&lt;/sub&gt;) of 94% or less while they were breathing ambient air or a ratio of the partial pressure of oxygen (Pao&lt;sub&gt;2&lt;/sub&gt;) to the fraction of inspired oxygen (Fio&lt;sub&gt;2&lt;/sub&gt;) of less than 300 mm Hg.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32195704
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
So far, actions have been taken including but not limited to nationwide actions and online education regarding special procedures of airway management, oxygen therapy, ventilation support, hemodynamic management, sedation, and analgesia.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32195705
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Timely, but not premature, intubation is crucial to counter a progressively enlarging oxygen debt despite high-flow oxygen therapy and bilevel positive airway pressure ventilation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32196707
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
All patients were given antiviral therapy (including oseltamivir), oxygen inhalation, and antibiotics.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32202343
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Suggested treatment included providing oxygen, inhalations, nutritional support and maintaining fluids and electrolyte balances.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32204751
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Approaching to treat severe respiratory disease in infants and children, the risks related to the development of atelectasis starting invasive or non-invasive ventilation support and the risk of oxygen toxicity must be taken into serious consideration.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32209890
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The blood oxygen saturation was significantly lower in the death group (85 [77, 91]% vs. […] Compared to the recovered group, more patients in the death group exhibited characteristics of advanced age, pre-existing comorbidities, dyspnea, oxygen saturation decrease, increased WBC count, decreased lymphocytes, and elevated CRP levels.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32216961
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Data were gathered regarding the presence of chest computed tomography (CT) abnormalities; the distribution, morphology, density, location, and stage of abnormal shadows on chest CT; and observing the correlation between the severity of chest infection and lymphocyte ratio and blood oxygen saturation (SPO&lt;sub&gt;2&lt;/sub&gt;) in patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32220650
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
All children received interferon alfa by aerosolisation twice a day, 14 (39%) received lopinavir-ritonavir syrup twice a day, and six (17%) needed oxygen inhalation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32221973
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In particular, we describe key elements of clinical management, including: safe oxygen therapy; airway management; personal protective equipment; and non-technical aspects of caring for patients diagnosed with coronavirus disease 2019.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32226287
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Four patients required oxygen therapy but none of them needed machinal ventilation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32226695
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Both COVID-19 and HAPE exhibit a decreased ratio of arterial oxygen partial pressure to fractional inspired oxygen with concomitant hypoxia and tachypnea.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32228825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
One of the COVID-19 treatments involves inhaling a mixture of gaseous hydrogen and oxygen, obtaining better results than with oxygen alone. […] In addition, germicidal UV radiation “breaks down” the oxygen O2 which then aggregate into O3 (ozone) molecules creating the ozone layer, capable of inhibiting viral replication and improving lung respiration.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32232685
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Most of the critically ill patients received high-flow nasal cannula (HFNC) oxygen therapy.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32234250
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Forty-nine patients with COVID-19 requiring supplementary oxygen before surgery had spinal anaesthesia (ropivacaine 0.75%), chiefly for Caesarean section (45/49 [91%]).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32239757
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
During our preparedness for the COVID-19 pandemic we identified that our GE Healthcare anaesthetic machines (GE Healthcare, Amersham Place, Little Chalfont, UK) had a ventilator which was gas-driven, using oxygen. […] This resulted in a large amount of wasted oxygen.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32242348
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Six patients (21.4%) required supplemental oxygen therapy, but no one needed mechanical ventilation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32246843
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
One of the key decisions faced by healthcare systems is in selecting the appropriate devices for oxygen administration. […] The use of high-flow nasal oxygen (HFNO) in COVID-19 is the subject of much debate, relating to the benefits and harms that may result for patients and healthcare workers alike.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32248146
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Healthcare workers are at high risk of contracting the infection particularly when applying respiratory devices such as oxygen cannulas or noninvasive ventilation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32248675
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Only one of the survivors (14%) still required oxygen at 28 days.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32259129
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Furthermore, the drug could decrease neutrophil-generated reactive oxygen species during inflammation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32259899
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
However some individuals develop a more fulminant syndrome including viral pneumonia, respiratory failure requiring oxygen, acute respiratory distress syndrome requiring mechanical ventilation, and in substantial fractions leading to death attributable to COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32267987
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In worldwide, the incubation period of COVID-19 was 3 to 7 days and approximately 80% of infections are mild or asymptomatic, 15% are severe, requiring oxygen, and 5% are critical infections, requiring ventilation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32268019
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We applied HFNC for oxygen therapy in severe and critical COVID-19 patients and summarized the following experiences. […] Thirdly, to avoid hypoxia or hypoxemia, the treatment goal of HFNC should be maintained the oxygen saturation (SpO&lt;sub&gt;2&lt;/sub&gt;) above 95% for patients without chronic pulmonary disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32271454
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Gene Ontology functional enrichment analysis demonstrated that the biological processes altered within the body after taking MXSGD were closely related to the regulation of such processes as the acute inflammatory response, chemokine production, vascular permeability, response to oxygen radicals, oxidative stress-induced apoptosis, T cell differentiation involved in the immune response, immunoglobulin secretion, and extracellular matrix disassembly.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275753
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Levels of their lung lesions, oxygen saturation and heart rates were compared before and after treatment by CT scanning images and patient monitor. […] Improvements of oxygen saturation were observed in 6 clinically severe patients. […] In the 2 patients with critical conditions, the oxygen levels have significantly increased from 79-82% to 91% just about 1 hour after the first inhalation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275812
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Patients were those with confirmed SARS-CoV-2 infection who had an oxygen saturation of 94% or less while they were breathing ambient air or who were receiving oxygen support. […] During a median follow-up of 18 days, 36 patients (68%) had an improvement in oxygen-support class, including 17 of 30 patients (57%) receiving mechanical ventilation who were extubated.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32279418
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Initial symptoms were fatigue, dry cough and coryza; she never had fever nor oxygen supplementation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32286679
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A significant number of patients with pneumonia require passive oxygen therapy. […] Non-invasive ventilation and high-flow nasal oxygen therapy can be applied in mild and moderate non-hypercapnia cases.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32289472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Management is predominantly focused on the provision of supportive care, with oxygen therapy representing the major treatment intervention.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32290644
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
One patient required supplemental oxygen.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292626
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The COS-COVID includes one outcome for the mild type (time to 2019-nCoV reverse transcription-polymerase chain reaction (RT-PCR) negativity), four outcomes for the ordinary type (length of hospital stay, composite events, score of clinical symptoms, and time to 2019-nCoV RT-PCR negativity), five outcomes for the severe type (composite events, length of hospital stay, arterial oxygen partial pressure (PaO&lt;sub&gt;2&lt;/sub&gt;)/fraction of inspired oxygen (FiO&lt;sub&gt;2&lt;/sub&gt;), duration of mechanical ventilation, and time to 2019-nCoV RT-PCR negativity), one outcome for critical type (all-cause mortality), and one outcome for rehabilitation period (pulmonary function).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This consensus included nursing assessment, nursing priorities, nursing goals, and thirteen key points of nursing procedures such as nursing of oxygen therapy and respiratory nursing.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292847
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Fulminant myocarditis due to direct viral infection can certainly occur, but patients with increased oxygen demands due to tachycardia and fever, and reduced oxygen delivery due to hypotension and hypoxemia can cause myocardial injury indirectly.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292866
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This latter stage is characterized by the development of progressive lung involvement with increasing oxygen requirements and occasionally signs of the haemophagocitic syndrome.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292903
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Of the other 29 (67.4%) patients who presented with symptomatic COVID-19 infection, three women ultimately required antenatal admission for viral symptoms, and an additional patient represented six days postpartum after a successful labor induction with worsening respiratory status that required oxygen supplementation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293020
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Based on the evidence to date, there are several treatment options to consider for the relief of fever (acetaminophen, NSAID, oral glucocorticoids), cough (morphine), breathlessness (morphine, oxygen, fan), anxiety (benzodiazepines) and pain (NSAID, morphine).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294289
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The definition of severe COVID-19 was the presence of at least one of following: respiratory rate ≥30 breaths /min; arterial oxygen saturation ≤93% at rest; PaO2/FiO2 ≤300 mmHg.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>OZONE</title>
      <link>/drugpanel/ozone/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/ozone/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db12510&#39; target=&#39;_blank&#39;&gt;db12510&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=ozone&#34; target=&#34;_blank&#34;&gt;ozone&lt;/a&gt; &lt;br&gt;
Synonymous :ozono
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;ozone&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32228825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In addition, germicidal UV radiation “breaks down” the oxygen O2 which then aggregate into O3 (ozone) molecules creating the ozone layer, capable of inhibiting viral replication and improving lung respiration.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PAPAIN</title>
      <link>/drugpanel/papain/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/papain/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db11193&#39; target=&#39;_blank&#39;&gt;db11193&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=papain&#34; target=&#34;_blank&#34;&gt;papain&lt;/a&gt; &lt;br&gt;
Synonymous :papaína
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;papain&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32120929
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Different modes of time-of-addition/removal assay indicated that tryptanthrin prevented the early and late stages of HCoV-NL63 replication, particularly by blocking viral RNA genome synthesis and papain-like protease 2 activity.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32167166
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The AS-SCoV2 located in the acidic-domain of papain-like protein of SARS-CoV-2 and bat-SL-CoV-RatG13 guided us to suggest that the novel 2019 coronavirus probably emerged by genetic drift from bat-SL-CoV-RaTG13. […] The implication of this amino acid signature in papain-like protein structure arrangement and function is something worth to be explored.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32181901
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among the nonstructural proteins, the leader protein (nsp1), the papain-like protease (nsp3), the nsp4, the 3C-like protease (nsp5), the nsp7, the nsp8, the nsp9, the nsp10, the RNA-directed RNA polymerase (nsp12), the helicase (nsp13), the guanine-N7 methyltransferase (nsp14), the uridylate-specific endoribonuclease (nsp15), the 2’-O-methyltransferase (nsp16), and the ORF7a protein could be built on the basis of homology templates.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32188728
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Coronaviruses express a multifunctional papain-like protease, termed PLP2. […] The coronavirus papain-like protease 2 (PLP2) domain possesses protease activity, which cleaves the viral replicase polyprotein, and also DUB activity (de-conjugating ubiquitin/ubiquitin-like molecules from modified substrates) using identical catalytic residues.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32216114
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Coronaviral proteases, including main proteases and papain-like proteases (PLP), are attractive antiviral targets because of their essential roles in polyprotein processing and thus viral maturation. […] Here, we describe the biochemical and structural identification of recombinant SADS papain-like protease 2 (PLP2) domain of nsp3.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281328
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The crystal structures of 3 CL protease(Mpro) and papain-like protease(PLP) were obtained from PDB database and homologous modeling respectively, and were used to conduct virtual screening of TCMD 2009 database by CDOCKER program.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Structure and screening results of important targets such as 3-chymotrypsin-like protease (3CLpro), Spike, RNA-dependent RNA polymerase (RdRp), and papain like protease (PLpro) were discussed in detail.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PARITAPREVIR</title>
      <link>/drugpanel/paritaprevir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/paritaprevir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db09297&#39; target=&#39;_blank&#39;&gt;db09297&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=paritaprevir&#34; target=&#34;_blank&#34;&gt;paritaprevir&lt;/a&gt; &lt;br&gt;
Synonymous :(2r,6s,12z,13ar,14ar,16as)-n-(cyclopropanesulfonyl)-6-[(5-methylpyrazine-2-carbonyl)amino]-5,16-dioxo-2-[(phenanthridin-6-yl)oxy]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5h)-carboxamide | paritaprevir | veruprevir
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;paritaprevir&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32266873
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
From the virtual screening results, two drug molecules were selected for each drug target protein [Paritaprevir (ΔG= -9.8 kcal/mol) &amp;amp;Raltegravir (ΔG= -7.8 kcal/mol) for 3CLpro and Dolutegravir (ΔG= -9.4 kcal/mol) and Bictegravir (ΔG= -8.4 kcal/mol) for 2’-OMTase]. […] After the extensive computational analysis, we proposed that Raltegravir, Paritaprevir, Bictegravir and Dolutegravir are excellent lead candidates for these crucial proteins and they could become potential therapeutic drugs against SARS-CoV-2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PENICILLIN</title>
      <link>/drugpanel/penicillin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/penicillin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=penicillin&#34; target=&#34;_blank&#34;&gt;penicillin&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;penicillin&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283308
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To collect the SARS-CoV-2 particles, ten air samples were collected into the sterile standard midget impingers containing 20 mL DMEM with 100 μg/mL streptomycin, 100 U/mL penicillin and 1% antifoam reagent for 1 h.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PHENYLALANINE</title>
      <link>/drugpanel/phenylalanine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/phenylalanine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00120&#39; target=&#39;_blank&#39;&gt;db00120&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=phenylalanine&#34; target=&#34;_blank&#34;&gt;phenylalanine&lt;/a&gt; &lt;br&gt;
Synonymous :(s)-2-amino-3-phenylpropionic acid | (s)-alpha-amino-beta-phenylpropionic acid | 3-phenyl-l-alanine | beta-phenyl-l-alanine | f | fenilalanina | l-phenylalanine | phe | phenylalanine | phenylalaninum | β-phenyl-l-alanine
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;phenylalanine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32081428
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A unique phenylalanine F486 in the flexible loop likely plays a major role because its penetration into a deep hydrophobic pocket in ACE2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PHOTOFRIN</title>
      <link>/drugpanel/photofrin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/photofrin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=photofrin&#34; target=&#34;_blank&#34;&gt;photofrin&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;photofrin&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32268515
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among possible interesting drugs for Covid-19 treatment, we found Nimesulide, Fluticasone Propionate, Thiabendazole, Photofrin, Didanosine and Flutamide.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>POTASSIUM</title>
      <link>/drugpanel/potassium/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/potassium/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db14500&#39; target=&#39;_blank&#39;&gt;db14500&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=potassium&#34; target=&#34;_blank&#34;&gt;potassium&lt;/a&gt; &lt;br&gt;
Synonymous :k | kalium | potasio | potassium metal | potassium, elemental | potassium, metal
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;potassium&lt;/em&gt; gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32173576
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Levels of potassium, albumin, lymphocyte were low, but increased persistently after treatment.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32284379
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Valinomycin, a potassium ionophore, was among our top targets. […] Valinomycin did not affect particle stability or infectivity, suggesting that it may preclude virus replication by altering cellular potassium ions, a known determinant of LACV entry. […] In sum, we demonstrate the importance of potassium ions to virus infection, suggesting a potential therapeutic target to disrupt virus replication.&lt;b&gt;Importance&lt;/b&gt; No antivirals are approved for the treatment of bunyavirus infection. […] We focused on a potassium ionophore, valinomycin, due to its promising &lt;i&gt;in vitro&lt;/i&gt; antiviral activity. […] We finally observe that valinomycin has activity against a wide array of human viral pathogens, suggesting that disrupting potassium ion homeostasis with valinomycin may be a potent host pathway to target to quell virus infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>POULTRY</title>
      <link>/drugpanel/poultry/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/poultry/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db11008&#39; target=&#39;_blank&#39;&gt;db11008&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=poultry&#34; target=&#34;_blank&#34;&gt;poultry&lt;/a&gt; &lt;br&gt;
Synonymous :chicken, turkey, duck, goose, or quail | poultry | poultry, unspecified
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;poultry&lt;/em&gt; gene in 4 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
31967321
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Many initial patients were exposed to wildlife animals at the Huanan seafood wholesale market, where poultry, snake, bats, and other farm animals were also sold.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32163661
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In poultry, the genetic diversity, evolution, distribution and taxonomy of CoVs dominant in birds other than chickens remain enigmatic. […] The surveillance demonstrated that CdCoVs, DdCoVs and the CoVs dominant in pigeons (PdCoVs) belong to different lineages, and they are all prevalent in live poultry markets and the backyard flocks in some regions of China.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293832
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Coronaviruses (CoVs) cause a broad spectrum of diseases in domestic and wild animals, poultry, and rodents, ranging from mild to severe enteric, respiratory, and systemic disease, and also cause the common cold or pneumonia in humans.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>POVIDONE</title>
      <link>/drugpanel/povidone/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/povidone/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db11061&#39; target=&#39;_blank&#39;&gt;db11061&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=povidone&#34; target=&#34;_blank&#34;&gt;povidone&lt;/a&gt; &lt;br&gt;
Synonymous :1-ethenyl-2-pyrrolidinone homopolymer | 1-vinyl-2-pyrrolidinone polymer | polividone | povidona | povidone | povidone, unspecified | povidonum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;povidone&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32217947
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;ol start=&#34;3&#34; style=&#34;list-style-type: decimal&#34;&gt;
&lt;li&gt;Decolonize patients using pre-procedural chlorhexidine wipes, 2 doses of nasal povidone iodine within one hour of incision, and chlorhexidine mouth rinse.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PREDNISOLONE</title>
      <link>/drugpanel/prednisolone/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/prednisolone/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00860&#39; target=&#39;_blank&#39;&gt;db00860&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=prednisolone&#34; target=&#34;_blank&#34;&gt;prednisolone&lt;/a&gt; &lt;br&gt;
Synonymous :(11β)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione | 1,4-pregnadiene-11β,17α,21-triol-3,20-dione | 1,4-pregnadiene-3,20-dione-11β,17α,21-triol | 3,20-dioxo-11β,17α,21-trihydroxy-1,4-pregnadiene | delta-dehydrocortisol | delta-dehydrohydrocortisone | delta-hydrocortisone | delta(1)-dehydrocortisol | delta(1)-dehydrohydrocortisone | delta(1)-hydrocortisone | hydroretrocortine | metacortandralone | prdl | prednisolona | prednisolone | prednisolonum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;prednisolone&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32256705
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low-dose prednisolone and tacrolimus may have beneficial impacts on COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PROCALCITONIN</title>
      <link>/drugpanel/procalcitonin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/procalcitonin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db14812&#39; target=&#39;_blank&#39;&gt;db14812&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=procalcitonin&#34; target=&#34;_blank&#34;&gt;procalcitonin&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;procalcitonin&lt;/em&gt; gene in 20 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32026671
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;ol start=&#34;2&#34; style=&#34;list-style-type: decimal&#34;&gt;
&lt;li&gt;The blood test of the patients showed normal or decreased white blood cell count (23/29), decreased lymphocyte count (20/29), increased hypersensitive C reactive protein (hs-CRP) (27/29), and normal procalcitonin.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32061066
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The median of CRP was 16.3 mg/L, including 5 patients with slightly elevated (5/9) , 4 patients with normal values (4/9) . the results of procalcitonin test were negative in5 patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32062875
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Elevated procalcitonin was found in 1 case and D-Dimer in 3 cases.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32077115
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Significantly higher levels of D-dimer, C-reactive protein, and procalcitonin were associated with severe patients compared to nonsevere patients (all P &amp;lt; .001).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32091414
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Correlation analysis showed that the pulmonary inflammation index value was significantly correlated with the values of lymphocyte count, monocyte count, C-reactive protein, procalcitonin, days from illness onset, and body temperature (P &amp;lt; 0.05).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32096367
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Antimicrobial prophylaxis should be prescribed rationally and was not recommended except for patients with long course of disease, repeated fever and elevated procalcitonin (PCT), meanwhile secondary fungal infection should be concerned.Some patients with COVID-19 showed intestinal microbialdysbiosis with decreasedprobiotics such as &lt;i&gt;Lactobacillus&lt;/i&gt; and &lt;i&gt;Bifidobacterium&lt;/i&gt;.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32118389
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Elevation of C-reactive protein (10%, 3/30), erythrocyte sedimentation rate(19%,4/21), procalcitonin(4%,1/28), liver enzyme(22%, 6/27) and muscle enzyme (15%, 4/27) occurred in different proportions.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32120458
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The observation indicators included total blood count, C-reactive protein (CRP), arterial blood gas analysis, myocardial injury markers, coagulation function, liver and kidney function, electrolyte, procalcitonin (PCT), B-type natriuretic peptide (BNP), blood lipid, pulmonary CT and pathogen detection. &lt;b&gt;Results:&lt;/b&gt; Compared with the general group, the lymphocyte count (0.74×10(9) (0.34×10(9), 0.94×10(9))/L vs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32134205
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
For laboratory findings, procalcitonin elevation (16/20, 80%) should be pay attention to, which is not common in adults. […] Procalcitonin elevation and consolidation with surrounding halo signs were common in pediatric patients which were different from adults.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32193831
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Laboratory findings revealed normal or increased whole blood counts (7/8), increased C-reactive protein, procalcitonin and lactate dehydrogenase (6/8), and abnormal liver function (4/8).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32211816
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A total of 82 patients (19.7%) had cardiac injury, and compared with patients without cardiac injury, these patients were older (median [range] age, 74 [34-95] vs 60 [21-90] years; P &amp;lt; .001); had more comorbidities (eg, hypertension in 49 of 82 [59.8%] vs 78 of 334 [23.4%]; P &amp;lt; .001); had higher leukocyte counts (median [interquartile range (IQR)], 9400 [6900-13 800] vs 5500 [4200-7400] cells/μL) and levels of C-reactive protein (median [IQR], 10.2 [6.4-17.0] vs 3.7 [1.0-7.3] mg/dL), procalcitonin (median [IQR], 0.27 [0.10-1.22] vs 0.06 [0.03-0.10] ng/mL), creatinine kinase-myocardial band (median [IQR], 3.2 [1.8-6.2] vs 0.9 [0.6-1.3] ng/mL), myohemoglobin (median [IQR], 128 [68-305] vs 39 [27-65] μg/L), high-sensitivity troponin I (median [IQR], 0.19 [0.08-1.12] vs &amp;lt;0.006 [&amp;lt;0.006-0.009] μg/L), N-terminal pro-B-type natriuretic peptide (median [IQR], 1689 [698-3327] vs 139 [51-335] pg/mL), aspartate aminotransferase (median [IQR], 40 [27-60] vs 29 [21-40] U/L), and creatinine (median [IQR], 1.15 [0.72-1.92] vs 0.64 [0.54-0.78] mg/dL); and had a higher proportion of multiple mottling and ground-glass opacity in radiographic findings (53 of 82 patients [64.6%] vs 15 of 334 patients [4.5%]).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32220650
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Typical abnormal laboratory findings were elevated creatine kinase MB (11 [31%]), decreased lymphocytes (11 [31%]), leucopenia (seven [19%]), and elevated procalcitonin (six [17%]). […] Besides radiographic presentations, variables that were associated significantly with severity of COVID-19 were decreased lymphocytes, elevated body temperature, and high levels of procalcitonin, D-dimer, and creatine kinase MB.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32232433
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
By univariate analysis, patients with ocular symptoms were more likely to have higher white blood cell and neutrophil counts and higher levels of procalcitonin, C-reactive protein, and lactate dehydrogenase than patients without ocular symptoms.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32237148
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
There were 38.5% of control patients had higher procalcitonin (PCT) levels than 0.5ng/ml, which was significantly higher than that percentage of COVID-19 patients (X&lt;sup&gt;2&lt;/sup&gt; =22.636, P &amp;lt;0.05), and COVID-19 patients were also more likely to have decreased or normal urea and creatinine levels than control patients (X&lt;sup&gt;2&lt;/sup&gt; =24.930, 8.480, P &amp;lt;0.05).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32268454
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
On post injury day (PID) 1, 3, 6, and 9, vein blood of patients were collected for determination of white blood cell (WBC) count, neutrophil, lymphocyte absolute value. and level of procalcitonin (PCT).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32278670
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Procalcitonin plasma above 0.5 µg/L was associated with 16% vs. 19% (p = 0.78) risk of death after 7 days.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32279081
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Through a multivariate analysis of the causes of death in older patients, we found that males, comorbidities, time from disease onset to hospitalization, abnormal kidney function, and elevated procalcitonin levels were all significantly associated with death.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282949
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Biomarkers, such high serum procalcitonin and ferritin have also emerged as poor prognostic factors.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283325
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Patients with abnormal liver function were more likely to be male, and had higher levels of procalcitonin and C-reactive protein.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293716
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Other findings included leukocytosis (12.6%) and elevated procalcitonin (17.5%).
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PROLINE</title>
      <link>/drugpanel/proline/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/proline/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00172&#39; target=&#39;_blank&#39;&gt;db00172&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=proline&#34; target=&#34;_blank&#34;&gt;proline&lt;/a&gt; &lt;br&gt;
Synonymous :(-)-2-pyrrolidinecarboxylic acid | (−)-(s)-proline | (−)-2-pyrrolidinecarboxylic acid | (−)-proline | (2s)-pyrrolidine-2-carboxylic acid | (s)-2-carboxypyrrolidine | (s)-2-pyrrolidinecarboxylic acid | (s)-pyrrolidine-2-carboxylic acid | 2-pyrrolidinecarboxylic acid | l-(−)-proline | l-alpha-pyrrolidinecarboxylic acid | l-prolin | l-proline | l-pyrrolidine-2-carboxylic acid | l-α-pyrrolidinecarboxylic acid | p | prolina | proline | prolinum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;proline&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32083328
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Position 723 in the COVID-2019 has a serine instead a glycine residue, while at aminoacidic position 1010 a proline instead an isoleucine.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PROPOFOL</title>
      <link>/drugpanel/propofol/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/propofol/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00818&#39; target=&#39;_blank&#39;&gt;db00818&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=propofol&#34; target=&#34;_blank&#34;&gt;propofol&lt;/a&gt; &lt;br&gt;
Synonymous :2,6-bis(1-methylethyl)phenol | 2,6-diisopropylphenol | propofol | propofolum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;propofol&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32133829
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Midazolam, Propofol and Morphine or fentanyl were used for sedation and analgesia, avoiding patients cough and agitated during the procedure.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PROTHROMBIN</title>
      <link>/drugpanel/prothrombin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/prothrombin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db11311&#39; target=&#39;_blank&#39;&gt;db11311&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=prothrombin&#34; target=&#34;_blank&#34;&gt;prothrombin&lt;/a&gt; &lt;br&gt;
Synonymous :coagulation factor ii (human) | coagulation factor ii human | factor ii | factor ii (prothrombin) | human coagulation factor ii
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;prothrombin&lt;/em&gt; gene in 9 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32031570
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lymphopenia (lymphocyte count, 0.8 × 109/L [interquartile range {IQR}, 0.6-1.1]) occurred in 97 patients (70.3%), prolonged prothrombin time (13.0 seconds [IQR, 12.3-13.7]) in 80 patients (58%), and elevated lactate dehydrogenase (261 U/L [IQR, 182-403]) in 55 patients (39.9%).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32073213
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The overall mortality was 11.5%, the non-survivors revealed significantly higher D-dimer and fibrin degradation product (FDP) levels, longer prothrombin time and activated partial thromboplastin time compared to survivors on admission (P &amp;lt; .05); 71.4% of non-survivors and 0.6% survivors met the criteria of disseminated intravascular coagulation during their hospital stay.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32153170
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Three cases had prothrombin activity (PTA) of ≤ 50%, 10 cases had elevated FDP, and 13 cases had elevated D-dimer, all of whom were severe or critically ill.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32164424
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Common presentations of confirmed cases include fever, fatigue, dry cough, upper airway congestion, sputum production, shortness of breath, myalgia/arthralgia with lymphopenia, prolonged prothrombin time, elevated C-reactive protein, and elevated lactate dehydrogenase.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32172226
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Compared with healthy controls, prothrombin time activity (PT-act) was lower in SARS-CoV-2 patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32220112
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The D-dimer, prothrombin time and age were positively, and platelet count was negatively, correlated with 28-day mortality in multivariate analysis.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32220276
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Prothrombin time (PT) were prolonged in 4 patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32287140
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Patients with digestive symptoms had higher mean liver enzyme levels, lower monocyte count, longer prothrombin time, and received more antimicrobial treatment than those without digestive symptoms.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32291094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Age (adjusted hazard ratio (aHR) 1.05/per year, 95%CI 1.004-1.01) and coagulopathy, defined as spontaneous prolongation of the prothrombin time &amp;gt; 3 s or activated partial thromboplastin time &amp;gt; 5 s (aHR 4.1, 95%CI 1.9-9.1), were independent predictors of thrombotic complications.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>QUERCETIN</title>
      <link>/drugpanel/quercetin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/quercetin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db04216&#39; target=&#39;_blank&#39;&gt;db04216&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=quercetin&#34; target=&#34;_blank&#34;&gt;quercetin&lt;/a&gt; &lt;br&gt;
Synonymous :2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4h-1-benzopyran-4-one | 3,3’,4’,5,7-pentahydroxyflavone | 3,5,7,3’,4’-pentahydroxyflavone | sophoretin | xanthaurine
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;quercetin&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32229706
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Similarly, two proposed therapeutics for the treatment of COVID-19 infection are Azithromycin and Quercetin, both drugs with significant senolytic activity.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>QUININE</title>
      <link>/drugpanel/quinine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/quinine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00468&#39; target=&#39;_blank&#39;&gt;db00468&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=quinine&#34; target=&#34;_blank&#34;&gt;quinine&lt;/a&gt; &lt;br&gt;
Synonymous :(-)-quinine | (−)-quinine | (8s,9r)-quinine | (r)-(−)-quinine | (r)-(6-methoxyquinolin-4-yl)((2s,4s,8r)-8-vinylquinuclidin-2-yl)methanol | 6’-methoxycinchonidine | chinin | chinine | chininum | quinina | quinine
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;quinine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281695
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We identified many cheap, available, and safe medicines, such as diphenidol, quinine, chloroquine, artemisinin, chlorpheniramine, yohimbine, and dextromethorphan, which may target the most common symptoms caused by 2019-nCoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>RALTEGRAVIR</title>
      <link>/drugpanel/raltegravir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/raltegravir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db06817&#39; target=&#39;_blank&#39;&gt;db06817&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=raltegravir&#34; target=&#34;_blank&#34;&gt;raltegravir&lt;/a&gt; &lt;br&gt;
Synonymous :raltegravir
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;raltegravir&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32266873
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
From the virtual screening results, two drug molecules were selected for each drug target protein [Paritaprevir (ΔG= -9.8 kcal/mol) &amp;amp;Raltegravir (ΔG= -7.8 kcal/mol) for 3CLpro and Dolutegravir (ΔG= -9.4 kcal/mol) and Bictegravir (ΔG= -8.4 kcal/mol) for 2’-OMTase]. […] After the extensive computational analysis, we proposed that Raltegravir, Paritaprevir, Bictegravir and Dolutegravir are excellent lead candidates for these crucial proteins and they could become potential therapeutic drugs against SARS-CoV-2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>REMDESIVIR</title>
      <link>/drugpanel/remdesivir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/remdesivir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db14761&#39; target=&#39;_blank&#39;&gt;db14761&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=remdesivir&#34; target=&#34;_blank&#34;&gt;remdesivir&lt;/a&gt; &lt;br&gt;
Synonymous :remdesivir | remdésivir | remdesivirum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;remdesivir&lt;/em&gt; gene in 38 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
31996494
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lopinavir /Ritonavir, Nucleoside analogues, Neuraminidase inhibitors, Remdesivir, peptide (EK1), abidol, RNA synthesis inhibitors (such as TDF, 3TC), anti-inflammatory drugs (such as hormones and other molecules), Chinese traditional medicine, such ShuFengJieDu Capsules and Lianhuaqingwen Capsule, could be the drug treatment options for 2019-nCoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32022370
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Herein, we suggest four potential drug candidates (an ACE2-based peptide, remdesivir, 3CLpro-1 and a novel vinylsulfone protease inhibitor) that could be used to treat patients suffering with the 2019-nCoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32023685
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32054787
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Remdesivir (GS-5734) effectively inhibited MERS coronavirus (MERS-CoV) replication in vitro, and showed efficacy against Severe Acute Respiratory Syndrome (SARS)-CoV in a mouse model. […] Here, we tested the efficacy of prophylactic and therapeutic remdesivir treatment in a nonhuman primate model of MERS-CoV infection, the rhesus macaque. […] Prophylactic remdesivir treatment initiated 24 h prior to inoculation completely prevented MERS-CoV-induced clinical disease, strongly inhibited MERS-CoV replication in respiratory tissues, and prevented the formation of lung lesions. […] Therapeutic remdesivir treatment initiated 12 h postinoculation also provided a clear clinical benefit, with a reduction in clinical signs, reduced virus replication in the lungs, and decreased presence and severity of lung lesions. […] The data presented here support testing of the efficacy of remdesivir treatment in the context of a MERS clinical trial.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32081636
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The one case of SARS-CoV-2 pneumonia in the USA is responding well to remdesivir, which is now undergoing a clinical trial in China.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32094225
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Remdesivir (RDV) is an investigational compound with a broad spectrum of antiviral activities against RNA viruses, including severe acute respiratory syndrome-CoV and Middle East respiratory syndrome (MERS-CoV).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32138488
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Management is primarily supportive, with newer antivirals (lopinavir ritonavir and Remdesivir) under investigation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32147628
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32152082
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The most promising compound is remdesivir (GS-5734), a nucleotide analog prodrug currently in clinical trials for treating Ebola virus infections. […] Remdesivir inhibited the replication of SARS-CoV and MERS-CoV in tissue cultures, and it displayed efficacy in non-human animal models. […] Remarkably, the therapeutic efficacy of remdesivir appeared to be superior to that of LPV/RTV-INFb against MERS-CoV in a transgenic humanized mice model.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32164424
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Similar to outbreaks of other newly identified virus, there is no proven regimen from conventional medicine and most reports managed the patients with lopinavir/ritonavir, ribavirin, beta-interferon, glucocorticoid and supportive treatment with remdesivir undergoing clinical trial.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32173241
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To date, effective treatment is lacking; however, clinical trials investigating the efficacy of several agents, including remdesivir and chloroquine, are underway in China.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32179150
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Chloroquine, remdesivir, lopinavir, ribavirin and ritonavir have shown efficacy to inhibit coronavirus in vitro.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32214286
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
These include vaccines, medications Remdesivir and hydroxychloroquine and potentially combination therapy.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32219882
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To help understand the advantages and limitations of differential treatments, we provide a timely review and discuss the complications and corresponding major treatments, especially controversial ones such as antiviral therapy (remdesivir, ribavirin, and chloroquine), glucocorticoid therapy, extracorporeal support including an artificial liver system, and extracorporeal membrane oxygenation based on available evidence.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32222463
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The results suggest the effectiveness of Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir as potent drugs against SARS-CoV-2 since they tightly bind to its RdRp.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32238094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
As a result three FDA approved drugs (Remdesivir, Saquinavir and Darunavir) and two natural compounds (. flavone and coumarine derivatives) were identified as promising hits.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32239125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among them, remdesivir, an analogue of adenosine, is what seems to have a more promising future. […] Although all studies have been carried out with SARS-CoV and MERS-CoV, it seems that by virological and functional analogy, remdesivir is one of the few antiviral drugs with proven efficacy.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243270
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This review summarizes the current evidence of potential therapeutic agents, such as lopinavir/ritonavir, remdesivir, favipiravir, chloroquine, hydroxychloroquine, interferon, ribavirin, tocilizumab and sarilumab.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247050
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Potential treatments included remdesivir, chloroquine, tocilizumab, convalescent plasma and vaccine immunization (when possible).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247927
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The first medication experience of the recovered patients in the US has led remdesivir to be the “specific drug”. […] China has also taken immediate action to put remdesivir into clinical trials with the purpose of applying it into clinical therapeutics for Corona Virus Disease 2019 (COVID-19). […] Further, we analyzed the pharmacological actions and previous trials of remdesivir to identify the feasibility of conducting experiments on COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251767
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We report the antiviral effect of remdesivir, lopinavir, homorringtonine, and emetine against SARS-CoV-2 virus in Vero E6 cells with the estimated 50% effective concentration at 23.15 μM, 26.63 μM, 2.55 μM and 0.46 μM, respectively. […] Synergy between remdesivir and emetine was observed, and remdesivir at 6.25 μM in combination with emetine at 0.195 μM may achieve 64.9% inhibition in viral yield.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253226
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Herein, we show that the ribonucleoside analog β-D-N&lt;sup&gt;4&lt;/sup&gt;-hydroxycytidine (NHC, EIDD-1931) has broad spectrum antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV, and related zoonotic group 2b or 2c Bat-CoVs, as well as increased potency against a coronavirus bearing resistance mutations to the nucleoside analog inhibitor remdesivir.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32256547
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We identified 24 clinical trials, involving more than 20 medicines, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, methylprednisolone, bevacizumab, and traditional Chinese medicines (TCM). […] Se identificaron 24 ensayos clínicos relacionados con más de 20 medicamentos, como inmunoglobulina humana, interferones, cloroquina, hidroxicloroquina, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, metilprednisolona, bevacizumab y medicina tradicional china. […] Foram identificados 24 ensaios clínicos envolvendo mais de 20 medicamentos, tais como imunoglobulina humana, interferons, cloroquina, hidroxicloroquina, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, metilprednisolona, bevacizumabe e medicamentos chineses tradicionais.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32258351
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Remdesivir (GS-5734™) is a broad-spectrum antiviral drug that is now being tested as a potential treatment for COVID-19 in international, multi-site clinical trials. […] Currently available evidence about the antiviral effects of remdesivir against coronaviruses is primarily based on &lt;i&gt;in vitro&lt;/i&gt; and &lt;i&gt;in vivo&lt;/i&gt; studies (including some on a chemically related compound, GS-441524™), which have demonstrated largely favorable findings. […] Thus, the purpose of this review is to synthesize the knowledge to date about remdesivir as a therapeutic option for coronaviruses, with a special focus on information relevant to the One Health community.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275812
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Remdesivir, a nucleotide analogue prodrug that inhibits viral RNA polymerases, has shown in vitro activity against SARS-CoV-2. […] We provided remdesivir on a compassionate-use basis to patients hospitalized with Covid-19, the illness caused by infection with SARS-CoV-2. […] Patients received a 10-day course of remdesivir, consisting of 200 mg administered intravenously on day 1, followed by 100 mg daily for the remaining 9 days of treatment. […] This report is based on data from patients who received remdesivir during the period from January 25, 2020, through March 7, 2020, and have clinical data for at least 1 subsequent day. […] Of the 61 patients who received at least one dose of remdesivir, data from 8 could not be analyzed (including 7 patients with no post-treatment data and 1 with a dosing error). […] In this cohort of patients hospitalized for severe Covid-19 who were treated with compassionate-use remdesivir, clinical improvement was observed in 36 of 53 patients (68%). […] Measurement of efficacy will require ongoing randomized, placebo-controlled trials of remdesivir therapy.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277040
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The RNA-dependent RNA polymerase (RdRp, also named nsp12) is the central component of coronaviral replication/transcription machinery and appears to be a primary target for the antiviral drug, remdesivir. […] A comparative analysis model shows how remdesivir binds to this polymerase.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277065
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The nucleotide analogue remdesivir is an investigational drug for the treatment of human coronavirus infection. […] Remdesivir is a phosphoramidate prodrug and is known to target viral RNA-dependent RNA polymerases. […] In this issue, Gordon &lt;i&gt;et al.&lt;/i&gt; identify that remdesivir acts as a delayed RNA chain terminator for MERS-CoV polymerase complexes.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277367
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Antiviral drugs like lopinavir/ritonavir, favipiravir and remdesivir are also being explored.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32280433
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The result showed that atazanavir, an antiretroviral medication used to treat and prevent the human immunodeficiency virus (HIV), is the best chemical compound, showing an inhibitory potency with &lt;i&gt;K&lt;sub&gt;d&lt;/sub&gt;&lt;/i&gt; of 94.94 nM against the SARS-CoV-2 3C-like proteinase, followed by remdesivir (113.13 nM), efavirenz (199.17 nM), ritonavir (204.05 nM), and dolutegravir (336.91 nM).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281114
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A case of late initiation of remdesivir antiviral therapy in the successful treatment of a patient with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a mixed medical ICU of a community teaching hospital is presented. […] A request for compassionate use remdesivir was submitted on the same hospital day as the positive COVID-19 PCR result. […] Supportive measures, in addition to a 5-day course of hydroxychloroquine, were maintained until remdesivir could be supplied on day 9 of hospitalization, 13 days after symptom onset. […] Sixty hours after initiating remdesivir, the patient was successfully extubated and was able to transition to room air within 24 hours of extubation. […] Late initiation of remdesivir may be effective in treating SARS-CoV-2, unlike antivirals utilized for different disease states, such as oseltamivir, which are most effective when started as soon as possible following symptom onset.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282022
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The most promising therapy is remdesivir. […] Remdesivir has potent in vitro activity against SARS-CoV-2, but it is not US Food and Drug Administration approved and currently is being tested in ongoing randomized trials.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282502
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
No established treatment is currently available; however, several therapies, including remdesivir, hydroxychloroquine and chloroquine, and interleukin (IL)-6 inhibitors, are being used off-label and evaluated in ongoing clinical trials.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282982
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Hydroxychloroquine (HCQ) was used by 78.1% of respondents; azithromycin by 46.9%; tocilizumab by 31.3%, and remdesivir by 25.0%.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283108
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We then map a promising NA candidate, GS-441524 (the active metabolite of Remdesivir) to the nucleoside active site of both proteins, identifying the residues important for nucleotide recognition, discrimination, and excision. […] Additionally, we propose structural and function implications of two previously identified RdRp resistance mutations in relation to resistance against Remdesivir.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32284326
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Replication of SARS-CoV-2 depends on the viral RNA-dependent RNA polymerase (RdRp), which is the likely target of the investigational nucleotide analogue remdesivir (RDV).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292909
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
For this emergency, the FDA has approved Remdesivir and Hydroxychloroquine for treatment of COVID-19 as Emergency Use Authorization.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293834
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The most frequently used agents both in Turkey and all over the world including chloroquine, hydroxychloroquine, lopinavir/ritonavir, favipiravir and remdesivir will be reviewed here .
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294562
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Several antiviral medications: Zanamivir, Indinavir, Saquinavir, and Remdesivir show potential as and 3CL&lt;sup&gt;PRO&lt;/sup&gt; main proteinase inhibitors and as a treatment of COVID-19. […] Zanamivir, Indinavir, Saquinavir, and Remdesivir are among the exciting hits on the 3CL&lt;sup&gt;PRO&lt;/sup&gt; main proteinase.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>RESINIFERATOXIN</title>
      <link>/drugpanel/resiniferatoxin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/resiniferatoxin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db06515&#39; target=&#39;_blank&#39;&gt;db06515&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=resiniferatoxin&#34; target=&#34;_blank&#34;&gt;resiniferatoxin&lt;/a&gt; &lt;br&gt;
Synonymous :rtx
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;resiniferatoxin&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292906
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We also propose to further explore the use of resiniferatoxin (RTX), an ultra-potent TRPV1 agonist currently in clinical trials for cancer and osteoarthritis pain, as a possible ablating agent of TRPV1 positive pulmonary pathways in patients with advanced COVID-19 disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>RESVERATROL</title>
      <link>/drugpanel/resveratrol/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/resveratrol/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db02709&#39; target=&#39;_blank&#39;&gt;db02709&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=resveratrol&#34; target=&#34;_blank&#34;&gt;resveratrol&lt;/a&gt; &lt;br&gt;
Synonymous :(e)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(e)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol | (e)-resveratrol | 3,4’,5-trihydroxy-trans-stilbene | 3,4’,5-trihydroxystilbene | 3,5,4’-trihydroxystilbene | 5-[(e)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol | trans-resveratrol
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;resveratrol&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32228827
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The drugs predicted by EpiMed’s apparent precision treatment prediction platform for disease-drug association analysis are mainly TNF-α inhibitors, resveratrol, ritonavir, paeony, retinoic acid, forsythia, and houttuynia cordata. &lt;b&gt;Conclusions:&lt;/b&gt; The abnormal activation of multiple inflammatory pathways may be the cause of heart failure in patients after coronavirus infection. […] Resveratrol, ritonavir, retinoic acid, amaranth, forsythia, houttuynia may have therapeutic effects.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>RIBAVIRIN</title>
      <link>/drugpanel/ribavirin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/ribavirin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00811&#39; target=&#39;_blank&#39;&gt;db00811&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=ribavirin&#34; target=&#34;_blank&#34;&gt;ribavirin&lt;/a&gt; &lt;br&gt;
Synonymous :1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide | 1-beta-d-ribofuranosyl-1h-1,2,4-triazole-3-carboxamide | rbv | ribavirin | ribavirina | ribavirine | ribavirinum | tribavirin
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;ribavirin&lt;/em&gt; gene in 15 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32023685
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32057209
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Combination of Ribavirin and Interferon-α is recommended by the 5(th) edition National Health Commission’s Regimen (Revised Edition) because of the effect on MERS (Middle East Respiratory Syndrome), and the effectiveness of Lopinavir/Ritonavir and Remdisivir needs to be confirmed by randomized controlled trial (RCT), given the situation of no specific antivirus drug on NCP is unavailable.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32119961
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Additionally, the newly emerged Wuhan HCoV RdRp model is targeted by anti-polymerase drugs, including the approved drugs Sofosbuvir and Ribavirin. […] The results suggest the effectiveness of Sofosbuvir, IDX-184, Ribavirin, and Remidisvir as potent drugs against the newly emerged HCoV disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32164424
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Similar to outbreaks of other newly identified virus, there is no proven regimen from conventional medicine and most reports managed the patients with lopinavir/ritonavir, ribavirin, beta-interferon, glucocorticoid and supportive treatment with remdesivir undergoing clinical trial.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32179150
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Chloroquine, remdesivir, lopinavir, ribavirin and ritonavir have shown efficacy to inhibit coronavirus in vitro.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32218301
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
These molecules proved to be the most effective antiviral agents, able to reach the potency profile of the licensed drug ribavirin.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32219882
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To help understand the advantages and limitations of differential treatments, we provide a timely review and discuss the complications and corresponding major treatments, especially controversial ones such as antiviral therapy (remdesivir, ribavirin, and chloroquine), glucocorticoid therapy, extracorporeal support including an artificial liver system, and extracorporeal membrane oxygenation based on available evidence.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32222463
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The results suggest the effectiveness of Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir as potent drugs against SARS-CoV-2 since they tightly bind to its RdRp.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32227274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Furthermore, COVID-19 mRNA clearance time was positively correlated with the length of hospital stay in patients treated with either IFN-α + lopinavir/ritonavir or IFN-α + lopinavir/ritonavir + ribavirin. […] Therapeutic regimens of IFN-α + lopinavir/ritonavir and IFN-α + lopinavir/ritonavir + ribavirin might be beneficial for treatment of COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32227493
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The access to direct antiviral drugs, such as ribavirin, that have an existing inventory and reliable supply chain may be a priority consideration for therapies developed for the 2019-nCoV infection outbreaks and any strain variants that may emerge. […] On the basis of the direct antiviral activity of ribavirin against 2019-nCoV in vitro and evidence for potency enhancement strategies developed during the prior SARS and MERS outbreaks, ribavirin may significantly impact our ability to end the lingering outbreaks in China and slow outbreaks in other countries. […] The apparent COVID-19 pandemic provides an opportunity to follow dosage guidelines for treatment with ribavirin, test new therapeutic concepts, and conduct controlled testing to apply the scientific rigor required to address the controversy around this mainstay of antiviral therapy.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243270
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This review summarizes the current evidence of potential therapeutic agents, such as lopinavir/ritonavir, remdesivir, favipiravir, chloroquine, hydroxychloroquine, interferon, ribavirin, tocilizumab and sarilumab.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32246834
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In addition to the recommended antiviral drugs such as interferon-ɑ, lopinavir/ritonavir, ribavirin, and chloroquine phosphate, some clinical trials focusing on virus RNA dependent RNA polymerase (RdRp) inhibitors have been registered and initiated.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The top 20 drugs in the virtual screening studies comprised a broad-spectrum antiviral (ribavirin), anti-hepatitis B virus (telbivudine), two vitamins (vitamin B12 and nicotinamide) and other miscellaneous systemically acting drugs. […] Of special interest, ribavirin had been used in treating cases of SARS CoV. […] Ribavirin, telbivudine, vitamin B12 and nicotinamide can be combined and used for COVID treatment.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251767
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Ribavirin or favipiravir that are currently evaluated under clinical trials showed no inhibition at 100 μM.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32284326
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this regard, the triphosphate forms of 2’-C-methylated compounds, including sofosbuvir, approved for the management of hepatitis C virus infection, and the broad-acting antivirals favipiravir and ribavirin, exhibited significant deficits.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>RIBOSE</title>
      <link>/drugpanel/ribose/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/ribose/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db15073&#39; target=&#39;_blank&#39;&gt;db15073&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=ribose&#34; target=&#34;_blank&#34;&gt;ribose&lt;/a&gt; &lt;br&gt;
Synonymous :aldehydo-d-ribose | d-ribo-2,3,4,5-tetrahydroxyvaleraldehyde | d-ribose | ribose
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;ribose&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32266873
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Two druggable targets, namely 3C-like proteinase (3CLpro) and 2’-O-ribose methyltransferase (2’-O-MTase) were selected in this study due to their indispensable nature in the viral life cycle. […] 3CLpro is a cysteine protease responsible for the proteolysis of replicase polyproteins resulting in the formation of various functional proteins, whereas 2’-O-MTase methylates the ribose 2’-O position of the first and second nucleotide of viral mRNA, which sequesters it from the host immune system.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283108
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Interestingly, GS-441524 addresses both enzyme active sites in a manner consistent with significant incorporation, delayed chain termination, and altered excision due to the ribose 1’-CN group, which may account for the increased antiviral effect compared to other available analogues.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>RITONAVIR</title>
      <link>/drugpanel/ritonavir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/ritonavir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00503&#39; target=&#39;_blank&#39;&gt;db00503&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=ritonavir&#34; target=&#34;_blank&#34;&gt;ritonavir&lt;/a&gt; &lt;br&gt;
Synonymous :ritonavir | ritonavirum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;ritonavir&lt;/em&gt; gene in 33 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
31996494
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lopinavir /Ritonavir, Nucleoside analogues, Neuraminidase inhibitors, Remdesivir, peptide (EK1), abidol, RNA synthesis inhibitors (such as TDF, 3TC), anti-inflammatory drugs (such as hormones and other molecules), Chinese traditional medicine, such ShuFengJieDu Capsules and Lianhuaqingwen Capsule, could be the drug treatment options for 2019-nCoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32023685
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32037389
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
All the patients were given antiviral treatment including lopinavir/ritonavir (Kaletra&lt;sup&gt;®&lt;/sup&gt;), arbidol, and Shufeng Jiedu Capsule (SFJDC, a traditional Chinese medicine) and other necessary support care. […] The efficacy of antiviral treatment including lopinavir/ritonavir, arbidol, and SFJDC warrants further verification in future study.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32056407
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Interestingly, after lopinavir/ritonavir (Kaletra, AbbVie) was administered, β-coronavirus viral loads significantly decreased and no or little coronavirus titers were observed.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32057209
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Combination of Ribavirin and Interferon-α is recommended by the 5(th) edition National Health Commission’s Regimen (Revised Edition) because of the effect on MERS (Middle East Respiratory Syndrome), and the effectiveness of Lopinavir/Ritonavir and Remdisivir needs to be confirmed by randomized controlled trial (RCT), given the situation of no specific antivirus drug on NCP is unavailable.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32062875
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Twenty patients were treated with lopinavir and ritonavir.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32096367
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Early antiviral treatment could alleviate disease severity and prevent illness progression, and we found lopinavir/ritonavir combined with abidol showed antiviraleffects in COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32125362
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Clinical course was summarized, including requirement for supplemental oxygen and intensive care and use of empirical treatment with lopinavir-ritonavir. […] Five individuals requiring supplemental oxygen were treated with lopinavir-ritonavir. […] Four of the 5 patients treated with lopinavir-ritonavir developed nausea, vomiting, and/or diarrhea, and 3 developed abnormal liver function test results.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32138488
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Management is primarily supportive, with newer antivirals (lopinavir ritonavir and Remdesivir) under investigation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32152082
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In addition, a combination of the human immunodeficiency virus type 1 (HIV-1) protease inhibitors, lopinavir/ritonavir, and interferon beta (LPV/RTV-INFb) were shown to be effective in patients infected with SARS-CoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32164424
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Similar to outbreaks of other newly identified virus, there is no proven regimen from conventional medicine and most reports managed the patients with lopinavir/ritonavir, ribavirin, beta-interferon, glucocorticoid and supportive treatment with remdesivir undergoing clinical trial.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32171866
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The Lopinavir and Ritonavir Tablets, Chinese medicine, oxygen therapy, and mechanical ventilation were statistically different in the elderly group and the young and middle-aged group, and the P values were all &amp;lt;0.05.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32171872
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We aimed to compare arbidol and lopinavir/ritonavir(LPV/r) treatment for patients with COVID-19 with LPV/r only.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32179150
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Chloroquine, remdesivir, lopinavir, ribavirin and ritonavir have shown efficacy to inhibit coronavirus in vitro.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32187464
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Patients were randomly assigned in a 1:1 ratio to receive either lopinavir-ritonavir (400 mg and 100 mg, respectively) twice a day for 14 days, in addition to standard care, or standard care alone. […] A total of 199 patients with laboratory-confirmed SARS-CoV-2 infection underwent randomization; 99 were assigned to the lopinavir-ritonavir group, and 100 to the standard-care group. […] Treatment with lopinavir-ritonavir was not associated with a difference from standard care in the time to clinical improvement (hazard ratio for clinical improvement, 1.24; 95% confidence interval [CI], 0.90 to 1.72). […] Mortality at 28 days was similar in the lopinavir-ritonavir group and the standard-care group (19.2% vs. […] In a modified intention-to-treat analysis, lopinavir-ritonavir led to a median time to clinical improvement that was shorter by 1 day than that observed with standard care (hazard ratio, 1.39; 95% CI, 1.00 to 1.91). […] Gastrointestinal adverse events were more common in the lopinavir-ritonavir group, but serious adverse events were more common in the standard-care group. […] Lopinavir-ritonavir treatment was stopped early in 13 patients (13.8%) because of adverse events. […] In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir-ritonavir treatment beyond standard care.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32202256
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In view of the earlier evidence about effectiveness of repurposed lopinavir/ritonavir against severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronavirus (CoV), as well as preliminary docking studies conducted by the ICMR-National Institute of Virology, Pune, the Central Drugs Standard Control Organization approved the restricted public health use of lopinavir/ritonavir combination amongst symptomatic COVID-19 patients detected in the country. […] Hospitalized adult patients with laboratory-confirmed SARS-CoV-2 infection with any one of the following criteria will be eligible to receive lopinavir/ritonavir for 14 days after obtaining written informed consent: (i) respiratory distress with respiratory rate ≥22/min or SpO2 of &amp;lt;94 per cent; (ii) lung parenchymal infiltrates on chest X-ray; (iii) hypotension defined as systolic blood pressure &amp;lt;90 mmHg or need for vasopressor/inotropic medication; (iv) new-onset organ dysfunction; and (v) high-risk groups - age &amp;gt;60 yr, diabetes mellitus, renal failure, chronic lung disease and immunocompromised persons.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32210741
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Our results showed that several HIV inhibitors such as lopinavir, ritonavir, and saquinavir produce strong interaction with the active site of SARS-CoV-2 main protease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32219357
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
She was treated with dobutamine, antiviral drugs (lopinavir/ritonavir), steroids, chloroquine, and medical treatment for heart failure, with progressive clinical and instrumental stabilization.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32220650
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
All children received interferon alfa by aerosolisation twice a day, 14 (39%) received lopinavir-ritonavir syrup twice a day, and six (17%) needed oxygen inhalation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32227274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Furthermore, COVID-19 mRNA clearance time was positively correlated with the length of hospital stay in patients treated with either IFN-α + lopinavir/ritonavir or IFN-α + lopinavir/ritonavir + ribavirin. […] Therapeutic regimens of IFN-α + lopinavir/ritonavir and IFN-α + lopinavir/ritonavir + ribavirin might be beneficial for treatment of COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32228827
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The drugs predicted by EpiMed’s apparent precision treatment prediction platform for disease-drug association analysis are mainly TNF-α inhibitors, resveratrol, ritonavir, paeony, retinoic acid, forsythia, and houttuynia cordata. &lt;b&gt;Conclusions:&lt;/b&gt; The abnormal activation of multiple inflammatory pathways may be the cause of heart failure in patients after coronavirus infection. […] Resveratrol, ritonavir, retinoic acid, amaranth, forsythia, houttuynia may have therapeutic effects.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243270
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This review summarizes the current evidence of potential therapeutic agents, such as lopinavir/ritonavir, remdesivir, favipiravir, chloroquine, hydroxychloroquine, interferon, ribavirin, tocilizumab and sarilumab.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32246834
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In addition to the recommended antiviral drugs such as interferon-ɑ, lopinavir/ritonavir, ribavirin, and chloroquine phosphate, some clinical trials focusing on virus RNA dependent RNA polymerase (RdRp) inhibitors have been registered and initiated.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32256547
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We identified 24 clinical trials, involving more than 20 medicines, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, methylprednisolone, bevacizumab, and traditional Chinese medicines (TCM). […] Se identificaron 24 ensayos clínicos relacionados con más de 20 medicamentos, como inmunoglobulina humana, interferones, cloroquina, hidroxicloroquina, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, metilprednisolona, bevacizumab y medicina tradicional china. […] Foram identificados 24 ensaios clínicos envolvendo mais de 20 medicamentos, tais como imunoglobulina humana, interferons, cloroquina, hidroxicloroquina, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, metilprednisolona, bevacizumabe e medicamentos chineses tradicionais.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32271456
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The study aimed to investigate whether lopinavir/ritonavir (LPV/r) in combination with other pneumonia-associated adjuvant drugs has a better therapeutic effect on COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277367
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Antiviral drugs like lopinavir/ritonavir, favipiravir and remdesivir are also being explored.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277555
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This case states the importance of close monitoring of the concentration of ciclosporin in patients treated with lopinavir/ritonavir, routine treatment of corticosteroid can be continued.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32279418
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Hydroxychloroquine and lopinavir/ritonavir were started, and the antiviral drug was replaced with darunavir/cobicistat after two days for diarrhea.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32280433
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The result showed that atazanavir, an antiretroviral medication used to treat and prevent the human immunodeficiency virus (HIV), is the best chemical compound, showing an inhibitory potency with &lt;i&gt;K&lt;sub&gt;d&lt;/sub&gt;&lt;/i&gt; of 94.94 nM against the SARS-CoV-2 3C-like proteinase, followed by remdesivir (113.13 nM), efavirenz (199.17 nM), ritonavir (204.05 nM), and dolutegravir (336.91 nM). […] Interestingly, lopinavir, ritonavir, and darunavir are all designed to target viral proteinases. […] In addition, we also found that several antiviral agents, such as Kaletra (lopinavir/ritonavir), could be used for the treatment of SARS-CoV-2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283143
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lopinavir/ritonavir and arbidol have been previously used to treat acute respiratory syndrome- coronavirus 2 (SARS-CoV-2) replication in clinical practice; nevertheless, their effectiveness remains controversial. […] In this study, we evaluated the antiviral effects and safety of lopinavir/ritonavir and arbidol in patients with the 2019-nCoV disease (COVID-19). […] Fifty patients with laboratory-confirmed COVID-19 were divided into two groups: including lopinavir/ritonavir group (34 cases) and arbidol group (16 cases). […] Lopinavir/ritonavir group received 400mg/100mg of Lopinavir/ritonavir, twice a day for a week, while the arbidol group was given 0.2g arbidol, three times a day. […] On day 14 after the admission, no viral load was detected in arbidol group, but the viral load was found in 15(44.1%) patients treated with lopinavir/ritonavir. […] Patients in the arbidol group had a shorter duration of positive RNA test compared to those in the lopinavir/ritonavir group (P&amp;lt;0.01). […] In conclusion, our data indicate that arbidol monotherapy may be superior to lopinavir/ritonavir in treating COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283325
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
There was no statistical difference between groups in medications taken before hospitalization; a significantly higher proportion of patients with abnormal liver function (57.8%) had received lopinavir/ritonavir after admission compared to patients with normal liver function (31.3%). […] A significantly higher proportion of patients with abnormal liver function had received lopinavir/ritonavir after admission; these drugs should be given with caution.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293834
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The most frequently used agents both in Turkey and all over the world including chloroquine, hydroxychloroquine, lopinavir/ritonavir, favipiravir and remdesivir will be reviewed here .
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293875
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
However, a combination of two HIV-1 protease inhibitors lopinavir and ritonavir has been found to be effective against SARS-CoV, and both drugs could bind well to the SARS-CoV 3C-like protease (SARS-CoV 3CL&lt;sup&gt;pro&lt;/sup&gt;). […] Ritonavir showed somewhat higher atomic contacts, binding efficiency and key binding residues than that of lopinavir in correspondence with slightly less water accessibility at the 3CL&lt;sup&gt;pro&lt;/sup&gt; active site. […] In addition, only ritonavir could interact with the oxyanion hole residues N142 and G143 via two hydrogen bond formations.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>RUXOLITINIB</title>
      <link>/drugpanel/ruxolitinib/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/ruxolitinib/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db08877&#39; target=&#39;_blank&#39;&gt;db08877&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=ruxolitinib&#34; target=&#34;_blank&#34;&gt;ruxolitinib&lt;/a&gt; &lt;br&gt;
Synonymous :ruxolitinib
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;ruxolitinib&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32276453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Two of these senotherapeutics, azithromycin and ruxolitinib, are currently undergoing testing for their efficacy in treating COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SAQUINAVIR</title>
      <link>/drugpanel/saquinavir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/saquinavir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01232&#39; target=&#39;_blank&#39;&gt;db01232&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=saquinavir&#34; target=&#34;_blank&#34;&gt;saquinavir&lt;/a&gt; &lt;br&gt;
Synonymous :saquinavir
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;saquinavir&lt;/em&gt; gene in 3 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32210741
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Our results showed that several HIV inhibitors such as lopinavir, ritonavir, and saquinavir produce strong interaction with the active site of SARS-CoV-2 main protease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32238094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
As a result three FDA approved drugs (Remdesivir, Saquinavir and Darunavir) and two natural compounds (. flavone and coumarine derivatives) were identified as promising hits.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294562
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Several antiviral medications: Zanamivir, Indinavir, Saquinavir, and Remdesivir show potential as and 3CL&lt;sup&gt;PRO&lt;/sup&gt; main proteinase inhibitors and as a treatment of COVID-19. […] Zanamivir, Indinavir, Saquinavir, and Remdesivir are among the exciting hits on the 3CL&lt;sup&gt;PRO&lt;/sup&gt; main proteinase.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SARILUMAB</title>
      <link>/drugpanel/sarilumab/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/sarilumab/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db11767&#39; target=&#39;_blank&#39;&gt;db11767&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=sarilumab&#34; target=&#34;_blank&#34;&gt;sarilumab&lt;/a&gt; &lt;br&gt;
Synonymous :regn88 | sar153191
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;sarilumab&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243270
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This review summarizes the current evidence of potential therapeutic agents, such as lopinavir/ritonavir, remdesivir, favipiravir, chloroquine, hydroxychloroquine, interferon, ribavirin, tocilizumab and sarilumab.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SELAMECTIN</title>
      <link>/drugpanel/selamectin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/selamectin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db11459&#39; target=&#39;_blank&#39;&gt;db11459&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=selamectin&#34; target=&#34;_blank&#34;&gt;selamectin&lt;/a&gt; &lt;br&gt;
Synonymous :selamectin
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;selamectin&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32149769
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Three drugs-cepharanthine (CEP), selamectin and mefloquine hydrochloride exhibited complete inhibition of cytopathic effects in cell culture at 10 μmol/L. […] CEP, selamectin and mefloquine hydrochloride are potential drugs for treating 2019-nCoV infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SERINE</title>
      <link>/drugpanel/serine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/serine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00133&#39; target=&#39;_blank&#39;&gt;db00133&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=serine&#34; target=&#34;_blank&#34;&gt;serine&lt;/a&gt; &lt;br&gt;
Synonymous :(s)-2-amino-3-hydroxypropanoic acid | (s)-serine | alpha-amino-beta-hydroxypropionic acid | beta-hydroxyalanine | l-serine | ser | serina | serine | serinum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;serine&lt;/em&gt; gene in 6 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32027036
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Despite the low heterogeneity of the 2019-nCoV genomes, we could identify at least two hypervariable genomic hotspots, one of which is responsible for a Serine/Leucine variation in the viral ORF8-encoded protein.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32083328
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Position 723 in the COVID-2019 has a serine instead a glycine residue, while at aminoacidic position 1010 a proline instead an isoleucine.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32142651
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Here, we demonstrate that SARS-CoV-2 uses the SARS-CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32271454
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The protein-protein interaction network exhibited hub targets of MXSGD, such as Heat shock protein 90, RAC-alpha serine/threonine-protein kinase, Transcription factor AP-1, Mitogen-activated protein kinase 1, Cellular tumor antigen p53, Vascular endothelial growth factor A, and Tumour necrosis factor.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32278065
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
SARS-CoV uses the the angiotensin-converting enzyme 2 (ACE2) and the serine protease TMPRSS2 for S protein priming.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32279064
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Similar to the respiratory mucosa, angiotensin converting enzyme-2 (ACE-2) receptor and transmembrane serine protease 2 TMPRSS2) co-express in the gastrointestinal tract, which facilitates viral entry into the tissue.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SETROBUVIR</title>
      <link>/drugpanel/setrobuvir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/setrobuvir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db12051&#39; target=&#39;_blank&#39;&gt;db12051&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=setrobuvir&#34; target=&#34;_blank&#34;&gt;setrobuvir&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;setrobuvir&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32222463
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In addition, the results suggest guanosine derivative (IDX-184), Setrobuvir, and YAK as top seeds for antiviral treatments with high potential to fight the SARS-CoV-2 strain specifically.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SILVER</title>
      <link>/drugpanel/silver/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/silver/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db12965&#39; target=&#39;_blank&#39;&gt;db12965&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=silver&#34; target=&#34;_blank&#34;&gt;silver&lt;/a&gt; &lt;br&gt;
Synonymous :argentum metallicum | colloidal silver | nanosilver | silver colloidal | silver nanoparticles | silver, colloidal
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;silver&lt;/em&gt; gene in 7 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277598
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
For many courses and programs however, it is not the long-term silver bullet solution to all learning provision and has consequences that must be considered.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SIROLIMUS</title>
      <link>/drugpanel/sirolimus/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/sirolimus/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00877&#39; target=&#39;_blank&#39;&gt;db00877&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=sirolimus&#34; target=&#34;_blank&#34;&gt;sirolimus&lt;/a&gt; &lt;br&gt;
Synonymous :(-)-rapamycin | rapamycin | sirolimús | sirolimus | sirolimusum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;sirolimus&lt;/em&gt; gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32040667
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Several adjunctive pharmacologic interventions have been studied for their immunomodulatory effects, including macrolides, corticosteroids, cyclooxygenase-2 inhibitors, sirolimus, statins, anti-influenza immune plasma, and vitamin C, but none is recommended at present in severe RVIs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32194980
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Using network proximity analyses of drug targets and HCoV-host interactions in the human interactome, we prioritize 16 potential anti-HCoV repurposable drugs (e.g., melatonin, mercaptopurine, and sirolimus) that are further validated by enrichment analyses of drug-gene signatures and HCoV-induced transcriptomics data in human cell lines. […] We further identify three potential drug combinations (e.g., sirolimus plus dactinomycin, mercaptopurine plus melatonin, and toremifene plus emodin) captured by the “&lt;i&gt;Complementary Exposure&lt;/i&gt;” pattern: the targets of the drugs both hit the HCoV-host subnetwork, but target separate neighborhoods in the human interactome network.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32229705
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Previous studies showed that postulated geroprotectors, such as sirolimus (rapamycin) and its close derivative rapalog everolimus (RAD001), decreased infection rates in a small sample of elderly patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SOFOSBUVIR</title>
      <link>/drugpanel/sofosbuvir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/sofosbuvir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db08934&#39; target=&#39;_blank&#39;&gt;db08934&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=sofosbuvir&#34; target=&#34;_blank&#34;&gt;sofosbuvir&lt;/a&gt; &lt;br&gt;
Synonymous :s)-isopropyl 2-((s)-(((2r,3r,4r,5r)-5-(2,4-dioxo-3,4- dihydropyrimidin-1(2h)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)- (phenoxy)phosphorylamino)propanoate | sofosbuvir
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;sofosbuvir&lt;/em&gt; gene in 3 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32119961
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Additionally, the newly emerged Wuhan HCoV RdRp model is targeted by anti-polymerase drugs, including the approved drugs Sofosbuvir and Ribavirin. […] The results suggest the effectiveness of Sofosbuvir, IDX-184, Ribavirin, and Remidisvir as potent drugs against the newly emerged HCoV disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32194944
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The drugs Epclusa (velpatasvir/sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) could be very effective owing to their dual inhibitory actions on two viral enzymes.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32222463
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The results suggest the effectiveness of Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir as potent drugs against SARS-CoV-2 since they tightly bind to its RdRp.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32284326
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this regard, the triphosphate forms of 2’-C-methylated compounds, including sofosbuvir, approved for the management of hepatitis C virus infection, and the broad-acting antivirals favipiravir and ribavirin, exhibited significant deficits.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SOJOURN</title>
      <link>/drugpanel/sojourn/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/sojourn/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=sojourn&#34; target=&#34;_blank&#34;&gt;sojourn&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;sojourn&lt;/em&gt; gene in 3 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32213270
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In the 366 epidemic clusters , the clusters in which the first confirmed cases with the history of sojourn in Wuhan or Hubei accounted for 47.0%(172/366). […] From 19 January to 3 February, 2020, the first confirmed cases with Wuhan or Hubei sojourn history accounted for 66.5%. […] From 4 to 25 February, the first confirmed cases who had Wuhan or Hubei sojourn history accounted for only 18.2%.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SSD</title>
      <link>/drugpanel/ssd/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/ssd/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=ssd&#34; target=&#34;_blank&#34;&gt;ssd&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;ssd&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32276095
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In treating highly infectious COVID-19 pneumonia, ICU nurses face a high risk of developing somatic symptom disorder (SSD). […] The present study aims to investigate the symptoms and causes of SSD of ICU nurses treating COVID-19 pneumonia.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>STREPTOMYCIN</title>
      <link>/drugpanel/streptomycin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/streptomycin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01082&#39; target=&#39;_blank&#39;&gt;db01082&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=streptomycin&#34; target=&#34;_blank&#34;&gt;streptomycin&lt;/a&gt; &lt;br&gt;
Synonymous :2,4-diguanidino-3,5,6-trihydroxycyclohexyl 5-deoxy-2-o-(2-deoxy-2-methylamino-alpha-l-glucopyranosyl)-3-c-formyl-beta-l-lyxopentanofuranoside | estreptomicina | streptomicina | streptomycin | streptomyzin
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;streptomycin&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283308
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To collect the SARS-CoV-2 particles, ten air samples were collected into the sterile standard midget impingers containing 20 mL DMEM with 100 μg/mL streptomycin, 100 U/mL penicillin and 1% antifoam reagent for 1 h.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TACROLIMUS</title>
      <link>/drugpanel/tacrolimus/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/tacrolimus/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00864&#39; target=&#39;_blank&#39;&gt;db00864&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=tacrolimus&#34; target=&#34;_blank&#34;&gt;tacrolimus&lt;/a&gt; &lt;br&gt;
Synonymous :anhydrous tacrolimus | tacrolimus | tacrolimus anhydrous | tacrolimus, anhydrous
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;tacrolimus&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32256705
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Using Ovid MEDLINE, we reviewed current evidence for immune-suppressing or -stimulating drugs: cytotoxic chemotherapy, low-dose steroids, tumour necrosis factorα (TNFα) blockers, interlukin-6 (IL-6) blockade, Janus kinase (JAK) inhibitors, IL-1 blockade, mycophenolate, tacrolimus, anti-CD20 and CTLA4-Ig. 89 studies were included. […] Low-dose prednisolone and tacrolimus may have beneficial impacts on COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32279418
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Immunosuppressant levels were closely monitored, and we observed very high tacrolimus trough levels despite initial dose reduction.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TAMIFLU</title>
      <link>/drugpanel/tamiflu/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/tamiflu/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=tamiflu&#34; target=&#34;_blank&#34;&gt;tamiflu&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;tamiflu&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32157862
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Initially, she was given Tamiflu.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TEICOPLANIN</title>
      <link>/drugpanel/teicoplanin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/teicoplanin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db06149&#39; target=&#39;_blank&#39;&gt;db06149&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=teicoplanin&#34; target=&#34;_blank&#34;&gt;teicoplanin&lt;/a&gt; &lt;br&gt;
Synonymous :teichomycin a2 | teicoplanin | teicoplanina | téicoplanine | teicoplaninum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;teicoplanin&lt;/em&gt; gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32179150
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Teicoplanin, an antibiotic used to treat staphylococcal infections, previously showed efficacy to inhibit the first stage of the Middle East respiratory syndrome coronavirus (MERS-CoV) viral life cycle in human cells. […] This activity is conserved against SARS-Cov-2, thus placing teicoplanin as a potential treatment for patients with this virus.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TELBIVUDINE</title>
      <link>/drugpanel/telbivudine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/telbivudine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01265&#39; target=&#39;_blank&#39;&gt;db01265&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=telbivudine&#34; target=&#34;_blank&#34;&gt;telbivudine&lt;/a&gt; &lt;br&gt;
Synonymous :1-(2-deoxy-β-l-ribofuranosyl)-5-methyluracil | 2’-deoxy-l-thymidine | beta-l-thymidine | epavudine | l-deoxythymidine | l-dt | l-thymidine | ldt | telbivudin | telbivudina | telbivudine | β-l-2’-deoxythymidine
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;telbivudine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The top 20 drugs in the virtual screening studies comprised a broad-spectrum antiviral (ribavirin), anti-hepatitis B virus (telbivudine), two vitamins (vitamin B12 and nicotinamide) and other miscellaneous systemically acting drugs. […] Ribavirin, telbivudine, vitamin B12 and nicotinamide can be combined and used for COVID treatment.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TENOFOVIR</title>
      <link>/drugpanel/tenofovir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/tenofovir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db14126&#39; target=&#39;_blank&#39;&gt;db14126&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=tenofovir&#34; target=&#34;_blank&#34;&gt;tenofovir&lt;/a&gt; &lt;br&gt;
Synonymous :(r)-pmpa | anhydrous tenofovir | tenofovir (anh.) | tenofovir (anhydrous) | tenofovir anhydrous
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;tenofovir&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32222463
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The results suggest the effectiveness of Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir as potent drugs against SARS-CoV-2 since they tightly bind to its RdRp.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TETRACYCLINE</title>
      <link>/drugpanel/tetracycline/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/tetracycline/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00759&#39; target=&#39;_blank&#39;&gt;db00759&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=tetracycline&#34; target=&#34;_blank&#34;&gt;tetracycline&lt;/a&gt; &lt;br&gt;
Synonymous :(4s,4as,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide | abramycin | anhydrotetracycline | deschlorobiomycin | tetracyclin | tétracycline | tetracycline | tetracyclinum | tetrazyklin | tsiklomitsin
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;tetracycline&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32267566
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Tetracyclines (e.g. tetracycline, doxycycline, and minocycline) are highly lipophilic antibiotics that are known to chelate zinc compounds on matrix metalloproteinases (MMPs)&lt;sup&gt;1&lt;/sup&gt; .
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>THEOPHYLLINE</title>
      <link>/drugpanel/theophylline/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/theophylline/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00277&#39; target=&#39;_blank&#39;&gt;db00277&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=theophylline&#34; target=&#34;_blank&#34;&gt;theophylline&lt;/a&gt; &lt;br&gt;
Synonymous :1,3-dimethyl-7h-purine-2,6-dione | 1,3-dimethylxanthine | teofilina | theophyllin | theophylline anhydrous | theophylline, anhydrous
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;theophylline&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32266867
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ZINC00003118440 is a theophylline derivative under the drug class ‘bronchodilEtors’ and further screening with approved bronchodilators was also studied to identify their ability to bind to the RNA binding region on the N protein. […] Hence this study suggests two important class of compounds, theophylline and pyrimidone derivaties as possible inhibitors of RNA binding to the N terminal domain of N protein of coronavirus, thus opening new avenues for in vitro validations.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>THIABENDAZOLE</title>
      <link>/drugpanel/thiabendazole/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/thiabendazole/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00730&#39; target=&#39;_blank&#39;&gt;db00730&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=thiabendazole&#34; target=&#34;_blank&#34;&gt;thiabendazole&lt;/a&gt; &lt;br&gt;
Synonymous :2-(1,3-thiazole-4-yl)-1h-benzimidazole | 2-(4-thiazolyl)-1h-benzimidazole | 2-(thiazol-4-yl)benzimidazole | 4-(2-benzimidazolyl)thiazole | tbdz | thiabendazole | tiabendazol | tiabendazole | tiabendazolum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;thiabendazole&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32268515
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among possible interesting drugs for Covid-19 treatment, we found Nimesulide, Fluticasone Propionate, Thiabendazole, Photofrin, Didanosine and Flutamide.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>THROMBIN</title>
      <link>/drugpanel/thrombin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/thrombin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db11300&#39; target=&#39;_blank&#39;&gt;db11300&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=thrombin&#34; target=&#34;_blank&#34;&gt;thrombin&lt;/a&gt; &lt;br&gt;
Synonymous :coagulation factor ii | thrombin bovine | thrombin, topical (bovine)
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;thrombin&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32172226
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Thrombin time in critical SARS-CoV-2 patients was also shorter than that in controls.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32181911
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A comparison of the hematological parameters between the mild and severe groups showed significant differences in interleukin-6 (IL-6), d-dimer (d-D), glucose, thrombin time, fibrinogen, and C-reactive protein (P &amp;lt; .05).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32267998
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Additionally, it has become clear that this is not a bleeding diathesis but rather a predominantly pro-thrombotic DIC with high venous thromboembolism rates, elevated D-dimer levels, high fibrinogen levels in concert with low anti-thrombin levels, and pulmonary congestion with microvascular thrombosis and occlusion on pathology in addition to mounting experience with high rates of central line thrombosis and vascular occlusive events (e.g. ischemic limbs, strokes, etc.) observed by those who care for critically ill COVID-19 patients (1-7).
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TOCILIZUMAB</title>
      <link>/drugpanel/tocilizumab/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/tocilizumab/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db06273&#39; target=&#39;_blank&#39;&gt;db06273&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=tocilizumab&#34; target=&#34;_blank&#34;&gt;tocilizumab&lt;/a&gt; &lt;br&gt;
Synonymous :atlizumab
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;tocilizumab&lt;/em&gt; gene in 7 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32222713
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
He remained in critical condition being treated with hydroxychloroquine and tocilizumab in addition to the standard medical management for septic shock and ARDS.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32234467
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Tocilizumab is a blocker of IL-6R, which can effectively block IL-6 signal transduction pathway. […] So, tocilizumab is likely to become an effective drug for patients with severe COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32240462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The efficacy of some promising antivirals, convalescent plasma transfusion, and tocilizumab needs to be investigated by ongoing clinical trials.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243270
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This review summarizes the current evidence of potential therapeutic agents, such as lopinavir/ritonavir, remdesivir, favipiravir, chloroquine, hydroxychloroquine, interferon, ribavirin, tocilizumab and sarilumab.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247050
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Potential treatments included remdesivir, chloroquine, tocilizumab, convalescent plasma and vaccine immunization (when possible).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253068
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Anti-IL-1 and anti-IL-6 may interfere with the cytokine storm in severe cases and use of tocilizumab has shown good outcomes in a small cohort.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253759
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Tocilizumab (TCZ), a monoclonal antibody against interleukin-6 (IL-6), emerged as an alternative treatment for COVID-19 patients with a risk of cytokine storms recently.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275256
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lastly, a collaborating group with immunologists and rheumatologists has been built with the aim of providing some guidance about the use of tocilizumab, a promising option for the treatment of the hyperinflammatory state occurring in most patients affected by COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277367
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
• Although preliminary results may be encouraging, high-quality clinical trials are needed to better understand the role of drugs commonly used in rheumatology like hydroxychloroquine and tocilizumab in COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282982
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Hydroxychloroquine (HCQ) was used by 78.1% of respondents; azithromycin by 46.9%; tocilizumab by 31.3%, and remdesivir by 25.0%.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32290839
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Moreover, Tocilizumab treatment that blocking IL-6 receptors showed inspiring clinical results including temperature returned to normal quickly and respiratory function improved. […] Therefore, we suggest that Tocilizumab is an effective treatment in severe patients of COVID-19 to calm the inflammatory storm and reduce mortality.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TODAY</title>
      <link>/drugpanel/today/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/today/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=today&#34; target=&#34;_blank&#34;&gt;today&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;today&lt;/em&gt; gene in 8 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32117569
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
While vaccine research should be pursued intensely, there exists today no therapy to treat 2019-nCoV upon infection, despite an urgent need to find options to help these patients and preclude potential death. […] The sequence of the ACE2-Fc protein is provided to investigators, allowing its possible use in recombinant protein expression systems to start producing drug today to treat patients under compassionate use, while formal clinical trials are later undertaken.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32119961
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Until today &amp;gt;2700 deaths from the 80,000 confirmed cases reported mainly in China and 40 other countries.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32213081
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Today, the world is experiencing a pandemic caused by a novel coronavirus.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32213476
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Although the world today must “flatten the curve” of spread of the virus, we argue that now is the time to “accelerate and bend the curve” on digital health. […] Increased investments in digital health today will yield unprecedented access to high-quality mental health care.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32231348
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The emergency that the world faces today demands that we develop urgent and effective measures to protect people at high risk of transmission.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32238978
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Today’s avalanche of conflicting news on how to deal with the coronavirus disease 2019 (Covid-19) brings to mind the Trinity nuclear bomb test with Enrico Fermi estimating its strength by releasing small pieces of paper into the air and measuring their displacement by the shock wave.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32246879
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Even today, many hemophilia patients and their families still retain painful and indelible memories of HIV and hepatitis C infections or are confronted with the progressive health consequences of these infections.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32274794
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
No person living today has ever witnessed such a crisis.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32279686
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
As Osler recognized, his concept of “one medicine, one health” defines what global public health is today.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32291351
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
As of today (7 April 2020), more than 81,000 people around the world have died from the coronavirus disease 19 (COVID-19) pandemic.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292847
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
But act today we must, and understanding the multiplicity of mechanisms of myocardial injury in COVID-19 infection will help us meet our mission unsupported by the comfort of strong data.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293743
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In general, respiratory viral co-infections are recognized more commonly today with the use of respiratory multiplex molecular diagnostic panels.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TOREMIFENE</title>
      <link>/drugpanel/toremifene/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/toremifene/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00539&#39; target=&#39;_blank&#39;&gt;db00539&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=toremifene&#34; target=&#34;_blank&#34;&gt;toremifene&lt;/a&gt; &lt;br&gt;
Synonymous :toremifene | toremifeno | toremifenum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;toremifene&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32194980
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We further identify three potential drug combinations (e.g., sirolimus plus dactinomycin, mercaptopurine plus melatonin, and toremifene plus emodin) captured by the “&lt;i&gt;Complementary Exposure&lt;/i&gt;” pattern: the targets of the drugs both hit the HCoV-host subnetwork, but target separate neighborhoods in the human interactome network.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TROMETHAMINE</title>
      <link>/drugpanel/tromethamine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/tromethamine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db03754&#39; target=&#39;_blank&#39;&gt;db03754&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=tromethamine&#34; target=&#34;_blank&#34;&gt;tromethamine&lt;/a&gt; &lt;br&gt;
Synonymous :1,1,1-tris(hydroxymethyl)methanamine | 2-amino-2-(hydroxymethyl)-1,3-propanediol | aminotris(hydroxymethyl)methane | tham | tris | tris(hydroxymethyl)aminomethane | trometamol | tromethamine
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;tromethamine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32145714
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;ol start=&#34;3&#34; style=&#34;list-style-type: decimal&#34;&gt;
&lt;li&gt;In the treatment of uterine contraction fatigue, carbetocin or carboprost tromethamine was used more in cesarean section for pregnant women with COVID-19 (1.3±0.6), compared with Non-COVID-19 group (0.5±0.7), the difference was statistically significant (&lt;i&gt;P&lt;/i&gt;=0.001). &lt;b&gt;Conclusions:&lt;/b&gt; If there is an indication for obstetric surgery or critical illness of COVID-19 in pregnant women, timely termination of pregnancy will not increase the risk of premature birth and asphyxia of the newborn, but it is beneficial to the treatment and rehabilitation of maternal pneumonia.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TRYPSIN</title>
      <link>/drugpanel/trypsin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/trypsin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db11237&#39; target=&#39;_blank&#39;&gt;db11237&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=trypsin&#34; target=&#34;_blank&#34;&gt;trypsin&lt;/a&gt; &lt;br&gt;
Synonymous :tripsina
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;trypsin&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32160149
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We found that the virus replicates to high titer in Vero-CCL81 cells and Vero E6 cells in the absence of trypsin.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TURKEY</title>
      <link>/drugpanel/turkey/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/turkey/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db10575&#39; target=&#39;_blank&#39;&gt;db10575&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=turkey&#34; target=&#34;_blank&#34;&gt;turkey&lt;/a&gt; &lt;br&gt;
Synonymous : &lt;em&gt;None&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;turkey&lt;/em&gt; gene in 4 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275463
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This study aims to evaluate the knowledge of anesthesiology specialists and residents in Turkey about COVID-19 and their attitudes toward the strategies and application methods to be used for a suspected/confirmed COVID-19 case that needs to be operated on or followed up in an intensive care unit, as well as to raise awareness about this issue. &lt;b&gt; &lt;i&gt;Methods:&lt;/i&gt; &lt;/b&gt; This descriptive study comprised anesthesiology specialists and residents working in various health institutions in Turkey.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283894
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Coronavirus Infectious Disease 2019 (COVID-19) is now a pandemic spreading in most countries including Turkey. […] Turkey is early in the outbreak.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293832
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
COVID-19 was seen for the first cases in Turkey on March 10, 2020 and was number 47,029 cases and 1,006 deaths after 1 month.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293834
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The most frequently used agents both in Turkey and all over the world including chloroquine, hydroxychloroquine, lopinavir/ritonavir, favipiravir and remdesivir will be reviewed here .
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>UREA</title>
      <link>/drugpanel/urea/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/urea/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db03904&#39; target=&#39;_blank&#39;&gt;db03904&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=urea&#34; target=&#34;_blank&#34;&gt;urea&lt;/a&gt; &lt;br&gt;
Synonymous :carbamide | carbonyldiamide | harnstoff | karbamid | urea | urée
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;urea&lt;/em&gt; gene in 11 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32229732
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Twelve (10.8%) patients showed mild increase of blood urea nitrogen or creatinine (&amp;lt;26 μmol/L within 48 h), and 8 (7.2%) patients showed trace or 1+ albuminuria in 111 COVID-19-confirmed patients without chronic kidney disease (CKD).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32237148
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
There were 38.5% of control patients had higher procalcitonin (PCT) levels than 0.5ng/ml, which was significantly higher than that percentage of COVID-19 patients (X&lt;sup&gt;2&lt;/sup&gt; =22.636, P &amp;lt;0.05), and COVID-19 patients were also more likely to have decreased or normal urea and creatinine levels than control patients (X&lt;sup&gt;2&lt;/sup&gt; =24.930, 8.480, P &amp;lt;0.05). […] Younger age, exposure to Wuhan, fever, cough, and slight changes in routine blood work-up parameters, urea and creatinine were important features discriminating COVID-19 from control patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The prevalence of elevated serum creatinine, elevated blood urea nitrogen and estimated glomerular filtration under 60 ml/min/1.73m&lt;sup&gt;2&lt;/sup&gt; were 14.4, 13.1 and 13.1%, respectively. […] Cox proportional hazard regression confirmed that elevated baseline serum creatinine (hazard ratio: 2.10, 95% confidence interval: 1.36-3.26), elevated baseline blood urea nitrogen (3.97, 2.57-6.14), AKI stage 1 (1.90, 0.76-4.76), stage 2 (3.51, 1.49-8.26), stage 3 (4.38, 2.31-8.31), proteinuria 1+ (1.80, 0.81-4.00), 2+∼3+ (4.84, 2.00-11.70), and hematuria 1+ (2.99, 1.39-6.42), 2+∼3+ (5.56,2.58- 12.01) were independent risk factors for in-hospital death after adjusting for age, sex, disease severity, comorbidity and leukocyte count.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32249089
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The most common symptoms on admission to hospital were fever (five patients, 100%), cough (five patients, 100%), myalgia or fatigue (three patients, 60%), and sputum production (three patients, 60%); serum creatinine or urea nitrogen levels were slightly higher than those before symptom onset.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32259132
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Patients with positive RT-PCR had significantly higher neutrophil (NEU) count (p = 0.0001), and C-reactive protein (CRP) (p = 0.04), lactate dehydrogenase (LDH) (p = 0.0001), aspartate aminotransferase (AST) (p = 0.001), alanine aminotransferase (ALT) (p = 0.0001), and Urea (p = 0.001) levels in serum. […] ALT (AUC = 0.879), CRP (AUC = 0.870), NEU (AUC = 0.858), LDH (AUC = 0.835), and Urea (AUC = 0.835) had very good accuracy in predicting cases with positive RT-PCR for COVID-19, respectively.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275643
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The parameters including homocysteine, urea, creatinine and serum cystatin C were significantly higher in imaging progression patients (all p &amp;lt; 0.05), while eGFR decreased (p &amp;lt; 0.001).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277023
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The interference factors causing false-positive reactivity in the two methods were analyzed, and the urea dissociation test was employed to dissociate the SARS-CoV-2 IgM-positive serum using the best dissociation concentration.&lt;b&gt;Results:&lt;/b&gt; Two methods detected positive SARS-CoV-2 IgM in 22 middle-high level RF-IgM-positive sera and 14 sera from COVID-19 patients; the other 50 sera were negative. […] When urea dissociation concentration was 6 mol/L, SARS-CoV-2 IgM were positive in 1 middle-high level RF-IgM-positive sera and in 14 COVID-19 patient sera detected using GICA. […] When urea dissociation concentration was 4 mol/L and the avidity index (AI) lower than 0.371 was set to negative, SARS-CoV-2 IgM were positive in 3 middle-high level RF-IgM-positive sera and in 14 COVID-19 patient sera detected using ELISA.&lt;b&gt;Conclusion:&lt;/b&gt; Middle-high level of RF-IgM could lead to false-positive reactivity of SARS-CoV-2 IgM detected using GICA and ELISA, and urea dissociation tests would be helpful in reducing false-positive results of SARS-CoV-2 IgM.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>VALINOMYCIN</title>
      <link>/drugpanel/valinomycin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/valinomycin/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db14057&#39; target=&#39;_blank&#39;&gt;db14057&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=valinomycin&#34; target=&#34;_blank&#34;&gt;valinomycin&lt;/a&gt; &lt;br&gt;
Synonymous :potassium ionophore i | valinomicin
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;valinomycin&lt;/em&gt; gene in 10 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32284379
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Valinomycin, a potassium ionophore, was among our top targets. […] We found that valinomycin exhibited potent anti-LACV activity in multiple cell types in a dose-dependent manner. […] Valinomycin did not affect particle stability or infectivity, suggesting that it may preclude virus replication by altering cellular potassium ions, a known determinant of LACV entry. […] We extended these results to other ionophores and found that the antiviral activity of valinomycin extended to other viral families including bunyaviruses (Rift Valley fever virus, Keystone virus), enteroviruses (Coxsackievirus, rhinovirus), flavirivuses (Zika), and coronaviruses (HCoV-229E and MERS-CoV). […] In all viral infections, we observed significant reductions in virus titer in valinomycin-treated cells. […] We focused on a potassium ionophore, valinomycin, due to its promising &lt;i&gt;in vitro&lt;/i&gt; antiviral activity. […] We demonstrate that valinomycin, as well as a selection of other ionophores, exhibits activity against La Crosse virus as well as several other distantly related bunyaviruses. […] We finally observe that valinomycin has activity against a wide array of human viral pathogens, suggesting that disrupting potassium ion homeostasis with valinomycin may be a potent host pathway to target to quell virus infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>VELPATASVIR</title>
      <link>/drugpanel/velpatasvir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/velpatasvir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db11613&#39; target=&#39;_blank&#39;&gt;db11613&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=velpatasvir&#34; target=&#34;_blank&#34;&gt;velpatasvir&lt;/a&gt; &lt;br&gt;
Synonymous :velpatasvir | velpatasvirum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;velpatasvir&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32194944
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among these, the antivirals ledipasvir or velpatasvir are particularly attractive as therapeutics to combat the new coronavirus with minimal side effects, commonly fatigue and headache. […] The drugs Epclusa (velpatasvir/sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) could be very effective owing to their dual inhibitory actions on two viral enzymes.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>WATER</title>
      <link>/drugpanel/water/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/water/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db09145&#39; target=&#39;_blank&#39;&gt;db09145&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=water&#34; target=&#34;_blank&#34;&gt;water&lt;/a&gt; &lt;br&gt;
Synonymous :agua | dihydrogen oxide | purified water | sterile water | water purified
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;water&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32096367
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The “Four-Anti and Two-Balance”strategy included antivirus, anti-shock, anti-hyoxemia, anti-secondary infection, and maintaining of water, electrolyte and acid base balance and microecological balance.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32196032
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Droplet microfluidic systems have the capability to overcome such limitations by conducting complex multi-step assays with high reliability, resolution, and throughput in a pico-liter volume water-in-oil emulsion droplet format.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32211765
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
No therapies are available, and the only way to contain the virus spread is to regularly and thoroughly clean oneself hands with an alcohol-based hand rub or wash them with soap and water, to maintain at least 1 metre (3 feet) distance from anyone who is coughing or sneezing, to avoid touching eyes, nose and mouth, and to stay home if one feels unwell.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32224550
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The threat of Coronavirus Disease 2019 (COVID-19) to health systems in sub-Saharan Africa (SSA) can be compared metaphorically to a lake in Africa infested with a bask of crocodiles and the saying: “the eye of the crocodile.” In the lake, only the eyes of the crocodile appear on the surface while the rest of the body is submerged in water.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32230995
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To efficiently solve this problem, we propose a hybrid algorithm based on the water wave optimization (WWO) metaheuristic and neighborhood search.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32232986
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The results showed that instant hand wiping using a wet towel soaked in water containing 1.00% soap powder, 0.05% active chlorine, or 0.25% active chlorine from sodium hypochlorite removed 98.36%, 96.62%, and 99.98% of the virus from hands, respectively.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32273245
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Optimal CL care behaviours should be the same as those under normal circumstances, which include appropriate hand washing (thoroughly with soap and water) and drying (with paper towels) before both CL application and removal. […] Daily CL cleaning and correct case care for reusable CL should be followed according to appropriate guidelines, and CL exposure to water must be avoided.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32279686
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Furthermore, they are exacerbated by an increasing number of vulnerable populations suffering from chronic deficiencies in food, water, and energy.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
PPE made of more breathable material may lead to a similar number of spots on the trunk (MD 1.60, 95% CI -0.15 to 3.35) compared to more water-repellent material but may have greater user satisfaction (MD -0.46, 95% CI -0.84 to -0.08, scale of 1 to 5).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293875
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Ritonavir showed somewhat higher atomic contacts, binding efficiency and key binding residues than that of lopinavir in correspondence with slightly less water accessibility at the 3CL&lt;sup&gt;pro&lt;/sup&gt; active site.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>YOHIMBINE</title>
      <link>/drugpanel/yohimbine/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/yohimbine/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01392&#39; target=&#39;_blank&#39;&gt;db01392&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=yohimbine&#34; target=&#34;_blank&#34;&gt;yohimbine&lt;/a&gt; &lt;br&gt;
Synonymous :(+)-yohimbine | (16α,17α)-17-hydroxyyohimban-16-carboxylic acid methyl ester | 17α-hydroxyyohimban-16α-carboxylic acid methyl ester | johimbin | quebrachin | yohimbic acid methyl ester | yohimbin | yohimbine | yohimbinum
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;yohimbine&lt;/em&gt; gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281695
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We identified many cheap, available, and safe medicines, such as diphenidol, quinine, chloroquine, artemisinin, chlorpheniramine, yohimbine, and dextromethorphan, which may target the most common symptoms caused by 2019-nCoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ZANAMIVIR</title>
      <link>/drugpanel/zanamivir/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/zanamivir/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db00558&#39; target=&#39;_blank&#39;&gt;db00558&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=zanamivir&#34; target=&#34;_blank&#34;&gt;zanamivir&lt;/a&gt; &lt;br&gt;
Synonymous :(2r,3r,4s)-3-(acetylamino)-4-carbamimidamido-2-[(1r,2r)-1,2,3-trihydroxypropyl]-3,4-dihydro-2h-pyran-6-carboxylic acid | 4-guanidino-2,4-dideoxy-2,3-dehydro-n-acetylneuraminic acid | 4-guanidino-neu5ac2en | 5-(acetylamino)-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-d-glycero-d-galacto-non-2-enonic acid | 5-acetamido-2,6-anhydro-3,4,5-trideoxy-4-guanidino-d-glycero-d-galacto-non-2-enonic acid | gana | zanamivir
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;zanamivir&lt;/em&gt; gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32023685
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294562
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Several antiviral medications: Zanamivir, Indinavir, Saquinavir, and Remdesivir show potential as and 3CL&lt;sup&gt;PRO&lt;/sup&gt; main proteinase inhibitors and as a treatment of COVID-19. […] Zanamivir, Indinavir, Saquinavir, and Remdesivir are among the exciting hits on the 3CL&lt;sup&gt;PRO&lt;/sup&gt; main proteinase.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ZINC</title>
      <link>/drugpanel/zinc/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/drugpanel/zinc/info/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
DrugBank ID: &lt;a href=&#39;https://www.drugbank.ca/drugs/db01593&#39; target=&#39;_blank&#39;&gt;db01593&lt;/a&gt; &lt;br&gt;
DrugCentral: &lt;a href=&#34;http://drugcentral.org/?q=zinc&#34; target=&#34;_blank&#34;&gt;zinc&lt;/a&gt; &lt;br&gt;
Synonymous :zinc, chelated | zinc, elemental | zincum metallicum | zn
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;drug-sentece-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Drug Sentece Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;zinc&lt;/em&gt; gene in 4 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
pmid
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32210741
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Furthermore, broad library protease inhibitors obtained from PubChem and ZINC (www.zinc.docking.org) were evaluated.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32267566
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Tetracyclines (e.g. tetracycline, doxycycline, and minocycline) are highly lipophilic antibiotics that are known to chelate zinc compounds on matrix metalloproteinases (MMPs)&lt;sup&gt;1&lt;/sup&gt; . […] Coronaviruses are also known to heavily rely on host MMPs for survival, cell infiltration, cell to cell adhesion, and replication, many of which have zinc as part of their MMP complex&lt;sup&gt;2,3&lt;/sup&gt; . […] It is possible that the zinc chelating properties of tetracyclines may also aid in inhibiting COVID-19 infection in humans limiting their ability to replicate within the host.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32289821
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The zinc finger antiviral protein (ZAP) binds specifically to CpG dinucleotides and recruits other proteins to degrade a variety of viral RNA genomes.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
By performing target-based virtual ligand screening, a total of 21 targets (including two human targets) were screened against compound libraries including ZINC drug database and our own database of natural products.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SDS</title>
      <link>/genepanel/10993/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/10993/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;serine dehydratase&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/10993&#34; target=&#34;_blank&#34;&gt;10993&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=10993&#34; target=&#34;_blank&#34;&gt; 12q24.13&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/612930&#39; target=&#39;_blank&#39;&gt;612930&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes one of three enzymes that are involved in metabolizing serine and glycine. L-serine dehydratase converts L-serine to pyruvate and ammonia and requires pyridoxal phosphate as a cofactor. The encoded protein can also metabolize threonine to NH4+ and 2-ketobutyrate. The encoded protein is found predominantly in the liver. [provided by RefSeq, Jul 2008] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>CHM</title>
      <link>/genepanel/1121/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1121/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;CHM Rab escort protein&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/1121&#34; target=&#34;_blank&#34;&gt;1121&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=1121&#34; target=&#34;_blank&#34;&gt; Xq21.2&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/303100&#39; target=&#39;_blank&#39;&gt;303100&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/300390&#39; target=&#39;_blank&#39;&gt;300390&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes component A of the RAB geranylgeranyl transferase holoenzyme. In the dimeric holoenzyme, this subunit binds unprenylated Rab GTPases and then presents them to the catalytic Rab GGTase subunit for the geranylgeranyl transfer reaction. Rab GTPases need to be geranylgeranyled on either one or two cysteine residues in their C-terminus to localize to the correct intracellular membrane. Mutations in this gene are a cause of choroideremia; also known as tapetochoroidal dystrophy (TCD). This X-linked disease is characterized by progressive dystrophy of the choroid, retinal pigment epithelium and retina. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2016] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>NRM</title>
      <link>/genepanel/11270/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/11270/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;nurim&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/11270&#34; target=&#34;_blank&#34;&gt;11270&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=11270&#34; target=&#34;_blank&#34;&gt; 6p21.33&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/&#39; target=&#39;_blank&#39;&gt;&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The protein encoded by this gene contains transmembrane domains and resides within the inner nuclear membrane, where it is tightly associated with the nucleus. This protein shares homology with isoprenylcysteine carboxymethyltransferase enzymes. Alternative splicing results in multiple transcript variants that encode different protein isoforms. [provided by RefSeq, Jul 2012] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>NLRP3</title>
      <link>/genepanel/114548/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/114548/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;NLR family pyrin domain containing 3&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/114548&#34; target=&#34;_blank&#34;&gt;114548&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=114548&#34; target=&#34;_blank&#34;&gt; 1q44&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/614521&#39; target=&#39;_blank&#39;&gt;614521&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/601626&#39; target=&#39;_blank&#39;&gt;601626&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/600880&#39; target=&#39;_blank&#39;&gt;600880&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/263300&#39; target=&#39;_blank&#39;&gt;263300&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/254450&#39; target=&#39;_blank&#39;&gt;254450&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/147796&#39; target=&#39;_blank&#39;&gt;147796&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/133100&#39; target=&#39;_blank&#39;&gt;133100&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes a pyrin-like protein containing a pyrin domain, a nucleotide-binding site (NBS) domain, and a leucine-rich repeat (LRR) motif. This protein interacts with the apoptosis-associated speck-like protein PYCARD/ASC, which contains a caspase recruitment domain, and is a member of the NALP3 inflammasome complex. This complex functions as an upstream activator of NF-kappaB signaling, and it plays a role in the regulation of inflammation, the immune response, and apoptosis. Mutations in this gene are associated with familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), chronic infantile neurological cutaneous and articular (CINCA) syndrome, and neonatal-onset multisystem inflammatory disease (NOMID). Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. Alternative 5’ UTR structures are suggested by available data; however, insufficient evidence is available to determine if all of the represented 5’ UTR splice patterns are biologically valid. [provided by RefSeq, Oct 2008] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>CP</title>
      <link>/genepanel/1356/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1356/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;ceruloplasmin&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/1356&#34; target=&#34;_blank&#34;&gt;1356&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=1356&#34; target=&#34;_blank&#34;&gt; 3q24-q25.1&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/604290&#39; target=&#39;_blank&#39;&gt;604290&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/117700&#39; target=&#39;_blank&#39;&gt;117700&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The protein encoded by this gene is a metalloprotein that binds most of the copper in plasma and is involved in the peroxidation of Fe(II)transferrin to Fe(III) transferrin. Mutations in this gene cause aceruloplasminemia, which results in iron accumulation and tissue damage, and is associated with diabetes and neurologic abnormalities. Two transcript variants, one protein-coding and the other not protein-coding, have been found for this gene. [provided by RefSeq, Feb 2012] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>CPE</title>
      <link>/genepanel/1363/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1363/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;carboxypeptidase E&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/1363&#34; target=&#34;_blank&#34;&gt;1363&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=1363&#34; target=&#34;_blank&#34;&gt; 4q32.3&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/114855&#39; target=&#39;_blank&#39;&gt;114855&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes a member of the M14 family of metallocarboxypeptidases. The encoded preproprotein is proteolytically processed to generate the mature peptidase. This peripheral membrane protein cleaves C-terminal amino acid residues and is involved in the biosynthesis of peptide hormones and neurotransmitters, including insulin. This protein may also function independently of its peptidase activity, as a neurotrophic factor that promotes neuronal survival, and as a sorting receptor that binds to regulated secretory pathway proteins, including prohormones. Mutations in this gene are implicated in type 2 diabetes. [provided by RefSeq, Nov 2015] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>CRP</title>
      <link>/genepanel/1401/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1401/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;C-reactive protein&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/1401&#34; target=&#34;_blank&#34;&gt;1401&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=1401&#34; target=&#34;_blank&#34;&gt; 1q23.2&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/123260&#39; target=&#39;_blank&#39;&gt;123260&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The protein encoded by this gene belongs to the pentaxin family. It is involved in several host defense related functions based on its ability to recognize foreign pathogens and damaged cells of the host and to initiate their elimination by interacting with humoral and cellular effector systems in the blood. Consequently, the level of this protein in plasma increases greatly during acute phase response to tissue injury, infection, or other inflammatory stimuli. [provided by RefSeq, Sep 2009] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>ACE</title>
      <link>/genepanel/1636/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1636/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;angiotensin I converting enzyme&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/1636&#34; target=&#34;_blank&#34;&gt;1636&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=1636&#34; target=&#34;_blank&#34;&gt; 17q23.3&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/614519&#39; target=&#39;_blank&#39;&gt;614519&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/612624&#39; target=&#39;_blank&#39;&gt;612624&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/267430&#39; target=&#39;_blank&#39;&gt;267430&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/106180&#39; target=&#39;_blank&#39;&gt;106180&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes an enzyme involved in catalyzing the conversion of angiotensin I into a physiologically active peptide angiotensin II. Angiotensin II is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure and fluid-electrolyte balance. This enzyme plays a key role in the renin-angiotensin system. Many studies have associated the presence or absence of a 287 bp Alu repeat element in this gene with the levels of circulating enzyme or cardiovascular pathophysiologies. Multiple alternatively spliced transcript variants encoding different isoforms have been identified, and two most abundant spliced variants encode the somatic form and the testicular form, respectively, that are equally active. [provided by RefSeq, May 2010] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>AGA</title>
      <link>/genepanel/175/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/175/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;aspartylglucosaminidase&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/175&#34; target=&#34;_blank&#34;&gt;175&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=175&#34; target=&#34;_blank&#34;&gt; 4q34.3&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/613228&#39; target=&#39;_blank&#39;&gt;613228&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/208400&#39; target=&#39;_blank&#39;&gt;208400&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes a member of the N-terminal nucleophile (Ntn) hydrolase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta chains that comprise the mature enzyme. This enzyme is involved in the catabolism of N-linked oligosaccharides of glycoproteins. It cleaves asparagine from N-acetylglucosamines as one of the final steps in the lysosomal breakdown of glycoproteins. Mutations in this gene are associated with the lysosomal storage disease aspartylglycosaminuria that results in progressive neurodegeneration. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is subject to proteolytic processing. [provided by RefSeq, Nov 2015] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>DPP4</title>
      <link>/genepanel/1803/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1803/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;dipeptidyl peptidase 4&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/1803&#34; target=&#34;_blank&#34;&gt;1803&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=1803&#34; target=&#34;_blank&#34;&gt; 2q24.2&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/102720&#39; target=&#39;_blank&#39;&gt;102720&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The DPP4 gene encodes dipeptidyl peptidase 4, which is identical to adenosine deaminase complexing protein-2, and to the T-cell activation antigen CD26. It is an intrinsic type II transmembrane glycoprotein and a serine exopeptidase that cleaves X-proline dipeptides from the N-terminus of polypeptides. Dipeptidyl peptidase 4 is highly involved in glucose and insulin metabolism, as well as in immune regulation. This protein was shown to be a functional receptor for Middle East respiratory syndrome coronavirus (MERS-CoV), and protein modeling suggests that it may play a similar role with SARS-CoV-2, the virus responsible for COVID-19. [provided by RefSeq, Apr 2020] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>ENPEP</title>
      <link>/genepanel/2028/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2028/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;glutamyl aminopeptidase&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/2028&#34; target=&#34;_blank&#34;&gt;2028&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=2028&#34; target=&#34;_blank&#34;&gt; 4q25&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/138297&#39; target=&#39;_blank&#39;&gt;138297&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The ENPEP gene encodes glutamyl aminopeptidase, a type II integral membrane protein with an extracellular zinc-binding domain. This protein can upregulate blood pressure by cleaving the N-terminal aspartate from angiotensin II, and can regulate blood vessel formation and enhance tumorigenesis in some tissues. Along with ANPEP and DPP4, ENPEP was found to be a candidate co-receptor for the coronavirus SARS-CoV-2, which causes COVID-19. [provided by RefSeq, Apr 2020] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>ALB</title>
      <link>/genepanel/213/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/213/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;albumin&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/213&#34; target=&#34;_blank&#34;&gt;213&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=213&#34; target=&#34;_blank&#34;&gt; 4q13.3&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/616000&#39; target=&#39;_blank&#39;&gt;616000&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/615999&#39; target=&#39;_blank&#39;&gt;615999&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/103600&#39; target=&#39;_blank&#39;&gt;103600&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes the most abundant protein in human blood. This protein functions in the regulation of blood plasma colloid osmotic pressure and acts as a carrier protein for a wide range of endogenous molecules including hormones, fatty acids, and metabolites, as well as exogenous drugs. Additionally, this protein exhibits an esterase-like activity with broad substrate specificity. The encoded preproprotein is proteolytically processed to generate the mature protein. A peptide derived from this protein, EPI-X4, is an endogenous inhibitor of the CXCR4 chemokine receptor. [provided by RefSeq, Jul 2016] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>EZH2</title>
      <link>/genepanel/2146/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2146/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;enhancer of zeste 2 polycomb repressive complex 2 subunit&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/2146&#34; target=&#34;_blank&#34;&gt;2146&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=2146&#34; target=&#34;_blank&#34;&gt; 7q36.1&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/601573&#39; target=&#39;_blank&#39;&gt;601573&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/277590&#39; target=&#39;_blank&#39;&gt;277590&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes a member of the Polycomb-group (PcG) family. PcG family members form multimeric protein complexes, which are involved in maintaining the transcriptional repressive state of genes over successive cell generations. This protein associates with the embryonic ectoderm development protein, the VAV1 oncoprotein, and the X-linked nuclear protein. This protein may play a role in the hematopoietic and central nervous systems. Multiple alternatively splcied transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Feb 2011] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>SIRT1</title>
      <link>/genepanel/23411/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/23411/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;sirtuin 1&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/23411&#34; target=&#34;_blank&#34;&gt;23411&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=23411&#34; target=&#34;_blank&#34;&gt; 10q21.3&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/604479&#39; target=&#39;_blank&#39;&gt;604479&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes a member of the sirtuin family of proteins, homologs to the yeast Sir2 protein. Members of the sirtuin family are characterized by a sirtuin core domain and grouped into four classes. The functions of human sirtuins have not yet been determined; however, yeast sirtuin proteins are known to regulate epigenetic gene silencing and suppress recombination of rDNA. Studies suggest that the human sirtuins may function as intracellular regulatory proteins with mono-ADP-ribosyltransferase activity. The protein encoded by this gene is included in class I of the sirtuin family. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2008] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>G6PD</title>
      <link>/genepanel/2539/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2539/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;glucose-6-phosphate dehydrogenase&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/2539&#34; target=&#34;_blank&#34;&gt;2539&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=2539&#34; target=&#34;_blank&#34;&gt; Xq28&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/611162&#39; target=&#39;_blank&#39;&gt;611162&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/305900&#39; target=&#39;_blank&#39;&gt;305900&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/300908&#39; target=&#39;_blank&#39;&gt;300908&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes glucose-6-phosphate dehydrogenase. This protein is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions. G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide ranging levels of enzyme activity and associated clinical symptoms. G6PD deficiency may cause neonatal jaundice, acute hemolysis, or severe chronic non-spherocytic hemolytic anemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>ANG</title>
      <link>/genepanel/283/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/283/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;angiogenin&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/283&#34; target=&#34;_blank&#34;&gt;283&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=283&#34; target=&#34;_blank&#34;&gt; 14q11.2&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/611895&#39; target=&#39;_blank&#39;&gt;611895&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/105850&#39; target=&#39;_blank&#39;&gt;105850&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The protein encoded by this gene is an exceedingly potent mediator of new blood vessel formation. It hydrolyzes cellular tRNAs resulting in decreased protein synthesis and is similar to pancreatic ribonuclease. In addition, the mature peptide has antimicrobial activity against some bacteria and fungi, including S. pneumoniae and C. albicans. Alternative splicing results in two transcript variants encoding the same protein. This gene and the gene that encodes ribonuclease, RNase A family, 4 share promoters and 5’ exons. Each gene splices to a unique downstream exon that contains its complete coding region. [provided by RefSeq, Aug 2014] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>CXCR3</title>
      <link>/genepanel/2833/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2833/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;C-X-C motif chemokine receptor 3&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/2833&#34; target=&#34;_blank&#34;&gt;2833&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=2833&#34; target=&#34;_blank&#34;&gt; Xq13.1&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/300574&#39; target=&#39;_blank&#39;&gt;300574&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes a G protein-coupled receptor with selectivity for three chemokines, termed CXCL9/Mig (monokine induced by interferon-g), CXCL10/IP10 (interferon-g-inducible 10 kDa protein) and CXCL11/I-TAC (interferon-inducible T cell a-chemoattractant). Binding of chemokines to this protein induces cellular responses that are involved in leukocyte traffic, most notably integrin activation, cytoskeletal changes and chemotactic migration. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. One of the isoforms (CXCR3-B) shows high affinity binding to chemokine, CXCL4/PF4 (&lt;a href=&#34;PMID:12782716&#34; class=&#34;uri&#34;&gt;PMID:12782716&lt;/a&gt;). [provided by RefSeq, Jun 2011] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>ANPEP</title>
      <link>/genepanel/290/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/290/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;alanyl aminopeptidase, membrane&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/290&#34; target=&#34;_blank&#34;&gt;290&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=290&#34; target=&#34;_blank&#34;&gt; 15q26.1&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/151530&#39; target=&#39;_blank&#39;&gt;151530&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;Aminopeptidase N is located in the small-intestinal and renal microvillar membrane, and also in other plasma membranes. In the small intestine aminopeptidase N plays a role in the final digestion of peptides generated from hydrolysis of proteins by gastric and pancreatic proteases. Its function in proximal tubular epithelial cells and other cell types is less clear. The large extracellular carboxyterminal domain contains a pentapeptide consensus sequence characteristic of members of the zinc-binding metalloproteinase superfamily. Sequence comparisons with known enzymes of this class showed that CD13 and aminopeptidase N are identical. The latter enzyme was thought to be involved in the metabolism of regulatory peptides by diverse cell types, including small intestinal and renal tubular epithelial cells, macrophages, granulocytes, and synaptic membranes from the CNS. Human aminopeptidase N is a receptor for one strain of human coronavirus that is an important cause of upper respiratory tract infections. Defects in this gene appear to be a cause of various types of leukemia or lymphoma. [provided by RefSeq, Jul 2008] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>HBM</title>
      <link>/genepanel/3042/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3042/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;hemoglobin subunit mu&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/3042&#34; target=&#34;_blank&#34;&gt;3042&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=3042&#34; target=&#34;_blank&#34;&gt; 16p13.3&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/609639&#39; target=&#39;_blank&#39;&gt;609639&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5’- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3’. This gene has an ORF encoding a 141 aa polypeptide which is similar to the delta globins found in reptiles and birds. This locus was originally described as a pseudogene; however, it is currently thought to be a protein-coding gene. [provided by RefSeq, Jul 2008] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>HGF</title>
      <link>/genepanel/3082/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3082/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;hepatocyte growth factor&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/3082&#34; target=&#34;_blank&#34;&gt;3082&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=3082&#34; target=&#34;_blank&#34;&gt; 7q21.11&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/608265&#39; target=&#39;_blank&#39;&gt;608265&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/142409&#39; target=&#39;_blank&#39;&gt;142409&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes a protein that binds to the hepatocyte growth factor receptor to regulate cell growth, cell motility and morphogenesis in numerous cell and tissue types. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate alpha and beta chains, which form the mature heterodimer. This protein is secreted by mesenchymal cells and acts as a multi-functional cytokine on cells of mainly epithelial origin. This protein also plays a role in angiogenesis, tumorogenesis, and tissue regeneration. Although the encoded protein is a member of the peptidase S1 family of serine proteases, it lacks peptidase activity. Mutations in this gene are associated with nonsyndromic hearing loss. [provided by RefSeq, Nov 2015] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>IL1B</title>
      <link>/genepanel/3553/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3553/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;interleukin 1 beta&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/3553&#34; target=&#34;_blank&#34;&gt;3553&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=3553&#34; target=&#34;_blank&#34;&gt; 2q14.1&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/147720&#39; target=&#39;_blank&#39;&gt;147720&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/137215&#39; target=&#39;_blank&#39;&gt;137215&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The protein encoded by this gene is a member of the interleukin 1 cytokine family. This cytokine is produced by activated macrophages as a proprotein, which is proteolytically processed to its active form by caspase 1 (CASP1/ICE). This cytokine is an important mediator of the inflammatory response, and is involved in a variety of cellular activities, including cell proliferation, differentiation, and apoptosis. The induction of cyclooxygenase-2 (PTGS2/COX2) by this cytokine in the central nervous system (CNS) is found to contribute to inflammatory pain hypersensitivity. This gene and eight other interleukin 1 family genes form a cytokine gene cluster on chromosome 2. [provided by RefSeq, Jul 2008] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>IL2</title>
      <link>/genepanel/3558/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3558/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;interleukin 2&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/3558&#34; target=&#34;_blank&#34;&gt;3558&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=3558&#34; target=&#34;_blank&#34;&gt; 4q27&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/147680&#39; target=&#39;_blank&#39;&gt;147680&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The protein encoded by this gene is a secreted cytokine that is important for the proliferation of T and B lymphocytes. The receptor of this cytokine is a heterotrimeric protein complex whose gamma chain is also shared by interleukin 4 (IL4) and interleukin 7 (IL7). The expression of this gene in mature thymocytes is monoallelic, which represents an unusual regulatory mode for controlling the precise expression of a single gene. The targeted disruption of a similar gene in mice leads to ulcerative colitis-like disease, which suggests an essential role of this gene in the immune response to antigenic stimuli. [provided by RefSeq, Jul 2008] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>IL6</title>
      <link>/genepanel/3569/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3569/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;interleukin 6&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/3569&#34; target=&#34;_blank&#34;&gt;3569&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=3569&#34; target=&#34;_blank&#34;&gt; 7p15.3&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/604302&#39; target=&#39;_blank&#39;&gt;604302&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/266600&#39; target=&#39;_blank&#39;&gt;266600&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/222100&#39; target=&#39;_blank&#39;&gt;222100&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/148000&#39; target=&#39;_blank&#39;&gt;148000&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/147620&#39; target=&#39;_blank&#39;&gt;147620&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/108010&#39; target=&#39;_blank&#39;&gt;108010&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes a cytokine that functions in inflammation and the maturation of B cells. In addition, the encoded protein has been shown to be an endogenous pyrogen capable of inducing fever in people with autoimmune diseases or infections. The protein is primarily produced at sites of acute and chronic inflammation, where it is secreted into the serum and induces a transcriptional inflammatory response through interleukin 6 receptor, alpha. The functioning of this gene is implicated in a wide variety of inflammation-associated disease states, including suspectibility to diabetes mellitus and systemic juvenile rheumatoid arthritis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>IL7</title>
      <link>/genepanel/3574/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3574/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;interleukin 7&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/3574&#34; target=&#34;_blank&#34;&gt;3574&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=3574&#34; target=&#34;_blank&#34;&gt; 8q21.13&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/618309&#39; target=&#39;_blank&#39;&gt;618309&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/146660&#39; target=&#39;_blank&#39;&gt;146660&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The protein encoded by this gene is a cytokine important for B and T cell development. This cytokine and the hepatocyte growth factor (HGF) form a heterodimer that functions as a pre-pro-B cell growth-stimulating factor. This cytokine is found to be a cofactor for V(D)J rearrangement of the T cell receptor beta (TCRB) during early T cell development. This cytokine can be produced locally by intestinal epithelial and epithelial goblet cells, and may serve as a regulatory factor for intestinal mucosal lymphocytes. Knockout studies in mice suggested that this cytokine plays an essential role in lymphoid cell survival. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional splice variants have been described but their presence in normal tissues has not been confirmed.[provided by RefSeq, Dec 2010] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>IL10</title>
      <link>/genepanel/3586/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3586/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;interleukin 10&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/3586&#34; target=&#34;_blank&#34;&gt;3586&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=3586&#34; target=&#34;_blank&#34;&gt; 1q32.1&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/614395&#39; target=&#39;_blank&#39;&gt;614395&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/609423&#39; target=&#39;_blank&#39;&gt;609423&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/180300&#39; target=&#39;_blank&#39;&gt;180300&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/124092&#39; target=&#39;_blank&#39;&gt;124092&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The protein encoded by this gene is a cytokine produced primarily by monocytes and to a lesser extent by lymphocytes. This cytokine has pleiotropic effects in immunoregulation and inflammation. It down-regulates the expression of Th1 cytokines, MHC class II Ags, and costimulatory molecules on macrophages. It also enhances B cell survival, proliferation, and antibody production. This cytokine can block NF-kappa B activity, and is involved in the regulation of the JAK-STAT signaling pathway. Knockout studies in mice suggested the function of this cytokine as an essential immunoregulator in the intestinal tract. Mutations in this gene are associated with an increased susceptibility to HIV-1 infection and rheumatoid arthritis.[provided by RefSeq, May 2011] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>IVD</title>
      <link>/genepanel/3712/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3712/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;isovaleryl-CoA dehydrogenase&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/3712&#34; target=&#34;_blank&#34;&gt;3712&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=3712&#34; target=&#34;_blank&#34;&gt; 15q15.1&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/607036&#39; target=&#39;_blank&#39;&gt;607036&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/243500&#39; target=&#39;_blank&#39;&gt;243500&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;Isovaleryl-CoA dehydrogenase (IVD) is a mitochondrial matrix enzyme that catalyzes the third step in leucine catabolism. The genetic deficiency of IVD results in an accumulation of isovaleric acid, which is toxic to the central nervous system and leads to isovaleric acidemia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2017] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>JAK2</title>
      <link>/genepanel/3717/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3717/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;Janus kinase 2&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/3717&#34; target=&#34;_blank&#34;&gt;3717&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=3717&#34; target=&#34;_blank&#34;&gt; 9p24.1&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/615319&#39; target=&#39;_blank&#39;&gt;615319&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene product is a protein tyrosine kinase involved in a specific subset of cytokine receptor signaling pathways. It has been found to be constituitively associated with the prolactin receptor and is required for responses to gamma interferon. Mice that do not express an active protein for this gene exhibit embryonic lethality associated with the absence of definitive erythropoiesis. [provided by RefSeq, Jul 2008] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>MB</title>
      <link>/genepanel/4151/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/4151/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;myoglobin&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/4151&#34; target=&#34;_blank&#34;&gt;4151&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=4151&#34; target=&#34;_blank&#34;&gt; 22q12.3&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/160000&#39; target=&#39;_blank&#39;&gt;160000&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes a member of the globin superfamily and is expressed in skeletal and cardiac muscles. The encoded protein is a haemoprotein contributing to intracellular oxygen storage and transcellular facilitated diffusion of oxygen. At least three alternatively spliced transcript variants encoding the same protein have been reported. [provided by RefSeq, Jul 2008] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>NHS</title>
      <link>/genepanel/4810/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/4810/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;NHS actin remodeling regulator&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/4810&#34; target=&#34;_blank&#34;&gt;4810&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=4810&#34; target=&#34;_blank&#34;&gt; Xp22.2-p22.13&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/302350&#39; target=&#39;_blank&#39;&gt;302350&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/302200&#39; target=&#39;_blank&#39;&gt;302200&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/300457&#39; target=&#39;_blank&#39;&gt;300457&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes a protein containing four conserved nuclear localization signals. The encoded protein functions in eye, tooth, craniofacial and brain development, and it can regulate actin remodeling and cell morphology. Mutations in this gene have been shown to cause Nance-Horan syndrome, and also X-linked cataract-40. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2014] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>TAS2R10</title>
      <link>/genepanel/50839/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/50839/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;taste 2 receptor member 10&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/50839&#34; target=&#34;_blank&#34;&gt;50839&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=50839&#34; target=&#34;_blank&#34;&gt; 12p13.2&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/604791&#39; target=&#39;_blank&#39;&gt;604791&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene product belongs to the family of candidate taste receptors that are members of the G-protein-coupled receptor superfamily. These proteins are specifically expressed in the taste receptor cells of the tongue and palate epithelia. They are organized in the genome in clusters and are genetically linked to loci that influence bitter perception in mice and humans. In functional expression studies, they respond to bitter tastants. This gene maps to the taste receptor gene cluster on chromosome 12p13. [provided by RefSeq, Jul 2008] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>PC</title>
      <link>/genepanel/5091/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/5091/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;pyruvate carboxylase&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/5091&#34; target=&#34;_blank&#34;&gt;5091&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=5091&#34; target=&#34;_blank&#34;&gt; 11q13.2&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/608786&#39; target=&#39;_blank&#39;&gt;608786&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/266150&#39; target=&#39;_blank&#39;&gt;266150&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes pyruvate carboxylase, which requires biotin and ATP to catalyse the carboxylation of pyruvate to oxaloacetate. The active enzyme is a homotetramer arranged in a tetrahedron which is located exclusively in the mitochondrial matrix. Pyruvate carboxylase is involved in gluconeogenesis, lipogenesis, insulin secretion and synthesis of the neurotransmitter glutamate. Mutations in this gene have been associated with pyruvate carboxylase deficiency. Alternatively spliced transcript variants with different 5’ UTRs, but encoding the same protein, have been found for this gene. [provided by RefSeq, Jul 2008] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>FOXP3</title>
      <link>/genepanel/50943/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/50943/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;forkhead box P3&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/50943&#34; target=&#34;_blank&#34;&gt;50943&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=50943&#34; target=&#34;_blank&#34;&gt; Xp11.23&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/304790&#39; target=&#39;_blank&#39;&gt;304790&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/300292&#39; target=&#39;_blank&#39;&gt;300292&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The protein encoded by this gene is a member of the forkhead/winged-helix family of transcriptional regulators. Defects in this gene are the cause of immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome (IPEX), also known as X-linked autoimmunity-immunodeficiency syndrome. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>TLR7</title>
      <link>/genepanel/51284/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/51284/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;toll like receptor 7&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/51284&#34; target=&#34;_blank&#34;&gt;51284&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=51284&#34; target=&#34;_blank&#34;&gt; Xp22.2&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/300365&#39; target=&#39;_blank&#39;&gt;300365&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This gene is predominantly expressed in lung, placenta, and spleen, and lies in close proximity to another family member, TLR8, on chromosome X. [provided by RefSeq, Jul 2008] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>TLR8</title>
      <link>/genepanel/51311/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/51311/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;toll like receptor 8&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/51311&#34; target=&#34;_blank&#34;&gt;51311&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=51311&#34; target=&#34;_blank&#34;&gt; Xp22.2&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/615557&#39; target=&#39;_blank&#39;&gt;615557&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/608556&#39; target=&#39;_blank&#39;&gt;608556&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/603031&#39; target=&#39;_blank&#39;&gt;603031&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/601744&#39; target=&#39;_blank&#39;&gt;601744&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This gene is predominantly expressed in lung and peripheral blood leukocytes, and lies in close proximity to another family member, TLR7, on chromosome X. [provided by RefSeq, Jul 2008] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>PLP2</title>
      <link>/genepanel/5355/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/5355/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;proteolipid protein 2&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/5355&#34; target=&#34;_blank&#34;&gt;5355&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=5355&#34; target=&#34;_blank&#34;&gt; Xp11.23&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/300112&#39; target=&#39;_blank&#39;&gt;300112&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes an integral membrane protein that localizes to the endoplasmic reticulum in colonic epithelial cells. The encoded protein can multimerize and may function as an ion channel. A polymorphism in the promoter of this gene may be linked to an increased risk of X-linked cognitive disability. A pseudogene of this gene is found on chromosome 5. [provided by RefSeq, Jan 2010] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>PID1</title>
      <link>/genepanel/55022/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/55022/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;phosphotyrosine interaction domain containing 1&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/55022&#34; target=&#34;_blank&#34;&gt;55022&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=55022&#34; target=&#34;_blank&#34;&gt; 2q36.3&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/617772&#39; target=&#39;_blank&#39;&gt;617772&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/607115&#39; target=&#39;_blank&#39;&gt;607115&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/606416&#39; target=&#39;_blank&#39;&gt;606416&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/191900&#39; target=&#39;_blank&#39;&gt;191900&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/148200&#39; target=&#39;_blank&#39;&gt;148200&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/120100&#39; target=&#39;_blank&#39;&gt;120100&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt; &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>HR</title>
      <link>/genepanel/55806/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/55806/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;HR lysine demethylase and nuclear receptor corepressor&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/55806&#34; target=&#34;_blank&#34;&gt;55806&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=55806&#34; target=&#34;_blank&#34;&gt; 8p21.3&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/602302&#39; target=&#39;_blank&#39;&gt;602302&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/209500&#39; target=&#39;_blank&#39;&gt;209500&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/203655&#39; target=&#39;_blank&#39;&gt;203655&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/146550&#39; target=&#39;_blank&#39;&gt;146550&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes a protein that is involved in hair growth. This protein functions as a transcriptional corepressor of multiple nuclear receptors, including thyroid hormone receptor, the retinoic acid receptor-related orphan receptors and the vitamin D receptors, and it interacts with histone deacetylases. The translation of this protein is modulated by a regulatory open reading frame (ORF) that exists upstream of the primary ORF. Mutations in this upstream ORF cause Marie Unna hereditary hypotrichosis (MUHH), an autosomal dominant form of genetic hair loss. Mutations in this gene also cause autosomal recessive congenital alopecia and atrichia with papular lesions, other diseases resulting in hair loss. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2014] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>SHD</title>
      <link>/genepanel/56961/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/56961/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;Src homology 2 domain containing transforming protein D&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/56961&#34; target=&#34;_blank&#34;&gt;56961&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=56961&#34; target=&#34;_blank&#34;&gt; 19p13.3&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/610481&#39; target=&#39;_blank&#39;&gt;610481&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt; &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>ACE2</title>
      <link>/genepanel/59272/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/59272/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;angiotensin I converting enzyme 2&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/59272&#34; target=&#34;_blank&#34;&gt;59272&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=59272&#34; target=&#34;_blank&#34;&gt; Xp22.2&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/300335&#39; target=&#39;_blank&#39;&gt;300335&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The protein encoded by this gene belongs to the angiotensin-converting enzyme family of dipeptidyl carboxydipeptidases and has considerable homology to human angiotensin 1 converting enzyme. This secreted protein catalyzes the cleavage of angiotensin I into angiotensin 1-9, and angiotensin II into the vasodilator angiotensin 1-7. The organ- and cell-specific expression of this gene suggests that it may play a role in the regulation of cardiovascular and renal function, as well as fertility. In addition, the encoded protein is a functional receptor for the spike glycoprotein of the human coronavirus HCoV-NL63 and the human severe acute respiratory syndrome coronaviruses, SARS-CoV and SARS-CoV-2 (COVID-19 virus). [provided by RefSeq, Mar 2020] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>NPS</title>
      <link>/genepanel/594857/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/594857/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;neuropeptide S&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/594857&#34; target=&#34;_blank&#34;&gt;594857&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=594857&#34; target=&#34;_blank&#34;&gt; 10q26.2&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/609513&#39; target=&#39;_blank&#39;&gt;609513&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt; &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>RHO</title>
      <link>/genepanel/6010/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/6010/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;rhodopsin&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/6010&#34; target=&#34;_blank&#34;&gt;6010&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=6010&#34; target=&#34;_blank&#34;&gt; 3q22.1&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/613731&#39; target=&#39;_blank&#39;&gt;613731&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/610445&#39; target=&#39;_blank&#39;&gt;610445&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/180380&#39; target=&#39;_blank&#39;&gt;180380&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/136880&#39; target=&#39;_blank&#39;&gt;136880&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The protein encoded by this gene is found in rod cells in the back of the eye and is essential for vision in low-light conditions. The encoded protein binds to 11-cis retinal and is activated when light hits the retinal molecule. Defects in this gene are a cause of congenital stationary night blindness. [provided by RefSeq, Aug 2017] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>CCL2</title>
      <link>/genepanel/6347/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/6347/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;C-C motif chemokine ligand 2&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/6347&#34; target=&#34;_blank&#34;&gt;6347&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=6347&#34; target=&#34;_blank&#34;&gt; 17q12&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/609423&#39; target=&#39;_blank&#39;&gt;609423&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/607948&#39; target=&#39;_blank&#39;&gt;607948&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/182940&#39; target=&#39;_blank&#39;&gt;182940&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/158105&#39; target=&#39;_blank&#39;&gt;158105&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene is one of several cytokine genes clustered on the q-arm of chromosome 17. Chemokines are a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of N-terminal cysteine residues of the mature peptide. This chemokine is a member of the CC subfamily which is characterized by two adjacent cysteine residues. This cytokine displays chemotactic activity for monocytes and basophils but not for neutrophils or eosinophils. It has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis and atherosclerosis. It binds to chemokine receptors CCR2 and CCR4. [provided by RefSeq, Jul 2013] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>BID</title>
      <link>/genepanel/637/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/637/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;BH3 interacting domain death agonist&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/637&#34; target=&#34;_blank&#34;&gt;637&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=637&#34; target=&#34;_blank&#34;&gt; 22q11.21&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/601997&#39; target=&#39;_blank&#39;&gt;601997&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes a death agonist that heterodimerizes with either agonist BAX or antagonist BCL2, and thus regulate apoptosis. The encoded protein is a member of the BCL-2 family of cell death regulators. It is a mediator of mitochondrial damage induced by caspase-8 (CASP8); CASP8 cleaves this encoded protein, and the COOH-terminal part translocates to mitochondria where it triggers cytochrome c release. Multiple alternatively spliced transcript variants have been found, but the full-length nature of some variants has not been defined. [provided by RefSeq, Jan 2020] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>SI</title>
      <link>/genepanel/6476/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/6476/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;sucrase-isomaltase&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/6476&#34; target=&#34;_blank&#34;&gt;6476&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=6476&#34; target=&#34;_blank&#34;&gt; 3q26.1&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/609845&#39; target=&#39;_blank&#39;&gt;609845&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/222900&#39; target=&#39;_blank&#39;&gt;222900&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes a sucrase-isomaltase enzyme that is expressed in the intestinal brush border. The encoded protein is synthesized as a precursor protein that is cleaved by pancreatic proteases into two enzymatic subunits sucrase and isomaltase. These two subunits heterodimerize to form the sucrose-isomaltase complex. This complex is essential for the digestion of dietary carbohydrates including starch, sucrose and isomaltose. Mutations in this gene are the cause of congenital sucrase-isomaltase deficiency.[provided by RefSeq, Apr 2010] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>TF</title>
      <link>/genepanel/7018/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7018/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;transferrin&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/7018&#34; target=&#34;_blank&#34;&gt;7018&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=7018&#34; target=&#34;_blank&#34;&gt; 3q22.1&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/209300&#39; target=&#39;_blank&#39;&gt;209300&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/190000&#39; target=&#39;_blank&#39;&gt;190000&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes a glycoprotein with an approximate molecular weight of 76.5 kDa. It is thought to have been created as a result of an ancient gene duplication event that led to generation of homologous C and N-terminal domains each of which binds one ion of ferric iron. The function of this protein is to transport iron from the intestine, reticuloendothelial system, and liver parenchymal cells to all proliferating cells in the body. This protein may also have a physiologic role as granulocyte/pollen-binding protein (GPBP) involved in the removal of certain organic matter and allergens from serum. [provided by RefSeq, Sep 2009] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>TLR4</title>
      <link>/genepanel/7099/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7099/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;toll like receptor 4&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/7099&#34; target=&#34;_blank&#34;&gt;7099&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=7099&#34; target=&#34;_blank&#34;&gt; 9q33.1&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/182128&#39; target=&#39;_blank&#39;&gt;182128&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor has been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>TLR5</title>
      <link>/genepanel/7100/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7100/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;toll like receptor 5&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/7100&#34; target=&#34;_blank&#34;&gt;7100&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=7100&#34; target=&#34;_blank&#34;&gt; 1q41&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/603030&#39; target=&#39;_blank&#39;&gt;603030&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes a member of the toll-like receptor (TLR) family, which plays a fundamental role in pathogen recognition and activation of innate immune responses. These receptors recognize distinct pathogen-associated molecular patterns that are expressed on infectious agents. The protein encoded by this gene recognizes bacterial flagellin, the principal component of bacterial flagella and a virulence factor. The activation of this receptor mobilizes the nuclear factor NF-kappaB, which in turn activates a host of inflammatory-related target genes. Mutations in this gene have been associated with both resistance and susceptibility to systemic lupus erythematosus, and susceptibility to Legionnaire disease.[provided by RefSeq, Dec 2009] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>TMPRSS2</title>
      <link>/genepanel/7113/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7113/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;transmembrane serine protease 2&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/7113&#34; target=&#34;_blank&#34;&gt;7113&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=7113&#34; target=&#34;_blank&#34;&gt; 21q22.3&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/602060&#39; target=&#39;_blank&#39;&gt;602060&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes a protein that belongs to the serine protease family. The encoded protein contains a type II transmembrane domain, a receptor class A domain, a scavenger receptor cysteine-rich domain and a protease domain. Serine proteases are known to be involved in many physiological and pathological processes. This gene was demonstrated to be up-regulated by androgenic hormones in prostate cancer cells and down-regulated in androgen-independent prostate cancer tissue. The protease domain of this protein is thought to be cleaved and secreted into cell media after autocleavage. This protein also facilitates entry of viruses into host cells by proteolytically cleaving and activating viral envelope glycoproteins. Viruses found to use this protein for cell entry include Influenza virus and the human coronaviruses HCoV-229E, MERS-CoV, SARS-CoV and SARS-CoV-2 (COVID-19 virus). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2020] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>TNF</title>
      <link>/genepanel/7124/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7124/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;tumor necrosis factor&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/7124&#34; target=&#34;_blank&#34;&gt;7124&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=7124&#34; target=&#34;_blank&#34;&gt; 6p21.33&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/611162&#39; target=&#39;_blank&#39;&gt;611162&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/600807&#39; target=&#39;_blank&#39;&gt;600807&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/191160&#39; target=&#39;_blank&#39;&gt;191160&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/157300&#39; target=&#39;_blank&#39;&gt;157300&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes a multifunctional proinflammatory cytokine that belongs to the tumor necrosis factor (TNF) superfamily. This cytokine is mainly secreted by macrophages. It can bind to, and thus functions through its receptors TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. This cytokine is involved in the regulation of a wide spectrum of biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation. This cytokine has been implicated in a variety of diseases, including autoimmune diseases, insulin resistance, and cancer. Knockout studies in mice also suggested the neuroprotective function of this cytokine. [provided by RefSeq, Jul 2008] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>VIP</title>
      <link>/genepanel/7432/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7432/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;vasoactive intestinal peptide&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/7432&#34; target=&#34;_blank&#34;&gt;7432&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=7432&#34; target=&#34;_blank&#34;&gt; 6q25.2&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/300366&#39; target=&#39;_blank&#39;&gt;300366&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The protein encoded by this gene belongs to the glucagon family. It stimulates myocardial contractility, causes vasodilation, increases glycogenolysis, lowers arterial blood pressure and relaxes the smooth muscle of trachea, stomach and gall bladder. The protein also acts as an antimicrobial peptide with antibacterial and antifungal activity. Alternative splicing occurs at this locus and two transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Nov 2014] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>TRPV1</title>
      <link>/genepanel/7442/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7442/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;transient receptor potential cation channel subfamily V member 1&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/7442&#34; target=&#34;_blank&#34;&gt;7442&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=7442&#34; target=&#34;_blank&#34;&gt; 17p13.2&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/602076&#39; target=&#39;_blank&#39;&gt;602076&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;Capsaicin, the main pungent ingredient in hot chili peppers, elicits a sensation of burning pain by selectively activating sensory neurons that convey information about noxious stimuli to the central nervous system. The protein encoded by this gene is a receptor for capsaicin and is a non-selective cation channel that is structurally related to members of the TRP family of ion channels. This receptor is also activated by increases in temperature in the noxious range, suggesting that it functions as a transducer of painful thermal stimuli in vivo. Four transcript variants encoding the same protein, but with different 5’ UTR sequence, have been described for this gene. [provided by RefSeq, Jul 2008] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>CAD</title>
      <link>/genepanel/790/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/790/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/790&#34; target=&#34;_blank&#34;&gt;790&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=790&#34; target=&#34;_blank&#34;&gt; 2p23.3&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/616457&#39; target=&#39;_blank&#39;&gt;616457&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/114010&#39; target=&#39;_blank&#39;&gt;114010&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The de novo synthesis of pyrimidine nucleotides is required for mammalian cells to proliferate. This gene encodes a trifunctional protein which is associated with the enzymatic activities of the first 3 enzymes in the 6-step pathway of pyrimidine biosynthesis: carbamoylphosphate synthetase (CPS II), aspartate transcarbamoylase, and dihydroorotase. This protein is regulated by the mitogen-activated protein kinase (MAPK) cascade, which indicates a direct link between activation of the MAPK cascade and de novo biosynthesis of pyrimidine nucleotides. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>CD4</title>
      <link>/genepanel/920/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/920/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;CD4 molecule&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/920&#34; target=&#34;_blank&#34;&gt;920&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=920&#34; target=&#34;_blank&#34;&gt; 12p13.31&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/613949&#39; target=&#39;_blank&#39;&gt;613949&lt;/a&gt; | &lt;a href=&#39;https://omim.org/entry/186940&#39; target=&#39;_blank&#39;&gt;186940&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;This gene encodes a membrane glycoprotein of T lymphocytes that interacts with major histocompatibility complex class II antigenes and is also a receptor for the human immunodeficiency virus. This gene is expressed not only in T lymphocytes, but also in B cells, macrophages, and granulocytes. It is also expressed in specific regions of the brain. The protein functions to initiate or augment the early phase of T-cell activation, and may function as an important mediator of indirect neuronal damage in infectious and immune-mediated diseases of the central nervous system. Multiple alternatively spliced transcript variants encoding different isoforms have been identified in this gene. [provided by RefSeq, Aug 2010] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>MSC</title>
      <link>/genepanel/9242/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/9242/info/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;musculin&lt;/p&gt;
&lt;hr /&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
&lt;p&gt;ENTREZID: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/9242&#34; target=&#34;_blank&#34;&gt;9242&lt;/a&gt; | Type: Protein Coding |
Map: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/genome/gdv/browser/gene/?id=9242&#34; target=&#34;_blank&#34;&gt; 8q13.3&lt;/a&gt;&lt;br&gt;&lt;/p&gt;
OMIM: &lt;a href=&#39;https://omim.org/entry/603628&#39; target=&#39;_blank&#39;&gt;603628&lt;/a&gt;
&lt;/p&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
&lt;strong&gt;Summary Entrez&lt;/strong&gt; &lt;br&gt;The protein encoded by this gene is a transcriptional repressor capable of binding an E-box element either as a homodimer or as a heterodimer with E2A in vitro. The encoded protein also forms heterodimers with E2A proteins in vivo. This protein is capable of inhibiting the transactivation capability of E47, an E2A protein, in mammalian cells. This gene is a downstream target of the B-cell receptor signal transduction pathway. [provided by RefSeq, Jul 2008] &lt;br&gt;&lt;br&gt;
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
    <item>
      <title>anterior</title>
      <link>/tissuepanel/anterior_/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/anterior_/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;cell-sentence-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Cell Sentence Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;anterior &lt;/em&gt; tissue in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32134681
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The mean CT score for the anterior area (4.4 ± 4.1) was significantly lower than that for the posterior area (7.7 ± 6.3) (&lt;i&gt;p&lt;/i&gt; = 0.003).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32175797
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Clinical entities such as conjunctivitis, anterior uveitis, retinitis, and optic neuritis have been documented in feline and murine models.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>bile duct</title>
      <link>/tissuepanel/bile_duct/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/bile_duct/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;cell-sentence-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Cell Sentence Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;bile duct&lt;/em&gt; tissue in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32077659
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Liver tissue results of single cell sequencing and immunohistochemistry showed that ACE2 was only expressed in bile duct epithelial cells of normal liver tissues, and very low in hepatocytes. […] Whether this phenomenon suggests that the bile duct epithelial cells with positive expression of Ace2 participate in the process of liver regeneration after partial hepatectomy deserves further study. […] In RNA-Seq data, 77 transcription factors were positively correlated with the expression of ACE2 (r &amp;gt; 0.2, FDR &amp;lt; 0.05), which were mainly enriched in the development, differentiation, morphogenesis and cell proliferation of glandular epithelial cells. &lt;b&gt;Conclusion:&lt;/b&gt; We assumed that in addition to the over activated inflammatory response in patients with NCP, the up-regulation of ACE2 expression in liver tissue caused by compensatory proliferation of hepatocytes derived from bile duct epithelial cells may also be the possible mechanism of liver tissue injury caused by 2019 novel coronavirus infection. &lt;b&gt;目的：&lt;/b&gt; 探索和分析新型冠状病毒感染肺炎（NCP）患者发生肝损伤的可能机制。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32270660
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.04, &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.01). &lt;b&gt;Conclusion:&lt;/b&gt; The baseline liver biochemical parameters of 324 cases with novel coronavirus pneumonia in Shanghai area was comparatively lower and the liverinjury degree was mild, and the bile duct cell damage was rare. &lt;b&gt;目的：&lt;/b&gt; 总结上海地区324例新型冠状病毒肺炎患者入院初肝脏生物化学指标的临床特点。
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>bone marrow</title>
      <link>/tissuepanel/bone_marrow/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/bone_marrow/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;bone marrow&lt;/em&gt; tissue in 4 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32172546
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;b&gt;Objective:&lt;/b&gt; To investigate the pathological characteristics and the clinical significance of novel coronavirus (2019-nCoV)-infected pneumonia (termed by WHO as corona virus disease 2019, COVID-19). &lt;b&gt;Methods:&lt;/b&gt; Minimally invasive autopsies from lung, heart, kidney, spleen, bone marrow, liver, pancreas, stomach, intestine, thyroid and skin were performed on three patients died of novel coronavirus pneumonia in Chongqing, China.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243697
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
First one is a 59-year old renal transplant recipient; the second is a 51-year old allogeneic bone marrow transplant recipient.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32270515
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We concluded that rhEPO could attenuate respiratory distress syndrome and confront the SARS-CoV-2 virus through multiple mechanisms including cytokine modulation, anti-apoptotic effects, leukocyte release from bone marrow, and iron redistribution away from the intracellular virus.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283185
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Eighteen received bone marrow and 256, peripheral blood grafts.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>breast</title>
      <link>/tissuepanel/breast/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/breast/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;breast&lt;/em&gt; tissue in 7 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32096395
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Breast dieases are clinical common diseases. […] In the central epidemic area of COVID-19, Hubei province, especially Wuhan, the clinical specialists of breast diseases should consider all of the following factors comprehensively: the prevention of COVID-19, the diagnosis and treatment of breast diseases and the accessibility of medical resources. […] Besides, we should select the appropriate therapy and optimize treatment process so as to prevent the propagation and cross infection of COVID-19 as well as manage the breast diseases without delay. […] Therefore, we carried out some management proposals of the patients with breast diseases in the central epidemic area during the epidemic of COVID-19 on the basis of conventional treatment guidelines and clinical experiences.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32100979
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In order to prevent cluster outbreaks, the government strengthened the management and control of personnel mobility, which had a great impact on the examination and treatment of breast cancer patients. […] This paper discusses how to realize scientific health management of breast cancer patients outside the hospital based on the existing epidemic situation, characteristics of breast cancer patients and public health safety factors. […] The breast cancer patients should synthetically consider the epidemic prevention situation of inhabitance, the disease stage and previous therapeutic schedule to decide the next therapeutic schedule.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243068
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Besides the possible consequences of COVID-19 infection on a pregnant woman and the fetus, a major concern is related to the potential effect on neonatal outcome, the appropriate management of the mother-newborn dyad and finally the compatibility of maternal COVID-19 infection with breastfeeding. […] The Italian Society on Neonatology (SIN) after reviewing the limited scientific knowledge on the compatibility of breastfeeding in the COVID-19 mother and the available statements from Health Care Organizations, has issued the following indications that have been endorsed by the Union of European Neonatal &amp;amp; Perinatal Societies (UENPS). […] If a mother previously identified as COVID-19 positive or under investigation for COVID-19 is asymptomatic or paucisymptomatic at delivery, rooming-in is feasible and direct breastfeeding is advisable, under strict measures of infection control. […] On the contrary, when a mother with COVID-19 is too sick to care for the newborn, the neonate will be managed separately and fed fresh expressed breast milk, with no need to pasteurize it, as human milk is not believed to be a vehicle of COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277836
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The wife (patient 1) was partially immunocompromised as a consequence of a recently started chemotherapy with fulvestrant and abemaciclid for recurring breast cancer, her husband (patient 2) had been healthy except for a history of controlled arterial hypertension.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32285380
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
SARS-CoV-2 RT-PCR in breast milk and amniotic fluid was negative too.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292842
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Breast radiotherapy accounts for a significant proportion of patient volume in contemporary radiation oncology practice. […] Here, we present evidence-based guidelines for omitting or abbreviating breast cancer radiotherapy, where appropriate, in an effort to mitigate risk to patients and optimize resource utilization. […] Multidisciplinary breast cancer experts at a high-volume comprehensive cancer center convened contingency planning meetings over the early days of the COVID-19 pandemic to review the relevant literature and establish recommendations for the application of hypofractionated and abbreviated breast radiation regimens. […] Substantial evidence exists to support omitting radiation among certain favorable risk subgroups of breast cancer patients and for abbreviating or accelerating regimens among others. […] For those who require either whole-breast or post-mastectomy radiation, with or without coverage of the regional lymph nodes, a growing body of literature supports various hypofractionated approaches that appear safe and effective. […] In the setting of a public health emergency with the potential to strain critical healthcare resources and place patients at infection risk, the parsimonious application of breast radiotherapy may alleviate a significant clinical burden without compromising long term oncologic outcomes.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294229
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Encouragement of breast feeding appears possible and safe when viral precautions are observed.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>bronchus</title>
      <link>/tissuepanel/bronchus/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/bronchus/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;bronchus&lt;/em&gt; tissue in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32134681
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
With regard to bronchial changes seen on CT, 45 patients (72.6%) had air bronchogram, and 11 (17.7%) had bronchus distortion. […] Compared with early-phase disease (≤ 7 days after the onset of symptoms), advanced-phase disease (8-14 days after the onset of symptoms) was characterized by significantly increased frequencies of GGO plus a reticular pattern, vacuolar sign, fibrotic streaks, a subpleural line, a subpleural transparent line, air bronchogram, bronchus distortion, and pleural effusion; however, GGO significantly decreased in advanced-phase disease. &lt;b&gt;CONCLUSION.&lt;/b&gt; CT examination of patients with COVID-19 pneumonia showed a mixed and diverse pattern with both lung parenchyma and the interstitium involved.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32272262
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
GGO and vascular enhancement sign were most frequent seen, followed by interlobular septal thickening and air bronchus sign as well as consolidation, fibrosis and air trapping.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>colon</title>
      <link>/tissuepanel/colon/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/colon/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;colon&lt;/em&gt; tissue in 4 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32074786
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Neoadjuvant therapy is highly recommended for gastrointestinal cancer at advanced stages that meet the indications of NCCN guideline (gastric cancer T stage ≥ 2/rectal cancer T stage ≥ 3/unresectable colon cancer).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32199615
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Although ACE2 is reported to be expressed in lung, liver, stomach, ileum, kidney and colon, its expressing levels are rather low, especially in the lung. […] Consistent with other recent reports, we confirmed that ACE2 was mainly expressed in lung AT2, liver cholangiocyte, colon colonocytes, esophagus keratinocytes, ileum ECs, rectum ECs, stomach epithelial cells, and kidney proximal tubules.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32249098
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
For each type of cancer-colon, pancreas, oesogastric, hepatocellular carcinoma-morbidity and mortality rates are stated and compared with the oncological risk incurred by deferring surgery and/or the tumour doubling time. […] For colonic cancers T1-2, N0, it is advisable to defer surgery. […] For advanced colonic lesions, it seems judicious to undertake neoadjuvant chemotherapy and then wait.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32278065
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ACE2 is expressed furthermore in the upper esophagus, liver, and colon.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>duodenum</title>
      <link>/tissuepanel/duodenum/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/duodenum/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;duodenum&lt;/em&gt; tissue in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32241899
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
SARS-CoV-2 RNA was detected in oesophagus, stomach, duodenum and rectum specimens for both two severe patients. […] In contrast, only duodenum was positive in one of the four non-severe patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>endothelial</title>
      <link>/tissuepanel/endothelial/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/endothelial/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;cell-sentence-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Cell Sentence Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;endothelial&lt;/em&gt; tissue in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32227090
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The pericytes injury due to virus infection may result in capillary endothelial cells dysfunction, inducing microvascular dysfunction.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32271454
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The protein-protein interaction network exhibited hub targets of MXSGD, such as Heat shock protein 90, RAC-alpha serine/threonine-protein kinase, Transcription factor AP-1, Mitogen-activated protein kinase 1, Cellular tumor antigen p53, Vascular endothelial growth factor A, and Tumour necrosis factor.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>esophagus</title>
      <link>/tissuepanel/esophagus/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/esophagus/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;esophagus&lt;/em&gt; tissue in 3 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32170560
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Through scRNA-seq data analyses, we identified the organs at risk, such as lung, heart, esophagus, kidney, bladder, and ileum, and located specific cell types (i.e., type II alveolar cells (AT2), myocardial cells, proximal tubule cells of the kidney, ileum and esophagus epithelial cells, and bladder urothelial cells), which are vulnerable to 2019-nCoV infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32199615
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Consistent with other recent reports, we confirmed that ACE2 was mainly expressed in lung AT2, liver cholangiocyte, colon colonocytes, esophagus keratinocytes, ileum ECs, rectum ECs, stomach epithelial cells, and kidney proximal tubules.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32278065
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ACE2 is expressed furthermore in the upper esophagus, liver, and colon.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>eye</title>
      <link>/tissuepanel/eye/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/eye/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;eye&lt;/em&gt; tissue in 14 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32124000
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Second, for environmental control, to reduce droplet transmission of COVID-19, installation of protective shields on slit lamps, frequent disinfection of equipment, and provision of eye protection to staff were implemented.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32127517
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The person-to-person transmission routes of 2019-nCoV included direct transmission, such as cough, sneeze, droplet inhalation transmission, and contact transmission, such as the contact with oral, nasal, and eye mucous membranes. 2019-nCoV can also be transmitted through the saliva, and the fetal-oral routes may also be a potential person-to-person transmission route.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32170800
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This is a consensus of Chinese experts on protective measures and advice on hand-cleaning- and medical-glove-related hand protection, mask- and goggles-related face protection, UV-related protection, eye protection, nasal and oral mucosa protection, outer ear, and hair protection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32222713
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
He was placed in droplet-eye precautions while awaiting COVID-19 test results.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32223068
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
However, in late February 2020, 2 patients presented simultaneously to our eye casualty with sudden onset of unilateral painful red eye associated with a decline in visual acuity, their intraocular pressure (IOP) were over 40 mmHg and slit-lamp examination findings were suggestive of acute primary angle closure (APAC).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32224550
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The threat of Coronavirus Disease 2019 (COVID-19) to health systems in sub-Saharan Africa (SSA) can be compared metaphorically to a lake in Africa infested with a bask of crocodiles and the saying: “the eye of the crocodile.” In the lake, only the eyes of the crocodile appear on the surface while the rest of the body is submerged in water. […] In this Viewpoint, the eyes and the body of the crocodile represent the public health preparedness and health systems, respectively, in SSA.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32264666
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Therefore, we aimed to have a contributor role for explaining this conundrum and present a bird’s eye view regarding this equivocal issue in this review.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32270477
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The following personal protective equipment should be used: sterile fluid-repellant surgical gloves, an underlying pair of gloves, eye protection, FFP3 mask, surgical cap, and gown.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32270581
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
For any care or intervention in the upper aerodigestive tract region, irrespective of the setting and a confirmed diagnosis (eg, rhinoscopy or flexible laryngoscopy in the outpatient setting and tracheostomy or rigid endoscopy under anesthesia), it is strongly recommended that all health care personnel wear personal protective equipment such as N95, gown, cap, eye protection, and gloves.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32273245
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
As information concerning the COVID-19 disease continues to evolve, patients look to their eye care practitioners for accurate eye health guidance. […] During the pandemic there will potentially be significant changes in access to local eyecare. […] Patients should also avoid touching their face, including their eyes, nose and mouth, with unwashed hands and avoid CL wear altogether if unwell (particularly with any cold or flu-like symptoms).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275082
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The conjunctival mucosa is directly exposed to infectious droplets expelled by patients during close contact and fomites when the eye is touched by contaminated hands.&lt;sup&gt;2, 3&lt;/sup&gt; More over, the mucosa of the conjunctiva and upper respiratory tract is connected by nasolacrimal duct, and share the same entry receptor of SARS-CoV-2, angiotensin-converting enzyme 2 (ACE2), on host cell membranes.&lt;sup&gt;2, 3&lt;/sup&gt; Hence, it is reasonable to postulate that the conjunctiva may be easily involved in SARS-CoV-2 infection, and may even act as a route of transmission during SARS-CoV-2 infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275742
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Complete postmortem examinations were performed according to standard procedures in a negative-pressure autopsy suite/isolation room using personal protective equipment, including N95 masks, eye protection, and gowns.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32284146
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The patient’s primary symptom was a red eye with watery discharge, though she did have mild respiratory symptoms, without fever. […] A conjunctival swab of the affected eye was positive for the SAR-CoV-2 virus.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32286916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Necessary otologic procedures on positive, suspected, or unknown COVID-19 status patients should be performed using enhanced personal protective equipment, including an N95 respirator and eye protection or powered air-purifying respirator (PAPR, preferred), disposable cap, disposable gown, and gloves. […] Powered instrumentation should be avoided unless absolutely necessary, and if performed, PAPR or sealed eye protection is recommended.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>gallbladder</title>
      <link>/tissuepanel/gallbladder/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/gallbladder/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;gallbladder&lt;/em&gt; tissue in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275128
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
With the guidance of MDT, one COVID-19 patient was transferred to designated provincial hospital after effective treatment; one patient complicated with acute cholecystitis underwent gallbladder puncture and drainage; and COVID-19 was excluded in a highly suspected patient after alveolar lavage fluid examination.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>glandular</title>
      <link>/tissuepanel/glandular/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/glandular/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;cell-sentence-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Cell Sentence Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;glandular&lt;/em&gt; tissue in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32077659
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In RNA-Seq data, 77 transcription factors were positively correlated with the expression of ACE2 (r &amp;gt; 0.2, FDR &amp;lt; 0.05), which were mainly enriched in the development, differentiation, morphogenesis and cell proliferation of glandular epithelial cells. &lt;b&gt;Conclusion:&lt;/b&gt; We assumed that in addition to the over activated inflammatory response in patients with NCP, the up-regulation of ACE2 expression in liver tissue caused by compensatory proliferation of hepatocytes derived from bile duct epithelial cells may also be the possible mechanism of liver tissue injury caused by 2019 novel coronavirus infection. &lt;b&gt;目的：&lt;/b&gt; 探索和分析新型冠状病毒感染肺炎（NCP）患者发生肝损伤的可能机制。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32270477
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In the context of the COVID-19 pandemic, patients need to be evaluated within 2-4 weeks in the following cases: cytology result of “squamous cell carcinoma,” “atypical glandular cells, favor neoplastic,” “endocervical adenocarcinoma in situ,” or “adenocarcinoma”; histopathological diagnosis of suspected invasion from cervical/vaginal biopsy, or invasive disease after a cervical excision procedure, vaginal excision, or vulvar biopsy/excision; sudden onset of strongly suggestive symptoms for malignancy.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>hair</title>
      <link>/tissuepanel/hair/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/hair/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;hair&lt;/em&gt; tissue in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32170800
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This is a consensus of Chinese experts on protective measures and advice on hand-cleaning- and medical-glove-related hand protection, mask- and goggles-related face protection, UV-related protection, eye protection, nasal and oral mucosa protection, outer ear, and hair protection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32223004
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Dermatoscope is a convenient diagnostic tool used by dermatologists in the diagnosis of skin, hair and nail disorders.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>hematopoietic</title>
      <link>/tissuepanel/hematopoietic/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/hematopoietic/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;cell-sentence-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Cell Sentence Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;hematopoietic&lt;/em&gt; tissue in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282949
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
COVID-19 is a systemic infection with a significant impact on the hematopoietic system and hemostasis.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283185
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The COVID-19 pandemic has created significant barriers to timely donor evaluation, cell collection and graft transport for allogeneic hematopoietic stem cell transplantation (allo-HCT). […] Graft cryopreservation does not significantly delay hematopoietic recovery, increase acute GVHD risk or NRM, or decrease overall survival after all-HCT using ptCY.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>hepatocytes</title>
      <link>/tissuepanel/hepatocytes/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/hepatocytes/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;cell-sentence-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Cell Sentence Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;hepatocytes&lt;/em&gt; tissue in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32077659
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Liver tissue results of single cell sequencing and immunohistochemistry showed that ACE2 was only expressed in bile duct epithelial cells of normal liver tissues, and very low in hepatocytes. […] In RNA-Seq data, 77 transcription factors were positively correlated with the expression of ACE2 (r &amp;gt; 0.2, FDR &amp;lt; 0.05), which were mainly enriched in the development, differentiation, morphogenesis and cell proliferation of glandular epithelial cells. &lt;b&gt;Conclusion:&lt;/b&gt; We assumed that in addition to the over activated inflammatory response in patients with NCP, the up-regulation of ACE2 expression in liver tissue caused by compensatory proliferation of hepatocytes derived from bile duct epithelial cells may also be the possible mechanism of liver tissue injury caused by 2019 novel coronavirus infection. &lt;b&gt;目的：&lt;/b&gt; 探索和分析新型冠状病毒感染肺炎（NCP）患者发生肝损伤的可能机制。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32274341
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
However, there is insufficient evidence for SARS-CoV-2 infected hepatocytes or virus-related liver injury in COVID-19 at present.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>hippocampus</title>
      <link>/tissuepanel/hippocampus/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/hippocampus/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;hippocampus&lt;/em&gt; tissue in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251791
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A brain MRI showed hyperintensity along the wall of right lateral ventricle and hyperintense signal changes in the right mesial temporal lobe and hippocampus, suggesting the possibility of SARS-CoV-2 meningitis.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>keratinocytes</title>
      <link>/tissuepanel/keratinocytes/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/keratinocytes/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;cell-sentence-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Cell Sentence Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;keratinocytes&lt;/em&gt; tissue in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32199615
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Consistent with other recent reports, we confirmed that ACE2 was mainly expressed in lung AT2, liver cholangiocyte, colon colonocytes, esophagus keratinocytes, ileum ECs, rectum ECs, stomach epithelial cells, and kidney proximal tubules.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>kidney</title>
      <link>/tissuepanel/kidney/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/kidney/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;kidney&lt;/em&gt; tissue in 38 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32077660
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Four cases (12.5%) were combined with one underlying disease (bronchial asthma, coronary heart disease, malignant tumor, chronic kidney disease), and one case (3.13%) was simultaneously combined with high blood pressure and malignant tumor.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32081428
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
However, since ACE2 is predominantly expressed in intestines, testis, and kidney, fecal-oral and other routes of transmission are also possible.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32105632
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Most patients had organ function damage, including 35 (67%) with ARDS, 15 (29%) with acute kidney injury, 12 (23%) with cardiac injury, 15 (29%) with liver dysfunction, and one (2%) with pneumothorax. 37 (71%) patients required mechanical ventilation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32120458
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The observation indicators included total blood count, C-reactive protein (CRP), arterial blood gas analysis, myocardial injury markers, coagulation function, liver and kidney function, electrolyte, procalcitonin (PCT), B-type natriuretic peptide (BNP), blood lipid, pulmonary CT and pathogen detection. &lt;b&gt;Results:&lt;/b&gt; Compared with the general group, the lymphocyte count (0.74×10(9) (0.34×10(9), 0.94×10(9))/L vs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32159234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The first pool was from a Carassius auratus (crusian carp) cell line and the second was from Ctenopharyngodon idella (grass carp) head kidney tissue.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32170560
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
However, some patients also exhibit non-respiratory symptoms, such as kidney failure, implying that 2019-nCoV could also invade other organs. […] Through scRNA-seq data analyses, we identified the organs at risk, such as lung, heart, esophagus, kidney, bladder, and ileum, and located specific cell types (i.e., type II alveolar cells (AT2), myocardial cells, proximal tubule cells of the kidney, ileum and esophagus epithelial cells, and bladder urothelial cells), which are vulnerable to 2019-nCoV infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32172546
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;b&gt;Objective:&lt;/b&gt; To investigate the pathological characteristics and the clinical significance of novel coronavirus (2019-nCoV)-infected pneumonia (termed by WHO as corona virus disease 2019, COVID-19). &lt;b&gt;Methods:&lt;/b&gt; Minimally invasive autopsies from lung, heart, kidney, spleen, bone marrow, liver, pancreas, stomach, intestine, thyroid and skin were performed on three patients died of novel coronavirus pneumonia in Chongqing, China. […] While the 2019-nCoV is mainly distributed in lung, the infection also involves in the damages of heart, vessels, liver, kidney and other organs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32181990
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This is a 52-year-old man who received kidney transplantation 12 years ago.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32199615
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Although ACE2 is reported to be expressed in lung, liver, stomach, ileum, kidney and colon, its expressing levels are rather low, especially in the lung. […] Consistent with other recent reports, we confirmed that ACE2 was mainly expressed in lung AT2, liver cholangiocyte, colon colonocytes, esophagus keratinocytes, ileum ECs, rectum ECs, stomach epithelial cells, and kidney proximal tubules.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32203970
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Here, we review the most recent findings on the effects of SARS-CoV-2 infection on kidney diseases, including acute kidney injury, and examine the potential effects of ARBs on the outcomes of patients with COVID-19. […] Lastly, we discuss the clinical management of COVID-19 patients with existing chronic renal disorders, particularly those in dialysis and with kidney transplants.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32209890
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.8%, χ = 93.222, P &amp;lt; 0.001), acute kidney injury (18.3% vs. 0, χ = 23.257, P &amp;lt; 0.001), shock (11.9% vs. 0, χ = 14.618, P &amp;lt; 0.001), and disseminated intravascular coagulation (DIC) (6.4% vs. 0, χ = 7.655, P = 0.006). […] More patients in the death groups had complications such as ARDS, acute cardiac injury, acute kidney injury, shock, and DIC.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32211816
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Complications were more common in patients with cardiac injury than those without cardiac injury and included acute respiratory distress syndrome (48 of 82 [58.5%] vs 49 of 334 [14.7%]; P &amp;lt; .001), acute kidney injury (7 of 82 [8.5%] vs 1 of 334 [0.3%]; P &amp;lt; .001), electrolyte disturbances (13 of 82 [15.9%] vs 17 of 334 [5.1%]; P = .003), hypoproteinemia (11 of 82 [13.4%] vs 16 of 334 [4.8%]; P = .01), and coagulation disorders (6 of 82 [7.3%] vs 6 of 334 [1.8%]; P = .02).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32216698
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Patients with hypertension, diabetes, coronary heart disease, cerebrovascular illness, chronic obstructive pulmonary disease, and kidney dysfunction have worse clinical outcomes when infected with SARS-CoV-2, for unknown reasons.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32217556
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Common complications observed more frequently in deceased patients included acute respiratory distress syndrome (113; 100%), type I respiratory failure (18/35; 51%), sepsis (113; 100%), acute cardiac injury (72/94; 77%), heart failure (41/83; 49%), alkalosis (14/35; 40%), hyperkalaemia (42; 37%), acute kidney injury (28; 25%), and hypoxic encephalopathy (23; 20%).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32222703
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this article, we report on a 75-year-old man infected with 2019 novel coronavirus who has end-stage kidney disease (ESKD).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32222713
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The risk factors for severe presentations are concentrated in patients with chronic kidney disease, particularly patients with end-stage renal disease (ESRD) who are dialysis dependent.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32224986
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In the sequel of this epidemic or contagious disease, the patient experiences fever, chest paint, chills, a rapid heartbeat, breathing difficulties, pneumonia, and kidney failure.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32228252
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Recognition that ACE2 is the coreceptor for the coronavirus has prompted new therapeutic approaches to block the enzyme or reduce its expression to prevent the cellular entry and SARS-CoV-2 infection in tissues that express ACE2 including lung, heart, kidney, brain, and gut.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32229732
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Whether the patients with coronavirus disease 19 (COVID-19) infected by severe acute respiratory syndrome (SARS)-CoV-2 would commonly develop acute kidney injury (AKI) is an important issue worthy of clinical attention. […] Twelve (10.8%) patients showed mild increase of blood urea nitrogen or creatinine (&amp;lt;26 μmol/L within 48 h), and 8 (7.2%) patients showed trace or 1+ albuminuria in 111 COVID-19-confirmed patients without chronic kidney disease (CKD).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32232218
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
According to the findings of the present study, hypertension, cardiovascular diseases, diabetes mellitus, smoking, chronic obstructive pulmonary disease (COPD), malignancy, and chronic kidney disease were among the most prevalent underlying diseases among hospitalized COVID-19 patients, respectively.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243672
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A kidney transplanted patient infected with SARS CoV2 infection showed a mild disease despite immune suppression.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243690
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Herein we report three cases of a familial cluster with one family member being a kidney transplant recipient.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Since information on kidney disease in patients with COVID-19 is limited, we determined the prevalence of acute kidney injury (AKI) in patients with COVID-19. […] Further, we evaluated the association between markers of abnormal kidney function and death in patients with COVID-19. […] Kaplan-Meier analysis demonstrated that patients with kidney disease had a significantly higher risk for in-hospital death. […] Thus, our findings show the prevalence of kidney disease on admission and the development of AKI during hospitalization in patients with COVID-19 is high and is associated with in-hospital mortality. […] Hence, clinicians should increase their awareness of kidney disease in patients with severe COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32249089
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The number of cases has increased rapidly, but no data concerning kidney transplant (KTx) recipients infected with COVID-19 are available.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32250968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The current COVID-19 pandemic has affected everyone, but presents profound consequences for patients with kidney disease, health care providers, and biomedical researchers. […] In this Viewpoint, I will discuss a number of kidney-specific aspects of COVID-19 infection, noting therapeutic and basic research opportunities.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251805
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Multiple organ dysfunction can be observed, the most common organ damage was lung, followed by heart, kidney and liver.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32255507
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Studies have shown that this virus causes worse outcomes and a higher mortality rate in older adults and those with comorbidities such as hypertension, cardiovascular disease, diabetes, chronic respiratory disease, and chronic kidney disease. […] Additionally, many adults with hypertension, diabetes, and chronic kidney disease are placed on angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32278616
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Knowledge about this growing infection is also increasing although many uncertainties remain, especially in the kidney transplant population. […] This manuscript presents a proposal for action with general and specific recommendations to protect and prevent infection in this vulnerable population such as kidney transplant recipients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32279081
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Through a multivariate analysis of the causes of death in older patients, we found that males, comorbidities, time from disease onset to hospitalization, abnormal kidney function, and elevated procalcitonin levels were all significantly associated with death.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32279418
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We present the case of a 36-year-old kidney transplanted woman affected by Senior-Loken syndrome diagnosed with COVID-19 pneumonia after a contact with her positive mother.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281331
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The location of the disease is lung, always involving spleen and stomach, and may further affect heart and kidney in severe cases.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281333
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The pungent medicines are mostly found in the early stage, the bitter drugs are the main flavor in the middle and severe stage, and the sweet medicines are mostly used in the recovery stage; ③the meridian of the drug is more concentrated at the lung, stomach, and heart, and most of drugs are into the lung meridian, accounting for 24.55%; these medicines are mostly into the lungs and stomach in the initial and middle stages, and into the heart and kidney in severe stages; ④oral drugs are mostly non-toxic, among which only 6 kinds are toxic, namely Armeniacae Semen Amarum, Dryopteridis Crassirhizomatis Rhizoma, Paridis Rhizoma, Pinelliae Rhizoma, Aconiti Lateralis Radix Praeparaia; ⑤most of the drugs have five types of functions: treating exterior syndromes, resolving dampness, clearing heat, replenishing deficiency, resolving phlegm, cough, and asthma.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281754
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We are in the midst of a health emergency that is totally new for us all and that requires a concerted effort, especially when it comes to safeguarding patients on hemodialysis, and kidney transplant recipients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282982
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Complete suspension of live donor kidney transplantation was reported by 71.8% and live donor liver by 67.7%. […] While complete suspension of deceased donor transplantation was less frequent, some restrictions to deceased donor kidney transplantation were reported by 84.0% and deceased donor liver by 73.3%; more stringent restrictions were associated with higher regional incidence of COVID-19. […] Respondents reported a total of 148 COVID-19 recipients from &amp;lt;1y to &amp;gt;10y post-transplant: 69.6% were kidney recipients, and 25.0% were critically ill.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Limited data are available regarding immunosuppression management in kidney transplant recipients (KTRs) with SARS-CoV-2 pneumonia.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32286245
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Biomarkers of inflammation, cardiac and muscle injury, liver and kidney function and coagulation measures were also significantly elevated in patients with both severe and fatal COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292866
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The management of the disease in patients with kidney disease is even more challenging, especially in those who are immunosuppressed or with severe comorbidities. […] Here we present the therapeutic approach employed in Brescia (Italy) for managing kidney transplant and hemodialysis patients with COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293003
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This is related to the role of angiotensin-converting enzyme 2 (ACE2) for SARS-CoV-2 entry into cells, and expression of ACE2 in the lung, cardiovascular system, kidney, and other tissues.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>Leydig</title>
      <link>/tissuepanel/leydig/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/leydig/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;cell-sentence-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Cell Sentence Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;Leydig&lt;/em&gt; tissue in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The results indicate that ACE2 is predominantly enriched in spermatogonia and Leydig and Sertoli cells. […] Cell-cell junction and immunity-related GO terms are increased in ACE2-positive Leydig and Sertoli cells, but mitochondria and reproduction-related GO terms are decreased.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>liver</title>
      <link>/tissuepanel/liver/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/liver/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;liver&lt;/em&gt; tissue in 53 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32062957
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Routine blood test revealed WBC &amp;lt;4.0×10(9)/L in 8 petients (26.67%) , (4-10) ×10(9)/L in 22 petients (73.33%) , and WBC&amp;gt;4.0×10(9)/L in 4 petients (13.33%) during the disease.Lymphocyte count &amp;lt;1.0×10(9)/L occurred in 12 petients (40%),abnormal liver function in 7 petients (23.33%) ,myocardial damage in 5 petients(16.67%), elevated D-dimer (&amp;gt;0.5mg/l) in 5 patients (16.67%). […] Compared with normal patients, the average exposure times, cumulative exposure time, BMI, Fever time, white blood cell count, liver enzyme, LDH, myoenzyme and D-dimer were significantly increased in severe patients, while the lymphocyte count and albumin levels in peripheral blood were significantly decreased.Chest CT mainly showed patchy shadows and interstitial changes.According to imaging examination, 11 patients (36.67%) showed Unilateral pneumonia and 19 patients (63.33%) showed bilateral pneumonia,4 patients (13.33%) showed bilateral multiple mottling and ground-glass opacity.Compared with the patients infected in the protected period, the proportion of severe infection and bilateral pneumonia were both increased in the patients infected in unprotected period. &lt;b&gt;Conclusion:&lt;/b&gt; Medical staffs are at higher risk of infection.Infection rates are associated with contact time, the amount of suction virus. […] Severe patients had BMI increased, heating time prolonged , white blood cell count, lymphocyte count, D-dimer and albumin level significantly changed and were prone to be complicated with liver damage and myocardial damage.Strict protection measures is important to prevent infection for medical workers. &lt;b&gt;目的：&lt;/b&gt; 探讨医务人员新型冠状病毒肺炎（简称新冠肺炎）的临床特征。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32075364
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Some patients accompany with liver function damage in addition to the main typical respiratory symptom. […] Here we analyzed the clinical features, susceptible population, potential causes and therapeutic strategies of NCP related liver injury.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32077659
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;b&gt;Objective:&lt;/b&gt; To explore and analyze the possible mechanism of liver injury in patients with coronavirus disease 2019 (novel coronavirus pneumonia, NCP). &lt;b&gt;Methods:&lt;/b&gt; The correlation between ALT, AST and other liver enzyme changes condition and NCP patients’ disease status reported in the literature was comprehensively analyzed. […] ACE2 expression in liver tissue for novel coronavirus was analyzed based on single cell sequencing (GSE115469) data. […] RNA-Seq method was used to analyze Ace2 expression and transcription factors related to its expression in liver tissues at various time-points after hepatectomy in mouse model of acute liver injury with partial hepatectomy. &lt;i&gt;t&lt;/i&gt;-test or Spearman rank correlation analysis was used for statistical analysis. &lt;b&gt;Results:&lt;/b&gt; ALT and AST were abnormally elevated in some patients with novel coronavirus infection, and the rate and extent of ALT and AST elevation in severe NCP patients were higher than those in non-severe patients. […] Liver tissue results of single cell sequencing and immunohistochemistry showed that ACE2 was only expressed in bile duct epithelial cells of normal liver tissues, and very low in hepatocytes. […] In a mouse model of acute liver injury with partial hepatectomy, Ace2 expression was down-regulated on the first day, but it was elevated up to twice of the normal level on the third day, and returned to normal level on seventh day when the liver recovered and hepatocyte proliferation stopped. […] Whether this phenomenon suggests that the bile duct epithelial cells with positive expression of Ace2 participate in the process of liver regeneration after partial hepatectomy deserves further study. […] In RNA-Seq data, 77 transcription factors were positively correlated with the expression of ACE2 (r &amp;gt; 0.2, FDR &amp;lt; 0.05), which were mainly enriched in the development, differentiation, morphogenesis and cell proliferation of glandular epithelial cells. &lt;b&gt;Conclusion:&lt;/b&gt; We assumed that in addition to the over activated inflammatory response in patients with NCP, the up-regulation of ACE2 expression in liver tissue caused by compensatory proliferation of hepatocytes derived from bile duct epithelial cells may also be the possible mechanism of liver tissue injury caused by 2019 novel coronavirus infection. &lt;b&gt;目的：&lt;/b&gt; 探索和分析新型冠状病毒感染肺炎（NCP）患者发生肝损伤的可能机制。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32077660
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;b&gt;Objective:&lt;/b&gt; To analyze the clinical characteristics of cases of novel coronavirus pneumonia and a preliminary study to explore the relationship between different clinical classification and liver damage. &lt;b&gt;Methods:&lt;/b&gt; Consecutively confirmed novel coronavirus infection cases admitted to seven designated hospitals during January 23, 2020 to February 8, 2020 were included. […] ALT, AST, ALB and TBil of the severe or critical subgroups were 60.25 (40.88 ~ 68.90) U/L, 37.00 (20.88 ~ 64.45) U/L, 35.75 (28.68 ~ 42.00) g/L, and 20.50 (11.28 ~ 25.00) mmol/L, respectively. &lt;b&gt;Conclusion:&lt;/b&gt; The results of this multicenter retrospective study suggests that novel coronavirus pneumonia combined with liver damage is more likely to be caused by adverse drug reactions and systemic inflammation in severe patients receiving medical treatment. […] Therefore, liver function monitoring and evaluation should be strengthened during the treatment of such patients. &lt;b&gt;目的：&lt;/b&gt; 分析新型冠状病毒肺炎病例的临床特征，初步探讨不同临床分型与肝功能损伤的关系。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32096367
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We also isolated alive viral strains from feces, indicating potential infectiousness of feces.Dynamic cytokine detection was necessary to timely identifyingcytokine storms and application of artificial liver blood purification system. […] The artificial liver blood purification system could rapidly remove inflammatory mediators and block cytokine storm.Moreover, it also favoredthe balance of fluid, electrolyte and acid-base and thus improved treatment efficacy in critical illness.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32105632
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Most patients had organ function damage, including 35 (67%) with ARDS, 15 (29%) with acute kidney injury, 12 (23%) with cardiac injury, 15 (29%) with liver dysfunction, and one (2%) with pneumothorax. 37 (71%) patients required mechanical ventilation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32109279
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Only 3 patients (3.75%) showed liver dysfunction. […] The proportion of patients having liver dysfunction and abnormal CT imaging was relatively lower than that of Wuhan.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32118389
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Elevation of C-reactive protein (10%, 3/30), erythrocyte sedimentation rate(19%,4/21), procalcitonin(4%,1/28), liver enzyme(22%, 6/27) and muscle enzyme (15%, 4/27) occurred in different proportions.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32120458
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The observation indicators included total blood count, C-reactive protein (CRP), arterial blood gas analysis, myocardial injury markers, coagulation function, liver and kidney function, electrolyte, procalcitonin (PCT), B-type natriuretic peptide (BNP), blood lipid, pulmonary CT and pathogen detection. &lt;b&gt;Results:&lt;/b&gt; Compared with the general group, the lymphocyte count (0.74×10(9) (0.34×10(9), 0.94×10(9))/L vs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32125362
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Four of the 5 patients treated with lopinavir-ritonavir developed nausea, vomiting, and/or diarrhea, and 3 developed abnormal liver function test results.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32153170
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;b&gt;Objective:&lt;/b&gt; To understand the clinical characteristics, change of liver function, influencing factors and prognosis in hospitalized patients with coronavirus disease-19 (COVID-19) combined with liver injury. &lt;b&gt;Methods:&lt;/b&gt; The general conditions, biochemical indicators of liver, blood clotting mechanism, routine blood test, UGT1A1 * 28 gene polymorphism and other data of 40 cases with COVID-19 admitted to the isolation ward of Tangdu Hospital were retrospectively analyzed. […] The clinical characteristics, influencing factors and prognosis of liver injury in patients with liver injury group and those with normal liver function group were compared. […] Multiple logistic regression analysis was used to analyze the main influencing factors of liver injury. &lt;b&gt;Results:&lt;/b&gt; Of the 40 cases, 25 were male (62.5%) and 15 were female (37.5%), aged 22 to 83 (53.87 ± 15.84) years. […] Liver injury was occurred in 22 cases (55%) during the course of the disease. […] Liver function injury was more likely to occur in patients who used many types of drugs and large amounts of hormones (&lt;i&gt;P&lt;/i&gt; = 0.002, &lt;i&gt;P&lt;/i&gt; = 0.031), and there was no correlation with the TA6TA7 mutation in the UGT1A1 * 28 gene locus. […] Multiple regression analysis showed that the occurrence of liver injury was only related to critical illness. […] The liver function of all patients had recovered within one week after conventional liver protection treatment. &lt;b&gt;Conclusion:&lt;/b&gt; COVID-19 combined with liver function injury may be due to the slight elevation of transaminase, mostly around the second week of the disease course. […] Severe patients have a higher proportion of liver injury, and critical type is an independent risk factor for liver injury. &lt;b&gt;目的：&lt;/b&gt; 了解新型冠状病毒肺炎（COVID-19）住院患者合并肝损伤的临床特点、肝功能变化、影响因素及预后。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32154135
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among these 9 pregnant women with confirmed 2019-nCoV infection, onset of clinical symptoms occurred before delivery in 4 cases, on the day of delivery in 2 cases, and after delivery in 3 cases. […] Clinically, the first symptom in the neonates was shortness of breath (n=6), but other initial symptoms such as fever (n=2), thrombocytopenia accompanied by abnormal liver function (n=2), rapid heart rate (n=1), vomiting (n=1), and pneumothorax (n=1) were observed. […] Perinatal 2019-nCoV infection may have adverse effects on newborns, causing problems such as fetal distress, premature labor, respiratory distress, thrombocytopenia accompanied by abnormal liver function, and even death.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32161968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Liver function damage is more frequent in NCOVID-19 than NON-NCOVID-19 patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32170806
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
However, liver injury has also been reported to occur during the course of the disease in severe cases. […] Similarly, previous studies have shown that liver damage was common in the patients infected by the other two highly pathogenic coronavirus - severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV), and associated with the severity of diseases. […] In this review, the characteristics and mechanism of liver injury caused by SARS-CoV, MERS-CoV as well as SARS-CoV-2 infection were summarized, which may provide help for further studies on the liver injury of COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32172546
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;b&gt;Objective:&lt;/b&gt; To investigate the pathological characteristics and the clinical significance of novel coronavirus (2019-nCoV)-infected pneumonia (termed by WHO as corona virus disease 2019, COVID-19). &lt;b&gt;Methods:&lt;/b&gt; Minimally invasive autopsies from lung, heart, kidney, spleen, bone marrow, liver, pancreas, stomach, intestine, thyroid and skin were performed on three patients died of novel coronavirus pneumonia in Chongqing, China. […] While the 2019-nCoV is mainly distributed in lung, the infection also involves in the damages of heart, vessels, liver, kidney and other organs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32188728
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We compared the pathogenesis of the DUBmut virus to the wild-type virus and found that the DUBmut-infected mice had a statistically significant reduction (p&amp;lt;0.05) in viral titer in livers and spleens at day 5 post-infection, albeit both wild-type and DUBmut virus infections resulted in similar liver pathology.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32193831
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Laboratory findings revealed normal or increased whole blood counts (7/8), increased C-reactive protein, procalcitonin and lactate dehydrogenase (6/8), and abnormal liver function (4/8).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32196707
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The laboratory results showed that compared to the normal values, the patients’ lymphocytes were reduced (four [80%] patients), and liver functions alanine aminotransferase and aspartate aminotransferase (two [40%] patients and two [40%] patients) and C-reactive protein (four [80%] patients) were increased when admitted to hospital. […] The main complications for the patients were acute respiratory distress syndrome (one [20%] patients), acute liver injury (three [60%] patients), and diarrhea (two [40%] patients).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32199615
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Although ACE2 is reported to be expressed in lung, liver, stomach, ileum, kidney and colon, its expressing levels are rather low, especially in the lung. […] Consistent with other recent reports, we confirmed that ACE2 was mainly expressed in lung AT2, liver cholangiocyte, colon colonocytes, esophagus keratinocytes, ileum ECs, rectum ECs, stomach epithelial cells, and kidney proximal tubules.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32213556
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among enrolled 651 patients, 74 (11.4%) presented with at least one GI symptom (nausea, vomiting or diarrhoea), average age of 46.14 years, 4-day incubation period and 10.8% had pre-existing liver disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32219882
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To help understand the advantages and limitations of differential treatments, we provide a timely review and discuss the complications and corresponding major treatments, especially controversial ones such as antiviral therapy (remdesivir, ribavirin, and chloroquine), glucocorticoid therapy, extracorporeal support including an artificial liver system, and extracorporeal membrane oxygenation based on available evidence.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32220017
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
It may rapidly progress to acute respiratory distress syndrome (ARDS) and result in multiorgan dysfunction or death in some cases.&lt;sup&gt;(1,2)&lt;/sup&gt; Here, we report the case of a patient with hepatocellular carcinoma (HCC) who underwent liver transplantation and experienced COVID-19 infection during the perioperative period.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32222119
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
All pregnant women did not have an antepartum fever but developed a low-grade fever (37.5℃-38.5℃) within 24 hours after delivery. […] All patients had normal liver and renal function, two patients had elevated plasma levels of the myocardial enzyme. […] All labors smoothly processed, the Apgar scores were 10 points 1 and 5 minutes after delivery, no complications were observed in the newborn. […] It is probable that pregnant women diagnosed with COVID-19 have no fever before delivery.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32233055
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Herein we provide the views of a liver transplant surgeon and transplant hepatologist in New York.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32239591
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Limited data are available for liver function in COVID-19 patients. […] We aimed to investigate the risk factors related to liver injury in the COVID-19 patients. […] The clinical characteristics of patients with liver injury and without liver injury were compared. […] Males were more likely to have liver injury when infected with COVID-19 (P &amp;lt; .05); compared with patients without liver injury, patients with liver injury had increased levels of white blood cell counts, neutrophils, CRP and CT score (P &amp;lt; .05) and had a longer length of stay (P &amp;lt; .05). […] Logistic regression analyses suggested that the extent of pulmonary lesions on CT was a predictor of liver function damage (P &amp;lt; .05). […] Liver injury is common in non-ICU hospitalized COVID-19 patients. […] Intense monitoring and evaluation of liver function in patients with severe pulmonary imaging lesions should be considered.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32239796
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The aim of our study was to investigate the changes of liver function and its clinical significance in COVID-19 patients. […] Liver function and related indexes were analyzed to evaluate its relationship with disease progression in COVID-19 patients. […] Part of the COVID-19 patients presented with varying degrees of abnormality in liver function indexes. […] Most of the liver function indexes in COVID-19 patients were correlated with CRP and NLR, the markers of inflammation. […] Although abnormalities of liver function indexes are common in COVID-19 patients, the impairment of liver function is not a prominent feature of COVID-19, and also may not have serious clinical consequences.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32240670
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Common complications included bacterial infection (42.8%), liver enzyme abnormalities (28.7%) and acute respiratory distress syndrome (21.0%).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243269
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Besides typical respiratory symptoms and signs of COVID-19, digestive symptoms and liver injury have been frequently reported during the course of the disease. […] In this review, we summarized the recent studies reporting of gastrointestinal and liver manifestations during the course of COVID-19. […] Attention should also be paid to monitor liver function during the course of COVID-19, especially in patients with higher disease severity.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243673
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Herein we presented the clinical course and outcome of a 50-year-old male post liver transplantation who contracted COVID-19, with subsequent infection of his wife.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247213
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Search terms were, COVID-19, treatment of coronavirus, COVID 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ACE-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251805
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Multiple organ dysfunction can be observed, the most common organ damage was lung, followed by heart, kidney and liver.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253172
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
While patients typically present with fever and a respiratory illness, mounting evidence indicates that patients might also report extra-pulmonary manifestations, including those affecting the liver and gastrointestinal tract.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32267833
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The meta-analysis revealed no correlation between increased risk of COVID-19 and liver disease, malignancy, or renal disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32270388
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The Liver Transplant Society of India (LTSI) has come up with guidelines for transplant centres across the country to deal with liver transplantation during this evolving pandemic of COVID-19 infection. […] The guidelines are applicable to both deceased donor as well as living donor liver transplants.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32270660
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;b&gt;Objective:&lt;/b&gt; To summarize the clinical characteristics and liver biochemical parameters of 324 cases admitted with novel coronavirus pneumonia in Shanghai area. &lt;b&gt;Methods:&lt;/b&gt; Clinical data and baseline liver biochemical parameters of 324 cases with novel coronavirus pneumonia admitted to the Shanghai Public Health Clinical Center from January 20, 2020 to February 24, 2020 were retrospectively analyzed. […] The differences in clinical data and baseline liver biochemical parameters of the two groups were described and compared. […] The enumeration data were expressed by frequency and rate, and chi-square test was used. &lt;b&gt;Results:&lt;/b&gt; Of the 324 cases with novel coronavirus pneumonia, 26 were severe cases (8%), with median onset of 5 days, 20 cases were HBsAg positive (6.2%), and 70 cases (21.6%) with fatty liver, diagnosed with X-ray computed tomography. […] 1.04, &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.01). &lt;b&gt;Conclusion:&lt;/b&gt; The baseline liver biochemical parameters of 324 cases with novel coronavirus pneumonia in Shanghai area was comparatively lower and the liverinjury degree was mild, and the bile duct cell damage was rare. &lt;b&gt;目的：&lt;/b&gt; 总结上海地区324例新型冠状病毒肺炎患者入院初肝脏生物化学指标的临床特点。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32274341
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Increasing evidence has witnessed the frequent incident liver injury in COVID-19 patients, and it is often manifested as transient elevation of serum aminotransferases; however, the patients seldom have liver failure and obvious intrahepatic cholestasis, unless pre-existing advanced liver disease was present. […] The underlying mechanisms of liver injury in cases of COVID-19 might include psychological stress, systemic inflammation response, drug toxicity, and progression of pre-existing liver diseases. […] However, there is insufficient evidence for SARS-CoV-2 infected hepatocytes or virus-related liver injury in COVID-19 at present. […] The clinical, pathological and laboratory characteristics as well as underlying pathophysiology and etiology of liver injury in COVID-19 remain largely unclear. […] In this review, we highlight these important issues based on the recent developments in the field, for optimizing the management and treatment of liver injury in Chinese patients with COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32274342
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Cases of liver damage or dysfunction (mainly characterized by moderately elevated serum aspartate aminotransferase levels) have been reported among patients with COVID-19. […] However, it is currently uncertain whether the COVID-19-related liver damage/dysfunction is due mainly to the viral infection per se or other coexisting conditions, such as the use of potentially hepatotoxic drugs and the coexistence of systemic inflammatory response, respiratory distress syndrome-induced hypoxia, and multiple organ dysfunction. […] Based on the current evidence from case reports and case series, this review article focuses on the demographic and clinical characteristics, potential mechanisms, and treatment options for COVID-19-related liver dysfunction. […] This review also describes the geographical and demographic distribution of COVID-19-related liver dysfunction, as well as possible underlying mechanisms linking COVID-19 to liver dysfunction, in order to facilitate future drug development, prevention, and control measures for COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275784
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Presently, only about one half of acute care hospitalizations for cirrhosis-related complications result in inpatient specialty care and the current hepatology workforce cannot meet the demand of patients with liver disease nationwide, particularly in less densely populated areas and in community-based practices not affiliated with academic centers. […] Telemedicine, defined as the delivery of health care services at a distance using electronic means for diagnosis and treatment, holds tremendous promise to increase access to broadly specialty care. […] The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) has, in the short-term, accelerated the growth of telemedicine delivery as a public health and social distancing measure.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277387
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Annually, around 850 liver transplantation is performed in Beijing, China. […] Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. […] It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. […] In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277591
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Liver injury is common in patients with COVID-19, but little is known about its clinical presentation and severity in the context of liver transplantation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32278065
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ACE2 is expressed furthermore in the upper esophagus, liver, and colon.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32279064
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Children with inflammatory bowel disease and post liver transplant patients do not have an increased risk of disease, and should remain on medications they are already on. […] Children with chronic liver disease should continue their medications as usual.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282972
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Following the December 2019 SARS-CoV-2 outbreak in China, France is now fifth in number of deaths worldwide while at the same time hosting one of the biggest European liver transplantation programs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282982
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Complete suspension of live donor kidney transplantation was reported by 71.8% and live donor liver by 67.7%. […] While complete suspension of deceased donor transplantation was less frequent, some restrictions to deceased donor kidney transplantation were reported by 84.0% and deceased donor liver by 73.3%; more stringent restrictions were associated with higher regional incidence of COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282986
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The first patient received liver transplantation due to hepatitis B virus-related hepatocellular carcinoma and was confirmed to have COVID-19 nine days later.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283325
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Some patients with SARS-CoV-2 infection have abnormal liver function. […] We aimed to clarify the features of COVID-19-related liver damage to provide references for clinical treatment. […] Patients were analyzed for clinical features, laboratory parameters (including liver function tests), medications, and length of hospital stay. […] Abnormal liver function was defined as increased levels of alanine and aspartate aminotransferase, gamma glutamyltransferase, alkaline phosphatase, and total bilirubin. […] Fifty-five patients (37.2%) had abnormal liver function at hospital admission; 14.5% of these patients had high fever (14.5%), compared with 4.3% of patients with normal liver function (P=.027). […] Patients with abnormal liver function were more likely to be male, and had higher levels of procalcitonin and C-reactive protein. […] There was no statistical difference between groups in medications taken before hospitalization; a significantly higher proportion of patients with abnormal liver function (57.8%) had received lopinavir/ritonavir after admission compared to patients with normal liver function (31.3%). […] Patients with abnormal liver function had longer mean hospital stays (15.09±4.79 days) than patients with normal liver function (12.76±4.14 days) (P=.021). […] More than one third of patients admitted to the hospital with SARS-CoV-2 infection have abnormal liver function, and this is associated with longer hospital stay. […] A significantly higher proportion of patients with abnormal liver function had received lopinavir/ritonavir after admission; these drugs should be given with caution.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32286245
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Biomarkers of inflammation, cardiac and muscle injury, liver and kidney function and coagulation measures were also significantly elevated in patients with both severe and fatal COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32287140
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Patients with digestive symptoms had higher mean liver enzyme levels, lower monocyte count, longer prothrombin time, and received more antimicrobial treatment than those without digestive symptoms. […] Moreover, these patients have a longer time from onset to admission, evidence of longer coagulation, and higher liver enzyme levels.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32289115
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
It remains unclear at this point to what extent chronic liver diseases should be considered as risk factors, due to a shortage of appropriate studies. […] However, patients with advanced liver disease and those after liver transplantation represent vulnerable patient cohorts with an increased risk of infection and/or a severe course of COVID-19. […] In addition, the current pandemic requires unusual allocation of healthcare resources which may negatively impact the care of patients with chronic liver disease that continue to require medical attention.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32291399
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To gain knowledge about the pathology that may contribute to disease progression and fatality, we performed postmortem needle core biopsies of lung, liver, and heart in four patients who died of COVID-19 pneumonia. […] The liver exhibits mild lobular infiltration by small lymphocytes, and centrilobular sinusoidal dilation. […] Changes in the liver and heart are likely secondary or related to the underlying diseases.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293716
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
About 37.2% of patients with elevated D-dimer, 25.9% of patients with leukopenia, along with abnormal levels of liver function (29%) and renal function (25.5%).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293741
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
There were 91 death cases who developed different complications including acute respiratory distress syndrome (ARDS) (73/91), myocardial injury (31/91), liver injury (15/91), renal insufficiency (14/91), multiple organ dysfunction syndrome (MODS) (14/91) and pneumothorax (1/91). […] The main complications of deceased patients with COVID-19 were ARDS, myocardial injury, liver injury, renal insufficiency and MODS.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294285
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The authors found that abnormalities of liver function tests are common in COVID-19 patients, but the clinically significant liver dysfunction in COVID-19 was not a prominent feature of this illness and also may not have serious clinical consequences.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>lung</title>
      <link>/tissuepanel/lung/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/lung/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;lung&lt;/em&gt; tissue in 169 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
31981224
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Gaining a deeper understanding of the interaction between Coronaviruses and the innate immune systems of the hosts may shed light on the development and persistence of inflammation in the lungs and hopefully can reduce the risk of lung inflammation caused by CoVs. […] In this review, we provide an update on CoV infections and relevant diseases, particularly the host defense against CoV-induced inflammation of lung tissue, as well as the role of the innate immune system in the pathogenesis and clinical treatment.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
31986261
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
They and one asymptomatic child (aged 10 years) had radiological ground-glass lung opacities. […] Older patients (aged &amp;gt;60 years) had more systemic symptoms, extensive radiological ground-glass lung changes, lymphopenia, thrombocytopenia, and increased C-reactive protein and lactate dehydrogenase levels.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32017661
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Typical CT findings included bilateral pulmonary parenchymal ground-glass and consolidative pulmonary opacities, sometimes with a rounded morphology and a peripheral lung distribution. […] Notably, lung cavitation, discrete pulmonary nodules, pleural effusions, and lymphadenopathy were absent. […] Follow-up imaging in a subset of patients during the study time window often demonstrated mild or moderate progression of disease, as manifested by increasing extent and density of lung opacities.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32020836
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The two patients shared common clinical features including fever, cough, and multiple ground-glass opacities in the bilateral lung field with patchy infiltration.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32027573
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Forty-four of 51 (86%) patients had bilateral lung involvement, while 41 of 51 (80%) involved the posterior part of the lungs and 44 of 51 (86%) were peripheral. […] There were more consolidated lung lesions in patients 5 days or more from disease onset to CT scan versus 4 days or fewer (431 of 712 lesions vs 129 of 612 lesions; &lt;i&gt;P&lt;/i&gt; &amp;lt; .001). […] Patients older than 50 years had more consolidated lung lesions than did those aged 50 years or younger (212 of 470 vs 198 of 854; &lt;i&gt;P&lt;/i&gt; &amp;lt; .001). […] Follow-up CT in 13 patients showed improvement in seven (54%) patients and progression in four (31%) patients.ConclusionPatients with fever and/or cough and with conspicuous ground-glass opacity lesions in the peripheral and posterior lungs on CT images, combined with normal or decreased white blood cells and a history of epidemic exposure, are highly suspected of having 2019 Novel Coronavirus (2019-nCoV) pneumonia.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32044814
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lung involvement was present in all cases, with most chest computed tomography scans showing lesions in multiple lung lobes, some of which were dense; ground-glass opacity co-existed with consolidation shadows or cord-like shadows.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32048163
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The viral load of 2019-nCoV detected from patient respiratory tracts was positively linked to lung disease severity. […] ALB, LYM, LYM (%), LDH, NEU (%), and CRP were highly correlated to the acute lung injury. […] Age, viral load, lung injury score, and blood biochemistry indexes, albumin (ALB), CRP, LDH, LYM (%), LYM, and NEU (%), may be predictors of disease severity. […] Moreover, the Angiotensin II level in the plasma sample from 2019-nCoV infected patients was markedly elevated and linearly associated to viral load and lung injury.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32053470
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Background Chest CT is used to assess the severity of lung involvement in COVID-19 pneumonia. […] The total CT score was the sum of lung involvement (5 lobes, score 1-5 for each lobe, range, 0 none, 25 maximum) was determined. […] Maximum lung involved peaked at approximately 10 days (with the calculated total CT score of 6) from the onset of initial symptoms (R2=0.25), p&amp;lt;0.001). […] Based on quartiles of patients from day 0 to day 26 involvement, 4 stages of lung CT were defined: Stage 1 (0-4 days): ground glass opacities (GGO) in 18/24 (75%) patients with the total CT score of 2±2; (2)Stage-2 (5-8d days): increased crazy-paving pattern 9/17 patients (53%) with a increase in total CT score (6±4, p=0.002); (3) Stage-3 (9-13days): consolidation 19/21 (91%) patients with the peak of total CT score (7±4); (4) Stage-4 (≥14 days): gradual resolution of consolidation 15/20 (75%) patients with a decreased total CT score (6±4) without crazy-paving pattern. […] Conclusion In patients recovering from COVID-19 pneumonia (without severe respiratory distress during the disease course), lung abnormalities on chest CT showed greatest severity approximately 10 days after initial onset of symptoms.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32054787
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Prophylactic remdesivir treatment initiated 24 h prior to inoculation completely prevented MERS-CoV-induced clinical disease, strongly inhibited MERS-CoV replication in respiratory tissues, and prevented the formation of lung lesions. […] Therapeutic remdesivir treatment initiated 12 h postinoculation also provided a clear clinical benefit, with a reduction in clinical signs, reduced virus replication in the lungs, and decreased presence and severity of lung lesions.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32061066
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Three patients were examined by chest X-ray examination, one of which was normal, one case showed infiltrates of right upper lung, and another showed in right lower lung. […] And 7 cases (7/9) showed multiple ground glass exudation, including 5 cases (5/7) involved bilateral lungs, 2 cases (2/7) involved unilateral lung, 3 cases (3/7) with patchy consolidation, and 2 cases (2/9) showed no abnormality. &lt;b&gt;Conclusions:&lt;/b&gt; The patents with 2019 novel coronavirus pneumonia in this study generally have an epidemiological history.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32062875
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The CT images of these patients showed bilateral multiple patchy or nodular ground-glass opacities and/or infiltrating shadows in middle and outer zone of the lung or under the pleura.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32064855
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Specific IgM antibody screening for patients whose pharyngeal swab nucleic acid test is negative but with ground glass-like lung lesions is very important for early detection and early isolation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32072255
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
• Novel coronavirus (COVID-19)-infected pneumonia usually manifests as bilateral ground-glass opacities in the lung periphery on chest CT scans. […] • Role of radiologists includes not only early detection of lung abnormality, but also suggestion of disease severity, potential progression to acute respiratory distress syndrome, and possible bacterial co-infection in hospitalized patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32077440
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
For patients with lung occupying lesions, the whole process of diagnosis and treatment can not be carried out as usual due to the epidemic.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32077441
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
With the spread of COVID-19, the routine clinical diagnosis and treatment for lung cancer patients has been disturbed. […] Due to the systemic immunosuppressive of lung cancer patients caused by the malignancy and anticancer treatments, lung cancer patients are more susceptible to infection than healthy individuals. […] Lung cancer patients should be the priority group for COVID-19 prevention. […] The protection provisions and control measures aiming to protect lung cancer patients from COVID-19 have been increasingly concerned. […] During the COVID-19 outbreak period, it should be carefully differentiated for fever and respiratory symptoms for lung cancer patients receiving anti-tumor treatment, in order to evaluate the risk of COVID-19. […] Moreover, it is necessary to carry out meticulous and individualized clinical management for lung cancer patients to effectively protect the patients from COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32077789
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
With a longer time after the onset of symptoms, CT findings were more frequent, including consolidation, bilateral and peripheral disease, greater total lung involvement, linear opacities, “crazy-paving” pattern and the “reverse halo” sign. […] Bilateral lung involvement was observed in 10/36 early patients (28%), 25/33 intermediate patients (76%), and 22/25 late patients (88%).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32081636
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Bilateral lung involvement with ground-glass opacity was the most common finding from computed tomography images of the chest.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32088847
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
All patients had peripheral ground-glass opacities and/or lung consolidations in more than two pulmonary lobes. […] Lung lesions were characterized by a high &lt;sup&gt;18&lt;/sup&gt;F-FDG uptake and there was evidence of lymph node involvement.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32091414
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Most of the lesions were multiple, with an average of 12 ± 6 lung segments involved. […] The most common involved lung segments were the dorsal segment of the right lower lobe (69/80, 86%), the posterior basal segment of the right lower lobe (68/80, 85%), the lateral basal segment of the right lower lobe (64/80, 80%), the dorsal segment of the left lower lobe (61/80, 76%), and the posterior basal segment of the left lower lobe (65/80, 81%). […] The common chest CT findings of COVID-19 are multiple ground glass opacity, consolidation, and interlobular septal thickening in both lungs, which are mostly distributed under the pleura.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32096366
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The shape, number and distribution of lung shadows, as well as the characteristics of the lesions on the CT images were reviewed. […] The obvious shadows infiltrating the lungs were shown on CT images in 50 cases, for other 2 cases there was no abnormal changes in the lungs during the first CT examination.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32098422
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This virus causes acute lung symptoms, leading to a condition that has been named as “coronavirus disease 2019” (COVID-19).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32100485
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The peripheral and posterior lung fields were involved in 78% and 67% of the lesions, respectively. […] COVID-19 pneumonia in Korea primarily manifested as pure to mixed ground-glass opacities with a patchy to confluent or nodular shape in the bilateral peripheral posterior lungs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32104915
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Furthermore, some coronaviruses have been demonstrated able to spread via a synapse-connected route to the medullary cardiorespiratory center from the mechanoreceptors and chemoreceptors in the lung and lower respiratory airways.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32105637
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The mean number of involved lung segments was 10·5 (SD 6·4) overall, 2·8 (3·3) in group 1, 11·1 (5·4) in group 2, 13·0 (5·7) in group 3, and 12·1 (5·9) in group 4.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32107577
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We analyzed the clinical characteristics of the patients, as well as the distribution characteristics, pattern, morphology, and accompanying manifestations of lung lesions. […] More than half of the patients presented bilateral, multifocal lung lesions, with peripheral distribution, and 53 (59%) patients had more than two lobes involved.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32112884
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
On chest computed tomography (CT), lung segments 6 and 10 were mostly involved. […] Lesions were more localized in the peripheral lung with a patchy form. […] The imaging pattern of multifocal peripheral ground glass or mixed opacity with predominance in the lower lung is highly suspicious of COVID-19 in the first week of disease onset.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32112966
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Several recent case reports have described common early chest imaging findings of lung pathology caused by 2019 novel Coronavirus (SARS-COV2) which appear to be similar to those seen previously in SARS-CoV and MERS-CoV infected patients. […] Moderate to severe progression of the lung infiltrates, with increasing percentage of high-density infiltrates sustained by a bilateral and multi-segmental extension of lung opacities, were seen. […] It could be an early alert radiological sign to predict initial lung deterioration. […] Finally, the pulmonary vessels enlargement in areas where new lung infiltrates develop in the follow-up CT scan, could describe an early predictor radiological sign of lung impairment.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32114094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Two patients who recently underwent lung lobectomies for adenocarcinoma were retrospectively found to have had COVID-19 at the time of the operation. […] Pathologic examinations revealed that apart from the tumors, the lungs of both patients exhibited edema, proteinaceous exudate, focal reactive hyperplasia of pneumocytes with patchy inflammatory cellular infiltration, and multinucleated giant cells. […] Because both patients did not exhibit symptoms of pneumonia at the time of operation, these changes likely represent an early phase of the lung pathology of COVID-19 pneumonia.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32114744
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Their clinical material including placental tissue and lung CT, and laboratory results were collected, meanwhile, nucleic acid detection of 2019-nCoV of the placentas were performed by RT-PCR. &lt;b&gt;Results:&lt;/b&gt; Three placentas delivered from pregnant women with confirmed 2019-nCoV infection, who were all in their third trimester with emergency caesarean section.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32118394
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The diagnosis and treatment of lung cancer patients have been challenged greatly because of extraordinary public health measures since the lung cancer patients are a high-risk population during the COVID-19 outbreak period. […] Strict protection for lung cancer patients is needed to avoid infection. […] Lung cancer patients are difficult to differentiate from patients with COVID-19 in terms of clinical symptoms, which will bring great trouble to the clinical work and physical and mental health of lung cancer patients. […] This review will demonstrate how to applicate appropriate and individual management for lung cancer patients to protect them from COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32124995
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
And we found that patients with a positive stool test did not experience gastrointestinal symptoms and had nothing to do with the severity of the lung infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32125130
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In order to achieve the overall victory of the 2019 novel coronavirus disease epidemic in this ‘war’, especially to prevent the disease recurrence from rebounding during the resumption of labor, the government has not loosened any control of personnel mobility, which has obviously affected the normal examination and treatment of lung cancer patients under the influence of this epidemic. […] Among the infected cancer patients, lung cancer is the most common type. […] It is necessary to provide more appropriate individualized treatment recommendations for patients with lung cancer based on the epidemic situation of the patient’s location and in combination with the patient’s own condition. […] Through active prevention of infection, timely conversion of treatment strategies, online and offline joint control, and positive psychological counseling, we significantly hope to help patients with lung cancer to survive this difficult period.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32125131
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The imaging data were reviewed and analyzed in detail. &lt;b&gt;Results:&lt;/b&gt; (1) Distribution: the lesion detected in the lung unilaterally in 14 cases (10.7%) and bilaterally in 116 cases (89.3%). […] According to the distribution in the lobes of the lung, all cases could be classified into subpleural distribution (102 cases, 78.4%), centrilobular distribution (99 cases, 76.1%) and diffused distribution (8 cases, 6.1%).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32125132
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Given the systemic immunosuppressive state caused by malignancy and anticancer treatments, patients with advanced lung cancer may be at a higher risk of COVID-19 infection. […] During epidemic of COVID-19, a guideline for the optimal management of patients with advanced lung cancer urgently needs to be proposed to distinguish the symptoms of COVID-19 and the side effects of antitumor drugs. […] This network questionnaire survey was conducted on the lung cancer group of the Chinese Thoracic Society, Chinese Medical Association; the lung cancer group of the Chinese Society of Clinical Oncology Youth Committee; and the Chinese Respiratory Oncology Collaboration. 321 valid questionnaires were received. […] Based on the guidelines on lung cancer and the results of the questionnaires, a consensus was reached. […] 对于目前新冠肺炎疫情期间，晚期非小细胞肺癌（non-small cell lung cancer，NSCLC）患者管理、抗肿瘤药物使用的策略、具体注意事项、药物不良反应与新冠肺炎疑诊患者的鉴别诊断要点等方面给予了建议和推荐。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32125642
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Currently there is no effective antiviral therapy for SARS-CoV-2 infection, which frequently leads to fatal inflammatory responses and acute lung injury. […] In the absence of a proven clinical FcR blocker, the use of intravenous immunoglobulin to block FcR activation may be a viable option for the urgent treatment of pulmonary inflammation to prevent severe lung injury.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32125873
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lesions present on CT images were more likely to have a peripheral distribution (88 [87.1%]) and bilateral involvement (83 [82.2%]) and be lower lung predominant (55 [54.5%]) and multifocal (55 [54.5%]). […] Lesions are more likely to have peripheral distribution and bilateral involvement and be lower lung predominant and multifocal.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32129583
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In heart failure group, the ratio of the expansion of small pulmonary veins was also higher (3/7 vs. 0, &lt;i&gt;P&lt;/i&gt;=0.013), and the lung lesions can be significantly improved after effective anti-heart failure treatment.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32129670
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This study explains the findings from lung computed tomography images of some patients with COVID-19 treated in this medical institution and discusses the difference between COVID-19 and other lung diseases.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32129843
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
It is still unclear how fast the virus evolved and how the virus interacts with other microorganisms in the lung.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32134681
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Compared with early-phase disease (≤ 7 days after the onset of symptoms), advanced-phase disease (8-14 days after the onset of symptoms) was characterized by significantly increased frequencies of GGO plus a reticular pattern, vacuolar sign, fibrotic streaks, a subpleural line, a subpleural transparent line, air bronchogram, bronchus distortion, and pleural effusion; however, GGO significantly decreased in advanced-phase disease. &lt;b&gt;CONCLUSION.&lt;/b&gt; CT examination of patients with COVID-19 pneumonia showed a mixed and diverse pattern with both lung parenchyma and the interstitium involved. […] Lesions presented with a characteristic multifocal distribution in the middle and lower lung regions and in the posterior lung area.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32150618
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Using the PBPK models, hydroxychloroquine concentrations in lung fluid were simulated under 5 different dosing regimens to explore the most effective regimen whilst considering the drug’s safety profile.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32157849
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Take epidemiological history, fever, and the blood lymphocytes decline as clinical indicators, used CT to evaluate the possibility of COVID-19 and range of lung involvement.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32162081
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Compared to reports in adults, we found similar but more modest lung abnormalities at CT in our small paediatric cohort.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32168162
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The imaging findings of the 2019-nCoV infection in our young diabetic patient featured ground-glass opacities and consolidations in both lungs. […] The lung lesions may involute rapidly during the course.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32170560
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Moreover, lung cells that have ACE2 expression may be the main target cells during 2019-nCoV infection. […] Through scRNA-seq data analyses, we identified the organs at risk, such as lung, heart, esophagus, kidney, bladder, and ileum, and located specific cell types (i.e., type II alveolar cells (AT2), myocardial cells, proximal tubule cells of the kidney, ileum and esophagus epithelial cells, and bladder urothelial cells), which are vulnerable to 2019-nCoV infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32170806
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lung lesions have been considered as the major damage caused by SARS-CoV-2 infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32171193
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Coronavirus-19 (COVI-19) involves humans as well as animals and may cause serious damage to the respiratory tract, including the lung: coronavirus disease (COVID-19). […] The binding of COVI-19 to the Toll Like Receptor (TLR) causes the release of pro-IL-1β which is cleaved by caspase-1, followed by inflammasome activation and production of active mature IL-1β which is a mediator of lung inflammation, fever and fibrosis.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32172546
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;b&gt;Objective:&lt;/b&gt; To investigate the pathological characteristics and the clinical significance of novel coronavirus (2019-nCoV)-infected pneumonia (termed by WHO as corona virus disease 2019, COVID-19). &lt;b&gt;Methods:&lt;/b&gt; Minimally invasive autopsies from lung, heart, kidney, spleen, bone marrow, liver, pancreas, stomach, intestine, thyroid and skin were performed on three patients died of novel coronavirus pneumonia in Chongqing, China. […] Focal hemorrhage in lung tissue, organization of exudates in some alveolar cavities, and pulmonary interstitial fibrosiswere observed. […] Furthermore, degeneration and necrosis of parenchymal cells, formation of hyaline thrombus in small vessels, and pathological changes of chronic diseases were observed in other organs and tissues, while no evidence of coronavirus infection was observed in these organs. &lt;b&gt;Conclusion:&lt;/b&gt; s The lungs from novel coronavirus pneumonia patients manifest significant pathological lesions, including the alveolar exudative inflammation and interstitial inflammation, alveolar epithelium proliferation and hyaline membrane formation. […] While the 2019-nCoV is mainly distributed in lung, the infection also involves in the damages of heart, vessels, liver, kidney and other organs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32172669
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The clinical features include fever, coughing, shortness of breath, and inflammatory lung infiltration.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32174095
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Although there are no reports on the mechanism of COVID-19 inducing pulmonary fibrosis, based on the existing theoretical basis, we focus on the possible mechanism of COVID-19 sustained lung damaging, the key role of abnormal immune mechanism in the initiation and promotion of pulmonary fibrosis, and the corresponding therapeutic measures.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32174128
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The median number of affected lung lobes and segments was higher in patients with positive RT-PCR results than in those with negative RT-PCR results (five vs 3.5 affected lobes and 15 vs nine affected segments; &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05). […] Although the air bronchogram reticular pattern was more frequently seen in patients with positive results, centrilobular nodules were less frequently seen in patients with positive results. &lt;b&gt;CONCLUSION.&lt;/b&gt; At the point during the COVID-19 outbreak when this study was performed, imaging patterns of multifocal, peripheral, pure GGO, mixed GGO, or consolidation with slight predominance in the lower lung and findings of more extensive GGO than consolidation on chest CT scans obtained during the first week of illness were considered findings highly suspicious of COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32189015
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Unlike other acute infectious diseases progressing to sepsis, the severe courses of COVID19 seemingly show prolonged progression from onset of first symptoms to life-threatening deterioration of (primarily) lung function.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32189175
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Multiple patchy ground-glass opacities (GGOs) were seen in bilateral lung, mostly in subpleural areas. […] Our case of COVID-19 pneumonia showed multiple subpleural GGOs in bilateral lung, rapid progression, and it also accompanied nodular GGOs on chest CT.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32189428
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We predict that these individuals are ‘primed’ to be at higher risk because nicotine can directly impact the putative receptor for the virus (ACE2) and lead to deleterious signaling in lung epithelial cells.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32191587
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A total of 366 CT scans were acquired and reviewed by 2 groups of radiologists for the patterns and distribution of lung abnormalities, total CT scores and number of zones involved. […] Conclusion The extent of lung abnormalities on CT peaked during illness days 6-11.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32191588
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Conclusions A deep learning model can accurately detect COVID-19 and differentiate it from community acquired pneumonia and other lung diseases.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32191764
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
CT findings of NCIP were featured by predominant ground glass opacities mixed with consolidations, mainly peripheral or combined peripheral and central distributions, bilateral and lower lung zones being mostly involved.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32191830
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Severe forms of the infection, being an indication for treatment in the intensive care unit, comprise acute lung inflammation, ARDS, sepsis and septic shock.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32193037
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Six patients (8%) were diagnosed as mild type pneumonia; these patients had no obvious abnormal CT findings or manifested mild changes of lung infection. […] All 43 patients (59 %) with common type presented unique or multiple ground-glass opacities (GGO) in the periphery of the lungs, with or without interlobular septal thickening. […] An extensive “white lung”, with atelectasis and pleural effusion were found in critical type patients (3, 4%).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32195705
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lung-protective ventilation, prone position ventilation, and adequate sedation and analgesia are essential components of ventilation management.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32196627
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We report the case of a young man with documented nCoV-19 infection evaluated with lung ultrasound and discuss potential applications of lung ultrasound in this setting. […] Lung ultrasound allowed the identification of nCoV-19 infection at bed-side. […] Moreover, lung ultrasound can have several other advantages, such as reduced health worker exposition to infected patients, repeatability during follow-up, low-costs and easier application in low-resource settings.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32196933
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
For this family of viruses the host innate immune response appears the main driver of lung tissue damage during infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32197085
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Therefore, we reinvestigated published data from pangolin lung samples from which SARS-CoV-like CoVs were detected by Liu et al.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32198291
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Based on the structure, we developed the lead compound into a potent inhibitor of the SARS-CoV-2 M&lt;sup&gt;pro&lt;/sup&gt; The pharmacokinetic characterization of the optimized inhibitor reveals a pronounced lung tropism and suitability for administration by the inhalative route.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32198915
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The lung injury and repair caused by COVID-19 has many similarities with the onset and progression of interstitial lung disease (ILD) .
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32199615
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Although ACE2 is reported to be expressed in lung, liver, stomach, ileum, kidney and colon, its expressing levels are rather low, especially in the lung. […] Consistent with other recent reports, we confirmed that ACE2 was mainly expressed in lung AT2, liver cholangiocyte, colon colonocytes, esophagus keratinocytes, ileum ECs, rectum ECs, stomach epithelial cells, and kidney proximal tubules.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32199619
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The lesions in each lung segment of the patient’s chest CT images were characterised. […] The lesions were located mainly in the subpleural area of the lungs (92.4%). […] Of the 80 cases, 76 patients (95%) had bilateral lung disease, four (5%) patients had unilateral lung disease, and eight (10%) patients had cord shadow. […] The chest CT of NCP patients is characterised by the onset of bilateral ground-glass lesions located in the subpleural area of the lung, and progressive lesions that result in consolidation with no migratory lesions. […] As patients can have inflammatory changes in the lungs alongside a negative early nucleic acid test, chest CT, in combination with epidemiological and laboratory tests, is a useful examination to evaluate the disease and curative effect.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32202256
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Hospitalized adult patients with laboratory-confirmed SARS-CoV-2 infection with any one of the following criteria will be eligible to receive lopinavir/ritonavir for 14 days after obtaining written informed consent: (i) respiratory distress with respiratory rate ≥22/min or SpO2 of &amp;lt;94 per cent; (ii) lung parenchymal infiltrates on chest X-ray; (iii) hypotension defined as systolic blood pressure &amp;lt;90 mmHg or need for vasopressor/inotropic medication; (iv) new-onset organ dysfunction; and (v) high-risk groups - age &amp;gt;60 yr, diabetes mellitus, renal failure, chronic lung disease and immunocompromised persons.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32204751
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Preventive treatment has an important role to control and avoid the spread of severe respiratory disease, but often is difficult to obtain and sometimes cannot be effective to reduce the risk of deterioration of the underlining lung pathology. […] For an appropriate and effective approach to treat severe pediatric respiratory diseases, two main different strategies can be proposed according to the stage and severity of the patient conditions: patient in the initial phase and with non-severe lung pathology and patient with severe initial respiratory impairment and/or with delay in arrival to observation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32204987
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High resolution computed tomography (CT) allows objective evaluation of the lung lesions, thus enabling us to better understand the pathogenesis of the disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32207208
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Under specific circumstances, such as during the current COVID-19 outbreak, pregnant women can be a target for respiratory infection, and lung examination may be required as part of their clinical evaluation, ideally avoiding exposure to radiation. […] We propose a practical approach for obstetricians/gynecologists to perform lung ultrasound, showing potential applications, semiology and practical aspects, which should be of particular importance in emergency situations, such as the current pandemic infection of COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32207255
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We report a case where serial follow-up chest computed tomography revealed progression of pulmonary lesions into confluent bilateral consolidation with lower lung predominance, thereby confirming COVID-19 pneumonia.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32211920
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Unlike other acute infectious diseases progressing to sepsis, the severe courses of COVID19 seemingly show prolonged progression from onset of first symptoms to life-threatening deterioration of (primarily) lung function.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32215613
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Cardiovascular disease and pharmacologic RAS inhibition both increase ACE2 levels, which may increase the virulence of SARS-CoV-2 within the lung and heart.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32215622
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Maximal clinical signs of rapid breathing, weight loss, histopathological changes from the initial exudative phase of diffuse alveolar damage with extensive apoptosis to the later proliferative phase of tissue repair, airway and intestinal involvement with virus nucleocapsid protein expression, high lung viral load, and spleen and lymphoid atrophy associated with marked cytokine activation were observed within the first week of virus challenge. […] The lung virus titre was between 105-107 TCID50/g. […] Immunoprophylaxis with early convalescent serum achieved significant decrease in lung viral load but not in lung pathology.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32215691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
CT visual quantitative evaluation was based on summing up the acute lung inflammatory lesions involving each lobe, which was scored as 0 (0%), 1 (1-25%), 2 (26-50%), 3 (51-75%), or 4 (76-100%), respectively.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32216717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A severity index was determined for each lung. […] The lung scores were summed to produce the final severity score.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32216961
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Chest CT revealed abnormal lung shadows in 110 patients. […] Regarding lesion distribution, multi-lobe lesions in both lungs were present in most patients (80 cases; 72.7%).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32217117
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This leads to a cytokine storm and subsequent progression to acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and often death.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32220574
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Both patients had no identified comorbidities and developed mild illness with temporal fever, persistent cough, and lung interstitial infiltrates.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32221983
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ACE2 is widely distributed in the heart, kidneys, lungs, and testes. […] Acute respiratory distress syndrome (ARDS) is a clinical high-mortality disease, and ACE2 has a protective effect on this type of acute lung injury.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32222121
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The inflammation indicators and fever of this patient were effectively controlled and the lung lesions remained stable after active anti-viral treatment, then the radical colorectomy was performed after the viral negative conversion for twice.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32222986
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Furthermore, we observed that the lesion regions in SARS-Cov-2 infected lungs with severe-/critical-type of medical staff were more likely to exhibit lesions in the right upper lobe (31.7% vs 0%; P = .028) and right lung (61% vs 18.2%; P = .012).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32223665
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
CT scores were determined according to CT findings and lung involvement.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32224151
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lung cancer was the most frequent cancer type (7, 25.0%).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32226695
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Patients with HAPE also exhibit patchy infiltrates throughout the pulmonary fields, often in an asymmetric pattern and CT findings reveal increased lung markings and ground glass-like changes as well.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32227357
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Clinical trials should also be undertaken to use statins, which are lipid-lowering drugs but have anti-inflammatory and immunomodulatory properties to prevent acute lung injury in COVID-19 infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32227492
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Growing evidence is showing the usefulness of lung ultrasound in patients with the 2019 new coronavirus disease (COVID-19). […] In this study, we share our experience and propose a standardized approach to optimize the use of lung ultrasound in patients with COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32227511
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A 57-year-old man was diagnosed with acute aortic dissection (AAD), but had marked infiltration shadows in his right lung. […] Intraoperative findings showed that large subadventitial hematomas had spread from the ascending aorta to the right pulmonary artery, which may have caused the infiltration of the lung.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32228252
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Recognition that ACE2 is the coreceptor for the coronavirus has prompted new therapeutic approaches to block the enzyme or reduce its expression to prevent the cellular entry and SARS-CoV-2 infection in tissues that express ACE2 including lung, heart, kidney, brain, and gut.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32228825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In addition, germicidal UV radiation “breaks down” the oxygen O2 which then aggregate into O3 (ozone) molecules creating the ozone layer, capable of inhibiting viral replication and improving lung respiration.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32235187
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Characteristic CT findings included the lobes of bilateral lung extensively involved, ground-glass opacity and ground-glass opacity with consolidation in the peripheral area, sometimes accompanied by interlobular septal thickening, and subpleural line and pleural thickening. […] Compared with the younger group, the proportion of extensive involvement of lung lobes was higher in the elderly group (71.4% vs. […] Elderly and younger patients with corona virus disease have some common CT features, but older patients are more likely to have extensive lung lobe involvement, and subpleural line and pleural thickening.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32235945
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This severe presentation corresponds to the usage of a virus receptor that is expressed predominantly in the lung&lt;sup&gt;2,4&lt;/sup&gt;. […] Infectious virus was readily isolated from throat- and lung-derived samples, but not from stool samples, in spite of high virus RNA concentration. […] Sequence-distinct virus populations were consistently detected in throat and lung samples from the same patient, proving independent replication.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32236856
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
U-HR-CT has a larger matrix size of 1024 × 1024 thinner slice thickness of 0.25 mm and can demonstrate terminal bronchioles in the normal lungs; as a result, Reid’s secondary lobules and their abnormalities can be identified. […] The distribution and hallmarks (ground-glass opacity, consolidation with or without architectural distortion, linear opacity, crazy paving) of the lung opacities on U-HRCT were visually evaluated on a 1 K monitor by two experienced reviewers. […] The CT lung volume was measured, and the ratio of the measured lung volume to the predicted total lung capacity (predTLC) based on sex, age and height was calculated. […] In these lesions, the secondary lobules were smaller than those in the un-affected lungs. […] CT lung volume decreased in two cases comparing predTLC. […] U-HRCT can evaluate not only the distribution and hallmarks of COVID-19 pneumonia but also visualize local lung volume loss.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32238223
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This case report underlines the appearance of a “walking pneumonia” in a novel coronavirus disease (COVID-19) patient, with evidence of progressive lung involvement on chest imaging studies.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32238232
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Like the SARS-CoV disease, COVID-19 is a systematic disease and targets the lungs, vasculatures, and the immune system. […] The basic pathogenesis involves two interlinked processes: a severe lung inflammation and immune deficiency, both of which are related to an inappropriate immune response and over-production of cytokines.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32238438
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
While the majority of infected cases appear mild, in some cases individuals present serious cardiorespiratory complications with possible long-term lung damage.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32238757
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Coronavirus disease 2019 (COVID-19), which causes serious respiratory illness such as pneumonia and lung failure, was first reported in Wuhan, the capital of Hubei, China.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32239472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
SNR and CNR were significantly different in several thoracic structures between HD-DECT and LDCT, with exception of lung parenchyma.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32239532
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lung ultrasound (LU) has rapidly become a tool for assessment of patients stricken by the novel coronavirus 2019 (COVID-19). […] Over the past two and a half months (January, February, and first half of March 2020) we have used this modality for identification of lung involvement along with pulmonary severity in patients with suspected or documented COVID-19 infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32240123
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The most commonly reported conditions were diabetes mellitus, chronic lung disease, and cardiovascular disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32240913
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We aimed to compare chest HRCT lung signs identified in scans of differently aged patients with COVID-19 infections. […] Patients aged 45-59 years and aged ≥60 years had more bilateral lung, lung lobe, and lung field involvement, and greater lesion numbers than patients &amp;lt;18 years.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32242947
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
COVID-19 is a new clinical infectious disease that mainly causes bilateral pneumonia and lung function deteriorates rapidly.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243697
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
After the diagnosis of COVID-19, immunosuppressive agents were discontinued and methylprednisolone with prophylactic antibiotics were initiated, however, the lung injury progressed.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243911
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
It is therefore necessary to explore biomarkers to determine the extent of lung lesions and disease severity. […] We aimed to assess the usefulness of CRP levels in the early stage of COVID-19 and to correlate them with lung lesions and severe presentation. […] On admission CRP levels were collected, and the diameter of the largest lung lesion was measured in the most severe lung lesion by lung CT scan. […] CRP levels and the diameter of the largest lung lesion in the moderate group were higher than those in the mild group (Mann-Whitney test=-2.647, -2.171, P˂0.05), those in the severe group were higher than those in the moderate group (Mann-Whitney test=0.693, -2.177, P˂0.05), and those in the critical group were higher than those in the severe group (Mann-Whitney test=-0.068, -1.549, P˂0.05). […] CRP levels were positively correlated with the diameter of lung lesion and severe presentation (correlation coefficient=0.873, 0.734, P˂0.001). […] In the early stage of COVID-19 CRP levels were positively correlated with lung lesions and could reflect disease severity.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32244059
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Ever since the first case was reported at the end of 2019, the SARS-COV-2 virus and associated lung disease COVID-19 has spread throughout the world and has become a pandemic.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32245904
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Patients with lung cancer are at risk of pulmonary complications from COVID-19. […] We hereby propose a tool to support oncologists and physicians in treatment decision for patients with lung cancer.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32246819
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Two of the 6 patients (33.3%) had bilateral lung involvements and 4 (66.7%) had single-lung involvement.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32246845
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Here, we investigate ACE2 and TMPRSS2 expression levels and their distribution across cell types in lung tissue (twelve donors, 39,778 cells) and in cells derived from subsegmental bronchial branches (four donors, 17,521 cells) by single nuclei and single cell RNA sequencing, respectively.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247317
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Early Lessons on the Importance of Lung Imaging in Novel Coronavirus Disease (COVID-19).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32248675
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Most of these patients recover and survive to ICU discharge with supportive care using lung protective ventilation strategies, avoiding excess fluids, screening and treating bacterial co-infection, and timely intubation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32248966
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
COVID-19 results in mild symptoms in the majority of infected patients, but can cause severe lung injury, cardiac injury, and death.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32249471
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We report a case of positive lung ultrasound findings consistent with COVID-19 in a woman with an initial negative RT-PCR result. […] The lung ultrasound-imaging findings were present between the negative and subsequent positive RT-PCR tests and correlated with CT findings. […] The point-of-care lung-ultrasound examination was easy to perform and, as such, could play an important role in the triage of women with suspected COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32250244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To the contrary, compelling evidence exists that the ACE-1/angiotensin(Ang)II/ATR-1 pathway is involved in SARS-CoV-2-induced ARDS, while the ACE-2/Ang(1-7)/ATR2/MasR pathway counteracts the harmful actions of AngII in the lung. […] A reduced ACE-1/ACE-2 ratio is, in fact, a feature of ARDS that can be rescued by human recombinant ACE-2 and Ang(1-7) administration, thus preventing SARS-CoV-2-induced damage to the lung.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251003
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lung transplantation (LT) as the sole therapy for end-stage pulmonary fibrosis related to acute respiratory distress syndrome has been considered as the ultimate rescue therapy for these patients. […] The pathological results of the explanted lungs were concordant with the critical clinical manifestation, and provided insight towards better understanding of the disease. […] Lung transplantation can be performed in end-stage patients with respiratory failure due to COVID-19-related pulmonary fibrosis.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251805
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Multiple organ dysfunction can be observed, the most common organ damage was lung, followed by heart, kidney and liver.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32252784
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Most of the lesions identified in chest CT images were multiple lesions of bilateral lungs, lesions were more localized in the peripheral lung, 109 (83%) patients had more than two lobes involved, 20 (15%) patients presented with patchy ground glass opacities, patchy ground glass opacities and consolidation of lesions co-existing in 61 (47%) cases.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253318
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Radiological examinations showed varying degrees of absorption of lung lesions within 7 d.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253400
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Chronic obstructive pulmonary disease (COPD) is a chronic, progressive lung disease with few successful treatments, and is strongly associated with cigarette smoking (CS). […] Since the novel coronavirus has spread worldwide seriously, there is growing concern that patients who have chronic respiratory conditions like COPD can easily be infected and are more prone to having severe illness and even mortality because of lung dysfunction. […] Loquat leaves have long been used as an important material for both pharmaceutical and functional applications in the treatment of lung disease in Asia, especially in China and Japan. […] The present study uses a CS-induced mouse model to estimate the morphological changes in lung tissue. […] The results demonstrated that TF suppressed the histological changes in the lungs of CS-challenged mice, as evidenced by reduced generation of pro-inflammatory cytokines including interleukin 6 (IL-6), IL-1β, tumor necrosis factor α (TNF-α), nitric oxide (NO), and inducible nitric oxide synthase (iNOS) and diminished the protein expression of transient receptor potential vanilloid 1 (TRPV1). […] Interestingly, TF could inhibit CS-induced oxidative stress in the lungs of COPD mice. […] Taken together, our findings showed that the protective effect and putative mechanism of the action of TF resulted in the inhibition of inflammation and oxidative stress through the regulation of TRPV1 and the related signal pathway in lung tissues.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32255437
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Peripheral distribution (45%) of lung lesions was predominant. […] Most of the lesions were multilobar (68%), with an average of three lung segments involved. […] Children with COVID-19 had relatively milder symptoms and less severe lung inflammation than adults.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32257554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Therefore, MSC therapy inhibiting the overactivation of the immune system and promoting endogenous repair by improving the lung microenvironment after the SARS-CoV-2 infection found in this study is striking.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32264791
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ACE2 is widely expressed, including, in the lungs, cardiovascular system, gut, kidneys, central nervous system, and adipose tissue. […] The ACE2 system is a critical protective pathway against heart failure with reduced and preserved ejection fraction including, myocardial infarction and hypertension, and against lung disease and diabetes.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32265310
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Limited pre-clinical data suggest that systemic MSC administration can significantly reduce respiratory virus (Influenza strains H5N1 and H9N2)-induced lung injury, however, there are no available data in models of coronavirus respiratory infection.There are a rapidly increasing number of clinical investigations of cell-based therapy approaches for COVID-19. […] To provide a rationale strategy to maximise potential therapeutic use, it is critically important to understand the relevant pre-clinical studies and postulated mechanisms of MSC actions in respiratory virus-induced lung injuries.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32265331
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A single intranasal administration of 10&lt;sup&gt;4&lt;/sup&gt; PFU PIV5-MERS-S provided complete protection against a lethal challenge with mouse-adapted MERS-CoV (MERS&lt;sub&gt;MA&lt;/sub&gt;6.1.2) and improved virus clearance in the lung. […] Intriguingly, an influx of eosinophils was observed only in the lungs of mice immunized with inactivated MERS-CoV, suggestive of a hypersensitivity-type response.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32267139
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Brain metastasis is a major cause for cancer death in patients with lung cancer. […] Sirtuin 1 (SIRT1) and hsa-miR-217 has been identified to mediate the development of non-small cell lung cancer (NSCLC). […] This axis might be a potential target for the treatment of brain metastasis of lung cancer.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32267998
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
There is evidence in both animals and humans that fibrinolytic therapy in Acute Lung Injury and ARDS improves survival, which also points to fibrin deposition in the pulmonary microvasculature as a contributory cause of ARDS and would be expected to be seen in patients with ARDS and concomitant diagnoses of DIC on their laboratory values such as what is observed in more than 70% of those who die of COVID-19 (8-10).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32268018
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The main medication characteristics are clearing heat, entilating lung, removing toxicity and removing turbidity.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32268454
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Chest CT of two patients showed bilateral lung texture was thickening, and chest CT of other patients was normal.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32268515
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In the present study we investigated in silico the basic mechanism of &lt;i&gt;ACE2&lt;/i&gt; in the lung and provided evidences for new potentially effective drugs for Covid-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32270184
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We comprehensively investigated the replication, cell tropism, and immune activation profile of SARS-CoV-2 infection in human lung tissues with SARS-CoV included as a comparison. […] SARS-CoV-2 infected and replicated in human lung tissues more efficiently than that of SARS-CoV. […] Within the 48-hour interval, SARS-CoV-2 generated 3.20 folds more infectious virus particles than that of SARS-CoV from the infected lung tissues (P&amp;lt;0.024). […] Importantly, despite the more efficient virus replication, SARS-CoV-2 did not significantly induce types I, II, or III interferons in the infected human lung tissues. […] Our study provided the first quantitative data on the comparative replication capacity and immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung tissues.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32270479
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Fifteen (65.2%) patients were asymptomatic with patchy ground-glass opacity in a single lung lobe.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32271459
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Compared with the non-severe group, the severe group showed statistical significance in older age, hypertension, bilateral lung plaque shadow, decrease in lymphocyte count, increase in C-reactive protein (CRP), aspartate aminotransferase (AST), lactate dehydrogenase, and creatine kinase. […] Age, combined hypertension, oxygenation index, double lung patch, decreased lymphocyte count, and elevated levels of C-reactive protein, aspartate aminotransferase, lactate dehydrogenase, and creatine kinase can be used as predictors of the disease severity.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32271942
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Experiments were conducted on two test lungs with different compliances (0.02 and 0.04 l.cmH&lt;sub&gt;2&lt;/sub&gt; O&lt;sup&gt;-1&lt;/sup&gt; ). […] The ventilator was used in both pressure and volume control modes and was set to ventilate the low compliance lungs at end-tidal volumes of 500 ± 20 ml. […] A flow restrictor apparatus consisting of a Hoffman clamp and tracheal tube was connected in series to the inspiratory limb of the high compliance test lungs and the resistance modified to achieve end-tidal volumes of 500 ± 20 ml. […] The restriction apparatus successfully modified the inspiratory pressure, minute ventilation, and volume delivered to the high compliance test lungs in both pressure control (27.3-17.8 cm H&lt;sub&gt;2&lt;/sub&gt; O, 15.2-8.0 l.min&lt;sup&gt;-1&lt;/sup&gt; and 980-499 ml, respectively), and volume control (21.0-16.7 cm H&lt;sub&gt;2&lt;/sub&gt; O, 10.7-7.9 l.min&lt;sup&gt;-1&lt;/sup&gt; and 659-498 ml, respectively) ventilation modes. […] However, these experiments demonstrate the capacity to simultaneously ventilate two test lungs of different compliances, and using only standard hospital equipment, modify the delivered pressure, flow, and volume in each test lung.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32272262
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Chest CT showed abnormal attenuation in bilateral multiple lung lobes, distributed in the lower and/or periphery of the lungs (94.98%), with multiple shapes. […] While chest HRCT provided the distribution, shape, attenuation and extent of lung lesions, as well as some typical CT signs of COVID-19 pneumonia.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32272630
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
However, asymptomatic lung involvement has not been reported. […] We hereby present the case of a 44-year-old health-care worker, who was found to be infected with the SARS-CoV-2 virus after a CT-scan performed for an unrelated condition revealed a lesion in the lung field compatible with COVID-19 infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32274773
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
COVID-19, a new viral disease affecting primarily the respiratory system and the lung, has caused a pandemic with serious challenges to health systems around the world. […] Therapy is based on established recommendations issued for patients with acute lung injury (ARDS). […] Lung protective ventilation, prone position, restrictive fluid management and an adequate management of organ failures are the mainstays of therapy. […] In case of fulminant lung failure, veno-venous extracorporeal membrane oxygenation may be used as a rescue in experienced centres.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275257
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The SARS-CoV-2 causes changes in blood cells and factors and makes lung abnormalities in patients, which can be detected by serological, molecular, and radiological techniques by detecting these changes and injuries.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275347
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Endomyocardial biopsy demonstrated low-grade myocardial inflammation and viral particles in the myocardium suggesting either a viraemic phase or, alternatively, infected macrophage migration from the lung.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275452
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
More patients had multiple lung lobe involvement and pleural effusion in the critical group as compared to moderate group. […] Involvement of multiple lung lobes and pleural effusion were associated with the severity of COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275742
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
He tested positive for SARS-CoV-2 on postmortem nasopharyngeal and lung parenchymal swabs. […] Postmortem nasopharyngeal swab was positive for SARS-CoV-2; lung parenchymal swabs were negative.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275753
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lungs from patients with coronavirus disease 2019 (COVID-19) have shown typical signs of acute respiratory distress syndrome (ARDS), formation of hyaline membrane mainly composed of fibrin, and ‘ground-glass’ opacity. […] We aimed to investigate whether plasminogen can improve lung lesions and hypoxemia of COVID-19. […] Levels of their lung lesions, oxygen saturation and heart rates were compared before and after treatment by CT scanning images and patient monitor. […] After plasminogen inhalation, conditions of lung lesions in 5 clinically moderate patients have quickly improved, shown as the decreased range and density of ‘ground glass’ opacity. […] Whereas it is reported that plasminogen is dramatically increased in adults with ARDS, this study suggests that additional plasminogen may be effective and efficient in treating lung lesions and hypoxemia during COVID-19 infections.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275766
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Ultrasound imaging of the lung and associated tissues may play an important role in the management of patients with COVID-19 associated lung injury. […] Compared to other monitoring modalities, such as auscultation or radiographic imaging, we argue lung ultrasound has high diagnostic accuracy, is ergonomically favourable and has fewer infection control implications. […] By informing the initiation, escalation, titration and weaning of respiratory support, lung ultrasound can be integrated into COVID-19 care pathways for patients with respiratory failure. […] Given the unprecedented pressure on healthcare services currently, supporting and educating clinicians is a key enabler of the wider implementation of lung ultrasound. […] This narrative review provides a summary of evidence and clinical guidance for the use and interpretation of lung ultrasound for patients with moderate, severe and critical COVID-19 associated lung injury. […] Mechanisms by which the potential lung ultrasound workforce can be deployed are explored, including a pragmatic approach to training, governance, imaging, interpretation of images and implementation of lung ultrasound into routine clinical practice.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277351
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
However, in a subgroup of patients, the secondary immune response may be exaggerated, leading to inflammatory-induced lung injury and other complications including pneumonitis, acute respiratory distress syndrome, respiratory failure, shock, organ failure, and potentially death.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277387
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32278065
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ACE2 and TMPRSS2 are not only expressed in lung, but also in the small intestinal epithelia.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32278670
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The most common comorbidities identified were obesity (n = 48%), arterial hypertension (n = 44%) and chronic lung disease (n = 37%).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281052
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
After the intravenous transplantation of MSCs, a significant population of cells accumulates in the lung, which they alongside immunomodulatory effect could protect alveolar epithelial cells, reclaim the pulmonary microenvironment, prevent pulmonary fibrosis, and cure lung dysfunction.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281268
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
HCov-229E is one of the four flu-causing coronaviruses which share great sequence similitude, while many symptoms of patients infected with COVID-19 resemble those of patients infected with these known flu-causing coronaviruses.&lt;sup&gt;2&lt;/sup&gt; A previous study reported that human lung epithelial A549 cells treated with glucose 6-phosphate dehydrogenase (G6PD) interfering RNA (RNAi) to lower G6PD activity displayed augmented (12-fold) viral production in comparison to normal counterparts when infected with coronavirus HCov-229E.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281328
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Rhei Radix et Rhizoma screened by Mpro and Trichosanthis Fructus screened by PLP were contained in Maxing Shigan Decoction and Xuanbai Chengqi Decoction, and could be applied to the syndromes of epidemic virus blocking lung. […] Mori Folium, Lonicerae Japonicae Flos and Forsythiae Fructus obtained by ACE2 inhibitors screening were included in the Sangju Decoction and Yinqiaosan, which might be applicable to the syndromes of warm pathogen attacking lung and cough and dyspnea.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281329
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
With the exudation of inflammatory factors, cytokines increase abnormally in tissues and organs, interfering with the immune system, causing excessive immune response of the body, resulting in diffuse damage of lung cells, pulmonary fibrosis, and multiple organ damage, even death.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281331
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The pathogeny of COVID-19 in TCM is damp-toxin, with the core pathogenesis of damp-toxin retention in lung and Qi repression. […] The location of the disease is lung, always involving spleen and stomach, and may further affect heart and kidney in severe cases.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281332
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among them, the four properties were mainly concentrated in temperature, cold and level, the five tastes were mainly concentrated in bitter, hot and sweet, and the meridians were mainly concentrated in lung, stomach and spleen.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281333
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The pungent medicines are mostly found in the early stage, the bitter drugs are the main flavor in the middle and severe stage, and the sweet medicines are mostly used in the recovery stage; ③the meridian of the drug is more concentrated at the lung, stomach, and heart, and most of drugs are into the lung meridian, accounting for 24.55%; these medicines are mostly into the lungs and stomach in the initial and middle stages, and into the heart and kidney in severe stages; ④oral drugs are mostly non-toxic, among which only 6 kinds are toxic, namely Armeniacae Semen Amarum, Dryopteridis Crassirhizomatis Rhizoma, Paridis Rhizoma, Pinelliae Rhizoma, Aconiti Lateralis Radix Praeparaia; ⑤most of the drugs have five types of functions: treating exterior syndromes, resolving dampness, clearing heat, replenishing deficiency, resolving phlegm, cough, and asthma.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283052
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The most anatomic distributions were bilateral lung infection (78.2%) and peripheral distribution (76.95%). […] The most common CT features in patients affected by COVID-19 included ground glass opacities and consolidation involving the bilateral lungs in a peripheral distribution.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32285974
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Here, we investigate ACE2 and TMPRSS2 expression levels and their distribution across cell types in lung tissue (twelve donors, 39,778 cells) and in cells derived from subsegmental bronchial branches (four donors, 17,521 cells) by single nuclei and single cell RNA sequencing, respectively.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32286679
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A lung-saving ventilation strategy must be implemented in acute respiratory distress syndrome and mechanically ventilated patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32289051
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lung US findings were consistent with diffuse B lines (100%) and subpleural consolidations (27.3%).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32289516
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Here we report seven cases who were confirmed infected with SARS-CoV-2 in the perioperative period of lung resection. […] Retrospective analysis suggested that one patient had been infected with the SARS-CoV-2 prior to the surgery, the other 6 patients contracted the infection after the lung resection. […] Fever, lymphopenia and ground-glass opacities on computerized tomography (CT) are the most common clinical manifestations of COVID-19 in patients after lung resection surgery. […] Three out seven patients died from COVID-19 pneumonia, suggesting that lung resection surgery might be a risk factor for death in patients with COVID-19 in the perioperative period.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32291399
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To gain knowledge about the pathology that may contribute to disease progression and fatality, we performed postmortem needle core biopsies of lung, liver, and heart in four patients who died of COVID-19 pneumonia. […] Histologically, the main findings are in the lungs, including injury to the alveolar epithelial cells, hyaline membrane formation, and hyperplasia of type II pneumocytes, all components of diffuse alveolar damage.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32291968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lung cancer has the highest morbidity and mortality in China and the world. […] Most patients with lung cancer are smokers with poor underlying lung conditions and low immunity, thus it is vital to protect them from epidemic diseases during cancer treatment. […] It is necessary to provide individualized medical treatment and management of treatment-related adverse events for patients with lung cancer based on patients’ conditions and regional epidemic patterns.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292213
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The clinical course of the disease known as coronavirus disease 2019 (COVID-19) ranges from mild respiratory symptoms to severe lung failure.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292624
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The degree of lesions was visually scored by the radiologist, as follows, for each of the 5 lung lobes: 0, no lesion present; 1, &amp;lt;1/3 involvement; 2, &amp;gt;1/3 and &amp;lt; 2/3 involvement; and 3, &amp;gt;2/3 involvement. […] The parameters obtained using the computer tool included lung volume (mL), lesion volume (mL), lesion percentage (%), and mean lesion density (HU) of the whole lung, right lung, left lung, and each lobe. […] A Chi-square test was used to test the consistency of radiologist- and computer-derived lesion percentage in the right/left lung, upper/lower lobe, and each of the 5 lobes.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292627
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Acute respiratory distress syndrome (ARDS), lung failure, and fulminant pneumonia are major lung diseases in H7N9 patients. […] Because H7N9 and the corona virus disease 2019 (COVID-19) share similar complications (such as ARDS and lung failure) and corresponding multi-organ dysfunction, MSC-based therapy could be a possible alternative for treating COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292866
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This latter stage is characterized by the development of progressive lung involvement with increasing oxygen requirements and occasionally signs of the haemophagocitic syndrome.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292901
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Failure of SARS and MERS vaccines in animal trials involved pathogenesis consistent with an immunological priming that could involve autoimmunity in lung tissues due to previous exposure to the SARS and MERS spike protein.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293003
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We provide a critical review on the relationship of hypertension, RAS, and risk of lung injury. […] We also review in detail the molecular mechanisms linking the RAS to lung damage and the potential clinical impact of treatment with RAS blockers in patients with COVID-19 and a high cardiovascular and renal risk. […] This is related to the role of angiotensin-converting enzyme 2 (ACE2) for SARS-CoV-2 entry into cells, and expression of ACE2 in the lung, cardiovascular system, kidney, and other tissues.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293710
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
COVID-19 infection and its severity can be explained by the concentration of glycosylated SARS- CoV-2 viral particles in the lung epithelium, the concentration of glycosylated angiotensin converting enzyme receptor 2 (ACE2) in the lung epithelium, and the degree and control of the pulmonary immune response to the SARS-CoV-2 spike protein at approximately day 8-10 after symptom onset, which may be related to both.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293716
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Only 25.8% of patients had lesions involving single lung and 75.7% of patients had lesions involving bilateral lungs. […] Bilateral lungs involvement was common.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294796
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This study was conducted to explore the clinical value of noninvasive assessment of bedside ultrasound in the diagnosis of lung lesions of Coronavirus Disease-19. […] All cases were examined by lung ultrasound and CT. […] Lung lesions were reviewed by blinded observers, with imaging scores being used to analyze the ultrasound findings of lung lesions in patients with Coronavirus Disease-19 and with chest CT being used as the reference standard. […] The clinical value of ultrasound in the noninvasive assessment of lung lesions was evaluated. […] Lung ultrasound signs in patients with Coronavirus Disease-19 were mainly manifested as interstitial pulmonary edema (90.0 %, 27/30) and pulmonary consolidations (20.0 %, 6/30). […] The lung lesions were mainly distributed in the subpleural and peripheral pulmonary zones. […] There was moderate agreement (Kappa = 0.529) between the noninvasive assessment of bedside ultrasound for lung lesions in patients with Coronavirus Disease-19 and CT. […] The ultrasound scores to evaluate mild, moderate and severe lung lesions exhibited sensitivity of 68.8 % (11/16), 77.8 % (7/9), 100.0 % (2/2), specificity of 85.7 % (12/14), 76.2 % (16/21), 92.9 % (26/28), and diagnostic accuracy of 76.7 % (23/30), 76.7 % (23/30), 93.3 % (28/30), respectively. […] The follow-up dynamic ultrasound examination showed that the condition of all patients worsened gradually, with the ultrasound scores of lung lesions increasing to varying degrees. […] Bedside ultrasound has important clinical significance for noninvasive assessment and dynamic observation of lung lesions in patients with Coronavirus Disease-19, which is worth further consideration. […] ZIEL: Diese Studie wurde durchgeführt, um den klinischen Wert der nicht-invasiven Beurteilung von Ultraschall direkt am Krankenbett bei der Diagnose von Lungenläsionen bei COVID-19-Erkrankung zu untersuchen. […] Alle Fälle wurden mittels Lungenultraschall und CT untersucht. […] Die Lungenläsionen wurden von verblindeten Beobachtern überprüft, wobei die sonografischen Befunde der Lungenläsionen bei COVID-19-Patienten mittels Bildgebungs-Scores analysiert wurden und Thorax-CT als Referenzstandard diente. […] Der klinische Nutzen der Sonografie bei der nicht-invasiven Beurteilung von Lungenläsionen wurde bewertet. […] Bei COVID-19-Patienten manifestierten sich die Lungenultraschallzeichen in erster Linie als interstitielles Lungenödem (90,0 %, 27/30) und Lungenkonsolidierungen (20,0 %, 6/30). […] Die Läsionen der Lunge waren überwiegend in den subpleuralen und peripheren Lungenzonen verteilt. […] Die Übereinstimmung zwischen der nicht-invasiven Beurteilung des Ultraschalls am Krankenbett und der CT für Lungenläsionen bei COVID-19-Patienten war moderat (Kappa = 0,529). […] Die Beurteilung mittels Ultraschall von leichten, moderaten und schweren Lungenläsionen ergab eine Sensitivität von 68,8 % (11/16), 77,8 % (7/9), 100,0 % (2/2), eine Spezifität von 85,7 % (12/14), 76,2 % (16/21), 92,9 % (26/28) und eine diagnostische Genauigkeit von 76,7 % (23/30), 76,7 % (23/30) bzw. […] Die anschließende dynamische Ultraschalluntersuchung zeigte, dass sich der Zustand aller Patienten allmählich verschlechterte, wobei die Ultraschall-Scores der Lungenläsionen in unterschiedlichem Maße anstiegen. […] Ultraschall direkt am Krankenbett hat eine wichtige klinische Bedeutung für die nicht-invasive Beurteilung und die dynamische Beobachtung von Lungenläsionen bei COVID-19-Patienten und sollte weiter in Betracht gezogen werden.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>lymph node</title>
      <link>/tissuepanel/lymph_node/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/lymph_node/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;lymph node&lt;/em&gt; tissue in 5 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32088847
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lung lesions were characterized by a high &lt;sup&gt;18&lt;/sup&gt;F-FDG uptake and there was evidence of lymph node involvement.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32118615
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Besides, severe/critical patients showed higher incidences of lymph node enlargement, pericardial effusion and pleural effusion than the ordinary patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32204990
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Two chest radiologists independently evaluated the imaging in terms of distribution, ground-glass opacity (GGO), consolidation, air bronchogram, stripe, enlarged mediastinal lymph node, and pleural effusion. […] Neither enlarged mediastinal lymph nodes nor pleural effusion were present.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32222433
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
For cervical cancer, the place of surgery must be re-evaluated in relation to radiotherapy and Radio-Chemotherapy-Concomitant and the value of lymph node staging surgeries must be reviewed on a case-by-case basis. […] For early stage endometrial cancer, in case of low and intermediate preoperative ESMO risk, hysterectomy with bilateral annexectomy associated with a sentinel lymph node procedure should be favored. […] For high ESMO risk, it ispossible to favor the MSKCC algorithm (combining PET-CT and sentinel lymph node biopsy) in order to omit pelvic and lumbar-aortic lymphadenectomies.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247066
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
For cervical cancer, radiotherapy and concomitant radiochemotherapy could replace surgery as first-line treatment and the value of lymph node staging should be reviewed on a case-by-case basis. […] For patients with early stage endometrial cancer of low and intermediate preoperative ESMO risk, hysterectomy with bilateral adnexectomy combined with a sentinel lymph node procedure is recommended. […] For patients of high ESMO risk, the MSKCC algorithm (combining PET-CT and sentinel lymph node biopsy) should be applied to avoid pelvic and lumbar-aortic lymphadenectomy.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>macrophages</title>
      <link>/tissuepanel/macrophages/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/macrophages/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;cell-sentence-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Cell Sentence Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;macrophages&lt;/em&gt; tissue in 9 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32171193
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Another inhibitory cytokine is IL-38, the newest cytokine of the IL-1 family members, produced by several immune cells including B cells and macrophages.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32172546
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The infiltrated immune cells in alveoli were majorly macrophages and monocytes. […] Immunohistochemical staining showed that part of the alveolar epithelia and macrophages were positive for 2019-nCoV antigen.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32188728
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We engineered a DUB mutation (Asp1772 to Ala) into a murine coronavirus and evaluated the replication and pathogenesis of the DUB mutant virus (DUBmut) in cultured macrophages and in mice. […] We found that the DUBmut virus replicates similarly as the wild-type virus in cultured cells, but the DUBmut virus activates an IFN response at earlier times compared to the wild-type virus infection in macrophages, consistent with DUB activity negatively regulating the IFN response. […] We engineered a recombinant murine coronavirus to express the DUB mutant and showed that the DUB mutant virus activated an earlier type I interferon response in macrophages and exhibited reduced replication in mice.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32188729
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We used transcriptomics approaches to compare the scope and kinetics of the host response to the wild-type, DUBmut, and EndoUmut viruses in infected macrophages. […] This study highlights the role of viral interferon antagonists in shaping the kinetics and magnitude of the host response during virus infection and demonstrates that inactivating a dominant viral antagonist, the coronavirus endoribonuclease, dramatically alters the host response in macrophages.&lt;b&gt;Importance&lt;/b&gt;Macrophages are an important cell type during coronavirus infections because they “notice” the infection and respond by inducing type I interferons, which limits virus replication. […] This study reveals that EndoU activity substantially contributes to the ability of coronaviruses to evade the host innate response and to replicate in macrophages.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32199615
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We found that macrophages frequently communicate with the CoVs targets through chemokine and phagocytosis signaling, highlighting the importance of tissue macrophages in immune defense and immune pathogenesis.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32229155
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The pro-inflammatory metabolites of AA and EPA such as prostaglandins, leukotrienes and thromboxanes induce inflammation whereas lipoxins, resolvins, protectins and maresins derived from AA, EPA and DHA not only suppress inflammation but also enhance would healing and augment phagocytosis of macrophages and other immunocytes and decrease microbial load.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32270184
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
SARS-CoV-2 and SARS-CoV were similar in cell tropism, with both targeting types I and II pneumocytes, and alveolar macrophages.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32289516
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The pathological examination of Patient 1, who was infected the SARS-CoV-2 before the surgery, revealed that apart from the tumor, there was a wide range of interstitial inflammation with plasma cells and macrophages infiltration. […] High density of macrophages and foam cells in the alveolar cavities but no obvious proliferation of pneumocyte was found.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293910
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This leads to imbalance of the innate/acquired immune response, delayed viral clearance, and hyper stimulated macrophages and neutrophils.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>medullary</title>
      <link>/tissuepanel/medullary/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/medullary/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;cell-sentence-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Cell Sentence Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;medullary&lt;/em&gt; tissue in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32104915
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Furthermore, some coronaviruses have been demonstrated able to spread via a synapse-connected route to the medullary cardiorespiratory center from the mechanoreceptors and chemoreceptors in the lung and lower respiratory airways.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>nasopharynx</title>
      <link>/tissuepanel/nasopharynx/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/nasopharynx/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;nasopharynx&lt;/em&gt; tissue in 3 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32125362
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among the 18 hospitalized patients with PCR-confirmed SARS-CoV-2 infection (median age, 47 years; 9 [50%] women), clinical presentation was an upper respiratory tract infection in 12 (67%), and viral shedding from the nasopharynx was prolonged for 7 days or longer among 15 (83%).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32196430
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Alternatively, repeated testing can be used because over time, the likelihood of the SARS-CoV-2 being present in the nasopharynx increases.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32267109
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The diagnosis is most often based on the detection of the viral genome in the nasopharynx by molecular biology methods. […] Le diagnostic repose, le plus souvent, sur la détection du génome viral au niveau du nasopharynx par des méthodes de biologie moléculaire.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>neuronal</title>
      <link>/tissuepanel/neuronal/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/neuronal/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;cell-sentence-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Cell Sentence Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;neuronal&lt;/em&gt; tissue in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283006
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Multiple non-neuronal cell types present in the olfactory epithelium express two host receptors, ACE2 and TMPRSS2 proteases, that facilitate SARS-CoV-2 binding, replication, and accumulation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292906
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We hypothesize that the morbidity, severity of the disease, and underlying physiological events leading to mortality are closely linked to the TRPV1 expressing neuronal system (afferent/efferent neurons) in the lungs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>oral mucosa</title>
      <link>/tissuepanel/oral_mucosa/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/oral_mucosa/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;oral mucosa&lt;/em&gt; tissue in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32170800
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This is a consensus of Chinese experts on protective measures and advice on hand-cleaning- and medical-glove-related hand protection, mask- and goggles-related face protection, UV-related protection, eye protection, nasal and oral mucosa protection, outer ear, and hair protection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>pancreas</title>
      <link>/tissuepanel/pancreas/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/pancreas/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;pancreas&lt;/em&gt; tissue in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32172546
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;b&gt;Objective:&lt;/b&gt; To investigate the pathological characteristics and the clinical significance of novel coronavirus (2019-nCoV)-infected pneumonia (termed by WHO as corona virus disease 2019, COVID-19). &lt;b&gt;Methods:&lt;/b&gt; Minimally invasive autopsies from lung, heart, kidney, spleen, bone marrow, liver, pancreas, stomach, intestine, thyroid and skin were performed on three patients died of novel coronavirus pneumonia in Chongqing, China.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32249098
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
For each type of cancer-colon, pancreas, oesogastric, hepatocellular carcinoma-morbidity and mortality rates are stated and compared with the oncological risk incurred by deferring surgery and/or the tumour doubling time.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>placenta</title>
      <link>/tissuepanel/placenta/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/placenta/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;placenta&lt;/em&gt; tissue in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32114744
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;b&gt;Objective:&lt;/b&gt; To investigate the clinical characteristics and placental pathology of 2019-nCoV infection in pregnancy, and to evaluate intrauterine vertical transmission potential of 2019-nCoV infection. &lt;b&gt;Methods:&lt;/b&gt; The placentas delivered from pregnant women with confirmed 2019-nCoV infection which were received in the Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology collected by February 4th, 2020 and retrospectively studied. […] Their clinical material including placental tissue and lung CT, and laboratory results were collected, meanwhile, nucleic acid detection of 2019-nCoV of the placentas were performed by RT-PCR. &lt;b&gt;Results:&lt;/b&gt; Three placentas delivered from pregnant women with confirmed 2019-nCoV infection, who were all in their third trimester with emergency caesarean section. […] There were various degrees of fibrin deposition inside and around the villi with local syncytial nodule increases in all three placentas. […] One case of placenta showed the concomitant morphology of chorionic hemangioma and another one with massive placental infarction. […] All samples from three placentas were negative for the nucleic acid of 2019-nCoV. &lt;b&gt;Conclusions:&lt;/b&gt; The clinical characteristics of pregnant women with 2019-nCoV infection in late pregnancy are similar to those of non-pregnant patients, and no severe adverse pregnancy outcome is found in the 3 cases of our observation. […] Pathological study suggests that there are no morphological changes related to infection in the three placentas.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>pneumocytes</title>
      <link>/tissuepanel/pneumocytes/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/pneumocytes/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;cell-sentence-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Cell Sentence Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;pneumocytes&lt;/em&gt; tissue in 4 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32114094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Pathologic examinations revealed that apart from the tumors, the lungs of both patients exhibited edema, proteinaceous exudate, focal reactive hyperplasia of pneumocytes with patchy inflammatory cellular infiltration, and multinucleated giant cells.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32270184
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
SARS-CoV-2 and SARS-CoV were similar in cell tropism, with both targeting types I and II pneumocytes, and alveolar macrophages.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277367
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Angiotensin converting enzyme 2 (ACE2) appears important for viral entry into pneumocytes; dysbalance in ACE2 as caused by ACE inhibitors or ibuprofen may predispose to severe disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32291399
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Histologically, the main findings are in the lungs, including injury to the alveolar epithelial cells, hyaline membrane formation, and hyperplasia of type II pneumocytes, all components of diffuse alveolar damage.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>posterior</title>
      <link>/tissuepanel/posterior_/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/posterior_/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;cell-sentence-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Cell Sentence Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;posterior &lt;/em&gt; tissue in 11 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32014114
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The basic reproductive number was estimated using Markov Chain Monte Carlo methods and presented using the resulting posterior mean and 95% credibile interval (CrI).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32027573
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Forty-four of 51 (86%) patients had bilateral lung involvement, while 41 of 51 (80%) involved the posterior part of the lungs and 44 of 51 (86%) were peripheral. […] Follow-up CT in 13 patients showed improvement in seven (54%) patients and progression in four (31%) patients.ConclusionPatients with fever and/or cough and with conspicuous ground-glass opacity lesions in the peripheral and posterior lungs on CT images, combined with normal or decreased white blood cells and a history of epidemic exposure, are highly suspected of having 2019 Novel Coronavirus (2019-nCoV) pneumonia.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32091414
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The most common involved lung segments were the dorsal segment of the right lower lobe (69/80, 86%), the posterior basal segment of the right lower lobe (68/80, 85%), the lateral basal segment of the right lower lobe (64/80, 80%), the dorsal segment of the left lower lobe (61/80, 76%), and the posterior basal segment of the left lower lobe (65/80, 81%).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32100485
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The peripheral and posterior lung fields were involved in 78% and 67% of the lesions, respectively. […] COVID-19 pneumonia in Korea primarily manifested as pure to mixed ground-glass opacities with a patchy to confluent or nodular shape in the bilateral peripheral posterior lungs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32134681
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The mean CT score for the anterior area (4.4 ± 4.1) was significantly lower than that for the posterior area (7.7 ± 6.3) (&lt;i&gt;p&lt;/i&gt; = 0.003). […] Lesions presented with a characteristic multifocal distribution in the middle and lower lung regions and in the posterior lung area.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32174129
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;b&gt;OBJECTIVE.&lt;/b&gt; Available information on CT features of the 2019 novel coronavirus disease (COVID-19) is scattered in different publications, and a cohesive literature review has yet to be compiled. &lt;b&gt;MATERIALS AND METHODS.&lt;/b&gt; This article includes a systematic literature search of PubMed, Embase (Elsevier), Google Scholar, and the World Health Organization database. &lt;b&gt;RESULTS.&lt;/b&gt; Known features of COVID-19 on initial CT include bilateral multilobar ground-glass opacification (GGO) with a peripheral or posterior distribution, mainly in the lower lobes and less frequently within the right middle lobe.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32213337
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We aimed to ascertain the serial respiratory viral load of SARS-CoV-2 in posterior oropharyngeal (deep throat) saliva samples from patients with COVID-19, and serum antibody responses. […] We obtained samples of blood, urine, posterior oropharyngeal saliva, and rectal swabs. […] The median viral load in posterior oropharyngeal saliva or other respiratory specimens at presentation was 5·2 log&lt;sub&gt;10&lt;/sub&gt; copies per mL (IQR 4·1-7·0). […] Posterior oropharyngeal saliva samples are a non-invasive specimen more acceptable to patients and health-care workers.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32220181
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Characteristic imaging changes were found with grass opacity (GGO), consolidation and septal thickening mainly distributed in peripheral and posterior area by thoracic CT scan in the 3 patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32241244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Typical CT findings included bilateral ground-glass opacity, pulmonary consolidation, and prominent distribution in the posterior and peripheral parts of the lungs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243238
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In the subgroup of RT-PCR-positive and CT-positive patients, ground-glass opacities (GGO) were present in 58/58 (100%), multilobe and posterior involvement were both present in 54/58 (93%), bilateral pneumonia in 53/58 (91%), and subsegmental vessel enlargement (&amp;gt; 3 mm) in 52/58 (89%) of study participants. […] Conclusion The typical pattern of COVID-19 pneumonia in Rome, Italy, was peripherally ground-glass opacities with multilobe and posterior involvement, bilateral distribution, and subsegmental vessel enlargement (&amp;gt; 3 mm).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32246905
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The weighted global ability to detect Wuhan-to-location imported cases of COVID-19 was estimated to be 38% (95% highest posterior density interval [HPDI] 22-64) of Singapore’s capacity.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>prostate</title>
      <link>/tissuepanel/prostate/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/prostate/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;prostate&lt;/em&gt; tissue in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32276929
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
TMPRSS2 is both the most frequently altered gene in primary prostate cancer and a critical factor enabling cellular infection by coronaviruses, including SARS-CoV-2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292839
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Prostate cancer is one of the most common cancers Radiation Oncology departments treat, and efficient resource utilization is essential in the setting of a pandemic. […] Herein, we aim to establish recommendations and a framework by which to evaluate prostate radiotherapy management decisions. […] Radiation Oncologists from the United States and United Kingdom rapidly conducted a systematic review and agreed upon recommendations to safely manage prostate cancer patients during the COVID-19 pandemic. […] Recommendations are provided by National Comprehensive Cancer Network (NCCN) risk group, including clinical node positive, post-prostatectomy, oligometastatic, and low volume M1 disease. […] Across all prostate cancer stages, telemedicine consultations and return visits were recommended when resources/staff available. […] Ultrahypofractionation was preferred for localized, oligometastatic, and low volume M1, and moderate hypofractionation was preferred for post-prostatectomy and clinical node positive disease. […] Resources can be reduced for all identified stages of prostate cancer.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>rectum</title>
      <link>/tissuepanel/rectum/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/rectum/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;rectum&lt;/em&gt; tissue in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32199615
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Consistent with other recent reports, we confirmed that ACE2 was mainly expressed in lung AT2, liver cholangiocyte, colon colonocytes, esophagus keratinocytes, ileum ECs, rectum ECs, stomach epithelial cells, and kidney proximal tubules.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32241899
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
SARS-CoV-2 RNA was detected in oesophagus, stomach, duodenum and rectum specimens for both two severe patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>secretory</title>
      <link>/tissuepanel/secretory/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/secretory/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;cell-sentence-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Cell Sentence Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;secretory&lt;/em&gt; tissue in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32246845
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
While TMPRSS2 is expressed in both tissues, in the subsegmental bronchial branches ACE2 is predominantly expressed in a transient secretory cell type.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32285974
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
While TMPRSS2 is strongly expressed in both tissues, in the subsegmental bronchial branches ACE2 is predominantly expressed in a transient secretory cell type.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>sertoli</title>
      <link>/tissuepanel/sertoli/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/sertoli/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;cell-sentence-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Cell Sentence Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;sertoli&lt;/em&gt; tissue in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The results indicate that ACE2 is predominantly enriched in spermatogonia and Leydig and Sertoli cells. […] Cell-cell junction and immunity-related GO terms are increased in ACE2-positive Leydig and Sertoli cells, but mitochondria and reproduction-related GO terms are decreased.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>skeletal muscle</title>
      <link>/tissuepanel/skeletal_muscle/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/skeletal_muscle/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;skeletal muscle&lt;/em&gt; tissue in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275288
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Patients with more severe infection had neurologic manifestations, such as acute cerebrovascular diseases (5 [5.7%] vs 1 [0.8%]), impaired consciousness (13 [14.8%] vs 3 [2.4%]), and skeletal muscle injury (17 [19.3%] vs 6 [4.8%]).
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>skin</title>
      <link>/tissuepanel/skin/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/skin/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;skin&lt;/em&gt; tissue in 13 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32170800
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Health professions preventing and controlling Coronavirus Disease 2019 are prone to skin and mucous membrane injury, which may cause acute and chronic dermatitis, secondary infection and aggravation of underlying skin diseases. […] Insufficient and excessive protection will have adverse effects on the skin and mucous membrane barrier.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32172546
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;b&gt;Objective:&lt;/b&gt; To investigate the pathological characteristics and the clinical significance of novel coronavirus (2019-nCoV)-infected pneumonia (termed by WHO as corona virus disease 2019, COVID-19). &lt;b&gt;Methods:&lt;/b&gt; Minimally invasive autopsies from lung, heart, kidney, spleen, bone marrow, liver, pancreas, stomach, intestine, thyroid and skin were performed on three patients died of novel coronavirus pneumonia in Chongqing, China.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32201983
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this paper we share our experiences in dealing with skin diseases in this special period and hope to provide some references for international colleagues in the epidemic situation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32219888
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Since then numerous additional cases have been reported and the dissemination of the infection does not only pose a major health challenge for the entire population, medical care facilities and the economy, but also for the medical training of future doctors and outpatient care of patients with skin disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32220276
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
All patients had acro-ischemia presentations including finger/toe cyanosis, skin bulla and dry gangrene.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32223004
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Dermatoscope is a convenient diagnostic tool used by dermatologists in the diagnosis of skin, hair and nail disorders.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32255197
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
During the outbreak of coronavirus disease 2019 (COVID-19), healthcare workers (HCWs) caring for COVID-19 patient have to wear personal protective equipment (PPE) and are therefore susceptible to PPE-related adverse skin reactions. […] However, little is known about the prevalence and characteristics of these adverse skin reactions and their associated risk factors.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32255510
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In patients with suspected or confirmed COVID-19 disease, all immunomodulators used for skin diseases should be immediately withheld, with the possible exception of systemic corticosteroid therapy, which needs to be weaned.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32268381
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
· Parents should be engaged in shared decision-making with options for rooming in, skin-to-skin contact, and breastfeeding..
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294259
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A skin rash has been reported in 2 out of 1.099 patients presenting with Coronavirus disease 2019 in China [1], as in 14 of 48 patients with the same disease in Italia, but unfortunately without further description of its semiology [2]. […] We wish to report here the case of a woman who presented, coincidently with Covid-19, a skin rash that had an original picture.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294264
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We have read with great interest Dr Recalcati’s review about skin manifestations in COVID-19 as it is the first report on this subject&lt;sup&gt;1&lt;/sup&gt; .
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294265
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Psoriasis is a major chronic inflammatory skin disease, affecting about 3% of the population in Italy, whose management require experienced specialists in order to guarantee high-quality standards of care.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294273
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
About skin manifestation, few cases of rashes on patients with laboratory-confirmed Covid-19 were described in two Chineses cohorts.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>spermatogonia</title>
      <link>/tissuepanel/spermatogonia/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/spermatogonia/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;cell-sentence-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Cell Sentence Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;spermatogonia&lt;/em&gt; tissue in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The results indicate that ACE2 is predominantly enriched in spermatogonia and Leydig and Sertoli cells. […] Gene Set Enrichment Analysis (GSEA) indicates that Gene Ontology (GO) categories associated with viral reproduction and transmission are highly enriched in ACE2-positive spermatogonia, while male gamete generation related terms are downregulated.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>spleen</title>
      <link>/tissuepanel/spleen/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/spleen/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;spleen&lt;/em&gt; tissue in 5 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32172546
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;b&gt;Objective:&lt;/b&gt; To investigate the pathological characteristics and the clinical significance of novel coronavirus (2019-nCoV)-infected pneumonia (termed by WHO as corona virus disease 2019, COVID-19). &lt;b&gt;Methods:&lt;/b&gt; Minimally invasive autopsies from lung, heart, kidney, spleen, bone marrow, liver, pancreas, stomach, intestine, thyroid and skin were performed on three patients died of novel coronavirus pneumonia in Chongqing, China. […] Decreased numbers of lymphocyte, cell degeneration and necrosis were observed in spleen.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32215622
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Maximal clinical signs of rapid breathing, weight loss, histopathological changes from the initial exudative phase of diffuse alveolar damage with extensive apoptosis to the later proliferative phase of tissue repair, airway and intestinal involvement with virus nucleocapsid protein expression, high lung viral load, and spleen and lymphoid atrophy associated with marked cytokine activation were observed within the first week of virus challenge.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281331
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The location of the disease is lung, always involving spleen and stomach, and may further affect heart and kidney in severe cases.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281332
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among them, the four properties were mainly concentrated in temperature, cold and level, the five tastes were mainly concentrated in bitter, hot and sweet, and the meridians were mainly concentrated in lung, stomach and spleen.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292697
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In China, a considerable number of convalescent SARS patients with steroid-associated ONFH had undergone conservative treatment by Traditional Chinese Medicine (TCM), and this study aims to evaluate the long-term results of a spleen-invigorating Huo-Gu Formula (HGF) therapy in these patients. and methods: A total of 33 convalescent SARS patients (nine males and 24 females) with bilateral steroid-associated ONFH (66 hips) were enrolled in this study.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>stomach</title>
      <link>/tissuepanel/stomach/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/stomach/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;stomach&lt;/em&gt; tissue in 6 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32172546
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;b&gt;Objective:&lt;/b&gt; To investigate the pathological characteristics and the clinical significance of novel coronavirus (2019-nCoV)-infected pneumonia (termed by WHO as corona virus disease 2019, COVID-19). &lt;b&gt;Methods:&lt;/b&gt; Minimally invasive autopsies from lung, heart, kidney, spleen, bone marrow, liver, pancreas, stomach, intestine, thyroid and skin were performed on three patients died of novel coronavirus pneumonia in Chongqing, China.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32199615
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Although ACE2 is reported to be expressed in lung, liver, stomach, ileum, kidney and colon, its expressing levels are rather low, especially in the lung. […] Consistent with other recent reports, we confirmed that ACE2 was mainly expressed in lung AT2, liver cholangiocyte, colon colonocytes, esophagus keratinocytes, ileum ECs, rectum ECs, stomach epithelial cells, and kidney proximal tubules.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32241899
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
SARS-CoV-2 RNA was detected in oesophagus, stomach, duodenum and rectum specimens for both two severe patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281331
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The location of the disease is lung, always involving spleen and stomach, and may further affect heart and kidney in severe cases.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281332
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among them, the four properties were mainly concentrated in temperature, cold and level, the five tastes were mainly concentrated in bitter, hot and sweet, and the meridians were mainly concentrated in lung, stomach and spleen.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281333
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The pungent medicines are mostly found in the early stage, the bitter drugs are the main flavor in the middle and severe stage, and the sweet medicines are mostly used in the recovery stage; ③the meridian of the drug is more concentrated at the lung, stomach, and heart, and most of drugs are into the lung meridian, accounting for 24.55%; these medicines are mostly into the lungs and stomach in the initial and middle stages, and into the heart and kidney in severe stages; ④oral drugs are mostly non-toxic, among which only 6 kinds are toxic, namely Armeniacae Semen Amarum, Dryopteridis Crassirhizomatis Rhizoma, Paridis Rhizoma, Pinelliae Rhizoma, Aconiti Lateralis Radix Praeparaia; ⑤most of the drugs have five types of functions: treating exterior syndromes, resolving dampness, clearing heat, replenishing deficiency, resolving phlegm, cough, and asthma.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>testis</title>
      <link>/tissuepanel/testis/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/testis/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;testis&lt;/em&gt; tissue in 3 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32081428
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
However, since ACE2 is predominantly expressed in intestines, testis, and kidney, fecal-oral and other routes of transmission are also possible.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247213
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Search terms were, COVID-19, treatment of coronavirus, COVID 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ACE-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
These findings provide evidence that the human testis is a potential target of SARS-CoV-2 infection, which may have significant impact on our understanding of the pathophysiology of this rapidly spreading disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>tubules</title>
      <link>/tissuepanel/tubules/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/tubules/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;cell-sentence-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Cell Sentence Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;tubules&lt;/em&gt; tissue in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32199615
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Consistent with other recent reports, we confirmed that ACE2 was mainly expressed in lung AT2, liver cholangiocyte, colon colonocytes, esophagus keratinocytes, ileum ECs, rectum ECs, stomach epithelial cells, and kidney proximal tubules.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>urothelial</title>
      <link>/tissuepanel/urothelial/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/urothelial/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;cell-sentence-context&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Cell Sentence Context&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;urothelial&lt;/em&gt; tissue in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32170560
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Through scRNA-seq data analyses, we identified the organs at risk, such as lung, heart, esophagus, kidney, bladder, and ileum, and located specific cell types (i.e., type II alveolar cells (AT2), myocardial cells, proximal tubule cells of the kidney, ileum and esophagus epithelial cells, and bladder urothelial cells), which are vulnerable to 2019-nCoV infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>vagina</title>
      <link>/tissuepanel/vagina/info/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/tissuepanel/vagina/info/</guid>
      <description> 

&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;div id=&#34;tissue-sentence-context&#34; class=&#34;section level3&#34;&gt;
&lt;h3&gt;Tissue Sentence Context&lt;/h3&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; Analysis of context sentence of &lt;em&gt;vagina&lt;/em&gt; tissue in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Senteces
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275072
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A live birth without SARS-CoV-2 infection was delivered successfully via the vagina.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title></title>
      <link>/supp/terms/global_category_words/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/supp/terms/global_category_words/</guid>
      <description>


&lt;div id=&#34;global-words---syntax-analysis&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Global Words - Syntax Analysis&lt;/h2&gt;
&lt;br&gt;
&lt;a style=&#34;font-size:20px&#34; align=&#34;center&#34; href=&#34;#&#34;&gt;Download the .xlsx file of all words&lt;/a&gt;
&lt;br&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Box 1.&lt;/strong&gt; Top 30 Words cited in Abstracts in COVID-19 literature.
&lt;/p&gt;
&lt;hr /&gt;
&lt;div class=&#34;row&#34;&gt;

&lt;div class=&#34;col&#34;&gt;
&lt;table&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Word
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Frequency
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
disease
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1949
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
health
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1446
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
respiratory
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1380
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
clinical
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1372
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
infection
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1367
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
severe
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1208
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
outbreak
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
958
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
novel
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
957
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
virus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
918
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pandemic
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
892
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
treatment
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
882
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div class=&#34;col&#34;&gt;

&lt;table&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Word
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Frequency
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
acute
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
806
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
care
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
777
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
syndrome
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
760
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
during
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
754
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pneumonia
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
725
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epidemic
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
710
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
risk
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
710
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
transmission
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
710
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
confirmed
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
664
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
reserved
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
655
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spread
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
635
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div class=&#34;col&#34;&gt;
&lt;table&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Word
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Frequency
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
study
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
628
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
control
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
625
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
symptoms
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
614
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
public
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
593
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
medical
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
574
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
viral
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
555
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
case
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
542
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
published
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
541
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
article
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
521
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hospital
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
473
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
infected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
471
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
&lt;div id=&#34;categoric-words---syntax-analysis&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Categoric Words - Syntax Analysis&lt;/h2&gt;
&lt;br&gt;
&lt;a style=&#34;font-size:20px&#34; align=&#34;center&#34; href=&#34;#&#34;&gt;Download the .xlsx file of all words&lt;/a&gt;
&lt;br&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Box 2.&lt;/strong&gt; Top 30 Words cited in Abstracts in COVID-19 literature.
&lt;/p&gt;
&lt;hr /&gt;
&lt;table&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Diagnose
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Frequency
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Treatment
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Frequency
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Epidemiology
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Frequency
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Transmission
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Frequency
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Clinical*
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Frequency
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
disease
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
402
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
treatment
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
882
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
disease
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
302
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
transmission
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
710
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
clinical
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1372
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
clinical
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
386
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
disease
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
728
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
clinical
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
297
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
disease
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
439
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
disease
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1353
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
diagnosis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
368
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
clinical
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
656
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epidemiological
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
247
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
infection
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
394
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
respiratory
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
999
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
infection
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
293
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
infection
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
555
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
infection
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
217
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
respiratory
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
375
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
infection
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
968
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
respiratory
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
283
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
respiratory
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
549
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
health
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
200
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
health
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
339
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
severe
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
884
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
treatment
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
269
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
severe
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
527
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
respiratory
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
195
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
virus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
291
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
health
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
883
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
severe
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
245
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
health
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
414
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epidemic
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
179
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
outbreak
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
treatment
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
660
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
health
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
virus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
340
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
confirmed
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
173
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
severe
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
254
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
novel
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
633
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
novel
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
207
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
novel
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
333
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
novel
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
164
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
novel
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
symptoms
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
614
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pneumonia
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
193
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
acute
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
331
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
outbreak
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
159
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
clinical
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
229
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
virus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
591
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
virus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
169
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
syndrome
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
316
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
transmission
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
confirmed
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
218
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
outbreak
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
585
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
outbreak
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
157
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
care
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
313
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
severe
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
150
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spread
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
212
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pandemic
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
575
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
acute
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
151
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pandemic
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
295
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
control
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
147
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
control
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
205
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
acute
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
562
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
symptoms
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
151
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
outbreak
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
289
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
case
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
145
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
syndrome
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
197
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pneumonia
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
545
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
confirmed
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
141
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pneumonia
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
278
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
symptoms
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
131
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
acute
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
192
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
syndrome
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
529
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epidemic
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
140
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
during
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
250
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spread
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
123
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
during
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
192
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
care
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
528
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
viral
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
133
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
medical
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
242
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
days
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
122
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
measures
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
190
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
during
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
498
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
syndrome
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
132
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
viral
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
235
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
syndrome
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
117
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epidemic
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
187
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
study
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
496
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
chest
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
127
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
symptoms
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
233
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
infected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
115
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
risk
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
187
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
transmission
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
462
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
control
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
127
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
group
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
230
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
virus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
115
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
case
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
175
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
confirmed
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
460
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
diagnostic
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
127
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
risk
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
221
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
characteristics
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
110
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
care
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
168
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
risk
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
456
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
transmission
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
124
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
study
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
212
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pneumonia
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
109
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
symptoms
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
166
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
viral
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
422
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
during
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
121
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
management
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
210
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
public
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
106
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pandemic
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
156
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epidemic
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
401
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
medical
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
121
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
therapy
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
190
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
treatment
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
102
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
public
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
155
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spread
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
394
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
positive
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
121
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
diagnosis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
188
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
acute
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
101
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
infected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
149
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
medical
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
392
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
care
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
120
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hospital
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
183
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
medical
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
100
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
reserved
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
135
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
control
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
379
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spread
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
117
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spread
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
183
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prevention
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
94
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
days
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
130
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
reserved
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
367
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prevention
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
110
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
drugs
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
175
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
period
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
91
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prevention
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
130
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hospital
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
366
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
children
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
108
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prevention
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
174
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epidemiology
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
83
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
viral
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
case
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
363
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pandemic
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
107
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
confirmed
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
172
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
published
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
83
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
contact
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
124
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
published
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
360
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;p style=&#34;font-size:11px&#34; align=&#34;center&#34;&gt;
*Clinical, signs and symptoms
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PlatCOVID: Platform COVID-19</title>
      <link>/supp/faq/what/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/supp/faq/what/</guid>
      <description>&lt;h2 id=&#34;what-is-platcovid&#34;&gt;What is PlatCOVID?&lt;/h2&gt;
&lt;p&gt;It is free web platform that allows to analyze and curate robust scientific data, enabling the identification of useful information concerning the 2019 new coronavirus (SARS-CoV-2) pandemic.&lt;/p&gt;
&lt;h2 id=&#34;what-is-the-purpose-of-platcovid&#34;&gt;What is the purpose of PlatCOVID?&lt;/h2&gt;
&lt;p&gt;The platform aims to provide scientific consensus about COVID-19 issues by analyzing, discussing and classifying published scientific data, making possible to assist and guide health care policies.&lt;/p&gt;
&lt;h2 id=&#34;who-can-use-the-platform&#34;&gt;Who can use the platform?&lt;/h2&gt;
&lt;p&gt;Scientists, professors, specialists in the field and health professionals.&lt;/p&gt;
&lt;h2 id=&#34;what-is-a-syntax-analysis&#34;&gt;What is a syntax analysis?&lt;/h2&gt;
&lt;p&gt;The compiler design process is divided into two phases: Lexical Analysis and Syntax Analysis. The Lexical Analysis or Tokenization is the process of breaking up a sequence of characters into pieces called tokens. The Syntax Analysis or Parsing comes after the Lexical Analysis and analyses the syntactical structure of the given input (source code or a program). It does so by building a data structure, that may be called a Parse tree or Syntax tree.&lt;/p&gt;
&lt;h2 id=&#34;what-are-the-panels-on-genedrugtissue-for&#34;&gt;What are the panels on gene/drug/tissue for?&lt;/h2&gt;
&lt;p&gt;The panels are meant to facilitate the screening of publications focusing on the genes, tissues and drugs involved with COVID-19.&lt;/p&gt;
&lt;h2 id=&#34;methods-used&#34;&gt;Methods Used&lt;/h2&gt;
&lt;p&gt;The complete detaling will be availible as soons is possible (uppon publication). In summary, we are able to perfom word and sentece atomization and tokenization automatically in order to develop syntax analysis. Also this approach is able to identify genes, tissues and drugs cited in COVID-19 literature.&lt;/p&gt;
&lt;h2 id=&#34;apps-and-packages&#34;&gt;Apps and Packages&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;
&lt;p&gt;RStudio Software&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;rentrez&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;pubmed.mineR&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;easyPubmed&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;tokenizers&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;tmap&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;VennDiagram&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;rmarkdown&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;ggplot2&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;plotly&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;DiagrammeR&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;gridExtra&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;kable and extrakable&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;stringr&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;WriteXLS&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;RCurl&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;dplyr&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;countrycode&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;h2 id=&#34;how-to-cite-platcovid&#34;&gt;How to cite PlatCOVID?&lt;/h2&gt;
&lt;p&gt;Vai depender da publicação&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>SDS</title>
      <link>/genepanel/10993/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/10993/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;serine dehydratase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; SDS expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
caudate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
caudate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
189.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000135094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CHM</title>
      <link>/genepanel/1121/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1121/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;CHM Rab escort protein&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; CHM expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
21.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
caudate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
nasopharynx
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
oral mucosa
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
vagina
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188419
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NRM</title>
      <link>/genepanel/11270/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/11270/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;nurim&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; NRM expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000137404
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000137404
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000137404
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000137404
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000137404
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000137404
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000137404
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000137404
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000137404
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000137404
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000137404
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NLRP3</title>
      <link>/genepanel/114548/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/114548/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;NLR family pyrin domain containing 3&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; NLRP3 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
34.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
vagina
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
nasopharynx
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
oral mucosa
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000162711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CP</title>
      <link>/genepanel/1356/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1356/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;ceruloplasmin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; CP expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
26.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
99.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
21.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
916.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
29.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
24.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
916.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000047457
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CPE</title>
      <link>/genepanel/1363/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1363/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;carboxypeptidase E&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; CPE expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
45.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
36.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
101.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
62.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
77.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
25.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
283.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
205.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
26.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
124.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1560.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
69.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
101.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
529.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
83.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
116.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
102.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
58.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
77.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
43.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
130.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
36.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
248.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
124.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
20.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
22.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
126.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
283.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
322.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
33.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
33.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
26.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1560.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
45.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
22.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
499.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
43.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
31.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
88.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000109472
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
156.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CRP</title>
      <link>/genepanel/1401/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1401/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;C-reactive protein&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; CRP expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000132693
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
532.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000132693
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
172.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000132693
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000132693
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000132693
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ACE</title>
      <link>/genepanel/1636/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1636/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;angiotensin I converting enzyme&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; ACE expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
178.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
291.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
29.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
74.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
22.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
83.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
26.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
74.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
34.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
83.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000159640
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>AGA</title>
      <link>/genepanel/175/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/175/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;aspartylglucosaminidase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; AGA expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
35.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
20.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
33.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
26.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
caudate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
oral mucosa
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
vagina
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
26.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
nasopharynx
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
25.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000038002
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>DPP4</title>
      <link>/genepanel/1803/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1803/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;dipeptidyl peptidase 4&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; DPP4 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
86.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
169.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
158.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
26.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
130.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
25.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
86.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
25.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
20.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
169.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
95.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
31.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000197635
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
550.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ENPEP</title>
      <link>/genepanel/2028/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2028/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;glutamyl aminopeptidase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; ENPEP expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
36.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
94.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
160.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
180.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
caudate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
21.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
21.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
21.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000138792
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ALB</title>
      <link>/genepanel/213/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/213/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;albumin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; ALB expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
nasopharynx
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
oral mucosa
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
331.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
vagina
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
482.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
105947.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
482.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
105947.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
331.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163631
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>EZH2</title>
      <link>/genepanel/2146/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2146/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;enhancer of zeste 2 polycomb repressive complex 2 subunit&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; EZH2 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
30.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
50.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
50.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
26.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
nasopharynx
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
oral mucosa
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
50.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
vagina
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000106462
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SIRT1</title>
      <link>/genepanel/23411/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/23411/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;sirtuin 1&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; SIRT1 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
40.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
20.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
49.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
caudate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
26.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
30.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
22.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
20.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
nasopharynx
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
30.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
22.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
20.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
49.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
21.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
24.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
24.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096717
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>G6PD</title>
      <link>/genepanel/2539/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2539/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;glucose-6-phosphate dehydrogenase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; G6PD expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
70.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
30.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
36.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
107.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
78.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
41.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
40.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
33.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
25.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
36.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
34.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
vagina
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
40.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
44.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
35.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
41.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
41.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
60.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
74.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
44.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
33.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
nasopharynx
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
oral mucosa
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
30.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
20.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
25.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
37.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
107.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
34.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
47.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000160211
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
30.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ANG</title>
      <link>/genepanel/283/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/283/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;angiogenin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; ANG expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
26.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
28.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
33.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
22.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
45.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1565.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
25.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
54.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
54.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
51.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
30.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
57.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000214274
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CXCR3</title>
      <link>/genepanel/2833/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2833/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;C-X-C motif chemokine receptor 3&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; CXCR3 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000186810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ANPEP</title>
      <link>/genepanel/290/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/290/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;alanyl aminopeptidase, membrane&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; ANPEP expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2386.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
191.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
263.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
144.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
137.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2133.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
53.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
85.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
45.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
65.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
64.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
53.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
45.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
259.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
263.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
33.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
137.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
50.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
45.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
259.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
163.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000166825
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HBM</title>
      <link>/genepanel/3042/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3042/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;hemoglobin subunit mu&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; HBM expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000206177
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
269.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000206177
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HGF</title>
      <link>/genepanel/3082/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3082/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;hepatocyte growth factor&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; HGF expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
vagina
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
25.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
caudate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
27.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
nasopharynx
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
oral mucosa
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
438.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000019991
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL1B</title>
      <link>/genepanel/3553/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3553/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;interleukin 1 beta&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; IL1B expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
53.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
68.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
106.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
27.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
22.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000125538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
28.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL2</title>
      <link>/genepanel/3558/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3558/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;interleukin 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; IL2 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL6</title>
      <link>/genepanel/3569/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3569/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;interleukin 6&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; IL6 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
41.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
41.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
37.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
61.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
50.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
21.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
29.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
73.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
27.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
136.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL7</title>
      <link>/genepanel/3574/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3574/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;interleukin 7&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; IL7 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
nasopharynx
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
oral mucosa
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
vagina
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000104432
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL10</title>
      <link>/genepanel/3586/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3586/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;interleukin 10&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; IL10 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
caudate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
nasopharynx
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136634
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IVD</title>
      <link>/genepanel/3712/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3712/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;isovaleryl-CoA dehydrogenase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; IVD expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
86.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
24.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
73.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
34.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
31.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
41.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
40.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
21.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
67.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
43.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
75.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
93.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
41.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
28.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
nasopharynx
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
74.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
81.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
34.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
65.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
27.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
34.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
41.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
151.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
21.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
29.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
73.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
34.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
41.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
75.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
56.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
40.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
24.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
73.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
caudate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
54.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
44.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
41.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
51.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
41.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
28.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
oral mucosa
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
56.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
26.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
34.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
vagina
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000128928
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
36.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>JAK2</title>
      <link>/genepanel/3717/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3717/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;Janus kinase 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; JAK2 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
20.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
nasopharynx
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
oral mucosa
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
20.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
28.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
27.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000096968
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>MB</title>
      <link>/genepanel/4151/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/4151/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;myoglobin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; MB expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6603.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12284.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
53.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
762.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
29.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
281.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000198125
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NHS</title>
      <link>/genepanel/4810/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/4810/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;NHS actin remodeling regulator&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; NHS expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
oral mucosa
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
caudate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
nasopharynx
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000188158
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TAS2R10</title>
      <link>/genepanel/50839/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/50839/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;taste 2 receptor member 10&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; TAS2R10 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PC</title>
      <link>/genepanel/5091/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/5091/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;pyruvate carboxylase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; PC expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
25.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
36.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
nasopharynx
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
38.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
caudate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
29.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
25.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
36.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
caudate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
29.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
oral mucosa
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000173599
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
63.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>FOXP3</title>
      <link>/genepanel/50943/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/50943/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;forkhead box P3&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; FOXP3 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000049768
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000049768
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000049768
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000049768
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000049768
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000049768
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000049768
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000049768
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000049768
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000049768
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000049768
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000049768
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000049768
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000049768
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000049768
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000049768
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000049768
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TLR7</title>
      <link>/genepanel/51284/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/51284/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;toll like receptor 7&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; TLR7 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196664
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TLR8</title>
      <link>/genepanel/51311/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/51311/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;toll like receptor 8&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; TLR8 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000101916
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PLP2</title>
      <link>/genepanel/5355/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/5355/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;proteolipid protein 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; PLP2 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
74.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
89.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
22.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
98.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
caudate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
147.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
133.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
53.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
316.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
105.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
48.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
22.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
71.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
nasopharynx
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
oral mucosa
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
49.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
91.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
96.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
24.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
152.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
26.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
480.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
235.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
51.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
91.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
40.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
139.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
138.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
vagina
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
123.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
136.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
133.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
130.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
71.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
111.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
91.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
480.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
51.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
139.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
160.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
123.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
241.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
87.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
caudate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
136.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
147.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
130.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
148.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
480.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
91.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
40.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
33.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000102007
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
79.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PID1</title>
      <link>/genepanel/55022/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/55022/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;phosphotyrosine interaction domain containing 1&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; PID1 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
21.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
37.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
67.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
21.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
21.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
22.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
38.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
20.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
67.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
30.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
21.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
20.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
36.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
37.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
23.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
20.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
24.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
27.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
67.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
21.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
36.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
39.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000153823
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
22.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HR</title>
      <link>/genepanel/55806/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/55806/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;HR lysine demethylase and nuclear receptor corepressor&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; HR expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
58.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000168453
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SHD</title>
      <link>/genepanel/56961/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/56961/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;Src homology 2 domain containing transforming protein D&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; SHD expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000105251
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000105251
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
22.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ACE2</title>
      <link>/genepanel/59272/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/59272/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;angiotensin I converting enzyme 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; ACE2 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
181.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
100.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
94.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
261.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
93.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
27.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
94.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000130234
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NPS</title>
      <link>/genepanel/594857/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/594857/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;neuropeptide S&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; NPS expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>RHO</title>
      <link>/genepanel/6010/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/6010/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;rhodopsin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; RHO expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000163914
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
retina
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CCL2</title>
      <link>/genepanel/6347/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/6347/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;C-C motif chemokine ligand 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; CCL2 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
236.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
68.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
41.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
51.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
oral mucosa
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
57.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
116.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
71.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
30.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
vagina
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
236.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
42.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
85.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
68.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
49.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
213.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
29.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
99.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
40.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
24.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
38.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
60.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
42.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
85.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
49.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
22.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
104.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
85.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
92.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
40.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
213.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
101.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
24.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
167.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
85.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
34.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
411.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
104.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
213.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
nasopharynx
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
29.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
138.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
62.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
40.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
30.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
138.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000108691
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
260.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>BID</title>
      <link>/genepanel/637/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/637/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;BH3 interacting domain death agonist&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; BID expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
41.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
nasopharynx
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
33.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
22.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
41.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
54.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
38.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
39.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
25.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000015475
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SI</title>
      <link>/genepanel/6476/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/6476/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;sucrase-isomaltase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; SI expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000090402
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
547.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000090402
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
493.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000090402
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000090402
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000090402
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000090402
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000090402
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
34.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000090402
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000090402
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TF</title>
      <link>/genepanel/7018/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7018/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;transferrin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; TF expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
caudate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
385.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
33.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
385.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5391.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5391.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000091513
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
109.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TLR4</title>
      <link>/genepanel/7099/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7099/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;toll like receptor 4&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; TLR4 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
36.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
25.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
37.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
48.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
48.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000136869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
37.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TLR5</title>
      <link>/genepanel/7100/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7100/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;toll like receptor 5&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; TLR5 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
25.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000187554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TMPRSS2</title>
      <link>/genepanel/7113/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7113/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;transmembrane serine protease 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; TMPRSS2 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
38.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
20.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
83.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
93.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
36.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
109.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
142.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
20.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
25.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
109.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
31.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
42.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
38.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
65.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
20.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
20.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
489.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000184012
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
142.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TNF</title>
      <link>/genepanel/7124/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7124/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;tumor necrosis factor&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; TNF expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000232810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000232810
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>VIP</title>
      <link>/genepanel/7432/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7432/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;vasoactive intestinal peptide&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; VIP expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
71.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
209.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
caudate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
58.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
vagina
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
71.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
209.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebellum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
71.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
nasopharynx
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
68.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
52.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
0.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000146469
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TRPV1</title>
      <link>/genepanel/7442/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7442/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;transient receptor potential cation channel subfamily V member 1&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; TRPV1 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000196689
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CAD</title>
      <link>/genepanel/790/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/790/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; CAD expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
High
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
caudate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hippocampus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
22.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skeletal muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bronchus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
nasopharynx
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
oral mucosa
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
22.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
soft tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000084774
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
9.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CD4</title>
      <link>/genepanel/920/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/920/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;CD4 molecule&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; CD4 expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
220.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Low
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
68.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
21.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
107.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
breast
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
17.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
19.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
31.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
25.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
34.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
54.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
8.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
liver
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
77.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
104.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
130.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pancreas
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
parathyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
549.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
66.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
11.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
33.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
30.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
36.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
18.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
thyroid gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
14.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
68.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Not detected
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
48.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
107.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.8
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
130.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
220.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
68.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000010610
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
53.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>MSC</title>
      <link>/genepanel/9242/gene_expression/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/9242/gene_expression/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;musculin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-expression&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Expression&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 1.&lt;/strong&gt; MSC expression overview from &lt;em&gt;human protein atlas database&lt;/em&gt;.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
ENSEMBL
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Tissue
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Protein
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
mRNA
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adipose tissue
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
10.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
adrenal gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.5
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
appendix
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
15.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
bone marrow
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cerebral cortex
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
7.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cervix, uterine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
colon
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
duodenum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
endometrium
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.7
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epididymis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
esophagus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
fallopian tube
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
gallbladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
16.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
heart muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
kidney
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lung
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lymph node
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
13.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ovary
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
6.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
placenta
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
22.4
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
prostate
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.0
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rectum
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
salivary gland
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
seminal vesicle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.3
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
skin
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
small intestine
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
smooth muscle
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.2
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
spleen
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
5.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
stomach
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
testis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
4.9
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
tonsil
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
3.1
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ENSG00000178860
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
urinary bladder
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
12.6
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>How to Help PlatCOVID</title>
      <link>/supp/faq/how_to_help/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/supp/faq/how_to_help/</guid>
      <description>&lt;h2 id=&#34;how-can-i-contribute-to-platcovid&#34;&gt;How can I contribute to PlatCOVID?&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;By help curating data&lt;/li&gt;
&lt;li&gt;Platform Development&lt;/li&gt;
&lt;li&gt;Donate&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;human-curation&#34;&gt;Human Curation&lt;/h2&gt;
&lt;p&gt;Explaing how to help&lt;/p&gt;
&lt;h2 id=&#34;platform-development&#34;&gt;Platform development&lt;/h2&gt;
&lt;p&gt;Explaing how to develop&lt;/p&gt;
&lt;h2 id=&#34;donate-to-platcovid&#34;&gt;Donate to PlatCOVID&lt;/h2&gt;
&lt;p&gt;Explaing how to donate&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title></title>
      <link>/supp/terms/term/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/supp/terms/term/</guid>
      <description> 



&lt;div id=&#34;categoric-terms&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Categoric Terms&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:20px&#34; align=&#34;justify&#34;&gt;
Terms used to catergorized all abstracts in 5 categories.
&lt;/p&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Box 1.&lt;/strong&gt; Terms to catergorized abstracts
&lt;/p&gt;
&lt;table&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Diagnosis
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Treatmnet
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Epidemiology
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Transmission
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Clinical*
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Diagnostic
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
treatment
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Epidemiology
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Transmission
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Clinical
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
diagnosis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Therapeutics
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Epidemiologic
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Sexually Transmitted Diseases
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Symptoms
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Techniques
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Therapy
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Pharmacoepidemiology
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Infectious Disease Transmission
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Sing
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Reagent Kits
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medication
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Health Services Research
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Disease Transmission
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Sing and Symptoms
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Immunologic Tests
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Health Resorts
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Infection Transmission
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Delivery of Health Care
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Nursing Diagnosis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Life Support Care
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Signs and Symptoms
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Serologic Tests
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Palliative Care
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Clinical Medicine
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Diagnostic Imaging
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Patient Care Planning
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medical Records
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Clinical Diagnosis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Patient Dropouts
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Treatment Outcome
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medicamentous Diagnosis
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Residential Treatment
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Practice Guideline
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Diagnosis of Health Situation
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
drug effects
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Critical Pathways
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Clinical Laboratory Techniques
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Intensive Care Units
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Disease Management
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Diagnostic Techniques and Procedures
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Pretreatment
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Decision Support Systems
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Molecular Diagnostic Techniques
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Clinical Protocols
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Equivalence Trial
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Telediagnostics
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Patient Compliance
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Treatment Outcome
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medical Futility
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Homebound Persons
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Withholding Treatment
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medication Therapy Management
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Medication Adherence
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Molecular Targeted Therapy
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Molecular Therapy
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Transitional Care
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Conservative Treatment
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Teletherapy
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
NA
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;p style=&#34;font-size:11px&#34; align=&#34;center&#34;&gt;
*Clinical, signs and symptoms
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
&lt;div id=&#34;common-terms-excluded&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Common Terms Excluded&lt;/h2&gt;
&lt;p&gt;&lt;br&gt;
&lt;a style=&#34;font-size:20px&#34; align=&#34;center&#34; href=&#34;#&#34;&gt;Download the .xlsx file of all common excluded words&lt;/a&gt;&lt;/p&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Box 2.&lt;/strong&gt; Top 30 to catergorized abstracts
&lt;/p&gt;
&lt;table&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Global
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Diagnosis
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Treatmnet
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Epidemiology
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Transmission
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Clinical*
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
covid-19
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2020
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
coronavirus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
china
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cases
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cases
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
patients
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2019
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
has
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2019
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
china
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2020
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
found
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
sars-cov-2
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2019
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
data
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
has
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2019
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
abstract
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
china
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cases
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
wuhan
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
wuhan
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
china
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
coronavirus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ct
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
sars-cov-2
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
sars-cov-2
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
had
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
been
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2020
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
(covid-19)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
been
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
been
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
(covid-19)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
data
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
cases
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
should
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
may
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
february
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
data
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
more
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
has
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
©
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
copyright
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
number
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
copyright
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ct
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
sars-cov-2
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2019-ncov
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
should
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
among
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
should
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
copyright
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2019
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
data
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
including
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
more
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rights
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
using
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
china
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
patient
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2019-ncov
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hubei
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
number
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
including
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
©
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
reported
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
patient
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
province
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
including
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
results
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
been
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
may
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rights
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
early
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
may
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
february
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
wuhan
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
february
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
such
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
including
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
february
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
among
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
(covid-19)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
review
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
chinese
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
copyright
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
among
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
patient
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
copyright
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
january
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
evidence
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
using
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
january
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
elsevier
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
had
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
used
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
reported
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
patient
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
december
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
used
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
data
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
s
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
elsevier
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
those
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
elsevier
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
december
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rights
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hubei
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
among
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
three
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
evidence
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
s
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
may
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
number
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
high
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
higher
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
such
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
higher
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
more
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
using
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
review
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
evidence
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
high
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
such
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
2019-ncov
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
high
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
february
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ct
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
results
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
early
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
reported
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
such
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
s
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
(sars-cov-2)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
review
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
review
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
should
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
three
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
however
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
s
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
however
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rapidly
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ct
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
evidence
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rapidly
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
however
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
within
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
(sars-cov-2)
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
number
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
rapidly
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
due
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
high
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ltd
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
while
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
including
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
however
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
january
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
further
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
while
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
both
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
february
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
need
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
both
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
chinese
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
known
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
hubei
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
results
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
while
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
while
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ltd
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
both
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
found
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
patient
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
elsevier
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
sars-cov
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
many
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
sars-cov
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
lower
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;p style=&#34;font-size:11px&#34; align=&#34;center&#34;&gt;
*Clinical, signs and symptoms
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SDS</title>
      <link>/genepanel/10993/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/10993/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;serine dehydratase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of SDS gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32223317
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The Self-Rating Anxiety Scale (SAS) and the Self-Rating Depression Scale (SDS) were used.&lt;b&gt;Results&lt;/b&gt;: Females’ anxiety risk was 3.01 times compared to males (95% &lt;i&gt;CI&lt;/i&gt; 1.39-6.52). […] SDS results indicated that the difference between education level and occupation was statistically significant (&lt;i&gt;p&lt;/i&gt; = 0.024, 0.005).
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CHM</title>
      <link>/genepanel/1121/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1121/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;CHM Rab escort protein&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of CHM gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32233641
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Traditional Chinese herbal medicines (CHM) have unique roles in the treatment of viral infections. […] In this article we analyzed the effectiveness and possible molecular mechanisms of CHM formulas for the prevention of COVID-19. […] The active ingredients and action targets of CHM formulas were obtained from the TCMSP database. […] The action mechanisms of these genes were predicted using a Gene Ontology (GO)-based functional enrichment and annotation tool and the Kyoto Encyclopedia of Genes and Genomes (KEGG). […] CHM formulas played a positive role in preventing COVID-19 and warrant further application. […] Our research provides new evidence to support the possible value of CHM formulas for the prevention of COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NRM</title>
      <link>/genepanel/11270/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/11270/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;nurim&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of NRM gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283185
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Secondary endpoints included acute and chronic graft-versus-host disease GVHD, non-relapse mortality (NRM), relapse/progression and disease-free survival (DFS). […] Similarly, rates neutrophil recovery (HR=0.91, 0.80-1.02, p=0.12), platelet recovery (HR=0.88, 0.78-1.00, p=0.05), grade 3-4 acute GVHD (HR=0.78, 0.50-1.22, p=0.27), NRM (HR=1.16, 0.86-1.55, p=0.32) and relapse/progression (HR=1.21, 0.97-1.50, p=0.09) were similar with cryopreserved versus fresh grafts. […] Graft cryopreservation does not significantly delay hematopoietic recovery, increase acute GVHD risk or NRM, or decrease overall survival after all-HCT using ptCY.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NLRP3</title>
      <link>/genepanel/114548/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/114548/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;NLR family pyrin domain containing 3&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of NLRP3 gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251729
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Among its potential mechanisms of action is the non-selective inhibition of NLRP3 inflammasome which is thought to be a major pathophysiologic component in the clinical course of patients with COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CP</title>
      <link>/genepanel/1356/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1356/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;ceruloplasmin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of CP gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253318
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
One dose of 200 mL of convalescent plasma (CP) derived from recently recovered donors with the neutralizing antibody titers above 1:640 was transfused to the patients as an addition to maximal supportive care and antiviral agents. […] The primary endpoint was the safety of CP transfusion. […] The second endpoints were the improvement of clinical symptoms and laboratory parameters within 3 d after CP transfusion. […] The median time from onset of illness to CP transfusion was 16.5 d. […] After CP transfusion, the level of neutralizing antibody increased rapidly up to 1:640 in five cases, while that of the other four cases maintained at a high level (1:640). […] This study showed CP therapy was well tolerated and could potentially improve the clinical outcomes through neutralizing viremia in severe COVID-19 cases. […] The optimal dose and time point, as well as the clinical benefit of CP therapy, needs further investigation in larger well-controlled trials.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32276333
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Assay reproducibility in terms of cycle threshold (Cp) values was satisfactory, with the total imprecision (% CV) values well below 5%.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CPE</title>
      <link>/genepanel/1363/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1363/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;carboxypeptidase E&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of CPE gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32120929
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The methanol extract of &lt;i&gt;S. cusia&lt;/i&gt; leaf effectively inhibited the cytopathic effect (CPE) and virus yield (IC&lt;sub&gt;50&lt;/sub&gt; = 0.64 μg/mL) in HCoV-NL63-infected cells. […] Among the six components identified in the methanol extract of &lt;i&gt;S. cusia&lt;/i&gt; leaf, tryptanthrin and indigodole B (5a&lt;i&gt;R&lt;/i&gt;-ethyltryptanthrin) exhibited potent antiviral activity in reducing the CPE and progeny virus production.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32205232
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The antiviral activity of LH against SARS-CoV-2 was assessed in Vero E6 cells using CPE and plaque reduction assay.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CRP</title>
      <link>/genepanel/1401/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1401/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;C-reactive protein&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of CRP gene in 25 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32026671
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;ol start=&#34;2&#34; style=&#34;list-style-type: decimal&#34;&gt;
&lt;li&gt;The blood test of the patients showed normal or decreased white blood cell count (23/29), decreased lymphocyte count (20/29), increased hypersensitive C reactive protein (hs-CRP) (27/29), and normal procalcitonin. […] However, there were no statistically significant differences in serum levels of tumor necrosis factor-alpha (TNF-α), IL-1, IL-8, IL-10, hs-CRP, lymphocyte count and LDH among the three groups (P&amp;gt;0.05). &lt;b&gt;Conclusion:&lt;/b&gt; The clinical characteristics of 2019-nCoV pneumonia are similar to those of common viral pneumonia. […] 2）患者外周血一般表现为白细胞总数正常或减低（23/29），淋巴细胞计数减少（20/29），超敏C-反应蛋白（hs-CRP）增高（27/29），降钙素原正常。 […] 而3组研究对象血清中的肿瘤坏死因子-α（TNF-α）、IL-1β、IL-8、IL-10、hs-CRP、淋巴细胞计数、LDH表达水平差异均无统计学意义（&lt;i&gt;P&lt;/i&gt;&amp;gt;0.05）。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32048163
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The most common laboratory abnormalities were hypoalbuminemia, lymphopenia, decreased percentage of lymphocytes (LYM) and neutrophils (NEU), elevated C-reactive protein (CRP) and lactate dehydrogenase (LDH), and decreased CD8 count. […] ALB, LYM, LYM (%), LDH, NEU (%), and CRP were highly correlated to the acute lung injury. […] Age, viral load, lung injury score, and blood biochemistry indexes, albumin (ALB), CRP, LDH, LYM (%), LYM, and NEU (%), may be predictors of disease severity.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32061066
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The median of CRP was 16.3 mg/L, including 5 patients with slightly elevated (5/9) , 4 patients with normal values (4/9) . the results of procalcitonin test were negative in5 patients. […] 5例患者外周血C反应蛋白（CRP）轻度升高，4例患者CRP正常，中位数为16.3 mg/L。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32120458
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The observation indicators included total blood count, C-reactive protein (CRP), arterial blood gas analysis, myocardial injury markers, coagulation function, liver and kidney function, electrolyte, procalcitonin (PCT), B-type natriuretic peptide (BNP), blood lipid, pulmonary CT and pathogen detection. &lt;b&gt;Results:&lt;/b&gt; Compared with the general group, the lymphocyte count (0.74×10(9) (0.34×10(9), 0.94×10(9))/L vs. […] 0.99×10(9) (0.71×10(9), 1.29×10(9))/L, &lt;i&gt;P&lt;/i&gt;=0.03) was extremely lower in the critical group, CRP (106.98 (81.57, 135.76) mg/L vs. […] 观察指标包括全血细胞计数、C反应蛋白（CRP）、动脉血气分析、心肌损伤标志物、凝血功能、肝肾功能、电解质、降钙素原（PCT）、B型利钠肽（BNP）、血脂、肺部CT及病原学检测。 […] &lt;b&gt;结果：&lt;/b&gt; 与普通组比较，危重组患者淋巴细胞计数[0.74×10(9)（0.34×10(9)，0.94×10(9)）/L比0.99×10(9)（0.71×10(9)，1.29×10(9)）/L，&lt;i&gt;P&lt;/i&gt;=0.03]较低，CRP[106.98（81.57，135.76）mg/L比34.34（9.55，76.54）mg/L，&lt;i&gt;P&lt;/i&gt;&amp;lt;0.001]和PCT[0.20（0.15，0.48）μg/L比0.11（0.06，0.20）μg/L，&lt;i&gt;P&lt;/i&gt;&amp;lt;0.001]较高；危重组体重指数（BMI）明显高于普通组[25.5（23.0，27.5）kg/m(2)比22.0（20.0， 24.0）kg/m(2)，&lt;i&gt;P&lt;/i&gt;=0.003]。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32141280
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Both univariate and multivariate logistic regression were used to analyze the correlation of past medical history including hypertension, diabetes and coronary heart disease (CHD) , as well as the levels of serum NT-proBNP and cTnI to the disease severity of COVID-19 patients. &lt;b&gt;Results:&lt;/b&gt; Age, hypersensitive C-reactive protein(hs-CRP) and serum creatinine levels of the patients were higher in critical care cases than in mild cases(all &lt;i&gt;P&lt;/i&gt;&amp;lt;0.05). […] Univariate logistic regression analysis showed that age, male, elevated NT-proBNP, elevated cTnI, elevated hs-CRP, elevated serum creatinine, hypertension, and CHD were significantly correlated with critical disease status(all &lt;i&gt;P&lt;/i&gt;&amp;lt;0.05). […] 收集入选患者住院期间实验室检查结果，包括血清N末端B型利钠肽原（NT-proBNP）、心肌肌钙蛋白I（cTnI）、超敏C反应蛋白（hs-CRP）和血肌酐的最高值，血红蛋白的最低值。 […] 危重型组患者的年龄、hs-CRP和血肌酐水平均高于非危重型组（&lt;i&gt;P&lt;/i&gt;均&amp;lt;0.05）。 […] 单因素logistic回归分析结果显示，年龄、男性、NT-proBNP升高、cTnI升高、hs-CRP升高、血肌酐升高、患有高血压、既往冠心病史是COVID-19危重型的相关因素（&lt;i&gt;P&lt;/i&gt;均&amp;lt;0.05）。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32166607
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Common laboratory findings include normal/ low white cell counts with elevated C-reactive protein (CRP).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32209890
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
C-reactive protein (CRP) levels were also significantly higher in the death group on admission (109.25 [35.00, 170.28] mg/L vs.3.22 [1.04, 21.80] mg/L, Z = 10.206, P &amp;lt; 0.001) showed no significant improvement after treatment (109.25 [35.0, 170.28] mg/L vs. […] Compared to the recovered group, more patients in the death group exhibited characteristics of advanced age, pre-existing comorbidities, dyspnea, oxygen saturation decrease, increased WBC count, decreased lymphocytes, and elevated CRP levels.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32233642
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Correlation analysis indicated total lymphocyte count was positively correlated with CD4+ T cell count, and no significant differences were found between the 2 groups in other laboratory measurements, including those of white blood cell (WBC) count, C-reactive protein (CRP), albumin, lactate dehydrogenase (LDH), and D-dimer.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32239591
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Males were more likely to have liver injury when infected with COVID-19 (P &amp;lt; .05); compared with patients without liver injury, patients with liver injury had increased levels of white blood cell counts, neutrophils, CRP and CT score (P &amp;lt; .05) and had a longer length of stay (P &amp;lt; .05).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32239796
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Most of the liver function indexes in COVID-19 patients were correlated with CRP and NLR, the markers of inflammation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32243911
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We aimed to assess the usefulness of CRP levels in the early stage of COVID-19 and to correlate them with lung lesions and severe presentation. […] On admission CRP levels were collected, and the diameter of the largest lung lesion was measured in the most severe lung lesion by lung CT scan. […] Differences in the diameter and CRP levels were compared in the following groups of patients: mild group, moderate group, severe group, and critical group. […] CRP levels and the diameter of the largest lung lesion in the moderate group were higher than those in the mild group (Mann-Whitney test=-2.647, -2.171, P˂0.05), those in the severe group were higher than those in the moderate group (Mann-Whitney test=0.693, -2.177, P˂0.05), and those in the critical group were higher than those in the severe group (Mann-Whitney test=-0.068, -1.549, P˂0.05). […] CRP levels were positively correlated with the diameter of lung lesion and severe presentation (correlation coefficient=0.873, 0.734, P˂0.001). […] In the early stage of COVID-19 CRP levels were positively correlated with lung lesions and could reflect disease severity.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32249918
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Compared to the controls, COVID-19 pneumonia patients had lower counts of white blood cells (WBC), neutrophils, C-reactive protein (CRP), and alanine aminotransferase (ALT) on admission. […] Increased levels of WBC, neutrophils, eosinophils, and CRP were found in postpartum blood tests of pneumonia patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251805
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The rising of neutrophils, SAA, PCT, CRP, cTnI, D-dimer, LDH and lactate levels can be used as indicators of disease progression, as well as the decline of lymphocytes counts.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253759
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The demographic, treatment, laboratory parameters of C-reactive protein (CRP) and IL-6 before and after TCZ therapy and clinical outcome in the 15 COVID-19 patients were retrospectively assessed. […] Although TCZ treatment ameliorated the increased CRP in all patients rapidly, for the four critically ill patients who received an only single dose of TCZ, three of them (No. 1, 2, and 3) still dead and the CRP level in the rest one patient (No. 7) failed to return to normal range with a clinical outcome of disease aggravation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32255437
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The most prevalent presenting symptoms were fever (64%) and cough (59%), and a mildly elevated mean (SD) C-reactive protein (CRP) level of 11.22(11.06) and erythrocyte sedimentation rate of 18.8 (15.17) were detected.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32259129
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this context, both &lt;i&gt;in vitro&lt;/i&gt; and &lt;i&gt;in vivo&lt;/i&gt; studies have revealed that metronidazole could decrease the levels of several cytokines, which are known to increase during the COVID-19 infection, including interleukin (IL)8, IL6, IL1B, tumor necrosis factor (TNF)α, IL12, IL1α, and interferon (IFN)γ, as well as the levels of C-reactive protein (CRP) and neutrophil count.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32259132
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Patients with positive RT-PCR had significantly higher neutrophil (NEU) count (p = 0.0001), and C-reactive protein (CRP) (p = 0.04), lactate dehydrogenase (LDH) (p = 0.0001), aspartate aminotransferase (AST) (p = 0.001), alanine aminotransferase (ALT) (p = 0.0001), and Urea (p = 0.001) levels in serum. […] ALT (AUC = 0.879), CRP (AUC = 0.870), NEU (AUC = 0.858), LDH (AUC = 0.835), and Urea (AUC = 0.835) had very good accuracy in predicting cases with positive RT-PCR for COVID-19, respectively. […] Our findings suggest that level of LDH, CRP, ALT and NEU can be used to predict the result of COVID-19 test.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32271459
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Compared with the non-severe group, the severe group showed statistical significance in older age, hypertension, bilateral lung plaque shadow, decrease in lymphocyte count, increase in C-reactive protein (CRP), aspartate aminotransferase (AST), lactate dehydrogenase, and creatine kinase.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32271602
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
No statistical difference was observed in plasma C-reactive protein (CRP) between the two groups (COVID-19 and non-COVID-19 ) of patients (P = 0.402), while the white blood cell count and lymphocyte count of the confirmed patients were slightly lower than those of the suspected patients (P &amp;lt; 0.05).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277967
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The dynamic changes of blood SAA, CRP, PCT, WBC, Lymphocyte (L), PLT, CT imaging, and disease progression were studied. […] COVID-19 patients had significantly increased SAA and CRP levels, while L count decreased, and PCT, WBC, and PLT were in the normal range. […] As disease progressed from mild to critically severe, SAA and CRP gradually increased, while L decreased, and PLT, WBC, and PCT had no significant changes; ROC curve analysis suggests that SAA/L, CRP, SAA, and L count are valuable in evaluating the severity of COVID-19 and distinguishing critically ill patients from mild ones; Patients with SAA consistently trending down during the course of disease have better prognosis, compared with the patients with SAA continuously rising; The initial SAA level is positively correlated with the dynamic changes of the serial CT scans.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281668
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The levels of C-reactive protein (CRP) in the severe group at the initial and progression stages were higher than those in the mild group. […] Correlation analysis showed that CRP (R=0.62, P&amp;lt;0.01), erythrocyte sedimentation rate (R=0.55, P&amp;lt;0.01) and granulocyte/lymphocyte ratio (R=0.49, P&amp;lt;0.01) were positively associated with the CT severity scores. […] Receiver-operating characteristic analysis demonstrated that area under the curve of CRP on the first visit for predicting severe COVID-19 was 0.87 (95% CI 0.10-1.00) at 20.42 mg/L cut-off, with sensitivity and specificity 83% and 91%, respectively. […] CRP in severe COVID-19 patients increased significantly at the initial stage, prior to CT findings. […] Importantly, CRP, which was associated with disease development, predicted early severe COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32282949
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
During the disease course, longitudinal evaluation of lymphocyte count dynamics and inflammatory indices, including LDH, CRP and IL-6 may help to identify cases with dismal prognosis and prompt intervention in order to improve outcomes.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283217
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The laboratory investigations showed leukopenia and lymphopenia as well as increased creatinine and CRP levels.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294503
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
During the prenatal and postpartum period, there was no difference in the count of WBC, Neutrophils and Lymphocyte, the radio of Neutrophils and Lymphocyte and the level of CRP between the confirmed COVID-19 group and the control group(p&amp;lt;0.05). 20 babies (from confirmed mother and from normal mother) were subjected to SARS-CoV-2 examination by throat swab samples in 24 hours after birth and no case was tested positive.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294504
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
After short-term follow-up, 16 patients (27.6%) presented symptoms with lower lymphocyte count and higher CRP, mainly including fever, cough and fatigue.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;&lt;/li&gt;
&lt;/ol&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ACE</title>
      <link>/genepanel/1636/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1636/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;angiotensin I converting enzyme&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of ACE gene in 19 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32061198
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The novel coronavirus 2019 (COVID-19) infected patients by binding human ACE2, leading to severe pneumonia and highly mortality rate in patients. […] ACE2 plays an important role in the RAS, and the imbalance between ACE/Ang II/AT1R pathway and ACE2/Ang (1-7)/Mas receptor pathway in the RAS system will lead to multi-system inflammation. […] Increased ACE and Ang II are poor prognostic factors for severe pneumonia. […] The binding of COVID-19 and ACE2 resulted in the exhaustion of ACE2, and then ACE2/Ang (1-7)/Mas receptor pathway was inhibited. […] The balance of the RAS system was broken, and this would lead to the exacerbation of acute severe pneumonia. […] Therefore, we speculate that ACEI and AT1R inhibitors could be used in patients with COVID-19 pneumonia under the condition of controlling blood pressure, and might reduce the pulmonary inflammatory response and mortality. […] 新型冠状病毒通过与人体血管紧张素转化酶2（ACE2）结合感染产生重症肺炎，传染性强，病死率高，目前无确切有效的治疗方式。 […] ACE2是肾素-血管紧张素系统（RAS）的重要组成部分，RAS系统中ACE/Ang II/AT1R通路与ACE2/Ang (1-7)/Mas受体通路失衡将导致多系统炎症。 […] ACE和Ang II升高是重症肺炎的不良预后因素。 […] 新型冠状病毒与ACE2的结合导致ACE2耗竭，ACE2/Ang (1-7)/Mas受体通路受到抑制，RAS系统失衡，使新型冠状病毒肺炎患者病死率升高。 […] 因此，在控制血压的情况下，对新型冠状病毒肺炎患者应用ACEI及AT1R抑制剂，有可能减轻患者肺部炎症反应，降低患者病死率。.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32159318
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
与严重急性呼吸系统综合征冠状病毒（SARS-CoV）一样，2019新型冠状病毒（2019-nCoV）亦是以血管紧张素转化酶2（ACE2）为受体感染细胞。 […] ACE2作为肾素-血管紧张素系统（RAS）的重要成员，与ACE互为拮抗，二者的平衡与失衡在维护心血管系统生理功能、机体炎症反应、肺损伤等过程中均发挥着重要作用，而其在冠状病毒感染与致病机制中亦发挥着非常重要的作用。 […] 目前为止，在7种人畜共患的冠状病毒中有3种以ACE2为受体感染细胞，即SARS-CoV、人类冠状病毒NL63（HCoV-NL63）和2019-nCoV，了解这些病毒与ACE2的相互作用对于冠状病毒感染的预防和治疗意义重大。 […] 本文对相关文献进行了梳理，总结了ACE2及RAS系统在冠状病毒感染、致病过程中发挥的作用，对于2019-nCoV防治过程中存在的争议进行了归纳，针对ACE2和RAS系统中可能存在的2019-nCoV的治疗靶点进行了展望。.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32166940
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
血管紧张素转化酶2（ACE2）作为受体介导2019-nCoV进入细胞，是目前最有可能防治COVID-19的靶点之一。 […] ACE2是肾素-血管紧张素系统重要的组成部分，以此系统为靶点的ACE抑制剂和血管紧张素受体阻断剂等药物，是目前临床治疗高血压、心肌重构和心力衰竭等心血管疾病的最主要的药物之一。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32208987
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Because the ACE2 (angiotensin-converting enzyme 2) protein is the receptor that facilitates coronavirus entry into cells, the notion has been popularized that treatment with renin-angiotensin system blockers might increase the risk of developing a severe and fatal severe acute respiratory syndrome coronavirus-2 infection. […] ACE2 in its full-length form is a membrane-bound enzyme, whereas its shorter (soluble) form circulates in blood at very low levels. […] As a mono-carboxypeptidase, ACE2 contributes to the degradation of several substrates including angiotensins I and II. […] ACE (angiotensin-converting enzyme) inhibitors do not inhibit ACE2 because ACE and ACE2 are different enzymes. […] Although angiotensin II type 1 receptor blockers have been shown to upregulate ACE2 in experimental animals, the evidence is not always consistent and differs among the diverse angiotensin II type 1 receptor blockers and differing organs. […] Moreover, there are no data to support the notion that ACE inhibitor or angiotensin II type 1 receptor blocker administration facilitates coronavirus entry by increasing ACE2 expression in either animals or humans. […] Indeed, animal data support elevated ACE2 expression as conferring potential protective pulmonary and cardiovascular effects.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32221983
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This article reviews the correlation between angiotensin-converting enzyme 2 (ACE2) and severe risk factors for coronavirus disease 2019 (COVID-19) and the possible mechanisms. […] ACE2 is a crucial component of the renin-angiotensin system (RAS). […] The classical RAS ACE-Ang II-AT1R regulatory axis and the ACE2-Ang 1-7-MasR counter-regulatory axis play an essential role in maintaining homeostasis in humans. […] ACE2 is widely distributed in the heart, kidneys, lungs, and testes. […] ACE2 antagonizes the activation of the classical RAS system and protects against organ damage, protecting against hypertension, diabetes, and cardiovascular disease. […] Similar to SARS-CoV, SARS-CoV-2 also uses the ACE2 receptor to invade human alveolar epithelial cells. […] Acute respiratory distress syndrome (ARDS) is a clinical high-mortality disease, and ACE2 has a protective effect on this type of acute lung injury. […] Because of these protective effects of ACE2 on chronic underlying diseases and ARDS, the development of spike protein-based vaccine and drugs enhancing ACE2 activity may become one of the most promising approaches for the treatment of COVID-19 in the future.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32228252
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The mechanism for SARS-CoV-2 infection is the requisite binding of the virus to the membrane-bound form of angiotensin-converting enzyme 2 (ACE2) and internalization of the complex by the host cell. […] Recognition that ACE2 is the coreceptor for the coronavirus has prompted new therapeutic approaches to block the enzyme or reduce its expression to prevent the cellular entry and SARS-CoV-2 infection in tissues that express ACE2 including lung, heart, kidney, brain, and gut. […] ACE2, however, is a key enzymatic component of the renin-angiotensin-aldosterone system (RAAS); ACE2 degrades ANG II, a peptide with multiple actions that promote CVD, and generates Ang-(1-7), which antagonizes the effects of ANG II. […] Moreover, experimental evidence suggests that RAAS blockade by ACE inhibitors, ANG II type 1 receptor antagonists, and mineralocorticoid antagonists, as well as statins, enhance ACE2 which, in part, contributes to the benefit of these regimens. […] The current perspective critically examines the evidence for ACE2 regulation by RAAS blockade and statins, the cardiovascular benefits of ACE2, and whether ACE2 blockade is a viable approach to attenuate COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32229706
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
One is CD26 and the other is ACE-2 (angiotensin-converting enzyme 2).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32232976
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ACE2 is a metalloproteinase and a homolog of carboxypeptidase ACE. […] It hydrolyzes a variety of angiotensin peptides and is the main active peptide of the renin-angiotensin system (RAS).&lt;sup&gt;[3]&lt;/sup&gt; ACE2, which is made of 805 amino acids, is a type I transmembrane glycoprotein with a single extracellular catalytic domain.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32242182
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
There has been a lot of speculation that patients with coronavirus disease 2019 (COVID-19) who are receiving angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) may be at increased risk for adverse outcomes.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247213
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Search terms were, COVID-19, treatment of coronavirus, COVID 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ACE-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32250244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The discovery that SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) binds to the angiotensin converting enzyme (ACE)-2, which is highly expressed in the lower airways, explained why SARS-CoV-2 causes acute respiratory distress syndrome (ARDS) and respiratory failure. […] After this, news spread that ACEis and ARBs would be harmful in SARS-CoV-2-infected subjects. […] To the contrary, compelling evidence exists that the ACE-1/angiotensin(Ang)II/ATR-1 pathway is involved in SARS-CoV-2-induced ARDS, while the ACE-2/Ang(1-7)/ATR2/MasR pathway counteracts the harmful actions of AngII in the lung. […] A reduced ACE-1/ACE-2 ratio is, in fact, a feature of ARDS that can be rescued by human recombinant ACE-2 and Ang(1-7) administration, thus preventing SARS-CoV-2-induced damage to the lung. […] Based on the current clinical evidence treatment with ACE-inhibitors I (ACEis) or angiotensin receptor blockers (ARBs) continues to provide cardiovascular and renal protection in patients diagnosed with COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251731
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The first step of the viral replication cycle [i.e. attachment to the surface of respiratory cells, mediated by the spike (S) viral protein] offers several potential therapeutic targets. […] The S protein uses the angiotension-converting enzyme-2 (ACE-2) receptor for entry, but also sialic acids linked to host cell surface gangliosides. […] This domain (111-158), which is fully conserved among clinical isolates worldwide, may improve attachment of the virus to lipid rafts and facilitate contact with the ACE-2 receptor.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32255507
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Additionally, many adults with hypertension, diabetes, and chronic kidney disease are placed on angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs). […] Studies have shown that these medications upregulate the ACE-2 receptor, the very receptor which the SARS-CoV-2 virus uses to enter host cells, which puts older adults at a further increased risk of infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32266708
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Cardiovascular diseases, in particular hypertension, as well as the cardiovascular treatment with Renin-Angiotensin System inhibitors such as Angiotensin Converting Enzyme (ACE) inhibitors and Angiotensin Receptor Blockers (ARBs), are claimed once again as mechanisms of Severe Acute Respiratory Syndrome (SARS) during the COVID-19 outbreak due to Cov-2 epidemics. […] In vitro studies are available to support the eventual role of ACE inhibitors and ARBs in both the promotion and antagonism of the disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32268343
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The possible reason about non-susceptibility of children to coronavirus may lie in different angiotensin-converting enzyme (ACE) activity and immunity of children.The first possible reason is about ACE activity. […] A research revealed that children had higher ACE activities.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32269893
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Emphasis is placed on evidence-based medicine to evaluate the frequency of presentation of various symptoms to create a stratification system of the most important epidemiological risk factors for COVID-19. […] Lastly, the current scientific data and status of governing bodies such as the Center of Disease Control (CDC) and the WHO on the usage of controversial therapies such as angiotensin-converting enzyme (ACE) inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs) (Ibuprofen), and corticosteroids usage in COVID-19 are discussed.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32274964
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Angiotensin-converting enzyme-2 (ACE-2) is one of the most important receptors on the cell membrane of the host cells (HCs) which its interaction with spike protein (SP) with a furin-cleavage site results in the SARS-CoV-2 invasion. […] Hence, in this review, we presented an overview on the interaction of ACE-2 and furin with SP. […] Furthermore, we discussed that the small molecular inhibitors can limit the interaction of ACE-2 and furin with SP and can be used as potential therapeutic platforms to combat the spreading CoV epidemic.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277367
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Angiotensin converting enzyme 2 (ACE2) appears important for viral entry into pneumocytes; dysbalance in ACE2 as caused by ACE inhibitors or ibuprofen may predispose to severe disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32279064
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Similar to the respiratory mucosa, angiotensin converting enzyme-2 (ACE-2) receptor and transmembrane serine protease 2 TMPRSS2) co-express in the gastrointestinal tract, which facilitates viral entry into the tissue.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>AGA</title>
      <link>/genepanel/175/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/175/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;aspartylglucosaminidase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of AGA gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283100
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The purpose of this AGA Institute Clinical Practice Update is to rapidly review the emerging evidence and provide timely expert recommendations regarding the management of patients with inflammatory bowel disease during the COVID-19 pandemic. […] This expert commentary was commissioned and approved by the AGA Institute Clinical Practice Updates Committee (CPUC) and the AGA Governing Board to provide timely perspective on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the CPUC and external peer review through standard procedures of Gastroenterology.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>DPP4</title>
      <link>/genepanel/1803/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1803/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;dipeptidyl peptidase 4&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of DPP4 gene in 3 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32199615
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Intriguingly, we found that the candidate co-receptors, manifesting the most similar expression patterns with ACE2 across 13 human tissues, are all peptidases, including ANPEP, DPP4 and ENPEP. […] Among them, ANPEP and DPP4 are the known receptors for human CoVs, suggesting ENPEP as another potential receptor for human CoVs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32265331
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this study, we evaluated parainfluenza virus 5 (PIV5)-based vaccine expressing the MERS-CoV envelope spike protein (PIV5/MERS-S) in a human DPP4 knockin C57BL/6 congenic mouse model (hDPP4 KI). […] Following a single-dose intranasal immunization, PIV5-MERS-S induced neutralizing antibody and robust T cell responses in hDPP4 KI mice.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294179
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Two coronavirus receptor proteins, Angiotensin Converting Enzyme 2 (ACE2) and Dipeptidyl Peptidase-4 (DPP4) are also established transducers of metabolic signals and pathways regulating inflammation, renal and cardiovascular physiology, and glucose homeostasis. […] Moreover, glucose-lowering agents such as the DPP4 inhibitors, widely used in subjects with T2D, are known to modify the biological activities of multiple immunomodulatory substrates. […] Here we review the basic and clinical science spanning the intersections of diabetes, coronavirus infections, ACE2, and DPP4 biology, highlighting clinical relevance and evolving areas of uncertainty underlying the pathophysiology and treatment of T2D in the context of coronavirus infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ENPEP</title>
      <link>/genepanel/2028/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2028/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;glutamyl aminopeptidase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of ENPEP gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32199615
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Intriguingly, we found that the candidate co-receptors, manifesting the most similar expression patterns with ACE2 across 13 human tissues, are all peptidases, including ANPEP, DPP4 and ENPEP. […] Among them, ANPEP and DPP4 are the known receptors for human CoVs, suggesting ENPEP as another potential receptor for human CoVs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ALB</title>
      <link>/genepanel/213/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/213/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;albumin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of ALB gene in 4 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32048163
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The most common laboratory abnormalities were hypoalbuminemia, lymphopenia, decreased percentage of lymphocytes (LYM) and neutrophils (NEU), elevated C-reactive protein (CRP) and lactate dehydrogenase (LDH), and decreased CD8 count. […] ALB, LYM, LYM (%), LDH, NEU (%), and CRP were highly correlated to the acute lung injury. […] Age, viral load, lung injury score, and blood biochemistry indexes, albumin (ALB), CRP, LDH, LYM (%), LYM, and NEU (%), may be predictors of disease severity.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32077660
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The results of laboratory examination showed that the alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin (ALB), and total bilirubin (TBil) for entire cohort were 26.98 (16.88 ~ 46.09) U/L and 24.75 (18.71 ~ 31.79) U/L, 39.00 (36.20 ~ 44.20) g/L and 16.40 (11.34- ~ 21.15) mmol/L, respectively. […] ALT, AST, ALB and TBil of the mild or moderate subgroups were 22.75 (16.31- ~ 37.25) U/L, 23.63 (18.71 ~ 26.50) U/L, 39.70 (36.50 ~ 46.10) g/L, and 15.95 (11.34 ~ 20.83) mmol/L, respectively. […] ALT, AST, ALB and TBil of the severe or critical subgroups were 60.25 (40.88 ~ 68.90) U/L, 37.00 (20.88 ~ 64.45) U/L, 35.75 (28.68 ~ 42.00) g/L, and 20.50 (11.28 ~ 25.00) mmol/L, respectively. &lt;b&gt;Conclusion:&lt;/b&gt; The results of this multicenter retrospective study suggests that novel coronavirus pneumonia combined with liver damage is more likely to be caused by adverse drug reactions and systemic inflammation in severe patients receiving medical treatment. […] 实验室检查结果提示：总队列病例的谷氨酸转氨酶（ALT）和天冬氨酸转氨酶（AST）分别为26.98（16.88～46.09）U/L和24.75（18.71～31.79）U/L，白蛋白（Alb）和总胆红素（TBil）分别为39.00 (36.20～44.20) g/L和16.40 (11.34～21.15) mmol/L。 […] 轻型或普通型亚组的ALT和AST分别为22.75 (16.31～37.25) U/L和23.63 (18.71～26.50）U/L，其中ALT &amp;gt; 40 U/L有6例（21.00%），AST &amp;gt; 40 U/L有1例（3.60%）；Alb和TBil分别为39.70 (36.50～46.10) g/L和15.95 (11.34～20.83) mmol/L。 […] 重型或危重型亚组的ALT和AST分别为60.25 (40.88～68.90) U/L和37.00 (20.88～64.45) U/L，其中ALT &amp;gt; 40 U/L有3例（75.00%），AST &amp;gt; 40 U/L有1例（25.00%）；Alb和TBil分别为35.75 (28.68～42.00) g/L和20.50 (11.28～25.00) mmol/L。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32198776
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Compared to the mild cases, the severe ones had lower lymphocyte counts and higher plasma levels of Pt, APTT, d-dimer, lactate dehydrogenase, PCT, ALB, C-reactive protein, and aspartate aminotransferase.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32270660
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), γ-glutamyl transferase (GGT), total bilirubin (TBil), albumin(ALB) and international normalized ratio (INR) of 324 cases at baseline were 27.86 ± 20.02 U/L, 29.33 ± 21.02 U/L, 59.93 ± 18.96 U / L, 39.00 ± 54.44 U/L, 9.46 ± 4.58 μmol / L, 40.64 ± 4.13 g / L and 1.02 ± 0.10. […] 8.05 μmol / L, &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.01), ALB (35.79 ± 4.75 vs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>EZH2</title>
      <link>/genepanel/2146/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2146/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;enhancer of zeste 2 polycomb repressive complex 2 subunit&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of EZH2 gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32291076
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In agreement with this result, we found in human embryonic stem cells that ACE2 expression was significantly increased in absence of EZH2, the major enzyme catalyzing H3K27me3. […] ChIP-seq analysis further confirmed decrease of H3K27me3 signal and increase of H3K27ac signal at ACE2 promoter upon EZH2 knockout. […] Therefore, we propose that EZH2-mediated H3K27me3 at ACE2 promoter region inhibits ACE2 expression in mammalian cells.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SIRT1</title>
      <link>/genepanel/23411/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/23411/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;sirtuin 1&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of SIRT1 gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32267139
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Sirtuin 1 (SIRT1) and hsa-miR-217 has been identified to mediate the development of non-small cell lung cancer (NSCLC). […] We performed this study to investigate the roles of hsa-miR-217, its target SIRT1, as well as P53/KAI1 axis in the brain metastasis from NSCLC. […] Human pulmonary adenocarcinoma brain metastasis cell line PC-14/B were incubated and treated with constructed lentiviral plasmids expressing miR-217 and/or SIRT1. […] The targeted regulation of miR-217 to SIRT1 was examined using dual luciferase reporter assay. […] Cell proliferation, migration, invasion and the expression of relate proteins were detected to examine the effect of miR-217/SIRT1 expression on metastasis. […] PC-14/B cells expressed higher SIRT1 and lower p53 and KAI1 compared with BEAS-2B control cells (P&amp;lt;0.05). […] SIRT1 was a direct target of miR-217. […] MiR-217 expression suppressed PC-14/B cell invasion (P=0.004), migration (P=0.001) and proliferation (P&amp;lt;0.05), whereas SIRT1 overexpression reversed all processes. […] SIRT1 expression inhibited P53, KAI1/CD82, matrix metalloproteinase (MMP)-9 and β-catenin but upregulated E-cadherin protein. […] Hsa-miR-217 and its target SIRT1 acted as metastasis suppressor and promoter gene in NSCLC, respectively. […] The hsa-miR-217/SIRT1/P53/KAI1 metastasis regulatory pathway showed novel and crucial roles in brain metastasis from NSCLC.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>G6PD</title>
      <link>/genepanel/2539/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2539/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;glucose-6-phosphate dehydrogenase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of G6PD gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281268
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
HCov-229E is one of the four flu-causing coronaviruses which share great sequence similitude, while many symptoms of patients infected with COVID-19 resemble those of patients infected with these known flu-causing coronaviruses.&lt;sup&gt;2&lt;/sup&gt; A previous study reported that human lung epithelial A549 cells treated with glucose 6-phosphate dehydrogenase (G6PD) interfering RNA (RNAi) to lower G6PD activity displayed augmented (12-fold) viral production in comparison to normal counterparts when infected with coronavirus HCov-229E. […] Moreover, viral replication in these G6PD-deficient cells was found to be 3-fold higher than normal cells, following a 10-h incubation, as estimated by quantitative polymerase chain reaction (qPCR).&lt;sup&gt;3&lt;/sup&gt; G6PD deficiency remains the most common human enzymatic disorder of red blood cells worldwide.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ANG</title>
      <link>/genepanel/283/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/283/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;angiogenin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of ANG gene in 6 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32061198
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ACE2 plays an important role in the RAS, and the imbalance between ACE/Ang II/AT1R pathway and ACE2/Ang (1-7)/Mas receptor pathway in the RAS system will lead to multi-system inflammation. […] Increased ACE and Ang II are poor prognostic factors for severe pneumonia. […] The binding of COVID-19 and ACE2 resulted in the exhaustion of ACE2, and then ACE2/Ang (1-7)/Mas receptor pathway was inhibited. […] ACE2是肾素-血管紧张素系统（RAS）的重要组成部分，RAS系统中ACE/Ang II/AT1R通路与ACE2/Ang (1-7)/Mas受体通路失衡将导致多系统炎症。 […] ACE和Ang II升高是重症肺炎的不良预后因素。 […] 新型冠状病毒与ACE2的结合导致ACE2耗竭，ACE2/Ang (1-7)/Mas受体通路受到抑制，RAS系统失衡，使新型冠状病毒肺炎患者病死率升高。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32221983
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This article reviews the correlation between angiotensin-converting enzyme 2 (ACE2) and severe risk factors for coronavirus disease 2019 (COVID-19) and the possible mechanisms. […] ACE2 is a crucial component of the renin-angiotensin system (RAS). […] The classical RAS ACE-Ang II-AT1R regulatory axis and the ACE2-Ang 1-7-MasR counter-regulatory axis play an essential role in maintaining homeostasis in humans.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32228252
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The mechanism for SARS-CoV-2 infection is the requisite binding of the virus to the membrane-bound form of angiotensin-converting enzyme 2 (ACE2) and internalization of the complex by the host cell. […] ACE2, however, is a key enzymatic component of the renin-angiotensin-aldosterone system (RAAS); ACE2 degrades ANG II, a peptide with multiple actions that promote CVD, and generates Ang-(1-7), which antagonizes the effects of ANG II. […] Moreover, experimental evidence suggests that RAAS blockade by ACE inhibitors, ANG II type 1 receptor antagonists, and mineralocorticoid antagonists, as well as statins, enhance ACE2 which, in part, contributes to the benefit of these regimens.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32250244
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The discovery that SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) binds to the angiotensin converting enzyme (ACE)-2, which is highly expressed in the lower airways, explained why SARS-CoV-2 causes acute respiratory distress syndrome (ARDS) and respiratory failure. […] To the contrary, compelling evidence exists that the ACE-1/angiotensin(Ang)II/ATR-1 pathway is involved in SARS-CoV-2-induced ARDS, while the ACE-2/Ang(1-7)/ATR2/MasR pathway counteracts the harmful actions of AngII in the lung. […] A reduced ACE-1/ACE-2 ratio is, in fact, a feature of ARDS that can be rescued by human recombinant ACE-2 and Ang(1-7) administration, thus preventing SARS-CoV-2-induced damage to the lung. […] Based on the current clinical evidence treatment with ACE-inhibitors I (ACEis) or angiotensin receptor blockers (ARBs) continues to provide cardiovascular and renal protection in patients diagnosed with COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32255491
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Angiotensin converting enzyme 2 (ACE2) is the major enzyme responsible for conversion of Ang II into Ang-(1-7).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32264791
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Angiotensin-converting enzyme (ACE2) has a multiplicity of physiological roles that revolve around its trivalent function: a negative regulator of the renin-angiotensin system (RAS), facilitator of amino acid transport, and the SARS-CoV and SARS-CoV-2 receptor. […] Recombinant ACE2, gene-delivery of Ace2, Ang 1-7 analogs, and Mas receptor agonists enhance ACE2 action and serve as potential therapies for disease conditions associated with an activated RAS. […] Recombinant human ACE2 has completed clinical trials and efficiently lowered or increased plasma angiotensin II and angiotensin 1-7 levels, respectively.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CXCR3</title>
      <link>/genepanel/2833/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2833/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;C-X-C motif chemokine receptor 3&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of CXCR3 gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253888
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The X chromosome influences the immune system by acting on many other proteins, including TLR8, CD40L and CXCR3 which can be over-expressed in women, and influence the response to viral infections and vaccinations.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32257537
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
After treatment, the peripheral lymphocytes were increased, the C-reactive protein decreased, and the overactivated cytokine-secreting immune cells CXCR3+CD4+ T cells, CXCR3+CD8+ T cells, and CXCR3+ NK cells disappeared in 3-6 days.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ANPEP</title>
      <link>/genepanel/290/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/290/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;alanyl aminopeptidase, membrane&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of ANPEP gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32199615
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Intriguingly, we found that the candidate co-receptors, manifesting the most similar expression patterns with ACE2 across 13 human tissues, are all peptidases, including ANPEP, DPP4 and ENPEP. […] Among them, ANPEP and DPP4 are the known receptors for human CoVs, suggesting ENPEP as another potential receptor for human CoVs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HBM</title>
      <link>/genepanel/3042/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3042/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;hemoglobin subunit mu&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of HBM gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32247680
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Community pharmacists can reinforce mitigation behaviors by applying the health belief model (HBM). […] This commentary provides an overview of the HBM and offers suggestions on how community pharmacists can use it as a guide to patient communication in these uncertain contexts.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HGF</title>
      <link>/genepanel/3082/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3082/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;hepatocyte growth factor&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of HGF gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292697
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In China, a considerable number of convalescent SARS patients with steroid-associated ONFH had undergone conservative treatment by Traditional Chinese Medicine (TCM), and this study aims to evaluate the long-term results of a spleen-invigorating Huo-Gu Formula (HGF) therapy in these patients. and methods: A total of 33 convalescent SARS patients (nine males and 24 females) with bilateral steroid-associated ONFH (66 hips) were enrolled in this study. […] All patients received oral HGF therapy for six months when they were confirmed the diagnosis of steroid-associated ONFH. […] Based on average 14 years of follow-up of HGF therapy (ranging from six to 16 years), 38 hips (57%) among the 66 hips developed definite osteoarthritis, and 14 hips (26%) in 53 pre-collapse hips (ARCO stage I or II) progressed to femoral head collapse(ARCO stage III or IV). […] Chinese herbal HGF therapy demonstrates beneficial effects on preventing femoral head collapse, delaying total hip arthroplasty (THA)surgery, and maintaining physical function in the treatment of steroid-associated ONFH. […] HGF therapy might be therefore a good alternative for the treatment of steroid-associated ONFH secondary to rheumatologic and infection diseases.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL1B</title>
      <link>/genepanel/3553/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3553/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;interleukin 1 beta&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of IL1B gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32259129
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this context, both &lt;i&gt;in vitro&lt;/i&gt; and &lt;i&gt;in vivo&lt;/i&gt; studies have revealed that metronidazole could decrease the levels of several cytokines, which are known to increase during the COVID-19 infection, including interleukin (IL)8, IL6, IL1B, tumor necrosis factor (TNF)α, IL12, IL1α, and interferon (IFN)γ, as well as the levels of C-reactive protein (CRP) and neutrophil count.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL2</title>
      <link>/genepanel/3558/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3558/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;interleukin 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of IL2 gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
31986264
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL6</title>
      <link>/genepanel/3569/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3569/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;interleukin 6&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of IL6 gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32176772
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Compared with SpO2≥90% group, patients of the SpO2&amp;lt;90% group were older, and showed more comorbidities and higher plasma levels of IL6, IL10, lactate dehydrogenase, and c reactive protein.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32259129
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this context, both &lt;i&gt;in vitro&lt;/i&gt; and &lt;i&gt;in vivo&lt;/i&gt; studies have revealed that metronidazole could decrease the levels of several cytokines, which are known to increase during the COVID-19 infection, including interleukin (IL)8, IL6, IL1B, tumor necrosis factor (TNF)α, IL12, IL1α, and interferon (IFN)γ, as well as the levels of C-reactive protein (CRP) and neutrophil count.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL7</title>
      <link>/genepanel/3574/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3574/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;interleukin 7&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of IL7 gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
31986264
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL10</title>
      <link>/genepanel/3586/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3586/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;interleukin 10&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of IL10 gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
31986264
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32176772
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Compared with SpO2≥90% group, patients of the SpO2&amp;lt;90% group were older, and showed more comorbidities and higher plasma levels of IL6, IL10, lactate dehydrogenase, and c reactive protein.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IVD</title>
      <link>/genepanel/3712/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3712/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;isovaleryl-CoA dehydrogenase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of IVD gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32260471
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
There have been tremendous advances in in vitro diagnostic (IVD) assays for coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). […] The main IVD assays used for COVID-19 employ real-time reverse transcriptase polymerase chain reaction (RT-PCR) that takes a few hours. […] The ongoing research efforts and advances in complementary technologies will pave the way to new POC IVD assays in the coming months. […] However, the performance of IVD assays needs to be critically evaluated before they are employed for the clinical diagnosis of COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>JAK2</title>
      <link>/genepanel/3717/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3717/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;Janus kinase 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of JAK2 gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32205092
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We reviewed TH17 responses in patients with SARS-CoV-2 and proposed an FDA approved JAK2 inhibitor Fedratinib for reducing mortality of patients with TH17 type immune profiles.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>MB</title>
      <link>/genepanel/4151/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/4151/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;myoglobin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of MB gene in 3 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32220650
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Since December, 2019, an outbreak of coronavirus disease 2019 (COVID-19) has spread globally. […] The route of transmission was by close contact with family members (32 [89%]) or a history of exposure to the epidemic area (12 [33%]); eight (22%) patients had both exposures. 19 (53%) patients had moderate clinical type with pneumonia; 17 (47%) had mild clinical type and either were asymptomatic (ten [28%]) or had acute upper respiratory symptoms (seven [19%]). […] Typical abnormal laboratory findings were elevated creatine kinase MB (11 [31%]), decreased lymphocytes (11 [31%]), leucopenia (seven [19%]), and elevated procalcitonin (six [17%]). […] Besides radiographic presentations, variables that were associated significantly with severity of COVID-19 were decreased lymphocytes, elevated body temperature, and high levels of procalcitonin, D-dimer, and creatine kinase MB.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32232979
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this study, we detected and analyzed the main laboratory indicators related to heart injury, creatine kinase isoenzyme-MB (CK-MB), myohemoglobin (MYO), cardiac troponin I (ultra-TnI), and N-terminal pro-brain natriuretic peptide (NT-proBNP), in 273 patients with COVID-19 and investigated the correlation between heart injury and severity of the disease. […] It was found that higher concentration in venous blood of CK-MB, MYO, ultra-TnI, and NT-proBNP were associated with the severity and case fatality rate of COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32267000
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this retrospective, single center study authors have discussed the role of acute cardiovascular injury marker including CK-MB, Myoglobulin, cardiac troponin I (cTnI) and NT- proBNP on the outcome of 273 patients with COVID-19 disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NHS</title>
      <link>/genepanel/4810/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/4810/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;NHS actin remodeling regulator&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of NHS gene in 6 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32196406
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
While these common sense points will always be helpful, it is important that you keep up to date with the advice being given by the &lt;b&gt;Centers for Disease Control and Prevention (CDC)&lt;/b&gt; and &lt;b&gt;NHS England&lt;/b&gt; and how it might affect you personally.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32232915
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The COVID-19 pandemic presents an unprecedented challenge to our National Health Service (NHS) (1). […] As the need to appropriately direct all efforts towards providing emergency supportive care to those suffering, there will be a knee-jerk tendency to cancel all outpatient activity by NHS trusts.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32267538
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This policy brief sets forth American Geriatrics Society (AGS) recommendations to guide federal, state, and local governments when making decisions about care for patients with COVID-19 in nursing homes (NHs) and other long-term care facilities (LTCFs). […] It is focused on NHs and other LTCFs, given their essential role in addressing the COVID-19 pandemic.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275770
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Reported shortages of personal protective equipment (PPE) in the NHS have caused anxiety amongst healthcare workers [1].
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32279545
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
&lt;b&gt;Jennie Burch&lt;/b&gt;, Head of Gastrointestinal Nurse Education, St Mark’s Hospital, London (&lt;a href=&#34;mailto:jburch1@nhs.net&#34; class=&#34;email&#34;&gt;jburch1@nhs.net&lt;/a&gt;), discusses the ramifications of coronavirus and the guidelines available to professionals working in gastroenterology.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32290904
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We present results from staff testing at Sheffield Teaching Hospitals NHS Foundation Trust, United Kingdom.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TAS2R10</title>
      <link>/genepanel/50839/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/50839/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;taste 2 receptor member 10&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of TAS2R10 gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281695
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Based on the idea of host-directed therapy (HDT), we performed a negative co-expression analysis using big data of 60 000 Affymetrix expression arrays and 5000 TCGA data sets to determine the functions of TAS2R10, which can be activated by numerous bitter substances. […] Excitingly, we found that the main functions of TAS2R10 involved controlling infectious diseases caused by bacteria, viruses, and parasites, suggesting that TAS2R10 is a key trigger of host defense pathways.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PC</title>
      <link>/genepanel/5091/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/5091/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;pyruvate carboxylase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of PC gene in 3 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32209118
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To capture the key information of the spike protein, three feature encoding algorithms (amino acid composition, AAC; parallel correlation-based pseudo-amino-acid composition, PC-PseAAC and G-gap dipeptide composition, GGAP) were used to train 41 random forest models.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32249102
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To discuss community pharmacists’ role and the content of pharmaceutical care (PC) during the novel coronavirus pandemic to promote effective prevention and control and safe drug use of the community patient population. […] Collect and summarize the experience Chinese community pharmacies gained from providing pharmacy services during the COVID-19 outbreak, and taking patients’ PC needs into consideration, analyze and discuss the methods and strategies that community pharmacies and pharmacists shall use to provide PC during the pandemic. […] Community pharmacy management teams shall support PC services by providing adequate supply of COVID-19 related medications and preventative products, following environment regulations, and providing sufficient staff trainings. […] Pharmacists shall use various approaches to provide PC services in drug dispensing, consulting and referrals, chronic disease management, safe use of infusions, patient education, home care guidance and psychological support to promote the COVID-19 pandemic control and ensure safe medication use of community patients during the pandemic. […] PC services in communities during the COVID-19 shall possess different properties due to disease characteristics and related change in patients’ need. […] Community pharmacists shall be prepared to provide skilled and effective PC services for community patient population to ensure medication safety and promote the overall COVID-19 pandemic control.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32267139
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Human pulmonary adenocarcinoma brain metastasis cell line PC-14/B were incubated and treated with constructed lentiviral plasmids expressing miR-217 and/or SIRT1. […] PC-14/B cells expressed higher SIRT1 and lower p53 and KAI1 compared with BEAS-2B control cells (P&amp;lt;0.05). […] MiR-217 expression suppressed PC-14/B cell invasion (P=0.004), migration (P=0.001) and proliferation (P&amp;lt;0.05), whereas SIRT1 overexpression reversed all processes.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>FOXP3</title>
      <link>/genepanel/50943/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/50943/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;forkhead box P3&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of FOXP3 gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253888
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In addition, on the X chromosome there are loci that code for the genes involved in the regulation of immune cells such as FOXP3, and transcription factor for Treg involved in virus pathogenesis.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TLR7</title>
      <link>/genepanel/51284/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/51284/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;toll like receptor 7&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of TLR7 gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253888
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The levels of activation of the immune cells are higher in women than in men, and it is correlated with the trigger of TLR7 and the production of IFN. […] TLR7 is higher in women than in men and its biallelic expression leads to higher immune responses and increases the resistance to viral infections. […] TLR7 is expressed in innate immune cells which recognizes single strand RNA virus by promoting the production of antibodies against the virus and the generation of pro-inflammatory cytokines including IL-6 and IL-1 family members.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TLR8</title>
      <link>/genepanel/51311/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/51311/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;toll like receptor 8&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of TLR8 gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253888
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The X chromosome influences the immune system by acting on many other proteins, including TLR8, CD40L and CXCR3 which can be over-expressed in women, and influence the response to viral infections and vaccinations.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PLP2</title>
      <link>/genepanel/5355/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/5355/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;proteolipid protein 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of PLP2 gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32188728
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Coronaviruses express a multifunctional papain-like protease, termed PLP2. […] PLP2 acts as a protease that cleaves the viral replicase polyprotein, and a deubiquitinating (DUB) enzyme which removes ubiquitin moieties from ubiquitin-conjugated proteins. […] Previous &lt;i&gt;in vitro&lt;/i&gt; studies implicated PLP2 DUB activity as a negative regulator of the host interferon (IFN) response, but the role of DUB activity during virus infection was unknown. […] Here, we used X-ray structure-guided mutagenesis and functional studies to identify amino acid substitutions within the ubiquitin-binding surface of PLP2 that reduced DUB activity without affecting polyprotein processing activity. […] Overall, this study demonstrates that structure-guided mutagenesis aids the identification of critical determinants of PLP2-ubiquitin complex, and that PLP2 DUB activity plays a role as an interferon antagonist in coronavirus pathogenesis.&lt;b&gt;IMPORTANCE&lt;/b&gt; Coronaviruses employ a genetic economy by encoding multifunctional proteins that function in viral replication and also modify the host environment to disarm the innate immune response. […] The coronavirus papain-like protease 2 (PLP2) domain possesses protease activity, which cleaves the viral replicase polyprotein, and also DUB activity (de-conjugating ubiquitin/ubiquitin-like molecules from modified substrates) using identical catalytic residues. […] We found that mutating the ubiquitin-binding residues results in a PLP2 that has reduced DUB activity but retains protease activity. […] The results of this study demonstrate that PLP2/DUB is an interferon antagonist and a virulence trait of coronaviruses.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32216114
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Here, we describe the biochemical and structural identification of recombinant SADS papain-like protease 2 (PLP2) domain of nsp3. […] The SADS-CoV PLP2 was shown to cleave nsp1 proteins and also peptides mimicking the nsp2|nsp3 cleavage site and also had deubiquitinating and deISGynating activity by in vitro assays. […] We characterize both conserved and unique structural features likely directing the interaction of PLP2 with the substrates, including the tentative mapping of active site and other essential residues.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PID1</title>
      <link>/genepanel/55022/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/55022/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;phosphotyrosine interaction domain containing 1&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of PID1 gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32268454
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Measurement data distributed normally were expressed as &lt;i&gt;x&lt;/i&gt; ± s, and measurement data distributed abnormally were expressed as M &lt;i&gt;(P(25), P(75))&lt;/i&gt;. &lt;b&gt;Results:&lt;/b&gt; (1) On PID1, 3, 6, and 9, WBC counts of patients were respectively (19.8±3.8)×10(9)/L, (17.2±3.4)×10(9)/L,(13.3±3.1)×10(9)/L, and (11.1±1.6)×10(9)/L, neutrophils of patients were respectively0.919±0.019,0.899±0.011, 0.855±0.034, and0.811±0.035, absolute values of lymphocytes of patients were respectively(0.65±0.18)×10(9)/L,(0.65±0.24)×10(9)/L,(0.91±0.34)×10(9)/L, and (1.23±0.42)×10(9)/L,and PCT values of patients were respectively0.49 (0.36, 1.64), 0.39 (0.26, 0.73), 0.28 (0.18, 0.33), and 0.12 (0.11, 0.20) ng/mL.The values of WBC and neutrophils of patients were higher than the normal value, showing a downward trend.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HR</title>
      <link>/genepanel/55806/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/55806/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;HR lysine demethylase and nuclear receptor corepressor&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of HR gene in 9 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32167524
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In bivariate Cox regression analysis, risk factors associated with the development of ARDS and progression from ARDS to death included older age (hazard ratio [HR], 3.26; 95% CI 2.08-5.11; and HR, 6.17; 95% CI, 3.26-11.67, respectively), neutrophilia (HR, 1.14; 95% CI, 1.09-1.19; and HR, 1.08; 95% CI, 1.01-1.17, respectively), and organ and coagulation dysfunction (eg, higher lactate dehydrogenase [HR, 1.61; 95% CI, 1.44-1.79; and HR, 1.30; 95% CI, 1.11-1.52, respectively] and D-dimer [HR, 1.03; 95% CI, 1.01-1.04; and HR, 1.02; 95% CI, 1.01-1.04, respectively]). […] High fever (≥39 °C) was associated with higher likelihood of ARDS development (HR, 1.77; 95% CI, 1.11-2.84) and lower likelihood of death (HR, 0.41; 95% CI, 0.21-0.82). […] Among patients with ARDS, treatment with methylprednisolone decreased the risk of death (HR, 0.38; 95% CI, 0.20-0.72).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32217650
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
After adjusting for age and smoking status, COPD [hazards ratio (HR) 2.681, 95% confidence interval (95%CI) 1.424-5.048], diabetes (HR 1.59, 95%CI 1.03-2.45), hypertension (HR 1.58, 95%CI 1.07-2.32) and malignancy (HR 3.50, 95%CI 1.60-7.64) were risk factors of reaching to the composite endpoints. […] The HR was 1.79 (95%CI 1.16-2.77) among patients with at least one comorbidity and 2.59 (95%CI 1.61-4.17) among patients with two or more comorbidities.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32224151
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this retrospective cohort study, we included cancer patients with laboratory confirmed COVID-19 from three designated hospitals in Wuhan, China. […] If the last anti-tumour treatment was within 14 days, it significantly increased the risk of developing severe events (HR=4.079, 95%CI 1.086-15.322, P=0.037). […] Furthermore, patchy consolidation on CT on admission was associated with a higher risk for developing severe events (HR=5.438, 95%CI 1.498-19.748, P=0.010).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32236856
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To review the chest computed tomography (CT) findings on the ultra-high-resolution CT (U-HRCT) in patients with the Novel coronavirus disease 2019 (COVID-19). […] In February 2020, six consecutive patients with COVID-19 pneumonia (median age, 69 years) underwent U-HR CT imaging. […] U-HR-CT has a larger matrix size of 1024 × 1024 thinner slice thickness of 0.25 mm and can demonstrate terminal bronchioles in the normal lungs; as a result, Reid’s secondary lobules and their abnormalities can be identified. […] The distribution and hallmarks (ground-glass opacity, consolidation with or without architectural distortion, linear opacity, crazy paving) of the lung opacities on U-HRCT were visually evaluated on a 1 K monitor by two experienced reviewers. […] All cases showed crazy paving pattern in U-HRCT. […] U-HRCT can evaluate not only the distribution and hallmarks of COVID-19 pneumonia but also visualize local lung volume loss.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32240670
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Symptoms of dyspnea (HR 2.35, P = 0.001), comorbidities including cardiovascular disease (HR 1.86, P = 0.031) and chronic obstructive pulmonary disease (HR 2.24, P = 0.023), and acute respiratory distress syndrome (HR 29.33, P &amp;lt; 0.001) were strong predictors of death. […] And a high level of lymphocytes was predictive of better outcome (HR 0.10, P &amp;lt; 0.001). […] Dyspnea, lymphocytopenia, comorbidities including cardiovascular disease and chronic obstructive pulmonary disease, and acute respiratory distress syndrome were predictive of poor outcome.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32266987
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Cox proportional hazards regression analysis indicated no association between corticosteroid treatment and virus clearance time (hazard ratio [HR], 1.26; 95% CI, 0.58-2.74), hospital length of stay (HR, 0.77; 95% CI, 0.33-1.78), or duration of symptoms (HR, 0.86; 95% CI, 0.40-1.83). […] Univariate analysis indicated that virus clearance was slower in two patients with chronic hepatitis B infections (mean difference, 10.6 days; 95% CI, 6.2-15.1 days).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32269086
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Patients in Hubei [severe event rate 23.0% &lt;i&gt;versus&lt;/i&gt; 11.1%, death rate 7.3% &lt;i&gt;versus&lt;/i&gt; 0.3%, hazards ratio (HR) for critical illness 1.59, 95%CI 1.05-2.41] have a poorer prognosis compared with patients outside of Hubei after adjusting for age and comorbidity. […] However, among patients outside of Hubei, the duration from symptom onset to hospitalisation (mean: 4.4 &lt;i&gt;versus&lt;/i&gt; 4.7 days) and prognosis (HR 0.84, 95%CI 0.40-1.80) were similar between patients with or without Wuhan-related exposure. […] In the overall population, the waiting time, but neither treated in Hubei nor Wuhan-related exposure, remained an independent prognostic factor (HR 1.05, 1.01-1.08).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283185
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Secondary endpoints included acute and chronic graft-versus-host disease GVHD, non-relapse mortality (NRM), relapse/progression and disease-free survival (DFS). […] In matched pair regression analysis, graft cryopreservation was not associated with a significantly higher risk of mortality (Hazard Ratio for cryopreserved versus fresh [HR] =1.05, 95% confidence interval, 0.86-1.29, p=0.60). […] Similarly, rates neutrophil recovery (HR=0.91, 0.80-1.02, p=0.12), platelet recovery (HR=0.88, 0.78-1.00, p=0.05), grade 3-4 acute GVHD (HR=0.78, 0.50-1.22, p=0.27), NRM (HR=1.16, 0.86-1.55, p=0.32) and relapse/progression (HR=1.21, 0.97-1.50, p=0.09) were similar with cryopreserved versus fresh grafts. […] There were somewhat lower rates chronic GVHD (HR=0.78, 0.61-0.99, p=0.04) and DFS (HR for treatment failure=1.19, 95%CI=1.01-1.29, p=0.04) with graft cryopreservation that were of marginal statistical significance after adjusting for multiple comparisons.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283877
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Myocardial injury was an important prognostic factor of COVID-19 (&lt;i&gt;HR&lt;/i&gt;=5.382, 95%&lt;i&gt;CI&lt;/i&gt; 2.404-12.05, &lt;i&gt;P&lt;/i&gt;&amp;lt;0.001). […] 多因素Cox回归分析显示，心肌损伤是COVID-19患者临床预后的重要预测因子（&lt;i&gt;HR&lt;/i&gt;=5.382,95%&lt;i&gt;CI&lt;/i&gt; 2.404~12.05, &lt;i&gt;P&lt;/i&gt;&amp;lt;0.001）。
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SHD</title>
      <link>/genepanel/56961/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/56961/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;Src homology 2 domain containing transforming protein D&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of SHD gene in 3 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32250751
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This has resulted in the inability to care for patients valvular and structural heart disease (SHD) in a timely fashion potentially placing these patients at increased risk for adverse cardiovascular complications including congestive heart failure and death. […] In this document, we suggest guidelines as to how to triage patients in need of SHD interventions and provide a framework of how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32251546
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This has resulted in the inability to care for patients valvular and structural heart disease (SHD) in a timely fashion potentially placing these patients at increased risk for adverse cardiovascular complications including congestive heart failure and death. […] In this document, we suggest guidelines as to how to triage patients in need of SHD interventions and provide a framework of how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32278716
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Patients with structural heart disease (SHD) are at increased risk of adverse outcomes from the coronavirus disease 19 (COVID-19) due to advanced age and comorbidity. […] The aim of these “crisis-driven” recommendations is (1) to ensure appropriate and timely treatment of SHD patients, (2) to minimize the risk of COVID-19 exposure to patients and healthcare workers, and (3) to limit resource utilization under conditions of constraint.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ACE2</title>
      <link>/genepanel/59272/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/59272/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;angiotensin I converting enzyme 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of ACE2 gene in 87 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
31996437
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Since the SARS-CoV outbreak in 2002, extensive structural analyses have revealed key atomic-level interactions between the SARS-CoV spike protein receptor-binding domain (RBD) and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of SARS-CoV. […] First, the sequence of 2019-nCoV RBD, including its receptor-binding motif (RBM) that directly contacts ACE2, is similar to that of SARS-CoV, strongly suggesting that 2019-nCoV uses ACE2 as its receptor. […] Second, several critical residues in 2019-nCoV RBM (particularly Gln493) provide favorable interactions with human ACE2, consistent with 2019-nCoV’s capacity for human cell infection. […] Third, several other critical residues in 2019-nCoV RBM (particularly Asn501) are compatible with, but not ideal for, binding human ACE2, suggesting that 2019-nCoV has acquired some capacity for human-to-human transmission. […] Last, while phylogenetic analysis indicates a bat origin of 2019-nCoV, 2019-nCoV also potentially recognizes ACE2 from a diversity of animal species (except mice and rats), implicating these animal species as possible intermediate hosts or animal models for 2019-nCoV infections. […] Our decade-long structural studies on the receptor recognition by SARS-CoV have identified key interactions between SARS-CoV spike protein and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of SARS-CoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32015507
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Notably, we confirmed that 2019-nCoV uses the same cell entry receptor-angiotensin converting enzyme II (ACE2)-as SARS-CoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32022370
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Herein, we suggest four potential drug candidates (an ACE2-based peptide, remdesivir, 3CLpro-1 and a novel vinylsulfone protease inhibitor) that could be used to treat patients suffering with the 2019-nCoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32023682
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
According to current observations, 2019-nCoV is weaker than SARS in pathogenesis, but has stronger transmission competence; it’s mechanism of cross-species spread might be related with angiotensin-converting enzyme Ⅱ (ACE2), which is consistent with the receptor SARS-CoV. […] 目前数据表明：2019-nCoV比SARS-CoV毒力弱，但传播力强；造成其能够跨种传播的受体可能与SARS-CoV一致，都是血管紧张素转化酶Ⅱ（ACE2）。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32061198
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The novel coronavirus 2019 (COVID-19) infected patients by binding human ACE2, leading to severe pneumonia and highly mortality rate in patients. […] ACE2 plays an important role in the RAS, and the imbalance between ACE/Ang II/AT1R pathway and ACE2/Ang (1-7)/Mas receptor pathway in the RAS system will lead to multi-system inflammation. […] The binding of COVID-19 and ACE2 resulted in the exhaustion of ACE2, and then ACE2/Ang (1-7)/Mas receptor pathway was inhibited. […] 新型冠状病毒通过与人体血管紧张素转化酶2（ACE2）结合感染产生重症肺炎，传染性强，病死率高，目前无确切有效的治疗方式。 […] ACE2是肾素-血管紧张素系统（RAS）的重要组成部分，RAS系统中ACE/Ang II/AT1R通路与ACE2/Ang (1-7)/Mas受体通路失衡将导致多系统炎症。 […] 新型冠状病毒与ACE2的结合导致ACE2耗竭，ACE2/Ang (1-7)/Mas受体通路受到抑制，RAS系统失衡，使新型冠状病毒肺炎患者病死率升高。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32065055
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The epitope of CR3022 does not overlap with the ACE2 binding site within 2019-nCoV RBD. […] Interestingly, some of the most potent SARS-CoV-specific neutralizing antibodies (e.g. m396, CR3014) that target the ACE2 binding site of SARS-CoV failed to bind 2019-nCoV spike protein, implying that the difference in the RBD of SARS-CoV and 2019-nCoV has a critical impact for the cross-reactivity of neutralizing antibodies, and that it is still necessary to develop novel monoclonal antibodies that could bind specifically to 2019-nCoV RBD.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32075877
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We also provide biophysical and structural evidence that the 2019-nCoV S protein binds angiotensin-converting enzyme 2 (ACE2) with higher affinity than does severe acute respiratory syndrome (SARS)-CoV S.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32077659
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ACE2 expression in liver tissue for novel coronavirus was analyzed based on single cell sequencing (GSE115469) data. […] RNA-Seq method was used to analyze Ace2 expression and transcription factors related to its expression in liver tissues at various time-points after hepatectomy in mouse model of acute liver injury with partial hepatectomy. &lt;i&gt;t&lt;/i&gt;-test or Spearman rank correlation analysis was used for statistical analysis. &lt;b&gt;Results:&lt;/b&gt; ALT and AST were abnormally elevated in some patients with novel coronavirus infection, and the rate and extent of ALT and AST elevation in severe NCP patients were higher than those in non-severe patients. […] Liver tissue results of single cell sequencing and immunohistochemistry showed that ACE2 was only expressed in bile duct epithelial cells of normal liver tissues, and very low in hepatocytes. […] In a mouse model of acute liver injury with partial hepatectomy, Ace2 expression was down-regulated on the first day, but it was elevated up to twice of the normal level on the third day, and returned to normal level on seventh day when the liver recovered and hepatocyte proliferation stopped. […] Whether this phenomenon suggests that the bile duct epithelial cells with positive expression of Ace2 participate in the process of liver regeneration after partial hepatectomy deserves further study. […] In RNA-Seq data, 77 transcription factors were positively correlated with the expression of ACE2 (r &amp;gt; 0.2, FDR &amp;lt; 0.05), which were mainly enriched in the development, differentiation, morphogenesis and cell proliferation of glandular epithelial cells. &lt;b&gt;Conclusion:&lt;/b&gt; We assumed that in addition to the over activated inflammatory response in patients with NCP, the up-regulation of ACE2 expression in liver tissue caused by compensatory proliferation of hepatocytes derived from bile duct epithelial cells may also be the possible mechanism of liver tissue injury caused by 2019 novel coronavirus infection. &lt;b&gt;目的：&lt;/b&gt; 探索和分析新型冠状病毒感染肺炎（NCP）患者发生肝损伤的可能机制。 […] &lt;b&gt;方法：&lt;/b&gt; 综合分析已报道文献中NCP患者的丙氨酸转氨酶（ALT）、天冬氨酸转氨酶（AST）等肝酶变化情况与疾病状态的相关性；基于肝组织单细胞测序数据（GSE115469）分析新冠病毒受体血管紧张素转换酶2（ACE2）在肝组织中的表达；采用RNA-seq方法分析半肝切除急性肝损伤小鼠模型肝切除后不同时间点残肝组织中Ace2的表达及与其表达相关的转录因子。 […] 肝组织单细胞测序和免疫组织化学检测结果显示，ACE2在正常肝组织中只在胆管上皮细胞表达，而在肝细胞中表达极低。 […] 在小鼠半肝切除急性肝损伤模型中，Ace2在术后第1天的急性损伤期表达下调，但在术后第3天的肝细胞增殖高峰期表达升高至正常水平的2倍以上，并在肝脏恢复、肝细胞增殖停止的第7天恢复到正常水平。 […] 这一现象是否提示ACE2表达阳性的胆管上皮细胞参与了部分肝切除后的肝再生过程，值得进一步的研究。 […] RNA-seq数据中有77个转录因子与Ace2表达呈正相关（&lt;i&gt;r&lt;/i&gt; &amp;gt; 0.2，FDR &amp;lt; 0.05），主要富集在腺体腔管表皮细胞的发育、分化、形态生成以及细胞增殖等功能。 […] &lt;b&gt;结论：&lt;/b&gt; 除了NCP患者过度激活的炎症反应可导致肝损伤外，胆管上皮细胞来源肝实质细胞的代偿性增生所致病毒受体ACE2在肝组织中的表达上调，可能是新型冠状病毒感染肝细胞造成肝组织损伤的可能机制。.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32081428
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Molecular modeling revealed that 2019-nCoV RBD has a stronger interaction with angiotensin converting enzyme 2 (ACE2). […] A unique phenylalanine F486 in the flexible loop likely plays a major role because its penetration into a deep hydrophobic pocket in ACE2. […] ACE2 is widely expressed with conserved primary structures throughout the animal kingdom from fish, amphibians, reptiles, birds, to mammals. […] Structural analysis suggests that ACE2 from these animals can potentially bind RBD of 2019-nCoV, making them all possible natural hosts for the virus. 2019-nCoV is thought to be transmitted through respiratory droplets. […] However, since ACE2 is predominantly expressed in intestines, testis, and kidney, fecal-oral and other routes of transmission are also possible. […] Finally, antibodies and small molecular inhibitors that can block the interaction of ACE2 with RBD should be developed to combat the virus.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32094336
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
It has been reported that ACE2 is the main host cell receptor of 2019-nCoV and plays a crucial role in the entry of virus into the cell to cause the final infection. […] RNA-seq profiling data of 13 organ types with para-carcinoma normal tissues from TCGA and 14 organ types with normal tissues from FANTOM5 CAGE were analyzed in order to explore and validate the expression of ACE2 on the mucosa of oral cavity. […] Further, single-cell transcriptomes from an independent data generated in-house were used to identify and confirm the ACE2-expressing cell composition and proportion in oral cavity. […] The results demonstrated that the ACE2 expressed on the mucosa of oral cavity.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32094589
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We also demonstrate how different lineage B viruses can recombine to gain entry into human cells, and confirm that human ACE2 is the receptor for the recently emerging SARS-CoV-2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32100877
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this study, we used systematic comparison and analysis to predict the interaction between the receptor-binding domain (RBD) of coronavirus spike protein and the host receptor, angiotensin-converting enzyme 2 (ACE2). […] The interaction between the key amino acids of S protein RBD and ACE2 indicated that, other than pangolins and snakes, as previously suggested, turtles (Chrysemys picta bellii, Chelonia mydas, and Pelodiscus sinensis) may act as the potential intermediate hosts transmitting SARS-CoV-2 to humans.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32117569
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The proposal is a biologic that blocks 2019-nCoV entry using a soluble version of the viral receptor, angiotensin-converting enzyme 2 (ACE2), fused to an immunoglobulin Fc domain, providing a neutralizing antibody with maximal breath to avoid any viral escape, while also helping to recruit the immune system to build lasting immunity. […] The sequence of the ACE2-Fc protein is provided to investigators, allowing its possible use in recombinant protein expression systems to start producing drug today to treat patients under compassionate use, while formal clinical trials are later undertaken.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32127517
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The 2019-nCoV was different from SARS-CoV, but shared the same host receptor the human angiotensin-converting enzyme 2 (ACE2).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32129518
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This idea is based on observations that the angiotensin-converting enzyme 2 (ACE2) very likely serves as the binding site for SARS-CoV-2, the strain implicated in the current COVID-19 epidemic, similarly to strain SARS-CoV implicated in the 2002-2003 SARS epidemic.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32132184
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Angiotensin-converting enzyme 2 (ACE2) is the cellular receptor for severe acute respiratory syndrome-coronavirus (SARS-CoV) and the new coronavirus (SARS-CoV-2) that is causing the serious coronavirus disease 2019 (COVID-19) epidemic. […] Here, we present cryo-electron microscopy structures of full-length human ACE2 in the presence of the neutral amino acid transporter B&lt;sup&gt;0&lt;/sup&gt;AT1 with or without the receptor binding domain (RBD) of the surface spike glycoprotein (S protein) of SARS-CoV-2, both at an overall resolution of 2.9 angstroms, with a local resolution of 3.5 angstroms at the ACE2-RBD interface. […] The ACE2-B&lt;sup&gt;0&lt;/sup&gt;AT1 complex is assembled as a dimer of heterodimers, with the collectrin-like domain of ACE2 mediating homodimerization. […] The RBD is recognized by the extracellular peptidase domain of ACE2 mainly through polar residues.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32138266
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Both viruses utilize the same receptor-angiotensin-converting enzyme 2 (ACE2)-for invading human bodies.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32141569
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Studies suggest that the human receptor for COVID-19 may be angiotensin-converting enzyme 2 (ACE2) receptor similar to that of SARS-CoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32142651
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Here, we demonstrate that SARS-CoV-2 uses the SARS-CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32149769
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Whether GX_P2X uses angiotensin-converting enzyme 2 (ACE2) as the cell receptor was investigated by using small interfering RNA (siRNA) -mediated silencing of ACE2. […] The spike protein of coronavirus GX_P2V shares 92.2% amino acid identity with that of 2019-nCoV isolate Wuhan-hu-1, and uses ACE2 as the receptor for infection just like 2019-nCoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32155444
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We show that SARS-CoV-2 S uses ACE2 to enter cells and that the receptor-binding domains of SARS-CoV-2 S and SARS-CoV S bind with similar affinities to human ACE2, correlating with the efficient spread of SARS-CoV-2 among humans.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32159318
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
与严重急性呼吸系统综合征冠状病毒（SARS-CoV）一样，2019新型冠状病毒（2019-nCoV）亦是以血管紧张素转化酶2（ACE2）为受体感染细胞。 […] ACE2作为肾素-血管紧张素系统（RAS）的重要成员，与ACE互为拮抗，二者的平衡与失衡在维护心血管系统生理功能、机体炎症反应、肺损伤等过程中均发挥着重要作用，而其在冠状病毒感染与致病机制中亦发挥着非常重要的作用。 […] 目前为止，在7种人畜共患的冠状病毒中有3种以ACE2为受体感染细胞，即SARS-CoV、人类冠状病毒NL63（HCoV-NL63）和2019-nCoV，了解这些病毒与ACE2的相互作用对于冠状病毒感染的预防和治疗意义重大。 […] 本文对相关文献进行了梳理，总结了ACE2及RAS系统在冠状病毒感染、致病过程中发挥的作用，对于2019-nCoV防治过程中存在的争议进行了归纳，针对ACE2和RAS系统中可能存在的2019-nCoV的治疗靶点进行了展望。.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32166940
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
血管紧张素转化酶2（ACE2）作为受体介导2019-nCoV进入细胞，是目前最有可能防治COVID-19的靶点之一。 […] ACE2是肾素-血管紧张素系统重要的组成部分，以此系统为靶点的ACE抑制剂和血管紧张素受体阻断剂等药物，是目前临床治疗高血压、心肌重构和心力衰竭等心血管疾病的最主要的药物之一。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32167153
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
It has been known since the 2003 SARS epidemic that the receptor critical for SARS-CoV entry into host cells is the angiotensin-converting enzyme 2 (ACE2). […] The S1 domain of the spike protein of SARS-CoV attaches the virus to its cellular receptor ACE2 on the host cells. […] We thought that it is timely to explain the connection between the SARS-CoV, SARS-CoV-2, ACE2 and the rationale for soluble ACE2 as a potential therapy.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32167747
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In a short time following the outbreak, it has been shown that, similar to SARS-CoV, COVID-19 virus exploits the angiotensin-converting enzyme 2 (ACE2) receptor to gain entry inside the cells. […] This finding raises the curiosity of investigating the expression of ACE2 in neurological tissue and determining the possible contribution of neurological tissue damage to the morbidity and mortality caused by COIVD-19. […] Here, we investigate the density of the expression levels of ACE2 in the CNS, the host-virus interaction and relate it to the pathogenesis and complications seen in the recent cases resulting from the COVID-19 outbreak.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32169119
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The novel coronavirus uses the same receptor, angiotensin-converting enzyme 2 (ACE2) as that for SARS-CoV, and mainly spreads through the respiratory tract.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32170560
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
It has been known that, the novel Coronavirus, 2019-nCoV, which is considered similar to SARS-CoV and originated from Wuhan (China), invades human cells via the receptor angiotensin converting enzyme II (ACE2). […] Moreover, lung cells that have ACE2 expression may be the main target cells during 2019-nCoV infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32174094
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
SARS-CoV通过结合血管紧张素转换酶2（ACE2）进入细胞，病变与病程相关，DAD渗出期一般见于病程10～14 d死亡患者。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32186711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Intravenous infusions of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in experimental animals increase the numbers of angiotensin-converting enzyme 2 (ACE2) receptors in the cardiopulmonary circulation. […] ACE2 receptors serve as binding sites for SARS-CoV-2 virions in the lungs.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32189428
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We predict that these individuals are ‘primed’ to be at higher risk because nicotine can directly impact the putative receptor for the virus (ACE2) and lead to deleterious signaling in lung epithelial cells.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32189489
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
由于2019-nCoV通过棘突糖蛋白与宿主呼吸道上皮细胞的血管紧张素转换酶2（ACE2）结合感染人体，ACE2已被确认为2019-nCoV的受体。 […] 另一方面，ACE2对于多种动脉粥样硬化性心血管疾病（ASCVD）和包括SARS在内的急性肺损伤具有积极的治疗作用。 […] 因此，在2019-nCoV感染背景下的ACE2究竟是人类的敌人还是朋友已成为一个激烈争论的问题。 […] 该文基于ACE2的相关研究成果，对此问题进行深入分析并提出研究展望，希望对2019-nCoV感染的认识和防治有所裨益。.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32197085
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Five key amino acid residues involved in the interaction with human ACE2 are completely consistent between Pangolin-CoV and SARS-CoV-2, but four amino acid mutations are present in RaTG13.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32198163
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The tissue receptor for COVID-19 is ACE2, and higher levels of ACE2 can protect against ARDS. […] Angiotensin receptor blockers and statins upregulate ACE2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32199615
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Angiotensin I converting enzyme 2 (ACE2), is the host receptor by SARS-CoV-2 to infect human cells. […] Although ACE2 is reported to be expressed in lung, liver, stomach, ileum, kidney and colon, its expressing levels are rather low, especially in the lung. […] SARS-CoV-2 may use co-receptors/auxiliary proteins as ACE2 partner to facilitate the virus entry. […] Consistent with other recent reports, we confirmed that ACE2 was mainly expressed in lung AT2, liver cholangiocyte, colon colonocytes, esophagus keratinocytes, ileum ECs, rectum ECs, stomach epithelial cells, and kidney proximal tubules. […] Intriguingly, we found that the candidate co-receptors, manifesting the most similar expression patterns with ACE2 across 13 human tissues, are all peptidases, including ANPEP, DPP4 and ENPEP.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32199943
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Angiotensin converting enzyme 2 (ACE2) is the receptor of SARS-CoV-2, but only ACE2s of certain species can be utilized by SARS-CoV-2. […] Here, we evaluated and ranked the receptor-utilizing capability of ACE2s from various species by phylogenetic clustering and sequence alignment with the currently known ACE2s utilized by SARS-CoV-2. […] As a result, we predicted that SARS-CoV-2 tends to utilize ACE2s of various mammals, except murines, and some birds, such as pigeon.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32201080
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ACE2 is the receptor for both SARS-CoV-2 and SARS-CoV. […] To predict the potential host range of SARS-CoV-2, we analyzed the key residues of ACE2 for recognizing S protein. […] The interaction interface between cat/dog/pangolin/Chinese hamster ACE2 and SARS-CoV/SARS-CoV-2 S protein was simulated through homology modeling. […] We identified that N82 in ACE2 showed a closer contact with SARS-CoV-2 S protein than M82 in human ACE2. […] Our finding will provide important insights into the host range of SARS-CoV-2 and a new strategy to design an optimized ACE2 for SARS-CoV-2 infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32203189
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Here, we identified the receptor-binding domain (RBD) in SARS-CoV-2 S protein and found that the RBD protein bound strongly to human and bat angiotensin-converting enzyme 2 (ACE2) receptors. […] SARS-CoV-2 RBD exhibited significantly higher binding affinity to ACE2 receptor than SARS-CoV RBD and could block the binding and, hence, attachment of SARS-CoV-2 RBD and SARS-CoV RBD to ACE2-expressing cells, thus inhibiting their infection to host cells.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32205090
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
These manifestations include asymptomatic infection, a hyper-affinity to ACE2 receptors resulting in high transmissibility, false negatives, and an incubation period of up to 22 days.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32208987
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Because the ACE2 (angiotensin-converting enzyme 2) protein is the receptor that facilitates coronavirus entry into cells, the notion has been popularized that treatment with renin-angiotensin system blockers might increase the risk of developing a severe and fatal severe acute respiratory syndrome coronavirus-2 infection. […] ACE2 in its full-length form is a membrane-bound enzyme, whereas its shorter (soluble) form circulates in blood at very low levels. […] As a mono-carboxypeptidase, ACE2 contributes to the degradation of several substrates including angiotensins I and II. […] ACE (angiotensin-converting enzyme) inhibitors do not inhibit ACE2 because ACE and ACE2 are different enzymes. […] Although angiotensin II type 1 receptor blockers have been shown to upregulate ACE2 in experimental animals, the evidence is not always consistent and differs among the diverse angiotensin II type 1 receptor blockers and differing organs. […] Moreover, there are no data to support the notion that ACE inhibitor or angiotensin II type 1 receptor blocker administration facilitates coronavirus entry by increasing ACE2 expression in either animals or humans. […] Indeed, animal data support elevated ACE2 expression as conferring potential protective pulmonary and cardiovascular effects.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32210742
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The observed changes have significant effect on SARS-CoV-2 spike/ACE2 interaction and produce a reduction in the binding energy, compared to the one of the Bat-CoV to this receptor. […] The data presented in this study suggest a higher affinity of the SARS-Cov-2 spike protein to the human ACE2 receptor, compared to the one of Bat-CoV spike and ACE2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32213556
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Bioinformatics showed sequence mutation of SARS-CoV-2 with m&lt;sup&gt;6&lt;/sup&gt;A methylation and changed binding capacity with ACE2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32215613
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In particular, activity of the angiotensin-converting enzyme 2 (ACE2) is dysregulated in cardiovascular disease, and this enzyme is used by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to initiate the infection. […] Cardiovascular disease and pharmacologic RAS inhibition both increase ACE2 levels, which may increase the virulence of SARS-CoV-2 within the lung and heart. […] Conversely, mechanistic evidence from related coronaviruses suggests that SARS-CoV-2 infection may downregulate ACE2, leading to toxic overaccumulation of Angiotensin II that induces acute respiratory distress syndrome and fulminant myocarditis.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32215622
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Molecular docking on the binding between angiotensin-converting enzyme 2 (ACE2) of common laboratory mammals and the receptor-binding domain of the surface spike protein of SARS-CoV-2 suggested that the golden Syrian hamster is an option.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32215956
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Studies have identified the SARS-CoV-2 RNA in stool specimens of infected patients, and its viral receptor angiotensin converting enzyme 2 (ACE2) was found to be highly expressed in gastrointestinal epithelial cells.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32219057
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Both SARS-CoV and SARS-CoV-2 exhibit a high degree of genetic similarity and bind to the same host cell ACE2 receptor.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32221983
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This article reviews the correlation between angiotensin-converting enzyme 2 (ACE2) and severe risk factors for coronavirus disease 2019 (COVID-19) and the possible mechanisms. […] ACE2 is a crucial component of the renin-angiotensin system (RAS). […] The classical RAS ACE-Ang II-AT1R regulatory axis and the ACE2-Ang 1-7-MasR counter-regulatory axis play an essential role in maintaining homeostasis in humans. […] ACE2 is widely distributed in the heart, kidneys, lungs, and testes. […] ACE2 antagonizes the activation of the classical RAS system and protects against organ damage, protecting against hypertension, diabetes, and cardiovascular disease. […] Similar to SARS-CoV, SARS-CoV-2 also uses the ACE2 receptor to invade human alveolar epithelial cells. […] Acute respiratory distress syndrome (ARDS) is a clinical high-mortality disease, and ACE2 has a protective effect on this type of acute lung injury. […] Because of these protective effects of ACE2 on chronic underlying diseases and ARDS, the development of spike protein-based vaccine and drugs enhancing ACE2 activity may become one of the most promising approaches for the treatment of COVID-19 in the future.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32225175
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
SARS-CoV-2 and SARS-CoV recognize the same receptor - human ACE2 (hACE2)&lt;sup&gt;3,4&lt;/sup&gt;. […] Here we determined the crystal structure of the SARS-CoV-2 receptor-binding domain (RBD) (engineered to facilitate crystallization) in complex with hACE2. […] Compared with the SARS-CoV RBD, a hACE2-binding ridge in SARS-CoV-2 RBD takes a more compact conformation; moreover, several residue changes in SARS-CoV-2 RBD stabilize two virus-binding hotspots at the RBD/hACE2 interface. […] These structural features of SARS-CoV-2 RBD enhance its hACE2-binding affinity. […] Additionally, we show that RaTG13, a bat coronavirus closely related to SARS-CoV-2, also uses hACE2 as its receptor. […] The differences among SARS-CoV-2, SARS-CoV and RaTG13 in hACE2 recognition shed light on potential animal-to-human transmission of SARS-CoV-2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32225176
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
To better understand the initial step of infection at an atomic level, we determined the crystal structure of the SARS-CoV-2 spike receptor-binding domain (RBD) bound to the cell receptor ACE2 at 2.45 Å resolution. […] The overall ACE2-binding mode of the SARS-CoV-2 RBD is nearly identical to that of the SARS-CoV RBD, which also utilizes ACE2 as the cell receptor&lt;sup&gt;4&lt;/sup&gt;. […] Structural analysis identified residues in the SARS-CoV-2 RBD that are critical for ACE2 binding, the majority of which either are highly conserved or share similar side chain properties with those in the SARS-CoV RBD. […] Such similarity in structure and sequence strongly argue for convergent evolution between the SARS-CoV-2 and SARS-CoV RBDs for improved binding to ACE2, although SARS-CoV-2 does not cluster within SARS and SARS-related coronaviruses&lt;sup&gt;1-3,5&lt;/sup&gt;.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32227090
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Angiotensin-converting enzyme 2 (ACE2), the key host cellular receptor of SARS-CoV-2, has been identified in multiple organs, but its cellular distribution in human heart is not illuminated clearly. […] This study performed the first state-of-art single cell atlas of adult human heart, and revealed that pericytes with high expression of ACE2 might act as the target cardiac cell of SARS-CoV-2. […] And patients with basic heart failure disease showed increased ACE2 expression at both mRNA and protein levels, meaning that if infected by the virus these patients may have higher risk of heart attack and critically ill condition.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32228252
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The mechanism for SARS-CoV-2 infection is the requisite binding of the virus to the membrane-bound form of angiotensin-converting enzyme 2 (ACE2) and internalization of the complex by the host cell. […] Recognition that ACE2 is the coreceptor for the coronavirus has prompted new therapeutic approaches to block the enzyme or reduce its expression to prevent the cellular entry and SARS-CoV-2 infection in tissues that express ACE2 including lung, heart, kidney, brain, and gut. […] ACE2, however, is a key enzymatic component of the renin-angiotensin-aldosterone system (RAAS); ACE2 degrades ANG II, a peptide with multiple actions that promote CVD, and generates Ang-(1-7), which antagonizes the effects of ANG II. […] Moreover, experimental evidence suggests that RAAS blockade by ACE inhibitors, ANG II type 1 receptor antagonists, and mineralocorticoid antagonists, as well as statins, enhance ACE2 which, in part, contributes to the benefit of these regimens. […] The current perspective critically examines the evidence for ACE2 regulation by RAAS blockade and statins, the cardiovascular benefits of ACE2, and whether ACE2 blockade is a viable approach to attenuate COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32232976
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
ACE2 is a metalloproteinase and a homolog of carboxypeptidase ACE. […] It hydrolyzes a variety of angiotensin peptides and is the main active peptide of the renin-angiotensin system (RAS).&lt;sup&gt;[3]&lt;/sup&gt; ACE2, which is made of 805 amino acids, is a type I transmembrane glycoprotein with a single extracellular catalytic domain.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32238232
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Due to the shared receptor ACE2 and the pathological similarities of the SARS-CoV and 2019-nCoV diseases. […] 分析表明，由于2019-nCoV和SARS冠状病变在人体细胞上有相同的受体(ACE2)，因而它们可能有相同的靶器官，如肺、心血管系统和免疫系统。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32238438
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Both viruses have evolved an ability to enter host cells through direct interaction with the angiotensin converting enzyme 2 (ACE2) protein at the surface of many cells. […] Here we consider the ability of SARS-CoV2 to enter and infect the human nervous system based on the strong expression of the ACE2 target throughout the brain. […] Moreover, we predict that nicotine exposure through various kinds of smoking (cigarettes, e-cigarettes, or vape) can increase the risk for COVID19 neuroinfection based on known functional interactions between the nicotinic receptor and ACE2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32239522
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Angiotensin-converting enzyme 2 (ACE2) is the receptor for SARS-CoV-2, which determines the potential host range for SARS-CoV-2. […] On the basis of structural information of the complex of human ACE2 and SARS-CoV-2 receptor-binding domain (RBD), we analyzed the affinity to S protein of the 20 key residues in ACE2 from mammal, bird, turtle, and snake. […] Several ACE2 proteins from Primates, Bovidae, Cricetidae, and Cetacea maintained the majority of key residues in ACE2 for associating with SARS-CoV-2 RBD. […] The simulated structures indicated that ACE2 proteins from Bovidae and Cricetidae were able to associate with SARS-CoV-2 RBD. […] The simulated structures showed several key contacts with SARS-CoV-2 RBD in turtle and snake ACE2 were abolished.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32244779
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We detected, amongst others, affected apoptotic and mitochondrial mechanisms, and a downregulation of the ACE2 protein receptor, notions that can be used to develop specific therapies against this new virus.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32244852
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Smoking can upregulate angiotensin-converting enzyme-2 (ACE2) receptor, the known receptor for both the severe acute respiratory syndrome (SARS)-coronavirus (SARS-CoV) and the human respiratory coronavirus NL638. […] ACE2 could be a novel adhesion molecule for SARS-CoV-2 causing Covid-19 and a potential therapeutic target for the prevention of fatal microbial infections, and therefore it should be fast tracked and prioritized for research and investigation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32246845
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
SARS-CoV-2 was reported to enter cells via binding to ACE2, followed by its priming by TMPRSS2. […] Here, we investigate ACE2 and TMPRSS2 expression levels and their distribution across cell types in lung tissue (twelve donors, 39,778 cells) and in cells derived from subsegmental bronchial branches (four donors, 17,521 cells) by single nuclei and single cell RNA sequencing, respectively. […] While TMPRSS2 is expressed in both tissues, in the subsegmental bronchial branches ACE2 is predominantly expressed in a transient secretory cell type.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32249956
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Human ACE2 is now established as a receptor for the SARS-CoV-2 spike protein. […] Where variations in the viral spike protein, in turn, lead to the cross-species transmission of the virus, genetic variations in the host receptor ACE2 may also contribute to the susceptibility and/or resistance against the viral infection. […] This study aims to explore the binding of the proteins encoded by different human ACE2 allelic variants with SARS-CoV-2 spike protein. […] Briefly, coding variants of ACE2 corresponding to the reported binding sites for its attachment with coronavirus spike protein were selected and molecular models of these variants were constructed by homology modeling. […] The models were then superimposed over the native ACE2 and ACE2-spike protein complex, to observe structural changes in the ACE2 variants and their intermolecular interactions with SARS-CoV-2 spike protein, respectively. […] Despite strong overall structural similarities, the spatial orientation of the key interacting residues varies in the ACE2 variants compared with the wild-type molecule. […] Most ACE2 variants showed a similar binding affinity for SARS-CoV-2 spike protein as observed in the complex structure of wild-type ACE2 and SARS-CoV-2 spike protein. […] However, ACE2 alleles, rs73635825 (S19P) and rs143936283 (E329G) showed noticeable variations in their intermolecular interactions with the viral spike protein. […] In summary, our data provide a structural basis of potential resistance against SARS-CoV-2 infection driven by ACE2 allelic variants.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32255491
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Angiotensin converting enzyme 2 (ACE2) is the major enzyme responsible for conversion of Ang II into Ang-(1-7). […] In recognition of the importance of ACE2 and to celebrate 20 years since its discovery, the journal will publish a focused issue on the basic science and (patho)physiological role of this multifunctional protein.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32257537
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Furthermore, the gene expression profile showed MSCs were ACE2&lt;sup&gt;-&lt;/sup&gt; and TMPRSS2&lt;sup&gt;-&lt;/sup&gt; which indicated MSCs are free from COVID-19 infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32264791
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Angiotensin-converting enzyme (ACE2) has a multiplicity of physiological roles that revolve around its trivalent function: a negative regulator of the renin-angiotensin system (RAS), facilitator of amino acid transport, and the SARS-CoV and SARS-CoV-2 receptor. […] ACE2 is widely expressed, including, in the lungs, cardiovascular system, gut, kidneys, central nervous system, and adipose tissue. […] ACE2 has recently been identified as the SARS-CoV-2 receptor, the infective agent responsible for COVID-19, providing a critical link between immunity, inflammation, ACE2, and cardiovascular disease. […] Although sharing a close evolutionary relationship with SARS-CoV, the receptor-binding domain of SARS-CoV-2 differs in several key amino acid residues, allowing for stronger binding affinity with the human ACE2 receptor, which may account for the greater pathogenicity of SARS-CoV-2. […] The loss of ACE2 function following binding by SARS-CoV-2 is driven by endocytosis and activation of proteolytic cleavage and processing. […] The ACE2 system is a critical protective pathway against heart failure with reduced and preserved ejection fraction including, myocardial infarction and hypertension, and against lung disease and diabetes. […] The control of gut dysbiosis and vascular permeability by ACE2 has emerged as an essential mechanism of pulmonary hypertension and diabetic cardiovascular complications. […] Recombinant ACE2, gene-delivery of Ace2, Ang 1-7 analogs, and Mas receptor agonists enhance ACE2 action and serve as potential therapies for disease conditions associated with an activated RAS. […] Recombinant human ACE2 has completed clinical trials and efficiently lowered or increased plasma angiotensin II and angiotensin 1-7 levels, respectively. […] Our review summarizes the progress over the past 20 years, highlighting the critical role of ACE2 as the novel SARS-CoV-2 receptor and as the negative regulator of the RAS, together with implications for the COVID-19 pandemic and associated cardiovascular diseases.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32266994
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The authors mentioned that angiotensin-converting enzyme 2 (ACE2) is protective against novel coronavirus disease 2019 (COVID-19). […] We would like to explain how cytosolic pH increases the COVID-19 infection by affecting the ACE2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32267499
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Angiotensin-converting enzyme 2 (ACE2) has emerged as a key regulator of the renin-angiotensin system in cardiovascular (CV) disease and plays a pivotal role in infections by coronaviruses and influenza viruses. […] The present review is primarily focused on the findings to indicate the role of ACE2 in the relationship of coronaviruses and influenza viruses to CV disease. […] It is postulated that the risk of coronavirus or influenza virus infection is high, at least partly due to high ACE2 expression in populations with a high CV risk.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32268515
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Previous studies reported that Angiotensin converting enzyme 2 (ACE2) is the main cell receptor of SARS-CoV and SARS-CoV-2. […] In the present study we investigated in silico the basic mechanism of &lt;i&gt;ACE2&lt;/i&gt; in the lung and provided evidences for new potentially effective drugs for Covid-19. […] Specifically, we used the gene expression profiles from public datasets including The Cancer Genome Atlas, Gene Expression Omnibus and Genotype-Tissue Expression, Gene Ontology and pathway enrichment analysis to investigate the main functions of &lt;i&gt;ACE2&lt;/i&gt;-correlated genes. […] We constructed a protein-protein interaction network containing the genes co-expressed with &lt;i&gt;ACE2&lt;/i&gt;. […] Our results demonstrate that the genes correlated with &lt;i&gt;ACE2&lt;/i&gt; are mainly enriched in the sterol biosynthetic process, Aryldialkylphosphatase activity, adenosylhomocysteinase activity, trialkylsulfonium hydrolase activity, acetate-CoA and CoA ligase activity.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32270559
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Cardiac manifestations etiology seems to be multifactorial, comprising direct viral myocardial damage, hypoxia, hypotension, enhanced inflammatory status, ACE2-receptors downregulation, drug toxicity, endogenous catecholamine adrenergic status, among others.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32273490
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
It remains unclear why children and young adults are less severely affected than older individuals, but this might involve differences in immune system function in the elderly and/or differences in the expression/function of the cellular receptor for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) - Angiotensin converting enzyme 2 (ACE2).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275082
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The conjunctival mucosa is directly exposed to infectious droplets expelled by patients during close contact and fomites when the eye is touched by contaminated hands.&lt;sup&gt;2, 3&lt;/sup&gt; More over, the mucosa of the conjunctiva and upper respiratory tract is connected by nasolacrimal duct, and share the same entry receptor of SARS-CoV-2, angiotensin-converting enzyme 2 (ACE2), on host cell membranes.&lt;sup&gt;2, 3&lt;/sup&gt; Hence, it is reasonable to postulate that the conjunctiva may be easily involved in SARS-CoV-2 infection, and may even act as a route of transmission during SARS-CoV-2 infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32275855
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Recently, ACE2 was reported as an entry receptor for SARS-CoV-2. […] In this study, we present the crystal structure of the C-terminal domain of SARS-CoV-2 (SARS-CoV-2-CTD) spike (S) protein in complex with human ACE2 (hACE2), which reveals a hACE2-binding mode similar overall to that observed for SARS-CoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32276140
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Specially, we provide evidence in lupus to suggest hypomethylation and overexpression of ACE2, which is located on the X chromosome and encodes a functional receptor for the SARS-CoV-2 spike glycoprotein. […] Oxidative stress induced by viral infections exacerbates the DNA methylation defect in lupus, possibly resulting in further ACE2 hypomethylation and enhanced viremia. […] Epigenetic control of the ACE2 gene might be a target for prevention and therapy in COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32277367
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Angiotensin converting enzyme 2 (ACE2) appears important for viral entry into pneumocytes; dysbalance in ACE2 as caused by ACE inhibitors or ibuprofen may predispose to severe disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32278065
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
SARS-CoV uses the the angiotensin-converting enzyme 2 (ACE2) and the serine protease TMPRSS2 for S protein priming. […] ACE2 and TMPRSS2 are not only expressed in lung, but also in the small intestinal epithelia. […] ACE2 is expressed furthermore in the upper esophagus, liver, and colon. […] SARS-CoV-2 binding affinity to ACE2 is significantly higher (10-20 times) compared with SARS-CoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32279908
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This observation has been related to the use of drugs that can increase the cellular expression of angiotensin-converting enzyme 2 (ACE2) that has been recognized as target to which the virus bind to cells.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281327
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The results showed that the research team screened out 46 active ingredients from candidate TCMs that could act on the novel coronavirus S-protein-binding site of human ACE2 protein, which were mainly attributed to 7 herbs such as Lonicerae Japonicae Flos and Mori Folium.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281328
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
By combining the diagnosis and treatment scheme of Hunan province’s and angiotensin converting enzyme 2(ACE2) inhibitors screening from literature, present study also discussed the rational application of candidate herbs to this epidemic situation. […] Trichosanthis Fructus obtained by PLP inhibitors screening and Fritillaria verticillata obtained by ACE2 inhibitors screening were parts of the Sangbei Zhisou Powder and Xiaoxianxiong Decoction, which might be applicable to the syndromes of cough and dyspnea. […] Mori Folium, Lonicerae Japonicae Flos and Forsythiae Fructus obtained by ACE2 inhibitors screening were included in the Sangju Decoction and Yinqiaosan, which might be applicable to the syndromes of warm pathogen attacking lung and cough and dyspnea.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283006
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Multiple non-neuronal cell types present in the olfactory epithelium express two host receptors, ACE2 and TMPRSS2 proteases, that facilitate SARS-CoV-2 binding, replication, and accumulation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283711
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
SARS-CoV-2 shares both high sequence similarity and the use of the same cell entry receptor, angiotensin-converting enzyme 2 (ACE2), with severe acute respiratory syndrome coronavirus (SARS-CoV). […] Here, we investigate the expression pattern of ACE2 in adult human testes at the level of single-cell transcriptomes. […] The results indicate that ACE2 is predominantly enriched in spermatogonia and Leydig and Sertoli cells. […] Gene Set Enrichment Analysis (GSEA) indicates that Gene Ontology (GO) categories associated with viral reproduction and transmission are highly enriched in ACE2-positive spermatogonia, while male gamete generation related terms are downregulated. […] Cell-cell junction and immunity-related GO terms are increased in ACE2-positive Leydig and Sertoli cells, but mitochondria and reproduction-related GO terms are decreased.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32285293
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Both COVID-19 and SARS-CoV belong to the coronavirus family and both invade target cells through ACE2. […] An in-depth understanding of ACE2 and a series of physiological and physiological changes caused by the virus invading the human body may help to discover and explain the corresponding clinical phenomena and then deal with them timely. […] In addition, ACE2 is a potential therapeutic target. […] This article will summarize the role of ACE2 in multiple organ damage caused by COVID-19 and SARS-CoV, targeted blocking drugs against ACE2, and drugs that inhibit inflammation in order to provide the basis for subsequent related research, diagnosis and treatment, and drug development.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32285974
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
SARS-CoV-2 was reported to enter cells via binding to ACE2, followed by its priming by TMPRSS2. […] Here, we investigate ACE2 and TMPRSS2 expression levels and their distribution across cell types in lung tissue (twelve donors, 39,778 cells) and in cells derived from subsegmental bronchial branches (four donors, 17,521 cells) by single nuclei and single cell RNA sequencing, respectively. […] While TMPRSS2 is strongly expressed in both tissues, in the subsegmental bronchial branches ACE2 is predominantly expressed in a transient secretory cell type.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32286790
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The inhibitors are mostly formed by two sequential self-supporting α-helices (bundle) extracted from the protease domain (PD) of angiotensin-converting enzyme 2 (ACE2), which bind to the SARS-CoV-2 receptor binding domains.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32290077
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Previous studies showed that SARS-CoV-2 is highly homologous to SARS-CoV and infects humans through the binding of the spike protein to ACE2. […] It was found that SARS-CoV-2 binds ACE2 with a higher affinity than SARS-CoV, which may partly explain that SARS-CoV-2 is much more infectious than SARS-CoV. […] Our computation also suggested that the RBD-ACE2 binding for SARS-CoV-2 is much more temperature-sensitive than that for SARS-CoV.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32291076
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
SARS-CoV-2 enters into and infects host cells through its spike glycoprotein recognizing the cell receptor Angiotensin-converting enzyme II (ACE2). […] Here, we noticed that ACE2 was further enhanced by SARS-CoV-2 infection. […] Human germ cells and early embryos express high level of ACE2. […] Notably, RNA-seq result showed that reduction of H3K27me3, but not H3K4/9/36me3, led to upregulation of Ace2 expression in mouse germ cell line GC-2. […] In agreement with this result, we found in human embryonic stem cells that ACE2 expression was significantly increased in absence of EZH2, the major enzyme catalyzing H3K27me3. […] ChIP-seq analysis further confirmed decrease of H3K27me3 signal and increase of H3K27ac signal at ACE2 promoter upon EZH2 knockout. […] Therefore, we propose that EZH2-mediated H3K27me3 at ACE2 promoter region inhibits ACE2 expression in mammalian cells. […] Our discovery provides clues for pathogenesis and targeted drug therapy towards ACE2 expression for prevention and adjuvant therapy of COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32291526
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Worse outcomes appear to be more prevalent in patients with hypertension and diabetes mellitus (DM), possibly due to overexpression of angiotensin-converting enzyme 2 (ACE2) receptor in airway alveolar epithelial cells. […] Investigators suspect that SARS-CoV-2 uses the ACE2 receptor to enter the lungs in a mechanism similar to SARS-CoV. […] Positive effects include ACE2 receptor blockade, disabling viral entry into the heart and lungs, and an overall decrease in inflammation secondary to ACEI/ARB. […] Negative effects include a possible retrograde feedback mechanism, by which ACE2 receptors are upregulated.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292884
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The SARS-CoV-2 virus uses the ACE2 receptor as the entry point to the host cells. […] ARBs/ACEIs which are widely used in elderly patients, have been found to be associated with overexpression of ACE2. […] To decrease the severity of COVID-19 infection, ARB/ACEI should be switched to another class drug not known to cause a rise in ACE2 until the COVID-19 infection subsides.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293003
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This is related to the role of angiotensin-converting enzyme 2 (ACE2) for SARS-CoV-2 entry into cells, and expression of ACE2 in the lung, cardiovascular system, kidney, and other tissues.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293710
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
COVID-19 infection and its severity can be explained by the concentration of glycosylated SARS- CoV-2 viral particles in the lung epithelium, the concentration of glycosylated angiotensin converting enzyme receptor 2 (ACE2) in the lung epithelium, and the degree and control of the pulmonary immune response to the SARS-CoV-2 spike protein at approximately day 8-10 after symptom onset, which may be related to both. […] Binding of ACE2 by SARS-CoV-2 in COVID-19 also suggests that prolonged uncontrolled hyperglycemia, and not just a history of diabetes mellitus, may be important in the pathogenesis of the disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293910
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The virus uses the ACE2 receptor for internalization, aided by TMPRSS2 protease. […] Virus-induced ACE2 down regulation may attenuate its function, diminish its anti-inflammatory role, and heightened angiotensin II effects in the predisposed patients.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294179
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Two coronavirus receptor proteins, Angiotensin Converting Enzyme 2 (ACE2) and Dipeptidyl Peptidase-4 (DPP4) are also established transducers of metabolic signals and pathways regulating inflammation, renal and cardiovascular physiology, and glucose homeostasis. […] Here we review the basic and clinical science spanning the intersections of diabetes, coronavirus infections, ACE2, and DPP4 biology, highlighting clinical relevance and evolving areas of uncertainty underlying the pathophysiology and treatment of T2D in the context of coronavirus infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NPS</title>
      <link>/genepanel/594857/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/594857/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;neuropeptide S&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of NPS gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32226287
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Clinical samples from all patients including nasopharyngeal swab (NPS)/sputum, urine, and feces were collected for serial virus RNA testing by standard qRT-PCR assay. […] There were positive SARS-CoV-2 RNA signals in all patients’ NPS and stool specimens but negative in all urine specimens. […] Based on our data on SARS-CoV-2 RNA shedding in stool and the possibility of a lag in viral detection in NPS specimens, the assessment of both fecal and respiratory specimen is recommended to enhance diagnostic sensitivity, and also to aid discharge decision before the role of viral RNA shedding in stool is clarified.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>RHO</title>
      <link>/genepanel/6010/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/6010/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;rhodopsin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of RHO gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32246845
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Interestingly, these transiently differentiating cells show an enrichment for pathways related to RHO GTPase function and viral processes suggesting increased vulnerability for SARS-CoV-2 infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32285974
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Interestingly, these transiently differentiating cells show an enrichment for pathways related to RHO GTPase function and viral processes suggesting increased vulnerability for SARS-CoV-2 infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CCL2</title>
      <link>/genepanel/6347/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/6347/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;C-C motif chemokine ligand 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of CCL2 gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32171193
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This cytokine inhibits class II histocompatibility complex (MHC) molecules and inflammation in inflammatory diseases by suppressing MyD88 and subsequently IL-1β, IL-6, TNF and CCL2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32228226
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Our results reveal distinct host inflammatory cytokine profiles to SARS-CoV-2 infection in patients, and highlight the association between COVID-19 pathogenesis and excessive cytokine release such as CCL2/MCP-1, CXCL10/IP-10, CCL3/MIP-1A, and CCL4/MIP1B.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>BID</title>
      <link>/genepanel/637/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/637/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;BH3 interacting domain death agonist&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of BID gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32285930
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
HCQ doses &amp;gt; 400 mg BID for ≥5 days were predicted to rapidly decrease viral loads, reduce the proportion of patients with detectable SARS-CoV-2 infection, and shorten treatment courses, compared to lower dose (≤400 mg daily) regimens. […] However, HCQ doses &amp;gt;600 mg BID were also predicted to prolong QTc intervals.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SI</title>
      <link>/genepanel/6476/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/6476/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;sucrase-isomaltase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of SI gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32007643
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We present estimates of the basic reproduction number, R&lt;sub&gt;0&lt;/sub&gt;, of 2019-nCoV in the early phase of the outbreak. […] With the estimated intrinsic growth rate (γ), we estimated R&lt;sub&gt;0&lt;/sub&gt; by using the serial intervals (SI) of two other well-known coronavirus diseases, MERS and SARS, as approximations for the true unknown SI. […] The mean estimate of R&lt;sub&gt;0&lt;/sub&gt; for the 2019-nCoV ranges from 2.24 to 3.58, and is significantly larger than 1.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32024089
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The 2019-nCoV cases might have been under-reported roughly from 1 to 15 January 2020, and thus we estimated the number of unreported cases and the basic reproduction number, &lt;i&gt;R&lt;/i&gt;&lt;sub&gt;0&lt;/sub&gt;, of 2019-nCoV. […] We used the serial intervals (SI) of infection caused by two other well-known coronaviruses (CoV), Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) CoVs, as approximations of the unknown SI for 2019-nCoV to estimate &lt;i&gt;R&lt;/i&gt;&lt;sub&gt;0&lt;/sub&gt;. […] The reporting rate after 17 January 2020 was likely to have increased 21-fold (95% CI: 18-25) in comparison to the situation from 1 to 17 January 2020 on average. […] The under-reporting was likely to have occurred during the first half of January 2020 and should be considered in future investigation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TF</title>
      <link>/genepanel/7018/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7018/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;transferrin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of TF gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253400
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Total flavonoids (TF), the main active components derived from loquat leaves, showed remarkable anti-inflammatory and antioxidant activities. […] The results demonstrated that TF suppressed the histological changes in the lungs of CS-challenged mice, as evidenced by reduced generation of pro-inflammatory cytokines including interleukin 6 (IL-6), IL-1β, tumor necrosis factor α (TNF-α), nitric oxide (NO), and inducible nitric oxide synthase (iNOS) and diminished the protein expression of transient receptor potential vanilloid 1 (TRPV1). […] Moreover, TF also inhibited phosphorylation of IKK, IκB and NFκB and increased p-Akt. […] Interestingly, TF could inhibit CS-induced oxidative stress in the lungs of COPD mice. […] TF treatment significantly inhibited the level of malondialdehyde (MDA) and increased the activity of superoxide dismutase (SOD). […] In addition, TF markedly downregulated TRPV1 and cytochrome P450 2E1 (CYP2E1) and upregulated the expression of SOD-2, while the p-JNK level was observed to be inhibited in COPD mice. […] Taken together, our findings showed that the protective effect and putative mechanism of the action of TF resulted in the inhibition of inflammation and oxidative stress through the regulation of TRPV1 and the related signal pathway in lung tissues. […] It suggested that TF derived from loquat leaves could be considered to be an alternative or a new functional material and used for the treatment of CS-induced COPD.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TLR4</title>
      <link>/genepanel/7099/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7099/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;toll like receptor 4&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of TLR4 gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32249203
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In variant constructs, we engineered immune stimulants (RS09 or flagellin, as TLR4 or TLR5 agonists, respectively) into this trimeric design.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TLR5</title>
      <link>/genepanel/7100/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7100/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;toll like receptor 5&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of TLR5 gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32249203
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In variant constructs, we engineered immune stimulants (RS09 or flagellin, as TLR4 or TLR5 agonists, respectively) into this trimeric design.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TMPRSS2</title>
      <link>/genepanel/7113/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7113/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;transmembrane serine protease 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of TMPRSS2 gene in 10 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32142651
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Here, we demonstrate that SARS-CoV-2 uses the SARS-CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming. […] A TMPRSS2 inhibitor approved for clinical use blocked entry and might constitute a treatment option.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32165541
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Here, we show that a TMPRSS2-expressing VeroE6 cell line is highly susceptible to SARS-CoV-2 infection, making it useful for isolating and propagating SARS-CoV-2. […] Our results reveal that, in common with SARS- and Middle East respiratory syndrome-CoV, SARS-CoV-2 infection is enhanced by TMPRSS2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32246845
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
SARS-CoV-2 was reported to enter cells via binding to ACE2, followed by its priming by TMPRSS2. […] Here, we investigate ACE2 and TMPRSS2 expression levels and their distribution across cell types in lung tissue (twelve donors, 39,778 cells) and in cells derived from subsegmental bronchial branches (four donors, 17,521 cells) by single nuclei and single cell RNA sequencing, respectively. […] While TMPRSS2 is expressed in both tissues, in the subsegmental bronchial branches ACE2 is predominantly expressed in a transient secretory cell type.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32257537
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Furthermore, the gene expression profile showed MSCs were ACE2&lt;sup&gt;-&lt;/sup&gt; and TMPRSS2&lt;sup&gt;-&lt;/sup&gt; which indicated MSCs are free from COVID-19 infection.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32276929
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
TMPRSS2 is both the most frequently altered gene in primary prostate cancer and a critical factor enabling cellular infection by coronaviruses, including SARS-CoV-2. […] The modulation of its expression by sex steroids could contribute to the male predominance of severe infections and given that TMPRSS2 has no known indispensable functions, and inhibitors are available, it is an appealing target for prevention or treatment of respiratory viral infections.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32278065
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
SARS-CoV uses the the angiotensin-converting enzyme 2 (ACE2) and the serine protease TMPRSS2 for S protein priming. […] ACE2 and TMPRSS2 are not only expressed in lung, but also in the small intestinal epithelia.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32279064
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Similar to the respiratory mucosa, angiotensin converting enzyme-2 (ACE-2) receptor and transmembrane serine protease 2 TMPRSS2) co-express in the gastrointestinal tract, which facilitates viral entry into the tissue.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32283006
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Multiple non-neuronal cell types present in the olfactory epithelium express two host receptors, ACE2 and TMPRSS2 proteases, that facilitate SARS-CoV-2 binding, replication, and accumulation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32285974
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
SARS-CoV-2 was reported to enter cells via binding to ACE2, followed by its priming by TMPRSS2. […] Here, we investigate ACE2 and TMPRSS2 expression levels and their distribution across cell types in lung tissue (twelve donors, 39,778 cells) and in cells derived from subsegmental bronchial branches (four donors, 17,521 cells) by single nuclei and single cell RNA sequencing, respectively. […] While TMPRSS2 is strongly expressed in both tissues, in the subsegmental bronchial branches ACE2 is predominantly expressed in a transient secretory cell type.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293910
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The virus uses the ACE2 receptor for internalization, aided by TMPRSS2 protease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TNF</title>
      <link>/genepanel/7124/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7124/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;tumor necrosis factor&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of TNF gene in 12 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32026671
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
However, there were no statistically significant differences in serum levels of tumor necrosis factor-alpha (TNF-α), IL-1, IL-8, IL-10, hs-CRP, lymphocyte count and LDH among the three groups (P&amp;gt;0.05). &lt;b&gt;Conclusion:&lt;/b&gt; The clinical characteristics of 2019-nCoV pneumonia are similar to those of common viral pneumonia. […] 而3组研究对象血清中的肿瘤坏死因子-α（TNF-α）、IL-1β、IL-8、IL-10、hs-CRP、淋巴细胞计数、LDH表达水平差异均无统计学意义（&lt;i&gt;P&lt;/i&gt;&amp;gt;0.05）。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32171193
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
This cytokine inhibits class II histocompatibility complex (MHC) molecules and inflammation in inflammatory diseases by suppressing MyD88 and subsequently IL-1β, IL-6, TNF and CCL2.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32205232
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
LH significantly inhibited SARS-CoV-2 replication in Vero E6 cells and markedly reduced pro-inflammatory cytokines (TNF-α, IL-6, CCL-2/MCP-1 and CXCL-10/IP-10) production at the mRNA levels.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32217834
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Increased cytokine levels (IL-6, IL-10, and TNF-α), lymphopenia (in CD4+ and CD8+ T cells), and decreased IFN-γ expression in CD4+ T cells are associated with severe COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32217835
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Compared with moderate cases, severe cases more frequently had dyspnea, lymphopenia, and hypoalbuminemia, with higher levels of alanine aminotransferase, lactate dehydrogenase, C-reactive protein, ferritin, and D-dimer as well as markedly higher levels of IL-2R, IL-6, IL-10, and TNF-α.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32228827
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
All differentially expressed genes were introduced into the SREING online analysis website for protein interaction network analysis, and core genes such as signal transducer and activator of transcription 3, IL-10, IL17, TNF, interferon regulatory factor 9, 2’-5’-oligoadenylate synthetase 1, mitogen-activated protein kinase 3, radical s-adenosyl methionine domain containing 2, c-x-c motif chemokine ligand 10, caspase 3 and other genes were screened. […] The drugs predicted by EpiMed’s apparent precision treatment prediction platform for disease-drug association analysis are mainly TNF-α inhibitors, resveratrol, ritonavir, paeony, retinoic acid, forsythia, and houttuynia cordata. &lt;b&gt;Conclusions:&lt;/b&gt; The abnormal activation of multiple inflammatory pathways may be the cause of heart failure in patients after coronavirus infection. […] 冠状病毒与心衰差异表达基因富集分析，取交集处理共有GO条目20条，主要富集在病毒反应、病毒防御反应、Ⅰ型干扰素反应、γ干扰素调节、先天免疫反应调节、病毒生命周期负调控、病毒基因组复制调控等；共有5条KEGG通路，主要与肿瘤坏死因子（TNF）信号通路、白细胞介素（IL）-17信号通路、细胞因子与受体相互作用、Toll样受体信号通路、人类巨细胞病毒感染有关。 […] 蛋白互作网络分析筛选出信号传导及转录激活蛋白3、IL-10、IL-17、TNF、干扰素调节因子9、2’,5’-寡腺苷酸合成酶1、丝裂原活化蛋白激酶3、S-腺苷甲硫氨酸基区域蛋白2、CXC趋化因子配体10、半胱氨酸天冬氨酸蛋白酶3共10个核心基因。 […] EpiMed平台预测可能对冠状病毒所致心衰有效的药物为TNF-α抑制剂、白藜醇、利托那韦、白芍、维甲酸、连翘、鱼腥草等。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253400
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The results demonstrated that TF suppressed the histological changes in the lungs of CS-challenged mice, as evidenced by reduced generation of pro-inflammatory cytokines including interleukin 6 (IL-6), IL-1β, tumor necrosis factor α (TNF-α), nitric oxide (NO), and inducible nitric oxide synthase (iNOS) and diminished the protein expression of transient receptor potential vanilloid 1 (TRPV1).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32257537
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Meanwhile, the level of TNF-α was significantly decreased, while IL-10 increased in MSC treatment group compared to the placebo control group.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32259129
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this context, both &lt;i&gt;in vitro&lt;/i&gt; and &lt;i&gt;in vivo&lt;/i&gt; studies have revealed that metronidazole could decrease the levels of several cytokines, which are known to increase during the COVID-19 infection, including interleukin (IL)8, IL6, IL1B, tumor necrosis factor (TNF)α, IL12, IL1α, and interferon (IFN)γ, as well as the levels of C-reactive protein (CRP) and neutrophil count.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32267560
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The main mechanism of ARDS is uncontrolled systemic inflammatory response and cytokine storm following release of proinflammatory cytokines (such as interferons (IFN), interleukines (IL), tumor necrosis factor (TNF)-α) and chemokines.&lt;sup&gt;2-3&lt;/sup&gt; So, some Chinese researchers proposed or used anti-inflammatory agents in the treatment regimen of patients with COVID-19.&lt;sup&gt;3-4&lt;/sup&gt;.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281329
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Arachidonic acid(AA) metabolic pathway is principally used to synthesize inflammatory cytokines, such as monocyte chemotactic protein 1(MCP-1), tumor necrosis factor(TNF), IL, IFN, etc., which is closely related to the occurrence, development and regression of inflammation.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32294485
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Elder age, underlying hypertension, high cytokine levels (IL-2R, IL-6, IL-10, and TNF-a), and high LDH level were significantly associated with severe COVID-19 on admission.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>VIP</title>
      <link>/genepanel/7432/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7432/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;vasoactive intestinal peptide&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of VIP gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32268923
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We will search electronic databases including PubMed, Embase, the Cochrane Central Register of Controlled Trials (CENTRAL), Chinese Biomedical Literature Database (CBM), China National Knowledge Infrastructure (CNKI), Chinese Science and Technology Periodical Database (VIP), and Wanfang database using keywords related to COVID-19 and traditional Chinese herbal medicine.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281332
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this paper, We collected and sorted the prescriptions of modern Chinese medicine for COVID-19 released by national government, different provinces, autonomous regions and municipalities, as well as online databases, such as CNKI, WanFang medical network, and VIP database.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TRPV1</title>
      <link>/genepanel/7442/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7442/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;transient receptor potential cation channel subfamily V member 1&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of TRPV1 gene in 2 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253400
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The results demonstrated that TF suppressed the histological changes in the lungs of CS-challenged mice, as evidenced by reduced generation of pro-inflammatory cytokines including interleukin 6 (IL-6), IL-1β, tumor necrosis factor α (TNF-α), nitric oxide (NO), and inducible nitric oxide synthase (iNOS) and diminished the protein expression of transient receptor potential vanilloid 1 (TRPV1). […] In addition, TF markedly downregulated TRPV1 and cytochrome P450 2E1 (CYP2E1) and upregulated the expression of SOD-2, while the p-JNK level was observed to be inhibited in COPD mice. […] Taken together, our findings showed that the protective effect and putative mechanism of the action of TF resulted in the inhibition of inflammation and oxidative stress through the regulation of TRPV1 and the related signal pathway in lung tissues.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292906
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
We hypothesize that the morbidity, severity of the disease, and underlying physiological events leading to mortality are closely linked to the TRPV1 expressing neuronal system (afferent/efferent neurons) in the lungs. […] TRPV1 expressing cells are responsible for pain transmission, inflammation and immunomodulation throughout the entire pulmonary system and are modulating the processes associated with localized cytokine release (storm) and overall rapid disease progression. […] We suggest that therapeutic approaches targeting TRPV1 containing nerve fibers in the lungs will modulate the inflammatory and immune signal activity, leading to reduced mortality and better overall outcomes. […] We also propose to further explore the use of resiniferatoxin (RTX), an ultra-potent TRPV1 agonist currently in clinical trials for cancer and osteoarthritis pain, as a possible ablating agent of TRPV1 positive pulmonary pathways in patients with advanced COVID-19 disease.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CAD</title>
      <link>/genepanel/790/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/790/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of CAD gene in 1 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32265088
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Computer-aided design (CAD) was used to produce the reusable components of the 3D face mask based on individual facial scans, which were acquired using a new-generation smartphone with two cameras and a face scanning application. […] 3D modelling can easily be done by CAD designers worldwide with free download software.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CD4</title>
      <link>/genepanel/920/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/920/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;CD4 molecule&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of CD4 gene in 11 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32118639
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The effects of cluster of differentiation 4 (CD4)+ T lymphocytes, inflammatory indicators, and glucocorticoid treatment on viral nucleic acid clearance were analyzed. […] Using a multiple linear regression model (F = 2.669, P = 0.044, and adjusted R = 0.122), the analysis showed that the CD4+ T lymphocyte count may help predict the duration of viral RNA detection in patients’ stools (t = -2.699, P = 0.010).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32171869
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In multivariate logistical analysis, age (Odds ratio [OR] = 1.06) and CD4 T cell count (OR = 0.55 per 100 cells/ul increase) were independently associated with ICU admission.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32172546
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Most of infiltrated lymphocytes were CD4-positive T cells. […] 淋巴细胞主要为CD4阳性T细胞。
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32193831
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Other findings included decreased CD16 + CD56 (4/8) and Th/Ts*(1/8), increased CD3 (2/8), CD4 (4/8) and CD8 (1/8), IL-6 (2/8), IL-10 (5/8) and IFN-γ (2/8).
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32217834
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Increased cytokine levels (IL-6, IL-10, and TNF-α), lymphopenia (in CD4+ and CD8+ T cells), and decreased IFN-γ expression in CD4+ T cells are associated with severe COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32217835
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Absolute numbers of T lymphocytes, CD4+ T cells, and CD8+ T cells decreased in nearly all the patients, and were markedly lower in severe cases (294.0, 177.5, and 89.0 × 106/L, respectively) than moderate cases (640.5, 381.5, and 254.0 × 106/L, respectively). […] The expression of IFN-γ by CD4+ T cells tended to be lower in severe cases (14.1%) than in moderate cases (22.8%). […] CONCLUSIONThe SARS-CoV-2 infection may affect primarily T lymphocytes, particularly CD4+ and CD8+ T cells, resulting in a decrease in numbers as well as IFN-γ production by CD4+ T cells.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32227123
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Total lymphocytes, CD4+ T cells, CD8+ T cells, B cells and natural killer (NK) cells decreased in COVID-19 patients, and severe cases had a lower level than mild cases. […] The subsets showed a significant association with the inflammatory status in COVID-19, especially CD8+ T cells and CD4+/CD8+ ratio. […] In multivariate analysis, post-treatment decrease of CD8+ T cells and B cells and increase of CD4+/CD8+ ratio were indicated as independent predictors for poor efficacy.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32233642
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Further analysis showed that the CD4+ T cell count but not the CD8+ T cell count of the aggravation group was significantly lower than that of the non-aggravation group. […] Correlation analysis indicated total lymphocyte count was positively correlated with CD4+ T cell count, and no significant differences were found between the 2 groups in other laboratory measurements, including those of white blood cell (WBC) count, C-reactive protein (CRP), albumin, lactate dehydrogenase (LDH), and D-dimer.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32253888
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
The immune regulatory genes encoded by X chromosome in female gender causes lower viral load levels, and less inflammation than in man, while CD4+ T cells are higher with better immune response. […] The X chromosome influences the immune system by acting on many other proteins, including TLR8, CD40L and CXCR3 which can be over-expressed in women, and influence the response to viral infections and vaccinations.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32257537
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
After treatment, the peripheral lymphocytes were increased, the C-reactive protein decreased, and the overactivated cytokine-secreting immune cells CXCR3+CD4+ T cells, CXCR3+CD8+ T cells, and CXCR3+ NK cells disappeared in 3-6 days.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32293910
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Lymphopenia occurs early and is prognostic, potentially associated with reduction of the CD4+ and some CD8+ T cells.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>MSC</title>
      <link>/genepanel/9242/gene_context/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/9242/gene_context/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/kePrint/kePrint.js&#34;&gt;&lt;/script&gt;


&lt;hr /&gt;
&lt;p&gt;musculin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;gene-context-sentence&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Gene Context Sentence&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Table 2.&lt;/strong&gt; Analysis of context sentence of MSC gene in 6 abstracts.
&lt;/p&gt;
&lt;table class=&#34;table table-striped&#34; style=&#34;width: auto !important; margin-left: auto; margin-right: auto;&#34;&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
PMID
&lt;/th&gt;
&lt;th style=&#34;text-align:center;position: sticky; top:0; background-color: #FFFFFF;&#34;&gt;
Gene Context Sentence
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32214286
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Finally, expanded umbilical cord mesenchymal stem cells or (UC-MSCs) may have a role and are being studied. […] Thus, at this point, the avoidance of the cytokine storm may be the key for the treatment of HCOV-19 infected patients.In China, where there was limited availability of effective modalities to manage COVID-19 several patients were treated with expanded UC-MSCs. […] The limited but emerging evidence regarding UC MSC in managing COVID-19 suggests that it might be considered for compassionate use in critically ill patients to reduce morbidity and mortality in the United States. […] The administration and Coronavirus Task Force might wish to approach the potential of expanded UC-MSCs as an evolutionary therapeutic strategy in managing COVID-19 illness with a 3-pronged approach: If proven safe and effective on a specific and limited basis…1.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32257537
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Mesenchymal stem cells (MSCs) have been shown to possess a comprehensive powerful immunomodulatory function. […] This study aims to investigate whether MSC transplantation improves the outcome of 7 enrolled patients with COVID-19 pneumonia in Beijing YouAn Hospital, China, from Jan 23, 2020 to Feb 16, 2020. […] The clinical outcomes, as well as changes of inflammatory and immune function levels and adverse effects of 7 enrolled patients were assessed for 14 days after MSC injection. […] MSCs could cure or significantly improve the functional outcomes of seven patients without observed adverse effects. […] The pulmonary function and symptoms of these seven patients were significantly improved in 2 days after MSC transplantation. […] Meanwhile, the level of TNF-α was significantly decreased, while IL-10 increased in MSC treatment group compared to the placebo control group. […] Furthermore, the gene expression profile showed MSCs were ACE2&lt;sup&gt;-&lt;/sup&gt; and TMPRSS2&lt;sup&gt;-&lt;/sup&gt; which indicated MSCs are free from COVID-19 infection. […] Thus, the intravenous transplantation of MSCs was safe and effective for treatment in patients with COVID-19 pneumonia, especially for the patients in critically severe condition.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32257554
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
A new study published by the journal Aging &amp;amp; Disease reported that intravenous administration of clinical-grade human mesenchymal stem cells (MSCs) into patients with coronavirus disease 2019 (COVID-19) resulted in improved functional outcomes (&lt;i&gt;Leng et al., Aging Dis, 11:216-228, 2020&lt;/i&gt;). […] This study demonstrated that intravenous infusion of MSCs is a safe and effective approach for treating patients with COVID-19 pneumonia, including elderly patients displaying severe pneumonia. […] Therefore, MSC therapy inhibiting the overactivation of the immune system and promoting endogenous repair by improving the lung microenvironment after the SARS-CoV-2 infection found in this study is striking.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32265310
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Cell-based approaches, primarily using mesenchymal stem (stromal) cells (MSCs), have demonstrated safety and possible efficacy in patients with the acute respiratory distress syndrome (ARDS), although not as yet well studied in respiratory virus-induced ARDS. […] Limited pre-clinical data suggest that systemic MSC administration can significantly reduce respiratory virus (Influenza strains H5N1 and H9N2)-induced lung injury, however, there are no available data in models of coronavirus respiratory infection.There are a rapidly increasing number of clinical investigations of cell-based therapy approaches for COVID-19. […] To provide a rationale strategy to maximise potential therapeutic use, it is critically important to understand the relevant pre-clinical studies and postulated mechanisms of MSC actions in respiratory virus-induced lung injuries.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32281052
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
In this regard, mesenchymal stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach and several clinical trials have begun. […] Recently, MSCs according to their immunomodulatory and regenerative properties attract attention in clinical trials. […] After the intravenous transplantation of MSCs, a significant population of cells accumulates in the lung, which they alongside immunomodulatory effect could protect alveolar epithelial cells, reclaim the pulmonary microenvironment, prevent pulmonary fibrosis, and cure lung dysfunction. […] In this study, we considered this new approach to improve patient’s immunological responses to COVID-19 using MSCs and discussed the aspects of this proposed treatment. […] However, currently, there are no approved MSC-based approaches for the prevention and/or treatment of COVID-19 patients but clinical trials ongoing.
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
32292627
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
Transplantation of mesenchymal stem cells (MSCs) is a promising choice for treating virus-induced pneumonia, and was needed to treat H7N9 induced ARDS at the time. […] MSCs transplant into patients with H7N9 induced ARDS were conducted in a single center and open-label clinical trial. […] Based on the principle of voluntariness and informed consent, 44 patients with H7N9 induced ARDS were included as a control group while 17 patients with H7N9 induced ARDS were served as an experimental group with allogeneic menstrual blood-derived MSC. […] Notably, MSC transplantation significantly lower the mortality compared with in control group (17.6% died in MSC group vs 54.5% died in control group). […] Furthermore, MSC transplantation did not result in harmful effects in human body within the 5 year follow up period with 4 patients. […] Collectively, these results suggest that MSCs significantly improve survival rate of H7N9 induced ARDS and provide a theoretical basis for the treatment of H7N9 induced ARDS in both preclinical research and clinical studies. […] Because H7N9 and the corona virus disease 2019 (COVID-19) share similar complications (such as ARDS and lung failure) and corresponding multi-organ dysfunction, MSC-based therapy could be a possible alternative for treating COVID-19.
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>How to use PlatCOVID</title>
      <link>/supp/faq/how_to_use/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/supp/faq/how_to_use/</guid>
      <description>&lt;h2 id=&#34;syntax-analysis&#34;&gt;Syntax Analysis&lt;/h2&gt;
&lt;h2 id=&#34;covid-19-panels&#34;&gt;COVID-19 Panels&lt;/h2&gt;
&lt;h2 id=&#34;platcovid-discussion&#34;&gt;PlatCOVID discussion&lt;/h2&gt;
</description>
    </item>
    
    <item>
      <title>SDS</title>
      <link>/genepanel/10993/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/10993/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;serine dehydratase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CHM</title>
      <link>/genepanel/1121/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1121/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;CHM Rab escort protein&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NRM</title>
      <link>/genepanel/11270/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/11270/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;nurim&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NLRP3</title>
      <link>/genepanel/114548/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/114548/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;NLR family pyrin domain containing 3&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CP</title>
      <link>/genepanel/1356/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1356/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;ceruloplasmin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CPE</title>
      <link>/genepanel/1363/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1363/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;carboxypeptidase E&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CRP</title>
      <link>/genepanel/1401/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1401/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;C-reactive protein&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ACE</title>
      <link>/genepanel/1636/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1636/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;angiotensin I converting enzyme&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>AGA</title>
      <link>/genepanel/175/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/175/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;aspartylglucosaminidase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>DPP4</title>
      <link>/genepanel/1803/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1803/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;dipeptidyl peptidase 4&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ENPEP</title>
      <link>/genepanel/2028/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2028/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;glutamyl aminopeptidase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ALB</title>
      <link>/genepanel/213/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/213/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;albumin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>EZH2</title>
      <link>/genepanel/2146/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2146/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;enhancer of zeste 2 polycomb repressive complex 2 subunit&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SIRT1</title>
      <link>/genepanel/23411/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/23411/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;sirtuin 1&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>G6PD</title>
      <link>/genepanel/2539/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2539/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;glucose-6-phosphate dehydrogenase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ANG</title>
      <link>/genepanel/283/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/283/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;angiogenin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CXCR3</title>
      <link>/genepanel/2833/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2833/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;C-X-C motif chemokine receptor 3&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ANPEP</title>
      <link>/genepanel/290/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/290/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;alanyl aminopeptidase, membrane&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HBM</title>
      <link>/genepanel/3042/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3042/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;hemoglobin subunit mu&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HGF</title>
      <link>/genepanel/3082/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3082/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;hepatocyte growth factor&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL1B</title>
      <link>/genepanel/3553/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3553/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;interleukin 1 beta&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL2</title>
      <link>/genepanel/3558/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3558/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;interleukin 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL6</title>
      <link>/genepanel/3569/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3569/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;interleukin 6&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL7</title>
      <link>/genepanel/3574/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3574/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;interleukin 7&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL10</title>
      <link>/genepanel/3586/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3586/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;interleukin 10&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IVD</title>
      <link>/genepanel/3712/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3712/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;isovaleryl-CoA dehydrogenase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>JAK2</title>
      <link>/genepanel/3717/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3717/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;Janus kinase 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>MB</title>
      <link>/genepanel/4151/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/4151/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;myoglobin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NHS</title>
      <link>/genepanel/4810/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/4810/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;NHS actin remodeling regulator&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TAS2R10</title>
      <link>/genepanel/50839/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/50839/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;taste 2 receptor member 10&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PC</title>
      <link>/genepanel/5091/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/5091/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;pyruvate carboxylase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>FOXP3</title>
      <link>/genepanel/50943/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/50943/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;forkhead box P3&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TLR7</title>
      <link>/genepanel/51284/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/51284/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;toll like receptor 7&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TLR8</title>
      <link>/genepanel/51311/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/51311/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;toll like receptor 8&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PLP2</title>
      <link>/genepanel/5355/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/5355/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;proteolipid protein 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PID1</title>
      <link>/genepanel/55022/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/55022/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;phosphotyrosine interaction domain containing 1&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HR</title>
      <link>/genepanel/55806/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/55806/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;HR lysine demethylase and nuclear receptor corepressor&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SHD</title>
      <link>/genepanel/56961/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/56961/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;Src homology 2 domain containing transforming protein D&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ACE2</title>
      <link>/genepanel/59272/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/59272/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;angiotensin I converting enzyme 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NPS</title>
      <link>/genepanel/594857/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/594857/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;neuropeptide S&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>RHO</title>
      <link>/genepanel/6010/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/6010/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;rhodopsin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CCL2</title>
      <link>/genepanel/6347/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/6347/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;C-C motif chemokine ligand 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>BID</title>
      <link>/genepanel/637/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/637/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;BH3 interacting domain death agonist&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SI</title>
      <link>/genepanel/6476/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/6476/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;sucrase-isomaltase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TF</title>
      <link>/genepanel/7018/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7018/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;transferrin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TLR4</title>
      <link>/genepanel/7099/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7099/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;toll like receptor 4&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TLR5</title>
      <link>/genepanel/7100/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7100/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;toll like receptor 5&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TMPRSS2</title>
      <link>/genepanel/7113/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7113/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;transmembrane serine protease 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TNF</title>
      <link>/genepanel/7124/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7124/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;tumor necrosis factor&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>VIP</title>
      <link>/genepanel/7432/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7432/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;vasoactive intestinal peptide&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TRPV1</title>
      <link>/genepanel/7442/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7442/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;transient receptor potential cation channel subfamily V member 1&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CAD</title>
      <link>/genepanel/790/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/790/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CD4</title>
      <link>/genepanel/920/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/920/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;CD4 molecule&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>MSC</title>
      <link>/genepanel/9242/clinvar/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/9242/clinvar/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;musculin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;clinvar-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;ClinVar Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SDS</title>
      <link>/genepanel/10993/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/10993/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;serine dehydratase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CHM</title>
      <link>/genepanel/1121/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1121/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;CHM Rab escort protein&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NRM</title>
      <link>/genepanel/11270/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/11270/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;nurim&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NLRP3</title>
      <link>/genepanel/114548/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/114548/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;NLR family pyrin domain containing 3&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CP</title>
      <link>/genepanel/1356/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1356/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;ceruloplasmin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CPE</title>
      <link>/genepanel/1363/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1363/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;carboxypeptidase E&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CRP</title>
      <link>/genepanel/1401/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1401/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;C-reactive protein&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ACE</title>
      <link>/genepanel/1636/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1636/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;angiotensin I converting enzyme&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>AGA</title>
      <link>/genepanel/175/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/175/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;aspartylglucosaminidase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>DPP4</title>
      <link>/genepanel/1803/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/1803/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;dipeptidyl peptidase 4&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ENPEP</title>
      <link>/genepanel/2028/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2028/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;glutamyl aminopeptidase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ALB</title>
      <link>/genepanel/213/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/213/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;albumin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>EZH2</title>
      <link>/genepanel/2146/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2146/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;enhancer of zeste 2 polycomb repressive complex 2 subunit&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SIRT1</title>
      <link>/genepanel/23411/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/23411/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;sirtuin 1&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>G6PD</title>
      <link>/genepanel/2539/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2539/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;glucose-6-phosphate dehydrogenase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ANG</title>
      <link>/genepanel/283/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/283/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;angiogenin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CXCR3</title>
      <link>/genepanel/2833/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/2833/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;C-X-C motif chemokine receptor 3&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ANPEP</title>
      <link>/genepanel/290/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/290/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;alanyl aminopeptidase, membrane&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HBM</title>
      <link>/genepanel/3042/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3042/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;hemoglobin subunit mu&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HGF</title>
      <link>/genepanel/3082/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3082/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;hepatocyte growth factor&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL1B</title>
      <link>/genepanel/3553/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3553/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;interleukin 1 beta&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL2</title>
      <link>/genepanel/3558/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3558/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;interleukin 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL6</title>
      <link>/genepanel/3569/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3569/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;interleukin 6&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL7</title>
      <link>/genepanel/3574/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3574/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;interleukin 7&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IL10</title>
      <link>/genepanel/3586/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3586/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;interleukin 10&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>IVD</title>
      <link>/genepanel/3712/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3712/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;isovaleryl-CoA dehydrogenase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>JAK2</title>
      <link>/genepanel/3717/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/3717/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;Janus kinase 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>MB</title>
      <link>/genepanel/4151/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/4151/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;myoglobin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NHS</title>
      <link>/genepanel/4810/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/4810/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;NHS actin remodeling regulator&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TAS2R10</title>
      <link>/genepanel/50839/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/50839/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;taste 2 receptor member 10&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PC</title>
      <link>/genepanel/5091/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/5091/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;pyruvate carboxylase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>FOXP3</title>
      <link>/genepanel/50943/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/50943/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;forkhead box P3&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TLR7</title>
      <link>/genepanel/51284/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/51284/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;toll like receptor 7&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TLR8</title>
      <link>/genepanel/51311/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/51311/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;toll like receptor 8&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PLP2</title>
      <link>/genepanel/5355/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/5355/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;proteolipid protein 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>PID1</title>
      <link>/genepanel/55022/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/55022/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;phosphotyrosine interaction domain containing 1&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>HR</title>
      <link>/genepanel/55806/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/55806/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;HR lysine demethylase and nuclear receptor corepressor&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SHD</title>
      <link>/genepanel/56961/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/56961/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;Src homology 2 domain containing transforming protein D&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>ACE2</title>
      <link>/genepanel/59272/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/59272/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;angiotensin I converting enzyme 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>NPS</title>
      <link>/genepanel/594857/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/594857/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;neuropeptide S&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>RHO</title>
      <link>/genepanel/6010/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/6010/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;rhodopsin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CCL2</title>
      <link>/genepanel/6347/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/6347/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;C-C motif chemokine ligand 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>BID</title>
      <link>/genepanel/637/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/637/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;BH3 interacting domain death agonist&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>SI</title>
      <link>/genepanel/6476/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/6476/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;sucrase-isomaltase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TF</title>
      <link>/genepanel/7018/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7018/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;transferrin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TLR4</title>
      <link>/genepanel/7099/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7099/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;toll like receptor 4&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TLR5</title>
      <link>/genepanel/7100/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7100/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;toll like receptor 5&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TMPRSS2</title>
      <link>/genepanel/7113/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7113/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;transmembrane serine protease 2&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TNF</title>
      <link>/genepanel/7124/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7124/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;tumor necrosis factor&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>VIP</title>
      <link>/genepanel/7432/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7432/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;vasoactive intestinal peptide&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>TRPV1</title>
      <link>/genepanel/7442/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/7442/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;transient receptor potential cation channel subfamily V member 1&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CAD</title>
      <link>/genepanel/790/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/790/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>CD4</title>
      <link>/genepanel/920/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/920/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;CD4 molecule&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>MSC</title>
      <link>/genepanel/9242/geo/</link>
      <pubDate>Sun, 05 May 2019 00:00:00 +0100</pubDate>
      <guid>/genepanel/9242/geo/</guid>
      <description>


&lt;hr /&gt;
&lt;p&gt;musculin&lt;/p&gt;
&lt;hr /&gt;
&lt;div id=&#34;geo-dataset-summary&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;GEO dataset Summary&lt;/h2&gt;
&lt;br&gt;
&lt;p style=&#34;font-size:16px&#34; align=&#34;center&#34;&gt;
Under development
&lt;/p&gt;
&lt;hr /&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).</title>
      <link>/publication/32252141/</link>
      <pubDate>Fri, 17 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32252141/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Covid-19 in patients on dialysis: infection prevention and control strategies].</title>
      <link>/publication/32281757/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32281757/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Fatal outcome of coronavirus disease 2019 in a previously healthy 50-year-old man].</title>
      <link>/publication/32286213/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32286213/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Palliation in patients with severe COVID-19].</title>
      <link>/publication/32293020/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32293020/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A case of imported COVID-19 diagnosed by PCR-positive lower respiratory specimen but with PCR-negative throat swabs.</title>
      <link>/publication/32238024/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32238024/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A Diabetic Patient With 2019-nCoV (COVID-19) Infection Who Recovered and Was Discharged From Hospital.</title>
      <link>/publication/32168162/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32168162/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A Review of SARS-CoV-2 and the Ongoing Clinical Trials.</title>
      <link>/publication/32290293/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32290293/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence.</title>
      <link>/publication/32201353/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32201353/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study.</title>
      <link>/publication/32171872/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32171872/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review.</title>
      <link>/publication/32281481/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32281481/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding.</title>
      <link>/publication/32284613/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32284613/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults.</title>
      <link>/publication/32134205/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32134205/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India.</title>
      <link>/publication/32290644/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32290644/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study.</title>
      <link>/publication/32220650/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32220650/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.</title>
      <link>/publication/32289548/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32289548/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis.</title>
      <link>/publication/32283155/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32283155/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation.</title>
      <link>/publication/32171867/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32171867/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study.</title>
      <link>/publication/32220284/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32220284/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical Progression of COVID-19 Patient with Extended Incubation Period, Delayed RT-PCR Time-to-positivity, and Potential Role of Chest CT-scan.</title>
      <link>/publication/32291376/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32291376/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical progression of patients with COVID-19 in Shanghai, China.</title>
      <link>/publication/32171869/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32171869/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2.</title>
      <link>/publication/32286790/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32286790/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc).</title>
      <link>/publication/32247213/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32247213/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus Disease 2019 (COVID-19) and Pregnancy: Responding to a Rapidly Evolving Situation.</title>
      <link>/publication/32213786/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32213786/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options.</title>
      <link>/publication/32284951/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32284951/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 and diabetes: Knowledge in progress.</title>
      <link>/publication/32278764/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32278764/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Covid-19 in Critically Ill Patients in the Seattle Region - Case Series.</title>
      <link>/publication/32227758/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32227758/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 Infection: Implications for Perioperative and Critical Care Physicians.</title>
      <link>/publication/32195698/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32195698/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19, ACE2, and the cardiovascular consequences.</title>
      <link>/publication/32228252/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32228252/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19: A promising cure for the global panic.</title>
      <link>/publication/32278175/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32278175/</guid>
      <description></description>
    </item>
    
    <item>
      <title>CT Scans of Patients with 2019 Novel Coronavirus (COVID-19) Pneumonia.</title>
      <link>/publication/32292517/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292517/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?</title>
      <link>/publication/32229322/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32229322/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection.</title>
      <link>/publication/32281785/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32281785/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus Disease 2019 patient.</title>
      <link>/publication/32229107/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32229107/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China.</title>
      <link>/publication/32289565/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32289565/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Epidemiological Characteristics on the Clustering Nature of COVID-19 in Qingdao City, 2020: A Descriptive Analysis.</title>
      <link>/publication/32228732/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32228732/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Evidence Based Management Guideline for the COVID-19 Pandemic - Review article.</title>
      <link>/publication/32289472/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32289472/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine.</title>
      <link>/publication/32253799/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32253799/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines.</title>
      <link>/publication/32289016/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32289016/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Household Transmission of SARS-CoV-2.</title>
      <link>/publication/32283139/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32283139/</guid>
      <description></description>
    </item>
    
    <item>
      <title>How to link patients with suspicious COVID-19 to health system from the community pharmacies? A route proposal.</title>
      <link>/publication/32224133/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32224133/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Immune-epidemiological parameters of the novel coronavirus - a perspective.</title>
      <link>/publication/32237901/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32237901/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Insight into COVID-2019 for pediatricians.</title>
      <link>/publication/32187887/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32187887/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Internet Hospitals Help Prevent and Control the Epidemic of COVID-19 in China: Multicenter User Profiling Study.</title>
      <link>/publication/32250962/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32250962/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19).</title>
      <link>/publication/32284146/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32284146/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings.</title>
      <link>/publication/32283217/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32283217/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Novel Coronavirus 2019 (2019-nCoV) Infection: Part I - Preparedness and Management in the Pediatric Intensive Care Unit in Resource-limited Settings.</title>
      <link>/publication/32238612/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32238612/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Novel Coronavirus 2019 (2019-nCoV) Infection: Part II - Respiratory Support in the Pediatric Intensive Care Unit in Resource-limited Settings.</title>
      <link>/publication/32238613/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32238613/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Novel coronavirus in a 15-day-old neonate with clinical signs of sepsis, a case report.</title>
      <link>/publication/32233816/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32233816/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB.</title>
      <link>/publication/32291526/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32291526/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model.</title>
      <link>/publication/32280433/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32280433/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.</title>
      <link>/publication/32283108/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32283108/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro.</title>
      <link>/publication/32251767/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32251767/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension.</title>
      <link>/publication/32266708/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32266708/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission.</title>
      <link>/publication/32222988/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32222988/</guid>
      <description></description>
    </item>
    
    <item>
      <title>SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes.</title>
      <link>/publication/32244059/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32244059/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment.</title>
      <link>/publication/32293807/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32293807/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.</title>
      <link>/publication/32213337/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32213337/</guid>
      <description></description>
    </item>
    
    <item>
      <title>TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib.</title>
      <link>/publication/32205092/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32205092/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The characteristics and clinical value of chest CT images of novel coronavirus pneumonia.</title>
      <link>/publication/32199619/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32199619/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study.</title>
      <link>/publication/32220655/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32220655/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The Importance of Chest CT Scan in COVID-19.</title>
      <link>/publication/32291374/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32291374/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society.</title>
      <link>/publication/32275978/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32275978/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.</title>
      <link>/publication/32222466/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32222466/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease.</title>
      <link>/publication/32251634/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32251634/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Why are pregnant women susceptible to COVID-19? An immunological viewpoint.</title>
      <link>/publication/32244166/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32244166/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Why tocilizumab could be an effective treatment for severe COVID-19?</title>
      <link>/publication/32290839/</link>
      <pubDate>Thu, 16 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32290839/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Application of tracheotomy in the treatment of severe cases of COVID-19].</title>
      <link>/publication/32292012/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292012/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Coronavirus: from common cold to severe pulmonary failure].</title>
      <link>/publication/32292213/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292213/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Diagnostic imaging findings in COVID-19].</title>
      <link>/publication/32286216/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32286216/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Distributions of time, place, and population of novel coronavirus disease 2019 (COVID-19) from January 20 to February 10, 2020, in China].</title>
      <link>/publication/32292205/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292205/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease.</title>
      <link>/publication/32294562/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32294562/</guid>
      <description></description>
    </item>
    
    <item>
      <title>An evidence-based framework for priority clinical research questions for COVID-19.</title>
      <link>/publication/32257173/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32257173/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Analysis of 92 deceased patients with COVID-19.</title>
      <link>/publication/32293741/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32293741/</guid>
      <description></description>
    </item>
    
    <item>
      <title>ANTIVIRAL TREATMENT OF COVID-19.</title>
      <link>/publication/32293834/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32293834/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Biological and Epidemiological Trends in the Prevalence and Mortality due to Outbreaks of Novel Coronavirus COVID-19.</title>
      <link>/publication/32292261/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292261/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection.</title>
      <link>/publication/32292899/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292899/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha.</title>
      <link>/publication/32271459/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32271459/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics of 3,062 COVID-19 patients: a meta-analysis.</title>
      <link>/publication/32293716/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32293716/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical efficacy of lopinavir/ritonavir in the treatment of Coronavirus disease 2019.</title>
      <link>/publication/32271456/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32271456/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical Features and Outcomes of Pregnant Women Suspected of Coronavirus Disease 2019.</title>
      <link>/publication/32294503/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32294503/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period.</title>
      <link>/publication/32275257/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32275257/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical study of mesenchymal stem cell treating acute respiratory distress syndrome induced by epidemic Influenza A (H7N9) infection, a hint for COVID-19 treatment.</title>
      <link>/publication/32292627/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292627/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coinfection with COVID-19 and Coronavirus HKU1 - the critical need for repeat testing if clinically indicated.</title>
      <link>/publication/32293743/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32293743/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019.</title>
      <link>/publication/32293714/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32293714/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus 101.</title>
      <link>/publication/32292300/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292300/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection.</title>
      <link>/publication/32253888/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32253888/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know.</title>
      <link>/publication/32105680/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32105680/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications.</title>
      <link>/publication/32294179/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32294179/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses.</title>
      <link>/publication/32292881/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292881/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus: Update Related to the Current Outbreak of COVID-19.</title>
      <link>/publication/32292686/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292686/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies.</title>
      <link>/publication/32292848/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292848/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals.</title>
      <link>/publication/32292903/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292903/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 pneumonia: A review of typical CT findings and differential diagnosis.</title>
      <link>/publication/32291197/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32291197/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19: From bench to bed side.</title>
      <link>/publication/32283498/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32283498/</guid>
      <description></description>
    </item>
    
    <item>
      <title>CT features of novel coronavirus pneumonia (COVID-19) in children.</title>
      <link>/publication/32291501/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32291501/</guid>
      <description></description>
    </item>
    
    <item>
      <title>CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China.</title>
      <link>/publication/32294504/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32294504/</guid>
      <description></description>
    </item>
    
    <item>
      <title>CT Manifestations of Novel Coronavirus Pneumonia: A Case Report</title>
      <link>/publication/32157862/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32157862/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Detectable SARS-CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia.</title>
      <link>/publication/32222992/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32222992/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019-2020.</title>
      <link>/publication/32292802/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292802/</guid>
      <description></description>
    </item>
    
    <item>
      <title>EZH2-mediated H3K27me3 inhibits ACE2 expression.</title>
      <link>/publication/32291076/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32291076/</guid>
      <description></description>
    </item>
    
    <item>
      <title>German recommendations for critically ill patients with COVID‑19.</title>
      <link>/publication/32291505/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32291505/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Management Of Patients On Dialysis And With Kidney Transplant During SARS-COV-2 (COVID-19) Pandemic In Brescia, Italy.</title>
      <link>/publication/32292866/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292866/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use.</title>
      <link>/publication/32283815/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32283815/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Ongoing Clinical Trials for the Management of the COVID-19 Pandemic.</title>
      <link>/publication/32291112/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32291112/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Outcome of Coronavirus spectrum infections (SARS, MERS, COVID 1 -19) during pregnancy: a systematic review and meta-analysis.</title>
      <link>/publication/32292902/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292902/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients.</title>
      <link>/publication/32250244/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32250244/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Progress and prospect on imaging diagnosis of COVID-19.</title>
      <link>/publication/32292880/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292880/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor.</title>
      <link>/publication/32293168/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32293168/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Recent advances and perspectives of nucleic acid detection for coronavirus.</title>
      <link>/publication/32292623/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292623/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment.</title>
      <link>/publication/32234465/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32234465/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy.</title>
      <link>/publication/32253068/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32253068/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks.</title>
      <link>/publication/32272857/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32272857/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Stem cell-based therapy for coronavirus disease 2019.</title>
      <link>/publication/32292113/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292113/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Successful treatment of COVID-19 using extracorporeal membrane oxygenation, a case report.</title>
      <link>/publication/32271455/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32271455/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies.</title>
      <link>/publication/32292909/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32292909/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The epidemiology and clinical information about COVID-19.</title>
      <link>/publication/32291542/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32291542/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.</title>
      <link>/publication/32113704/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32113704/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The possible of immunotherapy for COVID-19: A systematic review.</title>
      <link>/publication/32272396/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32272396/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Tocilizumab treatment in COVID-19: A single center experience.</title>
      <link>/publication/32253759/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32253759/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Translating transmissibility measures into recommendations for coronavirus prevention.</title>
      <link>/publication/32294667/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32294667/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Treatment with convalescent plasma for COVID-19 patients in Wuhan, China.</title>
      <link>/publication/32293713/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32293713/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Urticarial eruption in COVID-19 infection.</title>
      <link>/publication/32294273/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32294273/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.</title>
      <link>/publication/32281317/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32281317/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Utilizing integrating network pharmacological approaches to investigate the potential mechanism of Ma Xing Shi Gan Decoction in treating COVID-19.</title>
      <link>/publication/32271454/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32271454/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Vademecum for the treatment of people with COVID-19. Edition 2.0, 13 March 2020.</title>
      <link>/publication/32275256/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32275256/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Venous thromboembolism in COVID-19 patients.</title>
      <link>/publication/32294289/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32294289/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Viral exanthem in COVID-19, a clinical enigma with biological significance.</title>
      <link>/publication/32294270/</link>
      <pubDate>Wed, 15 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32294270/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Analysis of property and efficacy of traditional Chinese medicine in staging revention and treatment of coronavirus disease 2019].</title>
      <link>/publication/32281333/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32281333/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Analysis on pattern of prescriptions and syndromes of traditional Chinese medicine for prevention and treatment of COVID-19].</title>
      <link>/publication/32281331/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32281331/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking].</title>
      <link>/publication/32281327/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32281327/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Strategy of pharmaceutical care services for clinical Chinese pharmacists in coronavirus disease 2019 (COVID-19)].</title>
      <link>/publication/32281334/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32281334/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Study on medication regularity of traditional Chinese medicine in treatment of COVID-19 based on data mining].</title>
      <link>/publication/32281332/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32281332/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP].</title>
      <link>/publication/32281328/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32281328/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Study on treatment of &amp;quot;cytokine storm&amp;quot; by anti-2019-nCoV prescriptions based on arachidonic acid metabolic pathway].</title>
      <link>/publication/32281329/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32281329/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Whether conjunctival congestion in patients infected with 2019 novel coronavirus is definitely related the novel coronavirus?]</title>
      <link>/publication/32283878/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32283878/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A Model for COVID-19 Prediction in Iran Based on China Parameters.</title>
      <link>/publication/32271597/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32271597/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China.</title>
      <link>/publication/32275295/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32275295/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Chest CT Findings in Patients With Coronavirus Disease 2019 and Its Relationship With Clinical Features.</title>
      <link>/publication/32091414/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32091414/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics of 19 neonates born to mothers with COVID-19.</title>
      <link>/publication/32285380/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32285380/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study.</title>
      <link>/publication/32287140/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32287140/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms.</title>
      <link>/publication/32283980/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32283980/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran.</title>
      <link>/publication/32271596/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32271596/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1.</title>
      <link>/publication/32224074/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32224074/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Computed Tomography Imaging of an HIV-infected Patient with Coronavirus Disease 2019 (COVID-19).</title>
      <link>/publication/32285949/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32285949/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care.</title>
      <link>/publication/32273156/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32273156/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up.</title>
      <link>/publication/32240670/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32240670/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 challenge for modern medicine.</title>
      <link>/publication/32286679/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32286679/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 in the perioperative period of lung resection: a brief report from a single thoracic surgery department in Wuhan, China.</title>
      <link>/publication/32289516/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32289516/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 Pandemic: Experiences in China and implications for its prevention and treatment worldwide.</title>
      <link>/publication/32286947/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32286947/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Dentists&#39; Awareness, Perception, and Attitude Regarding COVID-19 and Infection Control: Cross-Sectional Study Among Jordanian Dentists.</title>
      <link>/publication/32250959/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32250959/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Epidemiology and Clinical Characteristics of COVID-19.</title>
      <link>/publication/32271601/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32271601/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Improved Early Recognition of Coronavirus Disease-2019 (COVID-19): Single-Center Data from a Shanghai Screening Hospital.</title>
      <link>/publication/32271602/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32271602/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.</title>
      <link>/publication/32275288/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32275288/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Optimizing hydroxychloroquine dosing for patients with COVID-19: An integrative modeling approach for effective drug repurposing.</title>
      <link>/publication/32285930/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32285930/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020.</title>
      <link>/publication/32156607/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32156607/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019.</title>
      <link>/publication/32276848/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32276848/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Proposal of a low-dose, long-pitch, dual-source chest CT protocol on third-generation dual-source CT using a tin filter for spectral shaping at 100 kVp for CoronaVirus Disease 2019 (COVID-19) patients: a feasibility study.</title>
      <link>/publication/32239472/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32239472/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence.</title>
      <link>/publication/32247927/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32247927/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV.</title>
      <link>/publication/32285293/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32285293/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Significance of Serology Testing to Assist Timely Diagnosis of SARS-CoV-2 infections: Implication from a Family Cluster.</title>
      <link>/publication/32286155/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32286155/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.</title>
      <link>/publication/32251731/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32251731/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults.</title>
      <link>/publication/32202343/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32202343/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The value of urine biochemical parameters in the prediction of the severity of coronavirus disease 2019.</title>
      <link>/publication/32286242/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32286242/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Three unsuspected CT diagnoses of COVID-19.</title>
      <link>/publication/32285222/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32285222/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-analysis.</title>
      <link>/publication/32268923/</link>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32268923/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Covid-19 diagnosis : clinical recommendations and performance of nasopharyngeal swab-PCR].</title>
      <link>/publication/32270938/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32270938/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Roles of multidisciplinary team (MDT) in diagnosis and treatment of suspected cases of corona virus disease 2019 (COVID-19)].</title>
      <link>/publication/32275128/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32275128/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[SARS CoV-2/COVID-19: Evidence-Based Recommendation on Diagnosis and Therapy].</title>
      <link>/publication/32274773/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32274773/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A Case of COVID-19 Pneumonia in a Young Male with Full Body Rash as a Presenting Symptom.</title>
      <link>/publication/32282312/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32282312/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Arbidol Monotherapy is Superior to Lopinavir/ritonavir in Treating COVID-19.</title>
      <link>/publication/32283143/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32283143/</guid>
      <description></description>
    </item>
    
    <item>
      <title>C-reactive protein correlates with CT findings and predicts severe COVID-19 early.</title>
      <link>/publication/32281668/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32281668/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals.</title>
      <link>/publication/32175797/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32175797/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Cardiovascular Considerations in Treating Patients with Coronavirus (COVID-19).</title>
      <link>/publication/32282502/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32282502/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease.</title>
      <link>/publication/32274341/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32274341/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical and computed tomographic (CT) images characteristics in the patients with COVID-19 infection: What should radiologists need to know?</title>
      <link>/publication/32280076/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32280076/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical and immunological features of severe and moderate coronavirus disease 2019.</title>
      <link>/publication/32217835/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32217835/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics and immunosuppressants management of coronavirus disease 2019 in solid organ transplant recipients.</title>
      <link>/publication/32282986/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32282986/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study.</title>
      <link>/publication/32239591/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32239591/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical Features of COVID-19-Related Liver Damage.</title>
      <link>/publication/32283325/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32283325/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests.</title>
      <link>/publication/32114193/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32114193/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Containing COVID-19 in the emergency room: the role of improved case detection and segregation of suspect cases.</title>
      <link>/publication/32281231/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32281231/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus disease 2019: new things to know!</title>
      <link>/publication/32281667/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32281667/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies.</title>
      <link>/publication/32274342/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32274342/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Crisis Symptom Management and Patient Communication Protocols Are Important Tools for All Clinicians Responding to COVID-19.</title>
      <link>/publication/32276102/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32276102/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Current Drugs with Potential for Treatment of COVID-19: A Literature Review.</title>
      <link>/publication/32251618/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32251618/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Cytokine Storm in COVID-19 and Treatment.</title>
      <link>/publication/32283152/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32283152/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Delayed Initiation of Remdesivir in a COVID-19 Positive Patient.</title>
      <link>/publication/32281114/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32281114/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis.</title>
      <link>/publication/32104917/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32104917/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Development of Reverse Transcription Loop-mediated Isothermal Amplification (RT-LAMP) Assays Targeting SARS-CoV-2.</title>
      <link>/publication/32276051/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32276051/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review.</title>
      <link>/publication/32282894/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32282894/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management.</title>
      <link>/publication/32278065/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32278065/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Existing bitter medicines for fighting 2019-nCoV-associated infectious diseases.</title>
      <link>/publication/32281695/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32281695/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Immunosuppressive therapy maintenance in a kidney transplant recipient SARS-CoV-2 pneumonia: a case report.</title>
      <link>/publication/32282991/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32282991/</guid>
      <description></description>
    </item>
    
    <item>
      <title>In Silico Discovery of Candidate Drugs against Covid-19.</title>
      <link>/publication/32268515/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32268515/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Incidental CT Findings Suspicious for Covid-19 Associated Pneumonia on Nuclear Medicine Exams: Recognition and Management Plan.</title>
      <link>/publication/32282404/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32282404/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic.</title>
      <link>/publication/32276137/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32276137/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Mesenchymal Stem Cell Therapy for COVID-19: Present or Future.</title>
      <link>/publication/32281052/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32281052/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Middle East respiratory syndrome.</title>
      <link>/publication/32145185/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32145185/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19.</title>
      <link>/publication/32233641/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32233641/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Performance of Electrophysiology Procedures at an Academic Medical Center Amidst the 2020 Coronavirus (COVID-19) Pandemic.</title>
      <link>/publication/32281214/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32281214/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.</title>
      <link>/publication/32282022/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32282022/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay.</title>
      <link>/publication/32276116/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32276116/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: a prospective contact-tracing study.</title>
      <link>/publication/32283156/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32283156/</guid>
      <description></description>
    </item>
    
    <item>
      <title>SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection.</title>
      <link>/publication/32283006/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32283006/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients.</title>
      <link>/publication/32283141/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32283141/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Symptom Cluster of ICU nurses treating COVID-19 pneumonia patients in Wuhan, China.</title>
      <link>/publication/32276095/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32276095/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis.</title>
      <link>/publication/32283144/</link>
      <pubDate>Mon, 13 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32283144/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A cross-sectional comparison of epidemiological and clinical features of patients with coronavirus disease (COVID-19) in Wuhan and outside Wuhan, China.</title>
      <link>/publication/32278758/</link>
      <pubDate>Sun, 12 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32278758/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.</title>
      <link>/publication/32187464/</link>
      <pubDate>Sun, 12 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32187464/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Association of chemosensory dysfunction and Covid-19 in patients presenting with influenza-like symptoms.</title>
      <link>/publication/32279441/</link>
      <pubDate>Sun, 12 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32279441/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study.</title>
      <link>/publication/32279081/</link>
      <pubDate>Sun, 12 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32279081/</guid>
      <description></description>
    </item>
    
    <item>
      <title>CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city.</title>
      <link>/publication/32279115/</link>
      <pubDate>Sun, 12 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32279115/</guid>
      <description></description>
    </item>
    
    <item>
      <title>In silico studies on therapeutic agents for COVID-19: Drug repurposing approach.</title>
      <link>/publication/32278693/</link>
      <pubDate>Sun, 12 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32278693/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19).</title>
      <link>/publication/32279418/</link>
      <pubDate>Sun, 12 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32279418/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19).</title>
      <link>/publication/32269893/</link>
      <pubDate>Sat, 11 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32269893/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical evaluation of the cobas SARS-CoV-2 test and a diagnostic platform switch during 48 hours in the midst of the COVID-19 pandemic.</title>
      <link>/publication/32277022/</link>
      <pubDate>Sat, 11 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32277022/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain.</title>
      <link>/publication/32247926/</link>
      <pubDate>Sat, 11 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32247926/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020.</title>
      <link>/publication/32277759/</link>
      <pubDate>Sat, 11 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32277759/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Fatal outcome in a liver transplant recipient with COVID-19.</title>
      <link>/publication/32277591/</link>
      <pubDate>Sat, 11 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32277591/</guid>
      <description></description>
    </item>
    
    <item>
      <title>First case of COVID-19 complicated with fulminant myocarditis: a case report and insights.</title>
      <link>/publication/32277408/</link>
      <pubDate>Sat, 11 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32277408/</guid>
      <description></description>
    </item>
    
    <item>
      <title>High-resolution Chest CT Features and Clinical Characteristics of Patients Infected with COVID-19 in Jiangsu, China.</title>
      <link>/publication/32272262/</link>
      <pubDate>Sat, 11 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32272262/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Hydroxychloroquine for treatment of SARS-CoV-2 infection? Improving our confidence in a model-based approach to dose selection.</title>
      <link>/publication/32268005/</link>
      <pubDate>Sat, 11 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32268005/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic.</title>
      <link>/publication/32277351/</link>
      <pubDate>Sat, 11 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32277351/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Novel Coronavirus (SARS-CoV-2) Infection in A Renal Transplant Recipient: Case Report.</title>
      <link>/publication/32277555/</link>
      <pubDate>Sat, 11 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32277555/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Novel Coronavirus Infection in Newborn Babies Under 28 Days in China.</title>
      <link>/publication/32269087/</link>
      <pubDate>Sat, 11 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32269087/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review.</title>
      <link>/publication/32110875/</link>
      <pubDate>Sat, 11 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32110875/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Presentation of new onset anosmia during the COVID-19 pandemic.</title>
      <link>/publication/32277751/</link>
      <pubDate>Sat, 11 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32277751/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Analysis of medication characteristics of traditional Chinese medicine in treating coronavirus disease-19 based on data mining].</title>
      <link>/publication/32268018/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32268018/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Clinical experience of high-flow nasal cannula oxygen therapy in severe corona virus disease 2019 (COVID-19) patients].</title>
      <link>/publication/32268019/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32268019/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[The network investigation on knowledge, attitude and practice about COVID-19 of the residents in Anhui Province].</title>
      <link>/publication/32268643/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32268643/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?</title>
      <link>/publication/32198834/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32198834/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries.</title>
      <link>/publication/32247211/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32247211/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia.</title>
      <link>/publication/32222119/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32222119/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Compassionate Use of Remdesivir for Patients with Severe Covid-19.</title>
      <link>/publication/32275812/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32275812/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Controversial treatments: An updated understanding of the coronavirus disease 2019.</title>
      <link>/publication/32219882/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32219882/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus Disease (COVID-19) in Children - What We Know So Far and What We Do Not?</title>
      <link>/publication/32273490/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32273490/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020.</title>
      <link>/publication/32271728/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32271728/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 patients&#39; clinical characteristics, discharge rate, and fatality rate of meta-analysis.</title>
      <link>/publication/32162702/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32162702/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 with Different Severity: A Multi-center Study of Clinical Features.</title>
      <link>/publication/32275452/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32275452/</guid>
      <description></description>
    </item>
    
    <item>
      <title>CT manifestations of coronavirus disease-2019: A retrospective analysis of 73 cases by disease severity.</title>
      <link>/publication/32193037/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32193037/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Current Status of Cell-Based Therapies for Respiratory Virus Infections: Applicability to COVID-19.</title>
      <link>/publication/32265310/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32265310/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19).</title>
      <link>/publication/32238757/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32238757/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Detection of SARS-CoV-2 Among Residents and Staff Members of an Independent and Assisted Living Community for Older Adults - Seattle, Washington, 2020.</title>
      <link>/publication/32271726/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32271726/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Diagnosing COVID-19: The Disease and Tools for Detection.</title>
      <link>/publication/32223179/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32223179/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.</title>
      <link>/publication/32181911/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32181911/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Epidemiological analysis of COVID-19 and practical experience from China.</title>
      <link>/publication/32237160/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32237160/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Epidemiology of 2019 novel coronavirus in Jiangsu Province, China after wartime control measures: A population-level retrospective study.</title>
      <link>/publication/32268195/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32268195/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths.</title>
      <link>/publication/32252338/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32252338/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: A systematic review and meta-analysis.</title>
      <link>/publication/32242947/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32242947/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area.</title>
      <link>/publication/32216961/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32216961/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Infants Born to Mothers With a New Coronavirus (COVID-19).</title>
      <link>/publication/32266184/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32266184/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Intubation and mechanical ventilation of patients with COVID-19: what should we tell them?</title>
      <link>/publication/32268719/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32268719/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19.</title>
      <link>/publication/32227493/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32227493/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Plasminogen improves lung lesions and hypoxemia in patients with COVID-19.</title>
      <link>/publication/32275753/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32275753/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Point-of-care lung ultrasound in patients with COVID-19 - a narrative review.</title>
      <link>/publication/32275766/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32275766/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal.</title>
      <link>/publication/32265220/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32265220/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Presymptomatic Transmission of SARS-CoV-2 - Singapore, January 23-March 16, 2020.</title>
      <link>/publication/32271722/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32271722/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Rapid assessment of regional SARS-CoV-2 community transmission through a convenience sample of healthcare workers, the Netherlands, March 2020.</title>
      <link>/publication/32234115/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32234115/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot.</title>
      <link>/publication/32205269/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32205269/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses.</title>
      <link>/publication/32265848/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32265848/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The clinical feature of silent infections of novel coronavirus infection (COVID-19) in Wenzhou.</title>
      <link>/publication/32275074/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32275074/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection.</title>
      <link>/publication/32259899/</link>
      <pubDate>Fri, 10 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32259899/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area].</title>
      <link>/publication/32270660/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32270660/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Coronavirus and COVID-19 : focus on a galopping pandemic].</title>
      <link>/publication/32267109/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32267109/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[COVID-19 andcardiovascular diseases].</title>
      <link>/publication/32267110/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32267110/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A family cluster of severe acute respiratory syndrome coronavirus 2 infections.</title>
      <link>/publication/32270413/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32270413/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A primer on viral-associated olfactory loss in the era of COVID-19.</title>
      <link>/publication/32271490/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32271490/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence.</title>
      <link>/publication/32256705/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32256705/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.</title>
      <link>/publication/32173241/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32173241/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics of a case series of children with coronavirus disease 2019.</title>
      <link>/publication/32270592/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32270592/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical trials on drug repositioning for COVID-19 treatment.</title>
      <link>/publication/32256547/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32256547/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19.</title>
      <link>/publication/32270184/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32270184/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus membrane fusion mechanism offers as a potential target for antiviral development.</title>
      <link>/publication/32272173/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32272173/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses.</title>
      <link>/publication/32257431/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32257431/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Delivery in pregnant women infected with SARS-CoV-2: A fast review.</title>
      <link>/publication/32271947/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32271947/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster.</title>
      <link>/publication/32247826/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32247826/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?</title>
      <link>/publication/32270515/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32270515/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Effect of delay in diagnosis on transmission of COVID-19.</title>
      <link>/publication/32233563/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32233563/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Epidemiological and Clinical Aspects of COVID-19; a Narrative Review.</title>
      <link>/publication/32259130/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32259130/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Epidemiology of COVID-19 Among Children in China.</title>
      <link>/publication/32179660/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32179660/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong.</title>
      <link>/publication/32131908/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32131908/</guid>
      <description></description>
    </item>
    
    <item>
      <title>High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019.</title>
      <link>/publication/32258207/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32258207/</guid>
      <description></description>
    </item>
    
    <item>
      <title>How young patients with cancer perceive the Covid-19 (coronavirus) epidemic in Milan, Italy: is there room for other fears?</title>
      <link>/publication/32240567/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32240567/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations.</title>
      <link>/publication/32272080/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32272080/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study.</title>
      <link>/publication/32259132/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32259132/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia.</title>
      <link>/publication/32257554/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32257554/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Metronidazole; a Potential Novel Addition to the COVID-19 Treatment Regimen.</title>
      <link>/publication/32259129/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32259129/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Pulmonary High-Resolution Computed Tomography (HRCT) Findings of Patients with Early-Stage Coronavirus Disease 2019 (COVID-19) in Hangzhou, China.</title>
      <link>/publication/32246819/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32246819/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Radiological findings and clinical characteristics of pregnant women with COVID-19 pneumonia.</title>
      <link>/publication/32270479/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32270479/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong.</title>
      <link>/publication/32259546/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32259546/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Structure of M&lt;sup&gt;pro&lt;/sup&gt; from COVID-19 virus and discovery of its inhibitors.</title>
      <link>/publication/32272481/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32272481/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Survey of COVID-19 Disease Among Orthopaedic Surgeons in Wuhan, People&#39;s Republic of China.</title>
      <link>/publication/32271208/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32271208/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease.</title>
      <link>/publication/32248966/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32248966/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality.</title>
      <link>/publication/32234467/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32234467/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The enlightenment from two cases of asymptomatic infection with SARS-CoV-2: is it safe after 14 days of isolation?</title>
      <link>/publication/32251796/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32251796/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The epidemiology, diagnosis and treatment of COVID-19.</title>
      <link>/publication/32234468/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32234468/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Transplantation of ACE2&lt;sup&gt;-&lt;/sup&gt; Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia.</title>
      <link>/publication/32257537/</link>
      <pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32257537/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[SARS-CoV-2 infection during pregnancy. Information and proposal of management care. CNGOF].</title>
      <link>/publication/32199996/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32199996/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A case report of COVID-19 with false negative RT-PCR test: necessity of chest CT.</title>
      <link>/publication/32266524/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32266524/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Anesthetic Management of Patients with COVID 19 Infections during Emergency Procedures.</title>
      <link>/publication/32178954/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32178954/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon</title>
      <link>/publication/32264666/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32264666/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Considerations for statin therapy in patients with COVID-19.</title>
      <link>/publication/32267560/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32267560/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19).</title>
      <link>/publication/32266987/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32266987/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto group of ESPGHAN.</title>
      <link>/publication/32235161/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32235161/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Digestive system involvement of novel coronavirus infection: prevention and control infection from a gastroenterology perspective.</title>
      <link>/publication/32267098/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32267098/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms.</title>
      <link>/publication/32213556/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32213556/</guid>
      <description></description>
    </item>
    
    <item>
      <title>In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends.</title>
      <link>/publication/32260471/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32260471/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease.</title>
      <link>/publication/32265202/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32265202/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Primary care management of the coronavirus (COVID-19).</title>
      <link>/publication/32242438/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32242438/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study.</title>
      <link>/publication/32105637/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32105637/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Review and Prospect of Pathological Features of Corona Virus Disease.</title>
      <link>/publication/32198986/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32198986/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients.</title>
      <link>/publication/32267220/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32267220/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment.</title>
      <link>/publication/32235575/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32235575/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society.</title>
      <link>/publication/32255413/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32255413/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Therapeutic Potential for Tetracyclines in the Treatment of COVID-19.</title>
      <link>/publication/32267566/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32267566/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series.</title>
      <link>/publication/32267998/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32267998/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Traditional Chinese Medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP).</title>
      <link>/publication/32245590/</link>
      <pubDate>Wed, 08 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32245590/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical Characteristics of Coronavirus Disease 2019 in China.</title>
      <link>/publication/32109013/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32109013/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical observation and management of COVID-19 patients.</title>
      <link>/publication/32208840/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32208840/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients?</title>
      <link>/publication/32218340/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32218340/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 Outbreak: An Overview.</title>
      <link>/publication/32259829/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32259829/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses.</title>
      <link>/publication/32258351/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32258351/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Deployment of convalescent plasma for the prevention and treatment of COVID-19.</title>
      <link>/publication/32254064/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32254064/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Effectiveness of convalescent plasma therapy in severe COVID-19 patients.</title>
      <link>/publication/32253318/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32253318/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington.</title>
      <link>/publication/32220208/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32220208/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?</title>
      <link>/publication/32253172/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32253172/</guid>
      <description></description>
    </item>
    
    <item>
      <title>High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2.</title>
      <link>/publication/32255761/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32255761/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China.</title>
      <link>/publication/32255382/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32255382/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.</title>
      <link>/publication/32196410/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32196410/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.</title>
      <link>/publication/32231345/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32231345/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Insight into 2019 novel coronavirus - an updated intrim review and lessons from SARS-CoV and MERS-CoV.</title>
      <link>/publication/32247050/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32247050/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Laboratory diagnosis of emerging human coronavirus infections - the state of the art.</title>
      <link>/publication/32196430/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32196430/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Maternal and Perinatal Outcomes with COVID-19: a systematic review of 108 pregnancies.</title>
      <link>/publication/32259279/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32259279/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Novel coronavirus infection in children outside of Wuhan, China.</title>
      <link>/publication/32259403/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32259403/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Nuclear medicine in SARS-CoV-2 pandemia: 18F-FDG-PET/CT to visualize COVID-19.</title>
      <link>/publication/32259853/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32259853/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.</title>
      <link>/publication/32253535/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32253535/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Radiographic and Clinical Features of Children with 2019 Novel Coronavirus (COVID-19) Pneumonia.</title>
      <link>/publication/32255437/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32255437/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019.</title>
      <link>/publication/32259313/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32259313/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The different clinical characteristics of corona virus disease cases between children and their families in China - the character of children with COVID-19.</title>
      <link>/publication/32208917/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32208917/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients.</title>
      <link>/publication/32255489/</link>
      <pubDate>Tue, 07 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32255489/</guid>
      <description></description>
    </item>
    
    <item>
      <title>2019 novel coronavirus (2019-nCoV) outbreak: A new challenge.</title>
      <link>/publication/32156648/</link>
      <pubDate>Mon, 06 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32156648/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A comparative-descriptive analysis of clinical characteristics in 2019-Coronavirus-infected children and adults.</title>
      <link>/publication/32249943/</link>
      <pubDate>Mon, 06 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32249943/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility - King County, Washington, March 2020.</title>
      <link>/publication/32240128/</link>
      <pubDate>Mon, 06 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32240128/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Characteristics of COVID-19 infection in Beijing.</title>
      <link>/publication/32112886/</link>
      <pubDate>Mon, 06 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32112886/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Characterization of the Humoral Immune Response to Porcine Epidemic Diarrhea Virus Infection under Experimental and Field Conditions Using an AlphaLISA Platform.</title>
      <link>/publication/32245150/</link>
      <pubDate>Mon, 06 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32245150/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2.</title>
      <link>/publication/32109443/</link>
      <pubDate>Mon, 06 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32109443/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China.</title>
      <link>/publication/32112884/</link>
      <pubDate>Mon, 06 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32112884/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital.</title>
      <link>/publication/32251842/</link>
      <pubDate>Mon, 06 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32251842/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19.</title>
      <link>/publication/32242348/</link>
      <pubDate>Mon, 06 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32242348/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Critically ill patients with COVID-19 in Hong Kong: a multicentre retrospective observational cohort study</title>
      <link>/publication/32248675/</link>
      <pubDate>Mon, 06 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32248675/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019.</title>
      <link>/publication/32251798/</link>
      <pubDate>Mon, 06 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32251798/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Eleven faces of coronavirus disease 2019.</title>
      <link>/publication/32196678/</link>
      <pubDate>Mon, 06 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32196678/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Emetine, Ipecac, Ipecac Alkaloids and Analogues as Potential Antiviral Agents for Coronaviruses.</title>
      <link>/publication/32245264/</link>
      <pubDate>Mon, 06 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32245264/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?</title>
      <link>/publication/32251794/</link>
      <pubDate>Mon, 06 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32251794/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis.</title>
      <link>/publication/32251668/</link>
      <pubDate>Mon, 06 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32251668/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Identification of Kidney Transplant Recipients with Coronavirus Disease 2019.</title>
      <link>/publication/32249089/</link>
      <pubDate>Mon, 06 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32249089/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Lung transplantation as therapeutic option in acute respiratory distress syndrome for COVID-19-related pulmonary fibrosis.</title>
      <link>/publication/32251003/</link>
      <pubDate>Mon, 06 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32251003/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Macrolide treatment for COVID-19: Will this be the way forward?</title>
      <link>/publication/32249257/</link>
      <pubDate>Mon, 06 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32249257/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Severe Acute Respiratory Syndrome (SARS) and Coronavirus disease-2019 (COVID-19): From Causes to Preventions in Hong Kong.</title>
      <link>/publication/32251790/</link>
      <pubDate>Mon, 06 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32251790/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study.</title>
      <link>/publication/32247326/</link>
      <pubDate>Sun, 05 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32247326/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia.</title>
      <link>/publication/32237278/</link>
      <pubDate>Sun, 05 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32237278/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.</title>
      <link>/publication/32221983/</link>
      <pubDate>Sun, 05 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32221983/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19.</title>
      <link>/publication/32219885/</link>
      <pubDate>Sun, 05 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32219885/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution.</title>
      <link>/publication/32248387/</link>
      <pubDate>Sun, 05 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32248387/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.</title>
      <link>/publication/32232433/</link>
      <pubDate>Sat, 04 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32232433/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 in Hemodialysis Patients: A Report of 5 Cases.</title>
      <link>/publication/32240718/</link>
      <pubDate>Sat, 04 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32240718/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2.</title>
      <link>/publication/32246317/</link>
      <pubDate>Sat, 04 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32246317/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection.</title>
      <link>/publication/32246834/</link>
      <pubDate>Sat, 04 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32246834/</guid>
      <description></description>
    </item>
    
    <item>
      <title>New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?</title>
      <link>/publication/32171740/</link>
      <pubDate>Sat, 04 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32171740/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Potential false-negative nucleic acid testing results for Severe Acute Respiratory Syndrome Coronavirus 2 from thermal inactivation of samples with low viral loads.</title>
      <link>/publication/32246822/</link>
      <pubDate>Sat, 04 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32246822/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Risks of Novel Coronavirus Disease (COVID-19) in Pregnancy; a Narrative Review.</title>
      <link>/publication/32232217/</link>
      <pubDate>Sat, 04 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32232217/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges.</title>
      <link>/publication/32245835/</link>
      <pubDate>Sat, 04 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32245835/</guid>
      <description></description>
    </item>
    
    <item>
      <title>&lt;sup&gt;18&lt;/sup&gt;F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases.</title>
      <link>/publication/32088847/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32088847/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Analysis of CT features of 15 children with 2019 novel coronavirus infection].</title>
      <link>/publication/32234131/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32234131/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Epidemiological characteristics of COVID-19 in Shaanxi province].</title>
      <link>/publication/32244260/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32244260/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias.</title>
      <link>/publication/32161968/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32161968/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period.</title>
      <link>/publication/32067043/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32067043/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Breastfeeding and Coronavirus Disease-2019. Ad interim indications of the Italian Society of Neonatology endorsed by the Union of European Neonatal &amp;amp; Perinatal Societies.</title>
      <link>/publication/32243068/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32243068/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Case Report on Early Diagnosis of COVID-19.</title>
      <link>/publication/32241316/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32241316/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Characteristics and Early Prognosis of COVID-19 Infection in Fracture Patients.</title>
      <link>/publication/32243304/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32243304/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Chest CT Features of COVID-19 in Rome, Italy.</title>
      <link>/publication/32243238/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32243238/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study.</title>
      <link>/publication/32242738/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32242738/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Consistent detection of 2019 novel coronavirus in saliva.</title>
      <link>/publication/32047895/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32047895/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19: what has been learned and to be learned about the novel coronavirus disease.</title>
      <link>/publication/32226295/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32226295/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Diagnosis and Management of First Case of COVID-19 in Canada: Lessons applied from SARS.</title>
      <link>/publication/32147731/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32147731/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Diagnostic Value and Key Features of Computed Tomography in Coronavirus Disease 2019.</title>
      <link>/publication/32241244/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32241244/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Dysregulation of immune response in patients with COVID-19 in Wuhan, China.</title>
      <link>/publication/32161940/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32161940/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau.</title>
      <link>/publication/32226287/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32226287/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Gastrointestinal and Liver Manifestations in Patients with COVID-19.</title>
      <link>/publication/32243269/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32243269/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection.</title>
      <link>/publication/32241899/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32241899/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.</title>
      <link>/publication/32107577/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32107577/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures.</title>
      <link>/publication/32192580/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32192580/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2.</title>
      <link>/publication/32226289/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32226289/</guid>
      <description></description>
    </item>
    
    <item>
      <title>SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat.</title>
      <link>/publication/32226285/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32226285/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China.</title>
      <link>/publication/32232685/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32232685/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The Presence of SARS-CoV-2 RNA in Feces of COVID-19 Patients.</title>
      <link>/publication/32243607/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32243607/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective.</title>
      <link>/publication/32226288/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32226288/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection.</title>
      <link>/publication/32243945/</link>
      <pubDate>Fri, 03 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32243945/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019].</title>
      <link>/publication/32220178/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32220178/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Clinical Study and CT Findings of a Familial Cluster of Pneumonia with Coronavirus Disease 2019 (COVID-19)].</title>
      <link>/publication/32220181/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32220181/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Epidemiological characteristics of COVID-19 in Gansu province].</title>
      <link>/publication/32234127/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32234127/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review].</title>
      <link>/publication/32220177/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32220177/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[From SARS to COVID-19: pathogens, receptor, pathogenesis and principles of the treatment].</title>
      <link>/publication/32238232/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32238232/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Investigation of an epidemic cluster caused by COVID⁃19 cases in incubation period in Shanghai].</title>
      <link>/publication/32234128/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32234128/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[The Management of Blood Glucose Should be Emphasized in the Treatment of COVID-19].</title>
      <link>/publication/32220179/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32220179/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A new threat from an old enemy: Re‑emergence of coronavirus (Review).</title>
      <link>/publication/32236624/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32236624/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Acetazolamide, Nifedipine and Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the Treatment of Coronavirus Disease 2019 (COVID-19).</title>
      <link>/publication/32226695/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32226695/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Case Report: Walking Pneumonia in Novel Coronavirus Disease (COVID-19): Mild Symptoms with Marked Abnormalities on Chest Imaging.</title>
      <link>/publication/32238223/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32238223/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease 2019 in Wuhan, China.</title>
      <link>/publication/32239127/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32239127/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical features and treatment of COVID-19 patients in northeast Chongqing.</title>
      <link>/publication/32198776/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32198776/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus disease 2019 (COVID-19): a clinical update.</title>
      <link>/publication/32240462/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32240462/</guid>
      <description></description>
    </item>
    
    <item>
      <title>First Mildly Ill, Non-Hospitalized Case of Coronavirus Disease 2019 (COVID-19) Without Viral Transmission in the United States - Maricopa County, Arizona, 2020.</title>
      <link>/publication/32240285/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32240285/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea.</title>
      <link>/publication/32237288/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32237288/</guid>
      <description></description>
    </item>
    
    <item>
      <title>INCIDENTAL FINDINGS SUGGESTIVE OF COVID-19 IN ASYMPTOMATIC PATIENTS UNDERGOING NUCLEAR MEDICINE PROCEDURES IN A HIGH PREVALENCE REGION.</title>
      <link>/publication/32238429/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32238429/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single center in Wuhan city, China.</title>
      <link>/publication/32239796/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32239796/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis.</title>
      <link>/publication/32235486/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32235486/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Perinatal-Neonatal Management of COVID-19 Infection - Guidelines of the Federation of Obstetric and Gynecological Societies of India (FOGSI), National Neonatology Forum of India (NNF), and Indian Academy of Pediatrics (IAP).</title>
      <link>/publication/32238615/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32238615/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus.</title>
      <link>/publication/32239142/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32239142/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension.</title>
      <link>/publication/32228222/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32228222/</guid>
      <description></description>
    </item>
    
    <item>
      <title>SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection.</title>
      <link>/publication/32241022/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32241022/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Teicoplanin: an alternative drug for the treatment of COVID-19?</title>
      <link>/publication/32179150/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32179150/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The Role of Emergency Radiology in COVID-19: From Preparedness to Diagnosis.</title>
      <link>/publication/32233876/</link>
      <pubDate>Thu, 02 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32233876/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Exploration of omics mechanism and drug prediction of coronavirus-induced heart failure based on clinical bioinformatics].</title>
      <link>/publication/32228827/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32228827/</guid>
      <description></description>
    </item>
    
    <item>
      <title>An update on the 2019-nCoV outbreak.</title>
      <link>/publication/32171622/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32171622/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis.</title>
      <link>/publication/32216803/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32216803/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Can we contain the COVID-19 outbreak with the same measures as for SARS?</title>
      <link>/publication/32145768/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32145768/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.</title>
      <link>/publication/32105632/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32105632/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients.</title>
      <link>/publication/32171866/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32171866/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China.</title>
      <link>/publication/32229732/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32229732/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?</title>
      <link>/publication/32229706/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32229706/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 in a Patient Presenting with Syncope and a Normal Chest X-ray.</title>
      <link>/publication/32226962/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32226962/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 infection and rheumatoid arthritis: Faraway, so close!</title>
      <link>/publication/32205186/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32205186/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.</title>
      <link>/publication/32186952/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32186952/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Diagnostic performance of chest CT to differentiate COVID-19 pneumonia in non-high-epidemic area in Japan.</title>
      <link>/publication/32232648/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32232648/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.</title>
      <link>/publication/31995857/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/31995857/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Epidemiological data from the COVID-19 outbreak, real-time case information.</title>
      <link>/publication/32210236/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32210236/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Evaluation of Nucleocapsid and Spike Protein-based ELISAs for detecting antibodies against SARS-CoV-2.</title>
      <link>/publication/32229605/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32229605/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.</title>
      <link>/publication/32214286/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32214286/</guid>
      <description></description>
    </item>
    
    <item>
      <title>How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1.</title>
      <link>/publication/32228825/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32228825/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.</title>
      <link>/publication/32205204/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32205204/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated &lt;i&gt;in vitro&lt;/i&gt; and with clinical specimens.</title>
      <link>/publication/32132196/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32132196/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2).</title>
      <link>/publication/32205232/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32205232/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19).</title>
      <link>/publication/32172228/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32172228/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Practical recommendations for the perioperative management of the patient with suspection or serious infection by coronavirus SARS-CoV.</title>
      <link>/publication/32197787/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32197787/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.</title>
      <link>/publication/32054787/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32054787/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Risk-adapted Treatment Strategy For COVID-19 Patients.</title>
      <link>/publication/32229257/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32229257/</guid>
      <description></description>
    </item>
    
    <item>
      <title>SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.</title>
      <link>/publication/32142651/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32142651/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression.</title>
      <link>/publication/32181990/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32181990/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks.</title>
      <link>/publication/32191623/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32191623/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The SARS-CoV-2 outbreak: what we know.</title>
      <link>/publication/32171952/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32171952/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).</title>
      <link>/publication/32219356/</link>
      <pubDate>Tue, 31 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32219356/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Caution should be exercised for the detection of SARS-CoV-2, especially in the elderly.</title>
      <link>/publication/32227494/</link>
      <pubDate>Tue, 31 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32227494/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia.</title>
      <link>/publication/32227123/</link>
      <pubDate>Tue, 31 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32227123/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China.</title>
      <link>/publication/32224151/</link>
      <pubDate>Tue, 31 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32224151/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 treatment by repurposing drugs until the vaccine is in sight.</title>
      <link>/publication/32227357/</link>
      <pubDate>Tue, 31 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32227357/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19).</title>
      <link>/publication/32224769/</link>
      <pubDate>Tue, 31 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32224769/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China.</title>
      <link>/publication/32196707/</link>
      <pubDate>Tue, 31 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32196707/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients.</title>
      <link>/publication/32227274/</link>
      <pubDate>Tue, 31 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32227274/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Timely Diagnosis and Treatment Shortens the Time to Resolution of Coronavirus Disease (COVID-19) Pneumonia and Lowers the Highest and Last CT Scores From Sequential Chest CT.</title>
      <link>/publication/32223665/</link>
      <pubDate>Tue, 31 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32223665/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.</title>
      <link>/publication/32219428/</link>
      <pubDate>Tue, 31 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32219428/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.</title>
      <link>/publication/32134116/</link>
      <pubDate>Tue, 31 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32134116/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus disease 2019: initial chest CT findings.</title>
      <link>/publication/32211963/</link>
      <pubDate>Mon, 30 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32211963/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 Infection in a Patient with End-Stage Kidney Disease.</title>
      <link>/publication/32222703/</link>
      <pubDate>Mon, 30 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32222703/</guid>
      <description></description>
    </item>
    
    <item>
      <title>CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19).</title>
      <link>/publication/32215691/</link>
      <pubDate>Mon, 30 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32215691/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Synthesis and Biological Evaluation of Novel (thio)semicarbazone-Based Benzimidazoles as Antiviral Agents against Human Respiratory Viruses.</title>
      <link>/publication/32218301/</link>
      <pubDate>Mon, 30 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32218301/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia].</title>
      <link>/publication/32220276/</link>
      <pubDate>Sun, 29 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32220276/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019.</title>
      <link>/publication/32221519/</link>
      <pubDate>Sun, 29 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32221519/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus disease 2019: What we know?</title>
      <link>/publication/32170865/</link>
      <pubDate>Sun, 29 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32170865/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients.</title>
      <link>/publication/32221523/</link>
      <pubDate>Sun, 29 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32221523/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.</title>
      <link>/publication/32220112/</link>
      <pubDate>Sat, 28 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32220112/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.</title>
      <link>/publication/32211816/</link>
      <pubDate>Sat, 28 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32211816/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).</title>
      <link>/publication/32219357/</link>
      <pubDate>Sat, 28 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32219357/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus disease-2019: is fever an adequate screening for the returning travelers?</title>
      <link>/publication/32165854/</link>
      <pubDate>Sat, 28 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32165854/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19).</title>
      <link>/publication/32220033/</link>
      <pubDate>Sat, 28 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32220033/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19.</title>
      <link>/publication/32181903/</link>
      <pubDate>Sat, 28 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32181903/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Unrevealing sequence and structural features of novel coronavirus using &lt;i&gt;in silico&lt;/i&gt; approaches: The main protease as molecular target.</title>
      <link>/publication/32210741/</link>
      <pubDate>Sat, 28 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32210741/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Analysis on cluster cases of COVID-19 in Tianjin].</title>
      <link>/publication/32213269/</link>
      <pubDate>Fri, 27 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32213269/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Epidemiological analysis on 1 052 cases of COVID-19 in epidemic clusters].</title>
      <link>/publication/32213270/</link>
      <pubDate>Fri, 27 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32213270/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Covid-19 and the Digestive System.</title>
      <link>/publication/32215956/</link>
      <pubDate>Fri, 27 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32215956/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Novel coronavirus and central nervous system.</title>
      <link>/publication/32216009/</link>
      <pubDate>Fri, 27 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32216009/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome.</title>
      <link>/publication/32213260/</link>
      <pubDate>Fri, 27 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32213260/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility.</title>
      <link>/publication/32215622/</link>
      <pubDate>Fri, 27 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32215622/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2).</title>
      <link>/publication/32179701/</link>
      <pubDate>Fri, 27 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32179701/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Clinical features and chest CT findings of coronavirus disease 2019 in infants and young children].</title>
      <link>/publication/32204756/</link>
      <pubDate>Thu, 26 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32204756/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[CT imaging features of patients with different clinical types of coronavirus disease 2019 (COVID-19)].</title>
      <link>/publication/32207591/</link>
      <pubDate>Thu, 26 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32207591/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[SARS-CoV-2 infection with gastrointestinal symptoms as the first manifestation in a neonate].</title>
      <link>/publication/32204755/</link>
      <pubDate>Thu, 26 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32204755/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Twin girls infected with SARS-CoV-2].</title>
      <link>/publication/32204757/</link>
      <pubDate>Thu, 26 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32204757/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Analysis of Epidemiological and Clinical features in older patients with Corona Virus Disease 2019 (COVID-19) out of Wuhan.</title>
      <link>/publication/32211844/</link>
      <pubDate>Thu, 26 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32211844/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study.</title>
      <link>/publication/32209890/</link>
      <pubDate>Thu, 26 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32209890/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Consideration of the respiratory support strategy of severe acute respiratory failure caused by SARS-CoV-2 infection in children.</title>
      <link>/publication/32204751/</link>
      <pubDate>Thu, 26 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32204751/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 - what should anaethesiologists and intensivists know about it?</title>
      <link>/publication/32191830/</link>
      <pubDate>Thu, 26 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32191830/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Epidemiological and Clinical Predictors of COVID-19.</title>
      <link>/publication/32211755/</link>
      <pubDate>Thu, 26 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32211755/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2.</title>
      <link>/publication/32207377/</link>
      <pubDate>Thu, 26 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32207377/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas, Milan experience.</title>
      <link>/publication/32211765/</link>
      <pubDate>Thu, 26 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32211765/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.</title>
      <link>/publication/32208987/</link>
      <pubDate>Thu, 26 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32208987/</guid>
      <description></description>
    </item>
    
    <item>
      <title>2019 Novel Coronavirus (COVID-19) Pneumonia: Serial Computed Tomography Findings.</title>
      <link>/publication/32100486/</link>
      <pubDate>Tue, 24 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32100486/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China.</title>
      <link>/publication/32207032/</link>
      <pubDate>Tue, 24 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32207032/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings.</title>
      <link>/publication/32205284/</link>
      <pubDate>Tue, 24 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32205284/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Ginkgolic acid inhibits fusion of enveloped viruses.</title>
      <link>/publication/32179788/</link>
      <pubDate>Tue, 24 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32179788/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Initial clinical features of suspected coronavirus disease 2019 in two emergency departments outside of Hubei, China.</title>
      <link>/publication/32167181/</link>
      <pubDate>Tue, 24 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32167181/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).</title>
      <link>/publication/32134278/</link>
      <pubDate>Tue, 24 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32134278/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL &lt;sup&gt;pro&lt;/sup&gt;) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates.</title>
      <link>/publication/32194944/</link>
      <pubDate>Tue, 24 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32194944/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Updated approaches against SARS-CoV-2.</title>
      <link>/publication/32205349/</link>
      <pubDate>Tue, 24 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32205349/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019].</title>
      <link>/publication/32192297/</link>
      <pubDate>Mon, 23 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32192297/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A Review of Coronavirus Disease-2019 (COVID-19).</title>
      <link>/publication/32166607/</link>
      <pubDate>Mon, 23 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32166607/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use.</title>
      <link>/publication/32202256/</link>
      <pubDate>Mon, 23 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32202256/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV.</title>
      <link>/publication/32098422/</link>
      <pubDate>Mon, 23 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32098422/</guid>
      <description></description>
    </item>
    
    <item>
      <title>What we know so far: COVID-19 current clinical knowledge and research.</title>
      <link>/publication/32139372/</link>
      <pubDate>Mon, 23 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32139372/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[When COVID-19 encounters interstitial lung disease: challenges and management].</title>
      <link>/publication/32198915/</link>
      <pubDate>Sat, 21 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32198915/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19).</title>
      <link>/publication/32198501/</link>
      <pubDate>Sat, 21 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32198501/</guid>
      <description></description>
    </item>
    
    <item>
      <title>An exclusive 42 amino acid signature in pp1ab protein provides insights into the evolutive history of the 2019 novel human-pathogenic coronavirus (SARS-CoV-2).</title>
      <link>/publication/32167166/</link>
      <pubDate>Fri, 20 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32167166/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Computed Tomography Manifestations of 5 Cases of the Novel Coronavirus Disease 2019 (COVID-19) Pneumonia From Patients Outside Wuhan.</title>
      <link>/publication/32195887/</link>
      <pubDate>Fri, 20 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32195887/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Early Epidemiological and Clinical Characteristics of 28 Cases of Coronavirus Disease in South Korea.</title>
      <link>/publication/32149037/</link>
      <pubDate>Fri, 20 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32149037/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia.</title>
      <link>/publication/32027573/</link>
      <pubDate>Fri, 20 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32027573/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions.</title>
      <link>/publication/32046137/</link>
      <pubDate>Fri, 20 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32046137/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020.</title>
      <link>/publication/32046815/</link>
      <pubDate>Fri, 20 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32046815/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Short-term Forecasts of the COVID-19 Epidemic in Guangdong and Zhejiang, China: February 13-23, 2020.</title>
      <link>/publication/32098289/</link>
      <pubDate>Fri, 20 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32098289/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The establishment of reference sequence for SARS-CoV-2 and variation analysis.</title>
      <link>/publication/32167180/</link>
      <pubDate>Fri, 20 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32167180/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights.</title>
      <link>/publication/32033064/</link>
      <pubDate>Fri, 20 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32033064/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China.</title>
      <link>/publication/32117569/</link>
      <pubDate>Fri, 20 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32117569/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version).</title>
      <link>/publication/32029004/</link>
      <pubDate>Thu, 19 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32029004/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients.</title>
      <link>/publication/32190904/</link>
      <pubDate>Thu, 19 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32190904/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Analysis of COVID-19 infection spread in Japan based on stochastic transition model.</title>
      <link>/publication/32188819/</link>
      <pubDate>Thu, 19 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32188819/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.</title>
      <link>/publication/32048163/</link>
      <pubDate>Thu, 19 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32048163/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review.</title>
      <link>/publication/32183901/</link>
      <pubDate>Thu, 19 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32183901/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Recent advances in the detection of respiratory virus infection in humans.</title>
      <link>/publication/31944312/</link>
      <pubDate>Thu, 19 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/31944312/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study.</title>
      <link>/publication/32191587/</link>
      <pubDate>Thu, 19 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32191587/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.</title>
      <link>/publication/32169119/</link>
      <pubDate>Thu, 19 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32169119/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China.</title>
      <link>/publication/31994742/</link>
      <pubDate>Thu, 19 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/31994742/</guid>
      <description></description>
    </item>
    
    <item>
      <title>2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness.</title>
      <link>/publication/32088679/</link>
      <pubDate>Wed, 18 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32088679/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Thoughts and practice on the treatment of severe and critical new coronavirus pneumonia].</title>
      <link>/publication/32186172/</link>
      <pubDate>Wed, 18 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32186172/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Using the big data ofinternet to understand coronavirus disease 2019&#39;s symptom characteristics: a big data study].</title>
      <link>/publication/32186171/</link>
      <pubDate>Wed, 18 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32186171/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.</title>
      <link>/publication/32151335/</link>
      <pubDate>Wed, 18 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32151335/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment.</title>
      <link>/publication/32037389/</link>
      <pubDate>Wed, 18 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32037389/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis.</title>
      <link>/publication/32108351/</link>
      <pubDate>Wed, 18 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32108351/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Critical care management of adults with community-acquired severe respiratory viral infection.</title>
      <link>/publication/32040667/</link>
      <pubDate>Wed, 18 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32040667/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Drug treatment options for the 2019-new coronavirus (2019-nCoV).</title>
      <link>/publication/31996494/</link>
      <pubDate>Wed, 18 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/31996494/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV.</title>
      <link>/publication/32022370/</link>
      <pubDate>Wed, 18 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32022370/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China.</title>
      <link>/publication/32017984/</link>
      <pubDate>Wed, 18 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32017984/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.</title>
      <link>/publication/32141570/</link>
      <pubDate>Wed, 18 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32141570/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Potential interventions for novel coronavirus in China: A systematic review.</title>
      <link>/publication/32052466/</link>
      <pubDate>Wed, 18 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32052466/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis.</title>
      <link>/publication/32186894/</link>
      <pubDate>Wed, 18 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32186894/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?</title>
      <link>/publication/32167153/</link>
      <pubDate>Wed, 18 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32167153/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The outbreak of COVID-19: An overview.</title>
      <link>/publication/32134861/</link>
      <pubDate>Wed, 18 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32134861/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A 55-Day-Old Female Infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage.</title>
      <link>/publication/32179908/</link>
      <pubDate>Tue, 17 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32179908/</guid>
      <description></description>
    </item>
    
    <item>
      <title>An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes.</title>
      <link>/publication/32180426/</link>
      <pubDate>Tue, 17 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32180426/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19.</title>
      <link>/publication/32179140/</link>
      <pubDate>Tue, 17 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32179140/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical features of pediatric patients with COVID-19: a report of two family cluster cases.</title>
      <link>/publication/32180140/</link>
      <pubDate>Tue, 17 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32180140/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical outcome of 55 asymptomatic cases at the time of hospital admission infected with SARS-Coronavirus-2 in Shenzhen, China.</title>
      <link>/publication/32179910/</link>
      <pubDate>Tue, 17 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32179910/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0).</title>
      <link>/publication/32172669/</link>
      <pubDate>Tue, 17 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32172669/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Early Clinical and CT Manifestations of Coronavirus Disease 2019 (COVID-19) Pneumonia.</title>
      <link>/publication/32181672/</link>
      <pubDate>Tue, 17 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32181672/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.</title>
      <link>/publication/32181807/</link>
      <pubDate>Tue, 17 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32181807/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.</title>
      <link>/publication/32125362/</link>
      <pubDate>Tue, 17 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32125362/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Era of molecular diagnosis for pathogen identification of unexplained pneumonia, lessons to be learned.</title>
      <link>/publication/32174267/</link>
      <pubDate>Tue, 17 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32174267/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.</title>
      <link>/publication/32167524/</link>
      <pubDate>Tue, 17 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32167524/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Management of corona virus disease-19 (COVID-19): the Zhejiang experience].</title>
      <link>/publication/32096367/</link>
      <pubDate>Mon, 16 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32096367/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A report of clinical diagnosis and treatment of nine cases of coronavirus disease 2019.</title>
      <link>/publication/32162699/</link>
      <pubDate>Mon, 16 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32162699/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19.</title>
      <link>/publication/32173110/</link>
      <pubDate>Mon, 16 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32173110/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR.</title>
      <link>/publication/32056407/</link>
      <pubDate>Mon, 16 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32056407/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China.</title>
      <link>/publication/32173725/</link>
      <pubDate>Mon, 16 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32173725/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical Features and Chest CT Manifestations of Coronavirus Disease 2019 (COVID-19) in a Single-Center Study in Shanghai, China.</title>
      <link>/publication/32174128/</link>
      <pubDate>Mon, 16 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32174128/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China.</title>
      <link>/publication/32176772/</link>
      <pubDate>Mon, 16 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32176772/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical features of deaths in the novel coronavirus epidemic in China.</title>
      <link>/publication/32175637/</link>
      <pubDate>Mon, 16 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32175637/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients.</title>
      <link>/publication/32174129/</link>
      <pubDate>Mon, 16 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32174129/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Discovering drugs to treat coronavirus disease 2019 (COVID-19).</title>
      <link>/publication/32147628/</link>
      <pubDate>Mon, 16 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32147628/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes.</title>
      <link>/publication/32065057/</link>
      <pubDate>Mon, 16 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32065057/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression.</title>
      <link>/publication/32173576/</link>
      <pubDate>Mon, 16 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32173576/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis.</title>
      <link>/publication/32173574/</link>
      <pubDate>Mon, 16 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32173574/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea.</title>
      <link>/publication/32080991/</link>
      <pubDate>Mon, 16 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32080991/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[A pathological report of three COVID-19 cases by minimally invasive autopsies].</title>
      <link>/publication/32172546/</link>
      <pubDate>Sun, 15 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32172546/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan.</title>
      <link>/publication/32170559/</link>
      <pubDate>Sat, 14 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32170559/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Epidemiological characteristics of confirmed COVID-19 cases in Tianjin].</title>
      <link>/publication/32164400/</link>
      <pubDate>Fri, 13 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32164400/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19?]</title>
      <link>/publication/32166939/</link>
      <pubDate>Fri, 13 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32166939/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.</title>
      <link>/publication/31986261/</link>
      <pubDate>Fri, 13 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/31986261/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia.</title>
      <link>/publication/32154135/</link>
      <pubDate>Fri, 13 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32154135/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.</title>
      <link>/publication/32031570/</link>
      <pubDate>Fri, 13 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32031570/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.</title>
      <link>/publication/31986264/</link>
      <pubDate>Fri, 13 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/31986264/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease.</title>
      <link>/publication/32164424/</link>
      <pubDate>Fri, 13 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32164424/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.</title>
      <link>/publication/32007143/</link>
      <pubDate>Fri, 13 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32007143/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Epidemiology of 2019 Novel Coronavirus Disease-19 in Gansu Province, China, 2020.</title>
      <link>/publication/32168465/</link>
      <pubDate>Fri, 13 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32168465/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Chest computed tomography in children with COVID-19 respiratory infection.</title>
      <link>/publication/32162081/</link>
      <pubDate>Thu, 12 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32162081/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia.</title>
      <link>/publication/32124995/</link>
      <pubDate>Thu, 12 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32124995/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The 2019 novel coronavirus resource.</title>
      <link>/publication/32102777/</link>
      <pubDate>Thu, 12 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32102777/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options.</title>
      <link>/publication/32161092/</link>
      <pubDate>Thu, 12 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32161092/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective.</title>
      <link>/publication/32141619/</link>
      <pubDate>Thu, 12 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32141619/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Construction and evaluation of a novel diagnosis process for 2019-Corona Virus Disease].</title>
      <link>/publication/32157849/</link>
      <pubDate>Wed, 11 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32157849/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[The differential diagnosis for novel coronavirus pneumonia and similar lung diseases in general hospitals].</title>
      <link>/publication/32153167/</link>
      <pubDate>Tue, 10 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32153167/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Compounds with therapeutic potential against novel respiratory 2019 coronavirus.</title>
      <link>/publication/32152082/</link>
      <pubDate>Tue, 10 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32152082/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The 2019 Novel Coronavirus Outbreak - A Global Threat.</title>
      <link>/publication/32138488/</link>
      <pubDate>Tue, 10 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32138488/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Epidemiological investigation of a family clustering of COVID-19].</title>
      <link>/publication/32149484/</link>
      <pubDate>Mon, 09 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32149484/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: protocol of a randomized controlled trial.</title>
      <link>/publication/32149773/</link>
      <pubDate>Mon, 09 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32149773/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV) related coronavirus model.</title>
      <link>/publication/32149769/</link>
      <pubDate>Mon, 09 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32149769/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Screening and management of asymptomatic infection of corona virus disease 2019 (COVID-19)].</title>
      <link>/publication/32145719/</link>
      <pubDate>Sun, 08 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32145719/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China.</title>
      <link>/publication/32146694/</link>
      <pubDate>Sun, 08 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32146694/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19].</title>
      <link>/publication/32141280/</link>
      <pubDate>Fri, 06 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32141280/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes.</title>
      <link>/publication/32134800/</link>
      <pubDate>Fri, 06 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32134800/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Epidemiological analysis on a family cluster of COVID-19].</title>
      <link>/publication/32133831/</link>
      <pubDate>Thu, 05 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32133831/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Investigation and analysis on characteristics of a cluster of COVID-19 associated with exposure in a department store in Tianjin].</title>
      <link>/publication/32133830/</link>
      <pubDate>Thu, 05 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32133830/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical trial analysis of 2019-nCoV therapy registered in China.</title>
      <link>/publication/32108352/</link>
      <pubDate>Thu, 05 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32108352/</guid>
      <description></description>
    </item>
    
    <item>
      <title>CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China.</title>
      <link>/publication/32134681/</link>
      <pubDate>Thu, 05 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32134681/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Comparison of heart failure and 2019 novel coronavirus pneumonia in chest CT features and clinical characteristics].</title>
      <link>/publication/32129583/</link>
      <pubDate>Wed, 04 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32129583/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.</title>
      <link>/publication/32129518/</link>
      <pubDate>Wed, 04 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32129518/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management.</title>
      <link>/publication/32130038/</link>
      <pubDate>Wed, 04 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32130038/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study.</title>
      <link>/publication/32125873/</link>
      <pubDate>Wed, 04 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32125873/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Management and clinical thinking of Coronavirus Disease 2019].</title>
      <link>/publication/32125126/</link>
      <pubDate>Tue, 03 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32125126/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Antiviral Action of Tryptanthrin Isolated from &lt;i&gt;Strobilanthes cusia&lt;/i&gt; Leaf against Human Coronavirus NL63.</title>
      <link>/publication/32120929/</link>
      <pubDate>Tue, 03 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32120929/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools.</title>
      <link>/publication/32125642/</link>
      <pubDate>Tue, 03 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32125642/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies].</title>
      <link>/publication/32114747/</link>
      <pubDate>Mon, 02 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32114747/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Cause analysis and treatment strategies of recurrence with novel coronavirus pneumonia (covid-19) patients after discharge from hospital].</title>
      <link>/publication/32118391/</link>
      <pubDate>Mon, 02 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32118391/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China].</title>
      <link>/publication/32118389/</link>
      <pubDate>Mon, 02 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32118389/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV].</title>
      <link>/publication/32120458/</link>
      <pubDate>Mon, 02 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32120458/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Epidemiological characteristics of novel coronavirus pneumonia in Henan].</title>
      <link>/publication/32118390/</link>
      <pubDate>Mon, 02 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32118390/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Pregnant women with new coronavirus infection: a clinical characteristics and placental pathological analysis of three cases].</title>
      <link>/publication/32114744/</link>
      <pubDate>Mon, 02 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32114744/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease.</title>
      <link>/publication/32118640/</link>
      <pubDate>Mon, 02 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32118640/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province.</title>
      <link>/publication/32044814/</link>
      <pubDate>Mon, 02 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32044814/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus disinfection in histopathology.</title>
      <link>/publication/32116147/</link>
      <pubDate>Mon, 02 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32116147/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.</title>
      <link>/publication/32118639/</link>
      <pubDate>Mon, 02 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32118639/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Real-time forecasts of the COVID-19 epidemic in China from February 5th to February 24th, 2020.</title>
      <link>/publication/32110742/</link>
      <pubDate>Mon, 02 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32110742/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The Clinical and Chest CT Features Associated with Severe and Critical COVID-19 Pneumonia.</title>
      <link>/publication/32118615/</link>
      <pubDate>Mon, 02 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32118615/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020.</title>
      <link>/publication/32106216/</link>
      <pubDate>Mon, 02 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32106216/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[The keypoints in treatment of the critical coronavirus disease 2019 patient].</title>
      <link>/publication/32111113/</link>
      <pubDate>Sat, 29 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32111113/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series.</title>
      <link>/publication/32075786/</link>
      <pubDate>Fri, 28 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32075786/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.</title>
      <link>/publication/32077115/</link>
      <pubDate>Thu, 27 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32077115/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Expert Recommendations for Tracheal Intubation in Critically ill Patients with Noval Coronavirus Disease 2019.</title>
      <link>/publication/32102726/</link>
      <pubDate>Thu, 27 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32102726/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Retracted: Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen].</title>
      <link>/publication/32062875/</link>
      <pubDate>Wed, 26 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32062875/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[What are the highlights of Diagnosis and treatment of Disease 2019 novel coronavirus infection suitable for Military support Hubei medical team].</title>
      <link>/publication/32098466/</link>
      <pubDate>Wed, 26 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32098466/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases.</title>
      <link>/publication/32101510/</link>
      <pubDate>Wed, 26 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32101510/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[The treatment proposal for the patients with breast diseases in the central epidemic area of 2019 coronavirus disease].</title>
      <link>/publication/32096395/</link>
      <pubDate>Tue, 25 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32096395/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Comparison of the clinical characteristics between RNA positive and negative patients clinically diagnosed with 2019 novel coronavirus pneumonia].</title>
      <link>/publication/32087623/</link>
      <pubDate>Sun, 23 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32087623/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[The keypoints in treatment of the critical novel coronavirus pneumonia patient].</title>
      <link>/publication/32087621/</link>
      <pubDate>Sun, 23 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32087621/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?</title>
      <link>/publication/32086938/</link>
      <pubDate>Sat, 22 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32086938/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Coronavirus Disease 2019 (COVID-19): A Perspective from China.</title>
      <link>/publication/32083985/</link>
      <pubDate>Fri, 21 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32083985/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].</title>
      <link>/publication/32075365/</link>
      <pubDate>Thu, 20 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32075365/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study].</title>
      <link>/publication/32077660/</link>
      <pubDate>Thu, 20 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32077660/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection.</title>
      <link>/publication/32077789/</link>
      <pubDate>Thu, 20 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32077789/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Recommendation for the diagnosis and treatment of novel coronavirus infection in children in Hubei (Trial version 1)].</title>
      <link>/publication/32051073/</link>
      <pubDate>Wed, 19 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32051073/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia].</title>
      <link>/publication/32062957/</link>
      <pubDate>Mon, 17 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32062957/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].</title>
      <link>/publication/32064853/</link>
      <pubDate>Mon, 17 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32064853/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[The network investigation on knowledge, attitude and practice about Novel coronavirus pneumonia of the residents in Anhui Province].</title>
      <link>/publication/32064854/</link>
      <pubDate>Mon, 17 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32064854/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Analysis of CT features of 15 Children with 2019 novel coronavirus infection].</title>
      <link>/publication/32061200/</link>
      <pubDate>Sun, 16 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32061200/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing].</title>
      <link>/publication/32061066/</link>
      <pubDate>Sat, 15 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32061066/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].</title>
      <link>/publication/32061198/</link>
      <pubDate>Sat, 15 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32061198/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Pharmacotherapeutics for the New Coronavirus Pneumonia].</title>
      <link>/publication/32057209/</link>
      <pubDate>Fri, 14 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32057209/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Recommendations for general surgery clinical practice in novel coronavirus pneumonia situation].</title>
      <link>/publication/32057212/</link>
      <pubDate>Fri, 14 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32057212/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia.</title>
      <link>/publication/32053470/</link>
      <pubDate>Thu, 13 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32053470/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing.</title>
      <link>/publication/32049601/</link>
      <pubDate>Wed, 12 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32049601/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Overview of The 2019 Novel Coronavirus (2019-nCoV): The Pathogen of Severe Specific Contagious Pneumonia (SSCP).</title>
      <link>/publication/32049687/</link>
      <pubDate>Wed, 12 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32049687/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Expert consensus for bronchoscopy during the epidemic of 2019 Novel Coronavirus infection (Trial version)].</title>
      <link>/publication/32033514/</link>
      <pubDate>Sat, 08 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32033514/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts&#39; consensus statement.</title>
      <link>/publication/32034659/</link>
      <pubDate>Sat, 08 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32034659/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020.</title>
      <link>/publication/32027631/</link>
      <pubDate>Fri, 07 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32027631/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].</title>
      <link>/publication/32026671/</link>
      <pubDate>Thu, 06 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32026671/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus.</title>
      <link>/publication/32026148/</link>
      <pubDate>Thu, 06 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32026148/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Diagnosis and clinical management of 2019 novel coronavirus infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)].</title>
      <link>/publication/32023681/</link>
      <pubDate>Wed, 05 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32023681/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Early detection and disease assessment of patients with novel coronavirus pneumonia].</title>
      <link>/publication/32023686/</link>
      <pubDate>Wed, 05 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32023686/</guid>
      <description></description>
    </item>
    
    <item>
      <title>[Efficient management of novel coronavirus pneumonia by efficient prevention and control in scientific manner].</title>
      <link>/publication/32023684/</link>
      <pubDate>Wed, 05 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32023684/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Privacy Policy</title>
      <link>/privacy/</link>
      <pubDate>Thu, 28 Jun 2018 00:00:00 +0100</pubDate>
      <guid>/privacy/</guid>
      <description>&lt;p&gt;&amp;hellip;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Terms</title>
      <link>/terms/</link>
      <pubDate>Thu, 28 Jun 2018 00:00:00 +0100</pubDate>
      <guid>/terms/</guid>
      <description>&lt;p&gt;&amp;hellip;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Syntax COVID-19 Analysis</title>
      <link>/syntax/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>/syntax/</guid>
      <description>
&lt;script src=&#34;/rmarkdown-libs/htmlwidgets/htmlwidgets.js&#34;&gt;&lt;/script&gt;
&lt;script src=&#34;/rmarkdown-libs/plotly-binding/plotly.js&#34;&gt;&lt;/script&gt;
&lt;script src=&#34;/rmarkdown-libs/typedarray/typedarray.min.js&#34;&gt;&lt;/script&gt;
&lt;script src=&#34;/rmarkdown-libs/jquery/jquery.min.js&#34;&gt;&lt;/script&gt;
&lt;link href=&#34;/rmarkdown-libs/crosstalk/css/crosstalk.css&#34; rel=&#34;stylesheet&#34; /&gt;
&lt;script src=&#34;/rmarkdown-libs/crosstalk/js/crosstalk.min.js&#34;&gt;&lt;/script&gt;
&lt;link href=&#34;/rmarkdown-libs/plotly-htmlwidgets-css/plotly-htmlwidgets.css&#34; rel=&#34;stylesheet&#34; /&gt;
&lt;script src=&#34;/rmarkdown-libs/plotly-main/plotly-latest.min.js&#34;&gt;&lt;/script&gt;
&lt;script src=&#34;/rmarkdown-libs/viz/viz.js&#34;&gt;&lt;/script&gt;
&lt;link href=&#34;/rmarkdown-libs/DiagrammeR-styles/styles.css&#34; rel=&#34;stylesheet&#34; /&gt;
&lt;script src=&#34;/rmarkdown-libs/grViz-binding/grViz.js&#34;&gt;&lt;/script&gt;


&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
The syntax analysis included &lt;strong&gt;2248&lt;/strong&gt; abstracts from &lt;strong&gt;4919&lt;/strong&gt; published articles. Last update in 2020-04-16 by &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/research/coronavirus/&#34;&gt;LitCovid&lt;/a&gt;. Most of them were Journal Article (61.34%), Letter (14.64%), Editorial (8.85%), Review (4%) and Comment (2.18%).
&lt;/p&gt;
&lt;center&gt;
&lt;div id=&#34;htmlwidget-1&#34; style=&#34;width:672px;height:480px;&#34; class=&#34;plotly html-widget&#34;&gt;&lt;/div&gt;
&lt;script type=&#34;application/json&#34; data-for=&#34;htmlwidget-1&#34;&gt;{&#34;x&#34;:{&#34;visdat&#34;:{&#34;4423e0ac765&#34;:[&#34;function () &#34;,&#34;plotlyVisDat&#34;]},&#34;cur_data&#34;:&#34;4423e0ac765&#34;,&#34;attrs&#34;:{&#34;4423e0ac765&#34;:{&#34;alpha_stroke&#34;:1,&#34;sizes&#34;:[10,100],&#34;spans&#34;:[1,20],&#34;x&#34;:[&#34;2020-03-20&#34;,&#34;2020-03-19&#34;,&#34;2020-02-20&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-02-18&#34;,&#34;2020-03-06&#34;,&#34;2020-02-24&#34;,&#34;2020-03-06&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-05&#34;,&#34;2020-02-04&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-04-07&#34;,&#34;2020-03-24&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-04&#34;,&#34;2020-02-04&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-19&#34;,&#34;2020-04-01&#34;,&#34;2020-02-04&#34;,&#34;2020-02-04&#34;,&#34;2020-03-23&#34;,&#34;2020-03-18&#34;,&#34;2020-03-17&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-04-08&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-02-12&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-02-11&#34;,&#34;2020-02-24&#34;,&#34;2020-02-11&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-01&#34;,&#34;2020-03-28&#34;,&#34;2020-03-17&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-02-29&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-11&#34;,&#34;2020-03-23&#34;,&#34;2020-02-10&#34;,&#34;2020-02-07&#34;,&#34;2020-02-10&#34;,&#34;2020-03-25&#34;,&#34;2020-03-16&#34;,&#34;2020-04-13&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-02-05&#34;,&#34;2020-03-22&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-13&#34;,&#34;2020-03-22&#34;,&#34;2020-02-11&#34;,&#34;2020-02-11&#34;,&#34;2020-02-06&#34;,&#34;2020-04-15&#34;,&#34;2020-03-30&#34;,&#34;2020-02-06&#34;,&#34;2020-02-06&#34;,&#34;2020-02-06&#34;,&#34;2020-02-06&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-02-07&#34;,&#34;2020-03-17&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-03-19&#34;,&#34;2020-02-11&#34;,&#34;2020-02-11&#34;,&#34;2020-02-07&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-03-27&#34;,&#34;2020-03-13&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-23&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-02-08&#34;,&#34;2020-02-08&#34;,&#34;2020-02-24&#34;,&#34;2020-02-08&#34;,&#34;2020-02-08&#34;,&#34;2020-02-08&#34;,&#34;2020-04-09&#34;,&#34;2020-02-08&#34;,&#34;2020-03-16&#34;,&#34;2020-03-23&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-08&#34;,&#34;2020-02-09&#34;,&#34;2020-02-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-03-06&#34;,&#34;2020-03-06&#34;,&#34;2020-02-19&#34;,&#34;2020-04-09&#34;,&#34;2020-03-03&#34;,&#34;2020-04-01&#34;,&#34;2020-03-18&#34;,&#34;2020-02-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-02-10&#34;,&#34;2020-03-19&#34;,&#34;2020-03-18&#34;,&#34;2020-02-10&#34;,&#34;2020-02-24&#34;,&#34;2020-02-12&#34;,&#34;2020-02-11&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-03-16&#34;,&#34;2020-03-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-02&#34;,&#34;2020-02-11&#34;,&#34;2020-02-16&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-12&#34;,&#34;2020-02-14&#34;,&#34;2020-02-14&#34;,&#34;2020-02-17&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-03-19&#34;,&#34;2020-02-21&#34;,&#34;2020-02-12&#34;,&#34;2020-04-08&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-02-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-17&#34;,&#34;2020-02-12&#34;,&#34;2020-03-20&#34;,&#34;2020-02-12&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-17&#34;,&#34;2020-03-23&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-04-10&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-26&#34;,&#34;2020-03-17&#34;,&#34;2020-02-13&#34;,&#34;2020-04-13&#34;,&#34;2020-02-26&#34;,&#34;2020-02-13&#34;,&#34;2020-02-13&#34;,&#34;2020-02-18&#34;,&#34;2020-03-05&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-02-21&#34;,&#34;2020-02-26&#34;,&#34;2020-04-01&#34;,&#34;2020-02-19&#34;,&#34;2020-03-30&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-03&#34;,&#34;2020-03-19&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-02-14&#34;,&#34;2020-02-14&#34;,&#34;2020-02-14&#34;,&#34;2020-02-14&#34;,&#34;2020-04-09&#34;,&#34;2020-03-19&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-03-06&#34;,&#34;2020-03-16&#34;,&#34;2020-02-21&#34;,&#34;2020-03-30&#34;,&#34;2020-02-15&#34;,&#34;2020-04-07&#34;,&#34;2020-02-15&#34;,&#34;2020-02-15&#34;,&#34;2020-02-16&#34;,&#34;2020-02-16&#34;,&#34;2020-02-16&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-26&#34;,&#34;2020-02-17&#34;,&#34;2020-04-09&#34;,&#34;2020-03-24&#34;,&#34;2020-02-17&#34;,&#34;2020-02-17&#34;,&#34;2020-02-17&#34;,&#34;2020-02-17&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-04-03&#34;,&#34;2020-02-17&#34;,&#34;2020-02-17&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-23&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-02-18&#34;,&#34;2020-04-01&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-21&#34;,&#34;2020-03-11&#34;,&#34;2020-03-17&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-02-19&#34;,&#34;2020-04-10&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-04-01&#34;,&#34;2020-03-25&#34;,&#34;2020-03-17&#34;,&#34;2020-02-19&#34;,&#34;2020-03-18&#34;,&#34;2020-02-19&#34;,&#34;2020-03-12&#34;,&#34;2020-03-22&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-21&#34;,&#34;2020-02-28&#34;,&#34;2020-02-25&#34;,&#34;2020-03-19&#34;,&#34;2020-02-27&#34;,&#34;2020-03-06&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-03-06&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-04-15&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-20&#34;,&#34;2020-02-21&#34;,&#34;2020-03-08&#34;,&#34;2020-03-03&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-02-21&#34;,&#34;2020-03-26&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-04-09&#34;,&#34;2020-04-03&#34;,&#34;2020-02-28&#34;,&#34;2020-02-21&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-04-01&#34;,&#34;2020-02-21&#34;,&#34;2020-02-22&#34;,&#34;2020-02-22&#34;,&#34;2020-02-22&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-04-14&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-02-24&#34;,&#34;2020-03-18&#34;,&#34;2020-02-24&#34;,&#34;2020-02-22&#34;,&#34;2020-02-22&#34;,&#34;2020-03-18&#34;,&#34;2020-04-08&#34;,&#34;2020-03-19&#34;,&#34;2020-03-26&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-02-23&#34;,&#34;2020-02-23&#34;,&#34;2020-03-05&#34;,&#34;2020-03-26&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-02-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-16&#34;,&#34;2020-02-24&#34;,&#34;2020-03-05&#34;,&#34;2020-02-24&#34;,&#34;2020-03-18&#34;,&#34;2020-04-14&#34;,&#34;2020-02-24&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-22&#34;,&#34;2020-03-08&#34;,&#34;2020-03-07&#34;,&#34;2020-03-18&#34;,&#34;2020-04-15&#34;,&#34;2020-03-18&#34;,&#34;2020-02-25&#34;,&#34;2020-04-06&#34;,&#34;2020-03-19&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-02-25&#34;,&#34;2020-02-25&#34;,&#34;2020-03-11&#34;,&#34;2020-03-03&#34;,&#34;2020-03-05&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-02-25&#34;,&#34;2020-02-25&#34;,&#34;2020-04-13&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-02-26&#34;,&#34;2020-03-23&#34;,&#34;2020-02-26&#34;,&#34;2020-03-17&#34;,&#34;2020-03-02&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-27&#34;,&#34;2020-02-28&#34;,&#34;2020-04-01&#34;,&#34;2020-02-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-08&#34;,&#34;2020-03-19&#34;,&#34;2020-03-12&#34;,&#34;2020-03-11&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-04-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-22&#34;,&#34;2020-03-17&#34;,&#34;2020-03-19&#34;,&#34;2020-02-27&#34;,&#34;2020-03-12&#34;,&#34;2020-03-02&#34;,&#34;2020-02-27&#34;,&#34;2020-02-27&#34;,&#34;2020-04-03&#34;,&#34;2020-04-11&#34;,&#34;2020-02-27&#34;,&#34;2020-03-01&#34;,&#34;2020-04-03&#34;,&#34;2020-03-12&#34;,&#34;2020-03-11&#34;,&#34;2020-03-18&#34;,&#34;2020-04-13&#34;,&#34;2020-02-28&#34;,&#34;2020-03-16&#34;,&#34;2020-02-27&#34;,&#34;2020-03-24&#34;,&#34;2020-03-17&#34;,&#34;2020-03-14&#34;,&#34;2020-03-27&#34;,&#34;2020-02-27&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-02-27&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-03-02&#34;,&#34;2020-04-15&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-18&#34;,&#34;2020-04-03&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-03-18&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-04-03&#34;,&#34;2020-03-27&#34;,&#34;2020-02-28&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-26&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-03-02&#34;,&#34;2020-04-11&#34;,&#34;2020-02-29&#34;,&#34;2020-02-29&#34;,&#34;2020-03-18&#34;,&#34;2020-03-19&#34;,&#34;2020-04-01&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-02&#34;,&#34;2020-04-03&#34;,&#34;2020-02-29&#34;,&#34;2020-02-29&#34;,&#34;2020-02-29&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-03-01&#34;,&#34;2020-03-01&#34;,&#34;2020-03-01&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-03-19&#34;,&#34;2020-03-18&#34;,&#34;2020-03-26&#34;,&#34;2020-03-30&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-03-11&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-03-26&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-02&#34;,&#34;2020-03-03&#34;,&#34;2020-04-11&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-03-03&#34;,&#34;2020-03-17&#34;,&#34;2020-04-02&#34;,&#34;2020-03-03&#34;,&#34;2020-03-06&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-04&#34;,&#34;2020-03-05&#34;,&#34;2020-03-04&#34;,&#34;2020-04-06&#34;,&#34;2020-03-24&#34;,&#34;2020-04-03&#34;,&#34;2020-03-25&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-04-15&#34;,&#34;2020-03-16&#34;,&#34;2020-03-11&#34;,&#34;2020-03-12&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-04-09&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-17&#34;,&#34;2020-03-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-25&#34;,&#34;2020-03-03&#34;,&#34;2020-03-04&#34;,&#34;2020-03-03&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-17&#34;,&#34;2020-03-04&#34;,&#34;2020-03-17&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-06&#34;,&#34;2020-03-19&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-03-17&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-04-03&#34;,&#34;2020-03-17&#34;,&#34;2020-04-12&#34;,&#34;2020-03-23&#34;,&#34;2020-03-04&#34;,&#34;2020-04-11&#34;,&#34;2020-03-05&#34;,&#34;2020-04-09&#34;,&#34;2020-03-05&#34;,&#34;2020-03-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-03-16&#34;,&#34;2020-03-05&#34;,&#34;2020-03-11&#34;,&#34;2020-03-16&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-04-07&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-19&#34;,&#34;2020-03-31&#34;,&#34;2020-04-01&#34;,&#34;2020-03-24&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-06&#34;,&#34;2020-03-18&#34;,&#34;2020-03-09&#34;,&#34;2020-03-26&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-10&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-09&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-23&#34;,&#34;2020-03-24&#34;,&#34;2020-03-06&#34;,&#34;2020-03-31&#34;,&#34;2020-03-29&#34;,&#34;2020-03-08&#34;,&#34;2020-03-06&#34;,&#34;2020-03-19&#34;,&#34;2020-03-11&#34;,&#34;2020-03-23&#34;,&#34;2020-03-06&#34;,&#34;2020-03-06&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-06&#34;,&#34;2020-03-17&#34;,&#34;2020-03-12&#34;,&#34;2020-03-24&#34;,&#34;2020-03-30&#34;,&#34;2020-03-06&#34;,&#34;2020-03-06&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-15&#34;,&#34;2020-03-09&#34;,&#34;2020-04-03&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-07&#34;,&#34;2020-03-12&#34;,&#34;2020-03-09&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-03-20&#34;,&#34;2020-04-13&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-03-23&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-04-03&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-03-16&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-14&#34;,&#34;2020-03-24&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-04-03&#34;,&#34;2020-03-09&#34;,&#34;2020-03-22&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-12&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-19&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-18&#34;,&#34;2020-03-10&#34;,&#34;2020-03-19&#34;,&#34;2020-04-07&#34;,&#34;2020-03-10&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-19&#34;,&#34;2020-04-08&#34;,&#34;2020-03-10&#34;,&#34;2020-03-10&#34;,&#34;2020-03-10&#34;,&#34;2020-03-10&#34;,&#34;2020-03-10&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-03-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-23&#34;,&#34;2020-04-06&#34;,&#34;2020-03-18&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-14&#34;,&#34;2020-04-06&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-16&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-14&#34;,&#34;2020-03-23&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-04-15&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-23&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-17&#34;,&#34;2020-04-03&#34;,&#34;2020-03-11&#34;,&#34;2020-03-22&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-03-11&#34;,&#34;2020-03-20&#34;,&#34;2020-03-11&#34;,&#34;2020-03-16&#34;,&#34;2020-03-12&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-12&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-03-25&#34;,&#34;2020-03-12&#34;,&#34;2020-04-03&#34;,&#34;2020-04-04&#34;,&#34;2020-03-26&#34;,&#34;2020-03-18&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-16&#34;,&#34;2020-04-10&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-04-10&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-04-03&#34;,&#34;2020-03-22&#34;,&#34;2020-03-30&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-03-12&#34;,&#34;2020-03-13&#34;,&#34;2020-03-26&#34;,&#34;2020-03-13&#34;,&#34;2020-03-17&#34;,&#34;2020-04-08&#34;,&#34;2020-03-26&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-03-17&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-03-28&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-03-13&#34;,&#34;2020-03-24&#34;,&#34;2020-03-13&#34;,&#34;2020-03-23&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-04-03&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-08&#34;,&#34;2020-03-17&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-04-08&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-19&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-19&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-10&#34;,&#34;2020-03-17&#34;,&#34;2020-03-14&#34;,&#34;2020-03-14&#34;,&#34;2020-03-14&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-29&#34;,&#34;2020-04-07&#34;,&#34;2020-03-27&#34;,&#34;2020-04-10&#34;,&#34;2020-04-01&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-03&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-03-24&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-03-15&#34;,&#34;2020-03-22&#34;,&#34;2020-04-01&#34;,&#34;2020-03-18&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-04-09&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-16&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-04-03&#34;,&#34;2020-03-24&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-21&#34;,&#34;2020-03-23&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-17&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-04-13&#34;,&#34;2020-03-16&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-04-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-03-17&#34;,&#34;2020-04-14&#34;,&#34;2020-03-17&#34;,&#34;2020-04-01&#34;,&#34;2020-03-30&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-02&#34;,&#34;2020-03-24&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-27&#34;,&#34;2020-03-24&#34;,&#34;2020-03-20&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-04&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-03-17&#34;,&#34;2020-03-20&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-10&#34;,&#34;2020-03-17&#34;,&#34;2020-04-15&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-05&#34;,&#34;2020-03-28&#34;,&#34;2020-03-24&#34;,&#34;2020-04-10&#34;,&#34;2020-04-12&#34;,&#34;2020-04-01&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-23&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-03-20&#34;,&#34;2020-03-19&#34;,&#34;2020-04-09&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-14&#34;,&#34;2020-03-20&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-11&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-03-18&#34;,&#34;2020-03-31&#34;,&#34;2020-03-19&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-01&#34;,&#34;2020-03-18&#34;,&#34;2020-03-24&#34;,&#34;2020-03-23&#34;,&#34;2020-04-06&#34;,&#34;2020-04-07&#34;,&#34;2020-03-18&#34;,&#34;2020-04-14&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-04-12&#34;,&#34;2020-03-25&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-20&#34;,&#34;2020-03-23&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-21&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-24&#34;,&#34;2020-04-10&#34;,&#34;2020-03-20&#34;,&#34;2020-03-25&#34;,&#34;2020-03-19&#34;,&#34;2020-04-03&#34;,&#34;2020-03-30&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-03-19&#34;,&#34;2020-03-28&#34;,&#34;2020-03-20&#34;,&#34;2020-04-08&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-25&#34;,&#34;2020-03-19&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-04-01&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-08&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-03-21&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-23&#34;,&#34;2020-03-20&#34;,&#34;2020-03-30&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-14&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-04-01&#34;,&#34;2020-03-20&#34;,&#34;2020-04-07&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-25&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-26&#34;,&#34;2020-04-10&#34;,&#34;2020-03-20&#34;,&#34;2020-04-07&#34;,&#34;2020-03-20&#34;,&#34;2020-04-07&#34;,&#34;2020-03-20&#34;,&#34;2020-04-02&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-20&#34;,&#34;2020-03-21&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-10&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-03-21&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-03-21&#34;,&#34;2020-03-25&#34;,&#34;2020-03-23&#34;,&#34;2020-03-21&#34;,&#34;2020-03-23&#34;,&#34;2020-03-25&#34;,&#34;2020-04-14&#34;,&#34;2020-03-25&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-21&#34;,&#34;2020-04-02&#34;,&#34;2020-03-23&#34;,&#34;2020-03-24&#34;,&#34;2020-03-25&#34;,&#34;2020-03-24&#34;,&#34;2020-04-01&#34;,&#34;2020-03-21&#34;,&#34;2020-03-25&#34;,&#34;2020-03-21&#34;,&#34;2020-03-21&#34;,&#34;2020-03-21&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-03-21&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-03-25&#34;,&#34;2020-04-10&#34;,&#34;2020-03-26&#34;,&#34;2020-04-01&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-22&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-23&#34;,&#34;2020-04-14&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-04-11&#34;,&#34;2020-03-22&#34;,&#34;2020-04-08&#34;,&#34;2020-03-22&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-23&#34;,&#34;2020-04-08&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-07&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-09&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-10&#34;,&#34;2020-04-12&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-03-23&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-03&#34;,&#34;2020-03-23&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-31&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-26&#34;,&#34;2020-04-06&#34;,&#34;2020-04-15&#34;,&#34;2020-04-06&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-08&#34;,&#34;2020-03-23&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-03-25&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-07&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-03&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-03-24&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-05&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-05&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-12&#34;,&#34;2020-04-04&#34;,&#34;2020-03-31&#34;,&#34;2020-03-24&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-15&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-30&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-03&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-31&#34;,&#34;2020-03-25&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-26&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-03-26&#34;,&#34;2020-04-04&#34;,&#34;2020-03-26&#34;,&#34;2020-04-15&#34;,&#34;2020-03-26&#34;,&#34;2020-04-04&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-31&#34;,&#34;2020-04-03&#34;,&#34;2020-03-29&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-01&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-01&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-30&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-28&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-03-26&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-03-26&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-09&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-02&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-01&#34;,&#34;2020-03-30&#34;,&#34;2020-04-01&#34;,&#34;2020-03-30&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-03-27&#34;,&#34;2020-04-02&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-03-27&#34;,&#34;2020-03-29&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-27&#34;,&#34;2020-03-31&#34;,&#34;2020-04-14&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-29&#34;,&#34;2020-03-30&#34;,&#34;2020-04-01&#34;,&#34;2020-04-08&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-15&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-15&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-06&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-28&#34;,&#34;2020-04-10&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-01&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-03-28&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-03-28&#34;,&#34;2020-03-29&#34;,&#34;2020-03-28&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-30&#34;,&#34;2020-04-07&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-06&#34;,&#34;2020-03-28&#34;,&#34;2020-04-07&#34;,&#34;2020-04-06&#34;,&#34;2020-04-07&#34;,&#34;2020-03-28&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-08&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-07&#34;,&#34;2020-03-30&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-04-14&#34;,&#34;2020-03-28&#34;,&#34;2020-04-10&#34;,&#34;2020-04-05&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-11&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-03-29&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-03-29&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-03-29&#34;,&#34;2020-03-30&#34;,&#34;2020-04-05&#34;,&#34;2020-04-10&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-10&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-03-30&#34;,&#34;2020-04-13&#34;,&#34;2020-03-30&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-07&#34;,&#34;2020-03-30&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-02&#34;,&#34;2020-03-30&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-08&#34;,&#34;2020-04-11&#34;,&#34;2020-03-30&#34;,&#34;2020-04-06&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-03-31&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-09&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-04-13&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-13&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-03-31&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-01&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-03-31&#34;,&#34;2020-04-09&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-03-31&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-07&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-12&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-11&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-04-14&#34;,&#34;2020-04-01&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-04&#34;,&#34;2020-04-03&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-14&#34;,&#34;2020-04-01&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-01&#34;,&#34;2020-04-12&#34;,&#34;2020-04-02&#34;,&#34;2020-04-12&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-12&#34;,&#34;2020-04-02&#34;,&#34;2020-04-11&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-11&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-14&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-04-05&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-07&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-08&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-14&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-14&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-14&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-15&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-08&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-08&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-04&#34;,&#34;2020-04-14&#34;,&#34;2020-04-03&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-05&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-03&#34;,&#34;2020-04-15&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-13&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-05&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-15&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-14&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-14&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-06&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-04&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-05&#34;,&#34;2020-04-09&#34;,&#34;2020-04-05&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-15&#34;,&#34;2020-04-05&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-05&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-05&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-05&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-15&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-07&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-13&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-11&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-11&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-12&#34;,&#34;2020-04-11&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-11&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;],&#34;type&#34;:&#34;histogram&#34;,&#34;name&#34;:&#34;Cumulative&lt;br /&gt;Publications&#34;,&#34;cumulative&#34;:{&#34;enabled&#34;:true},&#34;marker&#34;:{&#34;color&#34;:&#34;lightgreen&#34;},&#34;opacity&#34;:0.8,&#34;inherit&#34;:true},&#34;4423e0ac765.1&#34;:{&#34;alpha_stroke&#34;:1,&#34;sizes&#34;:[10,100],&#34;spans&#34;:[1,20],&#34;x&#34;:[&#34;2020-03-20&#34;,&#34;2020-03-19&#34;,&#34;2020-02-20&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-02-18&#34;,&#34;2020-03-06&#34;,&#34;2020-02-24&#34;,&#34;2020-03-06&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-05&#34;,&#34;2020-02-04&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-04-07&#34;,&#34;2020-03-24&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-04&#34;,&#34;2020-02-04&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-19&#34;,&#34;2020-04-01&#34;,&#34;2020-02-04&#34;,&#34;2020-02-04&#34;,&#34;2020-03-23&#34;,&#34;2020-03-18&#34;,&#34;2020-03-17&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-04-08&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-02-12&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-02-11&#34;,&#34;2020-02-24&#34;,&#34;2020-02-11&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-01&#34;,&#34;2020-03-28&#34;,&#34;2020-03-17&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-02-29&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-11&#34;,&#34;2020-03-23&#34;,&#34;2020-02-10&#34;,&#34;2020-02-07&#34;,&#34;2020-02-10&#34;,&#34;2020-03-25&#34;,&#34;2020-03-16&#34;,&#34;2020-04-13&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-02-05&#34;,&#34;2020-03-22&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-13&#34;,&#34;2020-03-22&#34;,&#34;2020-02-11&#34;,&#34;2020-02-11&#34;,&#34;2020-02-06&#34;,&#34;2020-04-15&#34;,&#34;2020-03-30&#34;,&#34;2020-02-06&#34;,&#34;2020-02-06&#34;,&#34;2020-02-06&#34;,&#34;2020-02-06&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-02-07&#34;,&#34;2020-03-17&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-03-19&#34;,&#34;2020-02-11&#34;,&#34;2020-02-11&#34;,&#34;2020-02-07&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-03-27&#34;,&#34;2020-03-13&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-23&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-02-08&#34;,&#34;2020-02-08&#34;,&#34;2020-02-24&#34;,&#34;2020-02-08&#34;,&#34;2020-02-08&#34;,&#34;2020-02-08&#34;,&#34;2020-04-09&#34;,&#34;2020-02-08&#34;,&#34;2020-03-16&#34;,&#34;2020-03-23&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-08&#34;,&#34;2020-02-09&#34;,&#34;2020-02-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-03-06&#34;,&#34;2020-03-06&#34;,&#34;2020-02-19&#34;,&#34;2020-04-09&#34;,&#34;2020-03-03&#34;,&#34;2020-04-01&#34;,&#34;2020-03-18&#34;,&#34;2020-02-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-02-10&#34;,&#34;2020-03-19&#34;,&#34;2020-03-18&#34;,&#34;2020-02-10&#34;,&#34;2020-02-24&#34;,&#34;2020-02-12&#34;,&#34;2020-02-11&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-03-16&#34;,&#34;2020-03-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-02&#34;,&#34;2020-02-11&#34;,&#34;2020-02-16&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-12&#34;,&#34;2020-02-14&#34;,&#34;2020-02-14&#34;,&#34;2020-02-17&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-03-19&#34;,&#34;2020-02-21&#34;,&#34;2020-02-12&#34;,&#34;2020-04-08&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-02-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-17&#34;,&#34;2020-02-12&#34;,&#34;2020-03-20&#34;,&#34;2020-02-12&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-17&#34;,&#34;2020-03-23&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-04-10&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-26&#34;,&#34;2020-03-17&#34;,&#34;2020-02-13&#34;,&#34;2020-04-13&#34;,&#34;2020-02-26&#34;,&#34;2020-02-13&#34;,&#34;2020-02-13&#34;,&#34;2020-02-18&#34;,&#34;2020-03-05&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-02-21&#34;,&#34;2020-02-26&#34;,&#34;2020-04-01&#34;,&#34;2020-02-19&#34;,&#34;2020-03-30&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-03&#34;,&#34;2020-03-19&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-02-14&#34;,&#34;2020-02-14&#34;,&#34;2020-02-14&#34;,&#34;2020-02-14&#34;,&#34;2020-04-09&#34;,&#34;2020-03-19&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-03-06&#34;,&#34;2020-03-16&#34;,&#34;2020-02-21&#34;,&#34;2020-03-30&#34;,&#34;2020-02-15&#34;,&#34;2020-04-07&#34;,&#34;2020-02-15&#34;,&#34;2020-02-15&#34;,&#34;2020-02-16&#34;,&#34;2020-02-16&#34;,&#34;2020-02-16&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-26&#34;,&#34;2020-02-17&#34;,&#34;2020-04-09&#34;,&#34;2020-03-24&#34;,&#34;2020-02-17&#34;,&#34;2020-02-17&#34;,&#34;2020-02-17&#34;,&#34;2020-02-17&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-04-03&#34;,&#34;2020-02-17&#34;,&#34;2020-02-17&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-23&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-02-18&#34;,&#34;2020-04-01&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-21&#34;,&#34;2020-03-11&#34;,&#34;2020-03-17&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-02-19&#34;,&#34;2020-04-10&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-04-01&#34;,&#34;2020-03-25&#34;,&#34;2020-03-17&#34;,&#34;2020-02-19&#34;,&#34;2020-03-18&#34;,&#34;2020-02-19&#34;,&#34;2020-03-12&#34;,&#34;2020-03-22&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-21&#34;,&#34;2020-02-28&#34;,&#34;2020-02-25&#34;,&#34;2020-03-19&#34;,&#34;2020-02-27&#34;,&#34;2020-03-06&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-03-06&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-04-15&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-20&#34;,&#34;2020-02-21&#34;,&#34;2020-03-08&#34;,&#34;2020-03-03&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-02-21&#34;,&#34;2020-03-26&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-04-09&#34;,&#34;2020-04-03&#34;,&#34;2020-02-28&#34;,&#34;2020-02-21&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-04-01&#34;,&#34;2020-02-21&#34;,&#34;2020-02-22&#34;,&#34;2020-02-22&#34;,&#34;2020-02-22&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-04-14&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-02-24&#34;,&#34;2020-03-18&#34;,&#34;2020-02-24&#34;,&#34;2020-02-22&#34;,&#34;2020-02-22&#34;,&#34;2020-03-18&#34;,&#34;2020-04-08&#34;,&#34;2020-03-19&#34;,&#34;2020-03-26&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-02-23&#34;,&#34;2020-02-23&#34;,&#34;2020-03-05&#34;,&#34;2020-03-26&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-02-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-16&#34;,&#34;2020-02-24&#34;,&#34;2020-03-05&#34;,&#34;2020-02-24&#34;,&#34;2020-03-18&#34;,&#34;2020-04-14&#34;,&#34;2020-02-24&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-22&#34;,&#34;2020-03-08&#34;,&#34;2020-03-07&#34;,&#34;2020-03-18&#34;,&#34;2020-04-15&#34;,&#34;2020-03-18&#34;,&#34;2020-02-25&#34;,&#34;2020-04-06&#34;,&#34;2020-03-19&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-02-25&#34;,&#34;2020-02-25&#34;,&#34;2020-03-11&#34;,&#34;2020-03-03&#34;,&#34;2020-03-05&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-02-25&#34;,&#34;2020-02-25&#34;,&#34;2020-04-13&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-02-26&#34;,&#34;2020-03-23&#34;,&#34;2020-02-26&#34;,&#34;2020-03-17&#34;,&#34;2020-03-02&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-27&#34;,&#34;2020-02-28&#34;,&#34;2020-04-01&#34;,&#34;2020-02-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-08&#34;,&#34;2020-03-19&#34;,&#34;2020-03-12&#34;,&#34;2020-03-11&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-04-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-22&#34;,&#34;2020-03-17&#34;,&#34;2020-03-19&#34;,&#34;2020-02-27&#34;,&#34;2020-03-12&#34;,&#34;2020-03-02&#34;,&#34;2020-02-27&#34;,&#34;2020-02-27&#34;,&#34;2020-04-03&#34;,&#34;2020-04-11&#34;,&#34;2020-02-27&#34;,&#34;2020-03-01&#34;,&#34;2020-04-03&#34;,&#34;2020-03-12&#34;,&#34;2020-03-11&#34;,&#34;2020-03-18&#34;,&#34;2020-04-13&#34;,&#34;2020-02-28&#34;,&#34;2020-03-16&#34;,&#34;2020-02-27&#34;,&#34;2020-03-24&#34;,&#34;2020-03-17&#34;,&#34;2020-03-14&#34;,&#34;2020-03-27&#34;,&#34;2020-02-27&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-02-27&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-03-02&#34;,&#34;2020-04-15&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-18&#34;,&#34;2020-04-03&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-03-18&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-04-03&#34;,&#34;2020-03-27&#34;,&#34;2020-02-28&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-26&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-03-02&#34;,&#34;2020-04-11&#34;,&#34;2020-02-29&#34;,&#34;2020-02-29&#34;,&#34;2020-03-18&#34;,&#34;2020-03-19&#34;,&#34;2020-04-01&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-02&#34;,&#34;2020-04-03&#34;,&#34;2020-02-29&#34;,&#34;2020-02-29&#34;,&#34;2020-02-29&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-03-01&#34;,&#34;2020-03-01&#34;,&#34;2020-03-01&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-03-19&#34;,&#34;2020-03-18&#34;,&#34;2020-03-26&#34;,&#34;2020-03-30&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-03-11&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-03-26&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-02&#34;,&#34;2020-03-03&#34;,&#34;2020-04-11&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-03-03&#34;,&#34;2020-03-17&#34;,&#34;2020-04-02&#34;,&#34;2020-03-03&#34;,&#34;2020-03-06&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-04&#34;,&#34;2020-03-05&#34;,&#34;2020-03-04&#34;,&#34;2020-04-06&#34;,&#34;2020-03-24&#34;,&#34;2020-04-03&#34;,&#34;2020-03-25&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-04-15&#34;,&#34;2020-03-16&#34;,&#34;2020-03-11&#34;,&#34;2020-03-12&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-04-09&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-17&#34;,&#34;2020-03-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-25&#34;,&#34;2020-03-03&#34;,&#34;2020-03-04&#34;,&#34;2020-03-03&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-17&#34;,&#34;2020-03-04&#34;,&#34;2020-03-17&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-06&#34;,&#34;2020-03-19&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-03-17&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-04-03&#34;,&#34;2020-03-17&#34;,&#34;2020-04-12&#34;,&#34;2020-03-23&#34;,&#34;2020-03-04&#34;,&#34;2020-04-11&#34;,&#34;2020-03-05&#34;,&#34;2020-04-09&#34;,&#34;2020-03-05&#34;,&#34;2020-03-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-03-16&#34;,&#34;2020-03-05&#34;,&#34;2020-03-11&#34;,&#34;2020-03-16&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-04-07&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-19&#34;,&#34;2020-03-31&#34;,&#34;2020-04-01&#34;,&#34;2020-03-24&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-06&#34;,&#34;2020-03-18&#34;,&#34;2020-03-09&#34;,&#34;2020-03-26&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-10&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-09&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-23&#34;,&#34;2020-03-24&#34;,&#34;2020-03-06&#34;,&#34;2020-03-31&#34;,&#34;2020-03-29&#34;,&#34;2020-03-08&#34;,&#34;2020-03-06&#34;,&#34;2020-03-19&#34;,&#34;2020-03-11&#34;,&#34;2020-03-23&#34;,&#34;2020-03-06&#34;,&#34;2020-03-06&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-06&#34;,&#34;2020-03-17&#34;,&#34;2020-03-12&#34;,&#34;2020-03-24&#34;,&#34;2020-03-30&#34;,&#34;2020-03-06&#34;,&#34;2020-03-06&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-15&#34;,&#34;2020-03-09&#34;,&#34;2020-04-03&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-07&#34;,&#34;2020-03-12&#34;,&#34;2020-03-09&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-03-20&#34;,&#34;2020-04-13&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-03-23&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-04-03&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-03-16&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-14&#34;,&#34;2020-03-24&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-04-03&#34;,&#34;2020-03-09&#34;,&#34;2020-03-22&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-12&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-19&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-18&#34;,&#34;2020-03-10&#34;,&#34;2020-03-19&#34;,&#34;2020-04-07&#34;,&#34;2020-03-10&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-19&#34;,&#34;2020-04-08&#34;,&#34;2020-03-10&#34;,&#34;2020-03-10&#34;,&#34;2020-03-10&#34;,&#34;2020-03-10&#34;,&#34;2020-03-10&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-03-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-23&#34;,&#34;2020-04-06&#34;,&#34;2020-03-18&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-14&#34;,&#34;2020-04-06&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-16&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-14&#34;,&#34;2020-03-23&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-04-15&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-23&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-17&#34;,&#34;2020-04-03&#34;,&#34;2020-03-11&#34;,&#34;2020-03-22&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-03-11&#34;,&#34;2020-03-20&#34;,&#34;2020-03-11&#34;,&#34;2020-03-16&#34;,&#34;2020-03-12&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-12&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-03-25&#34;,&#34;2020-03-12&#34;,&#34;2020-04-03&#34;,&#34;2020-04-04&#34;,&#34;2020-03-26&#34;,&#34;2020-03-18&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-16&#34;,&#34;2020-04-10&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-04-10&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-04-03&#34;,&#34;2020-03-22&#34;,&#34;2020-03-30&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-03-12&#34;,&#34;2020-03-13&#34;,&#34;2020-03-26&#34;,&#34;2020-03-13&#34;,&#34;2020-03-17&#34;,&#34;2020-04-08&#34;,&#34;2020-03-26&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-03-17&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-03-28&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-03-13&#34;,&#34;2020-03-24&#34;,&#34;2020-03-13&#34;,&#34;2020-03-23&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-04-03&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-08&#34;,&#34;2020-03-17&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-04-08&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-19&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-19&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-10&#34;,&#34;2020-03-17&#34;,&#34;2020-03-14&#34;,&#34;2020-03-14&#34;,&#34;2020-03-14&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-29&#34;,&#34;2020-04-07&#34;,&#34;2020-03-27&#34;,&#34;2020-04-10&#34;,&#34;2020-04-01&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-03&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-03-24&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-03-15&#34;,&#34;2020-03-22&#34;,&#34;2020-04-01&#34;,&#34;2020-03-18&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-04-09&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-16&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-04-03&#34;,&#34;2020-03-24&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-21&#34;,&#34;2020-03-23&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-17&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-04-13&#34;,&#34;2020-03-16&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-04-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-03-17&#34;,&#34;2020-04-14&#34;,&#34;2020-03-17&#34;,&#34;2020-04-01&#34;,&#34;2020-03-30&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-02&#34;,&#34;2020-03-24&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-27&#34;,&#34;2020-03-24&#34;,&#34;2020-03-20&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-04&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-03-17&#34;,&#34;2020-03-20&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-10&#34;,&#34;2020-03-17&#34;,&#34;2020-04-15&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-05&#34;,&#34;2020-03-28&#34;,&#34;2020-03-24&#34;,&#34;2020-04-10&#34;,&#34;2020-04-12&#34;,&#34;2020-04-01&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-23&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-03-20&#34;,&#34;2020-03-19&#34;,&#34;2020-04-09&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-14&#34;,&#34;2020-03-20&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-11&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-03-18&#34;,&#34;2020-03-31&#34;,&#34;2020-03-19&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-01&#34;,&#34;2020-03-18&#34;,&#34;2020-03-24&#34;,&#34;2020-03-23&#34;,&#34;2020-04-06&#34;,&#34;2020-04-07&#34;,&#34;2020-03-18&#34;,&#34;2020-04-14&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-04-12&#34;,&#34;2020-03-25&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-20&#34;,&#34;2020-03-23&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-21&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-24&#34;,&#34;2020-04-10&#34;,&#34;2020-03-20&#34;,&#34;2020-03-25&#34;,&#34;2020-03-19&#34;,&#34;2020-04-03&#34;,&#34;2020-03-30&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-03-19&#34;,&#34;2020-03-28&#34;,&#34;2020-03-20&#34;,&#34;2020-04-08&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-25&#34;,&#34;2020-03-19&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-04-01&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-08&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-03-21&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-23&#34;,&#34;2020-03-20&#34;,&#34;2020-03-30&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-14&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-04-01&#34;,&#34;2020-03-20&#34;,&#34;2020-04-07&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-25&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-26&#34;,&#34;2020-04-10&#34;,&#34;2020-03-20&#34;,&#34;2020-04-07&#34;,&#34;2020-03-20&#34;,&#34;2020-04-07&#34;,&#34;2020-03-20&#34;,&#34;2020-04-02&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-20&#34;,&#34;2020-03-21&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-10&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-03-21&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-03-21&#34;,&#34;2020-03-25&#34;,&#34;2020-03-23&#34;,&#34;2020-03-21&#34;,&#34;2020-03-23&#34;,&#34;2020-03-25&#34;,&#34;2020-04-14&#34;,&#34;2020-03-25&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-21&#34;,&#34;2020-04-02&#34;,&#34;2020-03-23&#34;,&#34;2020-03-24&#34;,&#34;2020-03-25&#34;,&#34;2020-03-24&#34;,&#34;2020-04-01&#34;,&#34;2020-03-21&#34;,&#34;2020-03-25&#34;,&#34;2020-03-21&#34;,&#34;2020-03-21&#34;,&#34;2020-03-21&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-03-21&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-03-25&#34;,&#34;2020-04-10&#34;,&#34;2020-03-26&#34;,&#34;2020-04-01&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-22&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-23&#34;,&#34;2020-04-14&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-04-11&#34;,&#34;2020-03-22&#34;,&#34;2020-04-08&#34;,&#34;2020-03-22&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-23&#34;,&#34;2020-04-08&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-07&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-09&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-10&#34;,&#34;2020-04-12&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-03-23&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-03&#34;,&#34;2020-03-23&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-31&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-26&#34;,&#34;2020-04-06&#34;,&#34;2020-04-15&#34;,&#34;2020-04-06&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-08&#34;,&#34;2020-03-23&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-03-25&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-07&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-03&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-03-24&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-05&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-05&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-12&#34;,&#34;2020-04-04&#34;,&#34;2020-03-31&#34;,&#34;2020-03-24&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-15&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-30&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-03&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-31&#34;,&#34;2020-03-25&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-26&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-03-26&#34;,&#34;2020-04-04&#34;,&#34;2020-03-26&#34;,&#34;2020-04-15&#34;,&#34;2020-03-26&#34;,&#34;2020-04-04&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-31&#34;,&#34;2020-04-03&#34;,&#34;2020-03-29&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-01&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-01&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-30&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-28&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-03-26&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-03-26&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-09&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-02&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-01&#34;,&#34;2020-03-30&#34;,&#34;2020-04-01&#34;,&#34;2020-03-30&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-03-27&#34;,&#34;2020-04-02&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-03-27&#34;,&#34;2020-03-29&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-27&#34;,&#34;2020-03-31&#34;,&#34;2020-04-14&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-29&#34;,&#34;2020-03-30&#34;,&#34;2020-04-01&#34;,&#34;2020-04-08&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-15&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-15&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-06&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-28&#34;,&#34;2020-04-10&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-01&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-03-28&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-03-28&#34;,&#34;2020-03-29&#34;,&#34;2020-03-28&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-30&#34;,&#34;2020-04-07&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-06&#34;,&#34;2020-03-28&#34;,&#34;2020-04-07&#34;,&#34;2020-04-06&#34;,&#34;2020-04-07&#34;,&#34;2020-03-28&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-08&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-07&#34;,&#34;2020-03-30&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-04-14&#34;,&#34;2020-03-28&#34;,&#34;2020-04-10&#34;,&#34;2020-04-05&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-11&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-03-29&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-03-29&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-03-29&#34;,&#34;2020-03-30&#34;,&#34;2020-04-05&#34;,&#34;2020-04-10&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-10&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-03-30&#34;,&#34;2020-04-13&#34;,&#34;2020-03-30&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-07&#34;,&#34;2020-03-30&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-02&#34;,&#34;2020-03-30&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-08&#34;,&#34;2020-04-11&#34;,&#34;2020-03-30&#34;,&#34;2020-04-06&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-03-31&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-09&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-04-13&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-13&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-03-31&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-01&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-03-31&#34;,&#34;2020-04-09&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-03-31&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-07&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-12&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-11&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-04-14&#34;,&#34;2020-04-01&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-04&#34;,&#34;2020-04-03&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-14&#34;,&#34;2020-04-01&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-01&#34;,&#34;2020-04-12&#34;,&#34;2020-04-02&#34;,&#34;2020-04-12&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-12&#34;,&#34;2020-04-02&#34;,&#34;2020-04-11&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-11&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-14&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-04-05&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-07&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-08&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-14&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-14&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-14&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-15&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-08&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-08&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-04&#34;,&#34;2020-04-14&#34;,&#34;2020-04-03&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-05&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-03&#34;,&#34;2020-04-15&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-13&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-05&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-15&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-14&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-14&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-06&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-04&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-05&#34;,&#34;2020-04-09&#34;,&#34;2020-04-05&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-15&#34;,&#34;2020-04-05&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-05&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-05&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-05&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-15&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-07&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-13&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-11&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-11&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-12&#34;,&#34;2020-04-11&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-11&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;],&#34;type&#34;:&#34;histogram&#34;,&#34;name&#34;:&#34;Daylly&lt;br /&gt;Publication&#34;,&#34;yaxis&#34;:&#34;y2&#34;,&#34;marker&#34;:{&#34;color&#34;:&#34;red&#34;},&#34;opacity&#34;:0.2,&#34;inherit&#34;:true}},&#34;layout&#34;:{&#34;margin&#34;:{&#34;b&#34;:40,&#34;l&#34;:60,&#34;t&#34;:25,&#34;r&#34;:10},&#34;barmode&#34;:&#34;overlay&#34;,&#34;bargap&#34;:0.1,&#34;xaxis&#34;:{&#34;domain&#34;:[0,1],&#34;automargin&#34;:true,&#34;title&#34;:[],&#34;tickangle&#34;:90,&#34;tickmode&#34;:&#34;linear&#34;,&#34;range&#34;:[&#34;2020-04-08&#34;,&#34;2020-04-15&#34;]},&#34;yaxis&#34;:{&#34;domain&#34;:[0,1],&#34;automargin&#34;:true,&#34;title&#34;:&#34;Cumulative&#34;,&#34;color&#34;:&#34;green&#34;,&#34;tickfont&#34;:{&#34;color&#34;:&#34;green&#34;}},&#34;yaxis2&#34;:{&#34;title&#34;:&#34;Dally&#34;,&#34;color&#34;:&#34;red&#34;,&#34;tickfont&#34;:{&#34;color&#34;:&#34;red&#34;},&#34;overlaying&#34;:&#34;y&#34;,&#34;side&#34;:&#34;right&#34;},&#34;hovermode&#34;:&#34;closest&#34;,&#34;showlegend&#34;:true},&#34;source&#34;:&#34;A&#34;,&#34;config&#34;:{&#34;showSendToCloud&#34;:false},&#34;data&#34;:[{&#34;x&#34;:[&#34;2020-03-20&#34;,&#34;2020-03-19&#34;,&#34;2020-02-20&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-02-18&#34;,&#34;2020-03-06&#34;,&#34;2020-02-24&#34;,&#34;2020-03-06&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-05&#34;,&#34;2020-02-04&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-04-07&#34;,&#34;2020-03-24&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-04&#34;,&#34;2020-02-04&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-19&#34;,&#34;2020-04-01&#34;,&#34;2020-02-04&#34;,&#34;2020-02-04&#34;,&#34;2020-03-23&#34;,&#34;2020-03-18&#34;,&#34;2020-03-17&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-04-08&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-02-12&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-02-11&#34;,&#34;2020-02-24&#34;,&#34;2020-02-11&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-01&#34;,&#34;2020-03-28&#34;,&#34;2020-03-17&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-02-29&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-11&#34;,&#34;2020-03-23&#34;,&#34;2020-02-10&#34;,&#34;2020-02-07&#34;,&#34;2020-02-10&#34;,&#34;2020-03-25&#34;,&#34;2020-03-16&#34;,&#34;2020-04-13&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-02-05&#34;,&#34;2020-03-22&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-13&#34;,&#34;2020-03-22&#34;,&#34;2020-02-11&#34;,&#34;2020-02-11&#34;,&#34;2020-02-06&#34;,&#34;2020-04-15&#34;,&#34;2020-03-30&#34;,&#34;2020-02-06&#34;,&#34;2020-02-06&#34;,&#34;2020-02-06&#34;,&#34;2020-02-06&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-02-07&#34;,&#34;2020-03-17&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-03-19&#34;,&#34;2020-02-11&#34;,&#34;2020-02-11&#34;,&#34;2020-02-07&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-03-27&#34;,&#34;2020-03-13&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-23&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-02-08&#34;,&#34;2020-02-08&#34;,&#34;2020-02-24&#34;,&#34;2020-02-08&#34;,&#34;2020-02-08&#34;,&#34;2020-02-08&#34;,&#34;2020-04-09&#34;,&#34;2020-02-08&#34;,&#34;2020-03-16&#34;,&#34;2020-03-23&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-08&#34;,&#34;2020-02-09&#34;,&#34;2020-02-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-03-06&#34;,&#34;2020-03-06&#34;,&#34;2020-02-19&#34;,&#34;2020-04-09&#34;,&#34;2020-03-03&#34;,&#34;2020-04-01&#34;,&#34;2020-03-18&#34;,&#34;2020-02-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-02-10&#34;,&#34;2020-03-19&#34;,&#34;2020-03-18&#34;,&#34;2020-02-10&#34;,&#34;2020-02-24&#34;,&#34;2020-02-12&#34;,&#34;2020-02-11&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-03-16&#34;,&#34;2020-03-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-02&#34;,&#34;2020-02-11&#34;,&#34;2020-02-16&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-12&#34;,&#34;2020-02-14&#34;,&#34;2020-02-14&#34;,&#34;2020-02-17&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-03-19&#34;,&#34;2020-02-21&#34;,&#34;2020-02-12&#34;,&#34;2020-04-08&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-02-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-17&#34;,&#34;2020-02-12&#34;,&#34;2020-03-20&#34;,&#34;2020-02-12&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-17&#34;,&#34;2020-03-23&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-04-10&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-26&#34;,&#34;2020-03-17&#34;,&#34;2020-02-13&#34;,&#34;2020-04-13&#34;,&#34;2020-02-26&#34;,&#34;2020-02-13&#34;,&#34;2020-02-13&#34;,&#34;2020-02-18&#34;,&#34;2020-03-05&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-02-21&#34;,&#34;2020-02-26&#34;,&#34;2020-04-01&#34;,&#34;2020-02-19&#34;,&#34;2020-03-30&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-03&#34;,&#34;2020-03-19&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-02-14&#34;,&#34;2020-02-14&#34;,&#34;2020-02-14&#34;,&#34;2020-02-14&#34;,&#34;2020-04-09&#34;,&#34;2020-03-19&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-03-06&#34;,&#34;2020-03-16&#34;,&#34;2020-02-21&#34;,&#34;2020-03-30&#34;,&#34;2020-02-15&#34;,&#34;2020-04-07&#34;,&#34;2020-02-15&#34;,&#34;2020-02-15&#34;,&#34;2020-02-16&#34;,&#34;2020-02-16&#34;,&#34;2020-02-16&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-26&#34;,&#34;2020-02-17&#34;,&#34;2020-04-09&#34;,&#34;2020-03-24&#34;,&#34;2020-02-17&#34;,&#34;2020-02-17&#34;,&#34;2020-02-17&#34;,&#34;2020-02-17&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-04-03&#34;,&#34;2020-02-17&#34;,&#34;2020-02-17&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-23&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-02-18&#34;,&#34;2020-04-01&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-21&#34;,&#34;2020-03-11&#34;,&#34;2020-03-17&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-02-19&#34;,&#34;2020-04-10&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-04-01&#34;,&#34;2020-03-25&#34;,&#34;2020-03-17&#34;,&#34;2020-02-19&#34;,&#34;2020-03-18&#34;,&#34;2020-02-19&#34;,&#34;2020-03-12&#34;,&#34;2020-03-22&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-21&#34;,&#34;2020-02-28&#34;,&#34;2020-02-25&#34;,&#34;2020-03-19&#34;,&#34;2020-02-27&#34;,&#34;2020-03-06&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-03-06&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-04-15&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-20&#34;,&#34;2020-02-21&#34;,&#34;2020-03-08&#34;,&#34;2020-03-03&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-02-21&#34;,&#34;2020-03-26&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-04-09&#34;,&#34;2020-04-03&#34;,&#34;2020-02-28&#34;,&#34;2020-02-21&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-04-01&#34;,&#34;2020-02-21&#34;,&#34;2020-02-22&#34;,&#34;2020-02-22&#34;,&#34;2020-02-22&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-04-14&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-02-24&#34;,&#34;2020-03-18&#34;,&#34;2020-02-24&#34;,&#34;2020-02-22&#34;,&#34;2020-02-22&#34;,&#34;2020-03-18&#34;,&#34;2020-04-08&#34;,&#34;2020-03-19&#34;,&#34;2020-03-26&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-02-23&#34;,&#34;2020-02-23&#34;,&#34;2020-03-05&#34;,&#34;2020-03-26&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-02-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-16&#34;,&#34;2020-02-24&#34;,&#34;2020-03-05&#34;,&#34;2020-02-24&#34;,&#34;2020-03-18&#34;,&#34;2020-04-14&#34;,&#34;2020-02-24&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-22&#34;,&#34;2020-03-08&#34;,&#34;2020-03-07&#34;,&#34;2020-03-18&#34;,&#34;2020-04-15&#34;,&#34;2020-03-18&#34;,&#34;2020-02-25&#34;,&#34;2020-04-06&#34;,&#34;2020-03-19&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-02-25&#34;,&#34;2020-02-25&#34;,&#34;2020-03-11&#34;,&#34;2020-03-03&#34;,&#34;2020-03-05&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-02-25&#34;,&#34;2020-02-25&#34;,&#34;2020-04-13&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-02-26&#34;,&#34;2020-03-23&#34;,&#34;2020-02-26&#34;,&#34;2020-03-17&#34;,&#34;2020-03-02&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-27&#34;,&#34;2020-02-28&#34;,&#34;2020-04-01&#34;,&#34;2020-02-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-08&#34;,&#34;2020-03-19&#34;,&#34;2020-03-12&#34;,&#34;2020-03-11&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-04-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-22&#34;,&#34;2020-03-17&#34;,&#34;2020-03-19&#34;,&#34;2020-02-27&#34;,&#34;2020-03-12&#34;,&#34;2020-03-02&#34;,&#34;2020-02-27&#34;,&#34;2020-02-27&#34;,&#34;2020-04-03&#34;,&#34;2020-04-11&#34;,&#34;2020-02-27&#34;,&#34;2020-03-01&#34;,&#34;2020-04-03&#34;,&#34;2020-03-12&#34;,&#34;2020-03-11&#34;,&#34;2020-03-18&#34;,&#34;2020-04-13&#34;,&#34;2020-02-28&#34;,&#34;2020-03-16&#34;,&#34;2020-02-27&#34;,&#34;2020-03-24&#34;,&#34;2020-03-17&#34;,&#34;2020-03-14&#34;,&#34;2020-03-27&#34;,&#34;2020-02-27&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-02-27&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-03-02&#34;,&#34;2020-04-15&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-18&#34;,&#34;2020-04-03&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-03-18&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-04-03&#34;,&#34;2020-03-27&#34;,&#34;2020-02-28&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-26&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-03-02&#34;,&#34;2020-04-11&#34;,&#34;2020-02-29&#34;,&#34;2020-02-29&#34;,&#34;2020-03-18&#34;,&#34;2020-03-19&#34;,&#34;2020-04-01&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-02&#34;,&#34;2020-04-03&#34;,&#34;2020-02-29&#34;,&#34;2020-02-29&#34;,&#34;2020-02-29&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-03-01&#34;,&#34;2020-03-01&#34;,&#34;2020-03-01&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-03-19&#34;,&#34;2020-03-18&#34;,&#34;2020-03-26&#34;,&#34;2020-03-30&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-03-11&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-03-26&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-02&#34;,&#34;2020-03-03&#34;,&#34;2020-04-11&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-03-03&#34;,&#34;2020-03-17&#34;,&#34;2020-04-02&#34;,&#34;2020-03-03&#34;,&#34;2020-03-06&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-04&#34;,&#34;2020-03-05&#34;,&#34;2020-03-04&#34;,&#34;2020-04-06&#34;,&#34;2020-03-24&#34;,&#34;2020-04-03&#34;,&#34;2020-03-25&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-04-15&#34;,&#34;2020-03-16&#34;,&#34;2020-03-11&#34;,&#34;2020-03-12&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-04-09&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-17&#34;,&#34;2020-03-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-25&#34;,&#34;2020-03-03&#34;,&#34;2020-03-04&#34;,&#34;2020-03-03&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-17&#34;,&#34;2020-03-04&#34;,&#34;2020-03-17&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-06&#34;,&#34;2020-03-19&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-03-17&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-04-03&#34;,&#34;2020-03-17&#34;,&#34;2020-04-12&#34;,&#34;2020-03-23&#34;,&#34;2020-03-04&#34;,&#34;2020-04-11&#34;,&#34;2020-03-05&#34;,&#34;2020-04-09&#34;,&#34;2020-03-05&#34;,&#34;2020-03-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-03-16&#34;,&#34;2020-03-05&#34;,&#34;2020-03-11&#34;,&#34;2020-03-16&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-04-07&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-19&#34;,&#34;2020-03-31&#34;,&#34;2020-04-01&#34;,&#34;2020-03-24&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-06&#34;,&#34;2020-03-18&#34;,&#34;2020-03-09&#34;,&#34;2020-03-26&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-10&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-09&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-23&#34;,&#34;2020-03-24&#34;,&#34;2020-03-06&#34;,&#34;2020-03-31&#34;,&#34;2020-03-29&#34;,&#34;2020-03-08&#34;,&#34;2020-03-06&#34;,&#34;2020-03-19&#34;,&#34;2020-03-11&#34;,&#34;2020-03-23&#34;,&#34;2020-03-06&#34;,&#34;2020-03-06&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-06&#34;,&#34;2020-03-17&#34;,&#34;2020-03-12&#34;,&#34;2020-03-24&#34;,&#34;2020-03-30&#34;,&#34;2020-03-06&#34;,&#34;2020-03-06&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-15&#34;,&#34;2020-03-09&#34;,&#34;2020-04-03&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-07&#34;,&#34;2020-03-12&#34;,&#34;2020-03-09&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-03-20&#34;,&#34;2020-04-13&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-03-23&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-04-03&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-03-16&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-14&#34;,&#34;2020-03-24&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-04-03&#34;,&#34;2020-03-09&#34;,&#34;2020-03-22&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-12&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-19&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-18&#34;,&#34;2020-03-10&#34;,&#34;2020-03-19&#34;,&#34;2020-04-07&#34;,&#34;2020-03-10&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-19&#34;,&#34;2020-04-08&#34;,&#34;2020-03-10&#34;,&#34;2020-03-10&#34;,&#34;2020-03-10&#34;,&#34;2020-03-10&#34;,&#34;2020-03-10&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-03-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-23&#34;,&#34;2020-04-06&#34;,&#34;2020-03-18&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-14&#34;,&#34;2020-04-06&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-16&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-14&#34;,&#34;2020-03-23&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-04-15&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-23&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-17&#34;,&#34;2020-04-03&#34;,&#34;2020-03-11&#34;,&#34;2020-03-22&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-03-11&#34;,&#34;2020-03-20&#34;,&#34;2020-03-11&#34;,&#34;2020-03-16&#34;,&#34;2020-03-12&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-12&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-03-25&#34;,&#34;2020-03-12&#34;,&#34;2020-04-03&#34;,&#34;2020-04-04&#34;,&#34;2020-03-26&#34;,&#34;2020-03-18&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-16&#34;,&#34;2020-04-10&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-04-10&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-04-03&#34;,&#34;2020-03-22&#34;,&#34;2020-03-30&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-03-12&#34;,&#34;2020-03-13&#34;,&#34;2020-03-26&#34;,&#34;2020-03-13&#34;,&#34;2020-03-17&#34;,&#34;2020-04-08&#34;,&#34;2020-03-26&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-03-17&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-03-28&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-03-13&#34;,&#34;2020-03-24&#34;,&#34;2020-03-13&#34;,&#34;2020-03-23&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-04-03&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-08&#34;,&#34;2020-03-17&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-04-08&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-19&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-19&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-10&#34;,&#34;2020-03-17&#34;,&#34;2020-03-14&#34;,&#34;2020-03-14&#34;,&#34;2020-03-14&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-29&#34;,&#34;2020-04-07&#34;,&#34;2020-03-27&#34;,&#34;2020-04-10&#34;,&#34;2020-04-01&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-03&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-03-24&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-03-15&#34;,&#34;2020-03-22&#34;,&#34;2020-04-01&#34;,&#34;2020-03-18&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-04-09&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-16&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-04-03&#34;,&#34;2020-03-24&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-21&#34;,&#34;2020-03-23&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-17&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-04-13&#34;,&#34;2020-03-16&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-04-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-03-17&#34;,&#34;2020-04-14&#34;,&#34;2020-03-17&#34;,&#34;2020-04-01&#34;,&#34;2020-03-30&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-02&#34;,&#34;2020-03-24&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-27&#34;,&#34;2020-03-24&#34;,&#34;2020-03-20&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-04&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-03-17&#34;,&#34;2020-03-20&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-10&#34;,&#34;2020-03-17&#34;,&#34;2020-04-15&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-05&#34;,&#34;2020-03-28&#34;,&#34;2020-03-24&#34;,&#34;2020-04-10&#34;,&#34;2020-04-12&#34;,&#34;2020-04-01&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-23&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-03-20&#34;,&#34;2020-03-19&#34;,&#34;2020-04-09&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-14&#34;,&#34;2020-03-20&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-11&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-03-18&#34;,&#34;2020-03-31&#34;,&#34;2020-03-19&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-01&#34;,&#34;2020-03-18&#34;,&#34;2020-03-24&#34;,&#34;2020-03-23&#34;,&#34;2020-04-06&#34;,&#34;2020-04-07&#34;,&#34;2020-03-18&#34;,&#34;2020-04-14&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-04-12&#34;,&#34;2020-03-25&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-20&#34;,&#34;2020-03-23&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-21&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-24&#34;,&#34;2020-04-10&#34;,&#34;2020-03-20&#34;,&#34;2020-03-25&#34;,&#34;2020-03-19&#34;,&#34;2020-04-03&#34;,&#34;2020-03-30&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-03-19&#34;,&#34;2020-03-28&#34;,&#34;2020-03-20&#34;,&#34;2020-04-08&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-25&#34;,&#34;2020-03-19&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-04-01&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-08&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-03-21&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-23&#34;,&#34;2020-03-20&#34;,&#34;2020-03-30&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-14&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-04-01&#34;,&#34;2020-03-20&#34;,&#34;2020-04-07&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-25&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-26&#34;,&#34;2020-04-10&#34;,&#34;2020-03-20&#34;,&#34;2020-04-07&#34;,&#34;2020-03-20&#34;,&#34;2020-04-07&#34;,&#34;2020-03-20&#34;,&#34;2020-04-02&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-20&#34;,&#34;2020-03-21&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-10&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-03-21&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-03-21&#34;,&#34;2020-03-25&#34;,&#34;2020-03-23&#34;,&#34;2020-03-21&#34;,&#34;2020-03-23&#34;,&#34;2020-03-25&#34;,&#34;2020-04-14&#34;,&#34;2020-03-25&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-21&#34;,&#34;2020-04-02&#34;,&#34;2020-03-23&#34;,&#34;2020-03-24&#34;,&#34;2020-03-25&#34;,&#34;2020-03-24&#34;,&#34;2020-04-01&#34;,&#34;2020-03-21&#34;,&#34;2020-03-25&#34;,&#34;2020-03-21&#34;,&#34;2020-03-21&#34;,&#34;2020-03-21&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-03-21&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-03-25&#34;,&#34;2020-04-10&#34;,&#34;2020-03-26&#34;,&#34;2020-04-01&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-22&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-23&#34;,&#34;2020-04-14&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-04-11&#34;,&#34;2020-03-22&#34;,&#34;2020-04-08&#34;,&#34;2020-03-22&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-23&#34;,&#34;2020-04-08&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-07&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-09&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-10&#34;,&#34;2020-04-12&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-03-23&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-03&#34;,&#34;2020-03-23&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-31&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-26&#34;,&#34;2020-04-06&#34;,&#34;2020-04-15&#34;,&#34;2020-04-06&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-08&#34;,&#34;2020-03-23&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-03-25&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-07&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-03&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-03-24&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-05&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-05&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-12&#34;,&#34;2020-04-04&#34;,&#34;2020-03-31&#34;,&#34;2020-03-24&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-15&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-30&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-03&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-31&#34;,&#34;2020-03-25&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-26&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-03-26&#34;,&#34;2020-04-04&#34;,&#34;2020-03-26&#34;,&#34;2020-04-15&#34;,&#34;2020-03-26&#34;,&#34;2020-04-04&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-31&#34;,&#34;2020-04-03&#34;,&#34;2020-03-29&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-01&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-01&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-30&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-28&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-03-26&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-03-26&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-09&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-02&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-01&#34;,&#34;2020-03-30&#34;,&#34;2020-04-01&#34;,&#34;2020-03-30&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-03-27&#34;,&#34;2020-04-02&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-03-27&#34;,&#34;2020-03-29&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-27&#34;,&#34;2020-03-31&#34;,&#34;2020-04-14&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-29&#34;,&#34;2020-03-30&#34;,&#34;2020-04-01&#34;,&#34;2020-04-08&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-15&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-15&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-06&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-28&#34;,&#34;2020-04-10&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-01&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-03-28&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-03-28&#34;,&#34;2020-03-29&#34;,&#34;2020-03-28&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-30&#34;,&#34;2020-04-07&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-06&#34;,&#34;2020-03-28&#34;,&#34;2020-04-07&#34;,&#34;2020-04-06&#34;,&#34;2020-04-07&#34;,&#34;2020-03-28&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-08&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-07&#34;,&#34;2020-03-30&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-04-14&#34;,&#34;2020-03-28&#34;,&#34;2020-04-10&#34;,&#34;2020-04-05&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-11&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-03-29&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-03-29&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-03-29&#34;,&#34;2020-03-30&#34;,&#34;2020-04-05&#34;,&#34;2020-04-10&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-10&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-03-30&#34;,&#34;2020-04-13&#34;,&#34;2020-03-30&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-07&#34;,&#34;2020-03-30&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-02&#34;,&#34;2020-03-30&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-08&#34;,&#34;2020-04-11&#34;,&#34;2020-03-30&#34;,&#34;2020-04-06&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-03-31&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-09&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-04-13&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-13&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-03-31&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-01&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-03-31&#34;,&#34;2020-04-09&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-03-31&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-07&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-12&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-11&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-04-14&#34;,&#34;2020-04-01&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-04&#34;,&#34;2020-04-03&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-14&#34;,&#34;2020-04-01&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-01&#34;,&#34;2020-04-12&#34;,&#34;2020-04-02&#34;,&#34;2020-04-12&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-12&#34;,&#34;2020-04-02&#34;,&#34;2020-04-11&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-11&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-14&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-04-05&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-07&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-08&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-14&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-14&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-14&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-15&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-08&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-08&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-04&#34;,&#34;2020-04-14&#34;,&#34;2020-04-03&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-05&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-03&#34;,&#34;2020-04-15&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-13&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-05&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-15&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-14&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-14&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-06&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-04&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-05&#34;,&#34;2020-04-09&#34;,&#34;2020-04-05&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-15&#34;,&#34;2020-04-05&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-05&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-05&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-05&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-15&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-07&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-13&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-11&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-11&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-12&#34;,&#34;2020-04-11&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-11&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;],&#34;type&#34;:&#34;histogram&#34;,&#34;name&#34;:&#34;Cumulative&lt;br /&gt;Publications&#34;,&#34;cumulative&#34;:{&#34;enabled&#34;:true},&#34;marker&#34;:{&#34;color&#34;:&#34;lightgreen&#34;,&#34;line&#34;:{&#34;color&#34;:&#34;rgba(31,119,180,1)&#34;}},&#34;opacity&#34;:0.8,&#34;error_y&#34;:{&#34;color&#34;:&#34;rgba(31,119,180,1)&#34;},&#34;error_x&#34;:{&#34;color&#34;:&#34;rgba(31,119,180,1)&#34;},&#34;xaxis&#34;:&#34;x&#34;,&#34;yaxis&#34;:&#34;y&#34;,&#34;frame&#34;:null},{&#34;x&#34;:[&#34;2020-03-20&#34;,&#34;2020-03-19&#34;,&#34;2020-02-20&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-02-18&#34;,&#34;2020-03-06&#34;,&#34;2020-02-24&#34;,&#34;2020-03-06&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-05&#34;,&#34;2020-02-04&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-04-07&#34;,&#34;2020-03-24&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-04&#34;,&#34;2020-02-04&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-19&#34;,&#34;2020-04-01&#34;,&#34;2020-02-04&#34;,&#34;2020-02-04&#34;,&#34;2020-03-23&#34;,&#34;2020-03-18&#34;,&#34;2020-03-17&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-04-08&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-02-12&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-02-11&#34;,&#34;2020-02-24&#34;,&#34;2020-02-11&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-01&#34;,&#34;2020-03-28&#34;,&#34;2020-03-17&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-02-29&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-11&#34;,&#34;2020-03-23&#34;,&#34;2020-02-10&#34;,&#34;2020-02-07&#34;,&#34;2020-02-10&#34;,&#34;2020-03-25&#34;,&#34;2020-03-16&#34;,&#34;2020-04-13&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-02-05&#34;,&#34;2020-03-22&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-05&#34;,&#34;2020-02-13&#34;,&#34;2020-03-22&#34;,&#34;2020-02-11&#34;,&#34;2020-02-11&#34;,&#34;2020-02-06&#34;,&#34;2020-04-15&#34;,&#34;2020-03-30&#34;,&#34;2020-02-06&#34;,&#34;2020-02-06&#34;,&#34;2020-02-06&#34;,&#34;2020-02-06&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-02-07&#34;,&#34;2020-03-17&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-03-19&#34;,&#34;2020-02-11&#34;,&#34;2020-02-11&#34;,&#34;2020-02-07&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-03-27&#34;,&#34;2020-03-13&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-23&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-02-08&#34;,&#34;2020-02-08&#34;,&#34;2020-02-24&#34;,&#34;2020-02-08&#34;,&#34;2020-02-08&#34;,&#34;2020-02-08&#34;,&#34;2020-04-09&#34;,&#34;2020-02-08&#34;,&#34;2020-03-16&#34;,&#34;2020-03-23&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-08&#34;,&#34;2020-02-09&#34;,&#34;2020-02-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-03-06&#34;,&#34;2020-03-06&#34;,&#34;2020-02-19&#34;,&#34;2020-04-09&#34;,&#34;2020-03-03&#34;,&#34;2020-04-01&#34;,&#34;2020-03-18&#34;,&#34;2020-02-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-02-10&#34;,&#34;2020-03-19&#34;,&#34;2020-03-18&#34;,&#34;2020-02-10&#34;,&#34;2020-02-24&#34;,&#34;2020-02-12&#34;,&#34;2020-02-11&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-03-16&#34;,&#34;2020-03-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-02&#34;,&#34;2020-02-11&#34;,&#34;2020-02-16&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-12&#34;,&#34;2020-02-14&#34;,&#34;2020-02-14&#34;,&#34;2020-02-17&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-03-19&#34;,&#34;2020-02-21&#34;,&#34;2020-02-12&#34;,&#34;2020-04-08&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-02-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-17&#34;,&#34;2020-02-12&#34;,&#34;2020-03-20&#34;,&#34;2020-02-12&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-17&#34;,&#34;2020-03-23&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-04-10&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-26&#34;,&#34;2020-03-17&#34;,&#34;2020-02-13&#34;,&#34;2020-04-13&#34;,&#34;2020-02-26&#34;,&#34;2020-02-13&#34;,&#34;2020-02-13&#34;,&#34;2020-02-18&#34;,&#34;2020-03-05&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-02-21&#34;,&#34;2020-02-26&#34;,&#34;2020-04-01&#34;,&#34;2020-02-19&#34;,&#34;2020-03-30&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-03&#34;,&#34;2020-03-19&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-02-14&#34;,&#34;2020-02-14&#34;,&#34;2020-02-14&#34;,&#34;2020-02-14&#34;,&#34;2020-04-09&#34;,&#34;2020-03-19&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-03-06&#34;,&#34;2020-03-16&#34;,&#34;2020-02-21&#34;,&#34;2020-03-30&#34;,&#34;2020-02-15&#34;,&#34;2020-04-07&#34;,&#34;2020-02-15&#34;,&#34;2020-02-15&#34;,&#34;2020-02-16&#34;,&#34;2020-02-16&#34;,&#34;2020-02-16&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-26&#34;,&#34;2020-02-17&#34;,&#34;2020-04-09&#34;,&#34;2020-03-24&#34;,&#34;2020-02-17&#34;,&#34;2020-02-17&#34;,&#34;2020-02-17&#34;,&#34;2020-02-17&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-04-03&#34;,&#34;2020-02-17&#34;,&#34;2020-02-17&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-23&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-02-18&#34;,&#34;2020-04-01&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-02-21&#34;,&#34;2020-03-11&#34;,&#34;2020-03-17&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-02-19&#34;,&#34;2020-04-10&#34;,&#34;2020-02-19&#34;,&#34;2020-02-19&#34;,&#34;2020-04-01&#34;,&#34;2020-03-25&#34;,&#34;2020-03-17&#34;,&#34;2020-02-19&#34;,&#34;2020-03-18&#34;,&#34;2020-02-19&#34;,&#34;2020-03-12&#34;,&#34;2020-03-22&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-21&#34;,&#34;2020-02-28&#34;,&#34;2020-02-25&#34;,&#34;2020-03-19&#34;,&#34;2020-02-27&#34;,&#34;2020-03-06&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-02-20&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-03-06&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-04-15&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-20&#34;,&#34;2020-02-21&#34;,&#34;2020-03-08&#34;,&#34;2020-03-03&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-02-21&#34;,&#34;2020-03-26&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-04-09&#34;,&#34;2020-04-03&#34;,&#34;2020-02-28&#34;,&#34;2020-02-21&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-04-01&#34;,&#34;2020-02-21&#34;,&#34;2020-02-22&#34;,&#34;2020-02-22&#34;,&#34;2020-02-22&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-04-14&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-02-24&#34;,&#34;2020-03-18&#34;,&#34;2020-02-24&#34;,&#34;2020-02-22&#34;,&#34;2020-02-22&#34;,&#34;2020-03-18&#34;,&#34;2020-04-08&#34;,&#34;2020-03-19&#34;,&#34;2020-03-26&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-02-23&#34;,&#34;2020-02-23&#34;,&#34;2020-03-05&#34;,&#34;2020-03-26&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-02-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-16&#34;,&#34;2020-02-24&#34;,&#34;2020-03-05&#34;,&#34;2020-02-24&#34;,&#34;2020-03-18&#34;,&#34;2020-04-14&#34;,&#34;2020-02-24&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-22&#34;,&#34;2020-03-08&#34;,&#34;2020-03-07&#34;,&#34;2020-03-18&#34;,&#34;2020-04-15&#34;,&#34;2020-03-18&#34;,&#34;2020-02-25&#34;,&#34;2020-04-06&#34;,&#34;2020-03-19&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-02-25&#34;,&#34;2020-02-25&#34;,&#34;2020-03-11&#34;,&#34;2020-03-03&#34;,&#34;2020-03-05&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-02-25&#34;,&#34;2020-02-25&#34;,&#34;2020-04-13&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-02-26&#34;,&#34;2020-03-23&#34;,&#34;2020-02-26&#34;,&#34;2020-03-17&#34;,&#34;2020-03-02&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-27&#34;,&#34;2020-02-28&#34;,&#34;2020-04-01&#34;,&#34;2020-02-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-08&#34;,&#34;2020-03-19&#34;,&#34;2020-03-12&#34;,&#34;2020-03-11&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-02-26&#34;,&#34;2020-04-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-22&#34;,&#34;2020-03-17&#34;,&#34;2020-03-19&#34;,&#34;2020-02-27&#34;,&#34;2020-03-12&#34;,&#34;2020-03-02&#34;,&#34;2020-02-27&#34;,&#34;2020-02-27&#34;,&#34;2020-04-03&#34;,&#34;2020-04-11&#34;,&#34;2020-02-27&#34;,&#34;2020-03-01&#34;,&#34;2020-04-03&#34;,&#34;2020-03-12&#34;,&#34;2020-03-11&#34;,&#34;2020-03-18&#34;,&#34;2020-04-13&#34;,&#34;2020-02-28&#34;,&#34;2020-03-16&#34;,&#34;2020-02-27&#34;,&#34;2020-03-24&#34;,&#34;2020-03-17&#34;,&#34;2020-03-14&#34;,&#34;2020-03-27&#34;,&#34;2020-02-27&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-02-27&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-03-02&#34;,&#34;2020-04-15&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-18&#34;,&#34;2020-04-03&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-03-18&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-02-28&#34;,&#34;2020-04-03&#34;,&#34;2020-03-27&#34;,&#34;2020-02-28&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-26&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-03-02&#34;,&#34;2020-04-11&#34;,&#34;2020-02-29&#34;,&#34;2020-02-29&#34;,&#34;2020-03-18&#34;,&#34;2020-03-19&#34;,&#34;2020-04-01&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-02&#34;,&#34;2020-04-03&#34;,&#34;2020-02-29&#34;,&#34;2020-02-29&#34;,&#34;2020-02-29&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-03-01&#34;,&#34;2020-03-01&#34;,&#34;2020-03-01&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-03-19&#34;,&#34;2020-03-18&#34;,&#34;2020-03-26&#34;,&#34;2020-03-30&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-03-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-03-11&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-03-26&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-02&#34;,&#34;2020-03-03&#34;,&#34;2020-04-11&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-03-03&#34;,&#34;2020-03-17&#34;,&#34;2020-04-02&#34;,&#34;2020-03-03&#34;,&#34;2020-03-06&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-04&#34;,&#34;2020-03-05&#34;,&#34;2020-03-04&#34;,&#34;2020-04-06&#34;,&#34;2020-03-24&#34;,&#34;2020-04-03&#34;,&#34;2020-03-25&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-04-15&#34;,&#34;2020-03-16&#34;,&#34;2020-03-11&#34;,&#34;2020-03-12&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-04-09&#34;,&#34;2020-03-03&#34;,&#34;2020-03-03&#34;,&#34;2020-03-17&#34;,&#34;2020-03-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-25&#34;,&#34;2020-03-03&#34;,&#34;2020-03-04&#34;,&#34;2020-03-03&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-17&#34;,&#34;2020-03-04&#34;,&#34;2020-03-17&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-06&#34;,&#34;2020-03-19&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-03-17&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-03-04&#34;,&#34;2020-04-03&#34;,&#34;2020-03-17&#34;,&#34;2020-04-12&#34;,&#34;2020-03-23&#34;,&#34;2020-03-04&#34;,&#34;2020-04-11&#34;,&#34;2020-03-05&#34;,&#34;2020-04-09&#34;,&#34;2020-03-05&#34;,&#34;2020-03-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-03-16&#34;,&#34;2020-03-05&#34;,&#34;2020-03-11&#34;,&#34;2020-03-16&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-04-07&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-19&#34;,&#34;2020-03-31&#34;,&#34;2020-04-01&#34;,&#34;2020-03-24&#34;,&#34;2020-03-05&#34;,&#34;2020-03-05&#34;,&#34;2020-03-06&#34;,&#34;2020-03-18&#34;,&#34;2020-03-09&#34;,&#34;2020-03-26&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-10&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-09&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-23&#34;,&#34;2020-03-24&#34;,&#34;2020-03-06&#34;,&#34;2020-03-31&#34;,&#34;2020-03-29&#34;,&#34;2020-03-08&#34;,&#34;2020-03-06&#34;,&#34;2020-03-19&#34;,&#34;2020-03-11&#34;,&#34;2020-03-23&#34;,&#34;2020-03-06&#34;,&#34;2020-03-06&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-06&#34;,&#34;2020-03-17&#34;,&#34;2020-03-12&#34;,&#34;2020-03-24&#34;,&#34;2020-03-30&#34;,&#34;2020-03-06&#34;,&#34;2020-03-06&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-15&#34;,&#34;2020-03-09&#34;,&#34;2020-04-03&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-07&#34;,&#34;2020-03-12&#34;,&#34;2020-03-09&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-03-20&#34;,&#34;2020-04-13&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-03-23&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-03-08&#34;,&#34;2020-03-08&#34;,&#34;2020-04-03&#34;,&#34;2020-03-18&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-03-16&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-14&#34;,&#34;2020-03-24&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-03-09&#34;,&#34;2020-04-03&#34;,&#34;2020-03-09&#34;,&#34;2020-03-22&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-12&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-19&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-18&#34;,&#34;2020-03-10&#34;,&#34;2020-03-19&#34;,&#34;2020-04-07&#34;,&#34;2020-03-10&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-19&#34;,&#34;2020-04-08&#34;,&#34;2020-03-10&#34;,&#34;2020-03-10&#34;,&#34;2020-03-10&#34;,&#34;2020-03-10&#34;,&#34;2020-03-10&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-03-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-23&#34;,&#34;2020-04-06&#34;,&#34;2020-03-18&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-14&#34;,&#34;2020-04-06&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-16&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-14&#34;,&#34;2020-03-23&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-04-15&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-23&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-17&#34;,&#34;2020-04-03&#34;,&#34;2020-03-11&#34;,&#34;2020-03-22&#34;,&#34;2020-03-11&#34;,&#34;2020-03-11&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-03-11&#34;,&#34;2020-03-20&#34;,&#34;2020-03-11&#34;,&#34;2020-03-16&#34;,&#34;2020-03-12&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-04-09&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-12&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-03-25&#34;,&#34;2020-03-12&#34;,&#34;2020-04-03&#34;,&#34;2020-04-04&#34;,&#34;2020-03-26&#34;,&#34;2020-03-18&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-16&#34;,&#34;2020-04-10&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-04-10&#34;,&#34;2020-03-12&#34;,&#34;2020-03-12&#34;,&#34;2020-04-03&#34;,&#34;2020-03-22&#34;,&#34;2020-03-30&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-03-12&#34;,&#34;2020-03-13&#34;,&#34;2020-03-26&#34;,&#34;2020-03-13&#34;,&#34;2020-03-17&#34;,&#34;2020-04-08&#34;,&#34;2020-03-26&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-03-17&#34;,&#34;2020-03-20&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-03-28&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-03-13&#34;,&#34;2020-03-24&#34;,&#34;2020-03-13&#34;,&#34;2020-03-23&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-04-03&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-18&#34;,&#34;2020-03-20&#34;,&#34;2020-03-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-18&#34;,&#34;2020-04-08&#34;,&#34;2020-03-17&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-04-08&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-13&#34;,&#34;2020-03-19&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-19&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-10&#34;,&#34;2020-03-17&#34;,&#34;2020-03-14&#34;,&#34;2020-03-14&#34;,&#34;2020-03-14&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-29&#34;,&#34;2020-04-07&#34;,&#34;2020-03-27&#34;,&#34;2020-04-10&#34;,&#34;2020-04-01&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-03&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-03-24&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-03-15&#34;,&#34;2020-03-22&#34;,&#34;2020-04-01&#34;,&#34;2020-03-18&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-03-15&#34;,&#34;2020-04-09&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-16&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-04-03&#34;,&#34;2020-03-24&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-21&#34;,&#34;2020-03-23&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-17&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-16&#34;,&#34;2020-03-18&#34;,&#34;2020-03-16&#34;,&#34;2020-04-13&#34;,&#34;2020-03-16&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-04-10&#34;,&#34;2020-03-16&#34;,&#34;2020-03-16&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-03-17&#34;,&#34;2020-04-14&#34;,&#34;2020-03-17&#34;,&#34;2020-04-01&#34;,&#34;2020-03-30&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-02&#34;,&#34;2020-03-24&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-03-27&#34;,&#34;2020-03-24&#34;,&#34;2020-03-20&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-04&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-03-17&#34;,&#34;2020-03-20&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-04-10&#34;,&#34;2020-03-17&#34;,&#34;2020-04-15&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-05&#34;,&#34;2020-03-28&#34;,&#34;2020-03-24&#34;,&#34;2020-04-10&#34;,&#34;2020-04-12&#34;,&#34;2020-04-01&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-17&#34;,&#34;2020-03-18&#34;,&#34;2020-03-23&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-03-20&#34;,&#34;2020-03-19&#34;,&#34;2020-04-09&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-14&#34;,&#34;2020-03-20&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-11&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-03-18&#34;,&#34;2020-03-31&#34;,&#34;2020-03-19&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-03-18&#34;,&#34;2020-04-01&#34;,&#34;2020-03-18&#34;,&#34;2020-03-24&#34;,&#34;2020-03-23&#34;,&#34;2020-04-06&#34;,&#34;2020-04-07&#34;,&#34;2020-03-18&#34;,&#34;2020-04-14&#34;,&#34;2020-03-18&#34;,&#34;2020-04-07&#34;,&#34;2020-04-12&#34;,&#34;2020-03-25&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-20&#34;,&#34;2020-03-23&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-21&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-24&#34;,&#34;2020-04-10&#34;,&#34;2020-03-20&#34;,&#34;2020-03-25&#34;,&#34;2020-03-19&#34;,&#34;2020-04-03&#34;,&#34;2020-03-30&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-03-19&#34;,&#34;2020-03-28&#34;,&#34;2020-03-20&#34;,&#34;2020-04-08&#34;,&#34;2020-03-19&#34;,&#34;2020-03-23&#34;,&#34;2020-03-25&#34;,&#34;2020-03-19&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-03-19&#34;,&#34;2020-03-19&#34;,&#34;2020-04-01&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-08&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-03-21&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-23&#34;,&#34;2020-03-20&#34;,&#34;2020-03-30&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-14&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-04-01&#34;,&#34;2020-03-20&#34;,&#34;2020-04-07&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-25&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-26&#34;,&#34;2020-04-10&#34;,&#34;2020-03-20&#34;,&#34;2020-04-07&#34;,&#34;2020-03-20&#34;,&#34;2020-04-07&#34;,&#34;2020-03-20&#34;,&#34;2020-04-02&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-20&#34;,&#34;2020-03-21&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-10&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-03-20&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-03-21&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-03-21&#34;,&#34;2020-03-25&#34;,&#34;2020-03-23&#34;,&#34;2020-03-21&#34;,&#34;2020-03-23&#34;,&#34;2020-03-25&#34;,&#34;2020-04-14&#34;,&#34;2020-03-25&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-21&#34;,&#34;2020-04-02&#34;,&#34;2020-03-23&#34;,&#34;2020-03-24&#34;,&#34;2020-03-25&#34;,&#34;2020-03-24&#34;,&#34;2020-04-01&#34;,&#34;2020-03-21&#34;,&#34;2020-03-25&#34;,&#34;2020-03-21&#34;,&#34;2020-03-21&#34;,&#34;2020-03-21&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-03-21&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-03-25&#34;,&#34;2020-04-10&#34;,&#34;2020-03-26&#34;,&#34;2020-04-01&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-22&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-23&#34;,&#34;2020-04-14&#34;,&#34;2020-03-22&#34;,&#34;2020-03-22&#34;,&#34;2020-04-11&#34;,&#34;2020-03-22&#34;,&#34;2020-04-08&#34;,&#34;2020-03-22&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-23&#34;,&#34;2020-04-08&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-07&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-09&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-25&#34;,&#34;2020-03-26&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-10&#34;,&#34;2020-04-12&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-04-10&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-03-23&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-03&#34;,&#34;2020-03-23&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-31&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-03-26&#34;,&#34;2020-04-06&#34;,&#34;2020-04-15&#34;,&#34;2020-04-06&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-08&#34;,&#34;2020-03-23&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-03-25&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-07&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-03&#34;,&#34;2020-03-23&#34;,&#34;2020-03-23&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-03-24&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-05&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-05&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-12&#34;,&#34;2020-04-04&#34;,&#34;2020-03-31&#34;,&#34;2020-03-24&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-15&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-09&#34;,&#34;2020-03-30&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-24&#34;,&#34;2020-04-03&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-24&#34;,&#34;2020-03-31&#34;,&#34;2020-03-25&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-26&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-03-25&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-03-26&#34;,&#34;2020-04-04&#34;,&#34;2020-03-26&#34;,&#34;2020-04-15&#34;,&#34;2020-03-26&#34;,&#34;2020-04-04&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-31&#34;,&#34;2020-04-03&#34;,&#34;2020-03-29&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-01&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-01&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-30&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-28&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-03-26&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-03-26&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-03-26&#34;,&#34;2020-04-01&#34;,&#34;2020-03-26&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-09&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-02&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-01&#34;,&#34;2020-03-30&#34;,&#34;2020-04-01&#34;,&#34;2020-03-30&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-03-27&#34;,&#34;2020-04-02&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-03-27&#34;,&#34;2020-03-29&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-27&#34;,&#34;2020-03-31&#34;,&#34;2020-04-14&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-29&#34;,&#34;2020-03-30&#34;,&#34;2020-04-01&#34;,&#34;2020-04-08&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-15&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-15&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-04-06&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-03-27&#34;,&#34;2020-03-27&#34;,&#34;2020-03-28&#34;,&#34;2020-04-10&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-01&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-03-28&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-03-28&#34;,&#34;2020-03-29&#34;,&#34;2020-03-28&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-30&#34;,&#34;2020-04-07&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-06&#34;,&#34;2020-03-28&#34;,&#34;2020-04-07&#34;,&#34;2020-04-06&#34;,&#34;2020-04-07&#34;,&#34;2020-03-28&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-08&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-07&#34;,&#34;2020-03-30&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-03-28&#34;,&#34;2020-04-14&#34;,&#34;2020-03-28&#34;,&#34;2020-04-10&#34;,&#34;2020-04-05&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-11&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-03-28&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-03-29&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-03-29&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-01&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-03-29&#34;,&#34;2020-03-30&#34;,&#34;2020-04-05&#34;,&#34;2020-04-10&#34;,&#34;2020-03-29&#34;,&#34;2020-03-29&#34;,&#34;2020-04-10&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-03-30&#34;,&#34;2020-04-13&#34;,&#34;2020-03-30&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-07&#34;,&#34;2020-03-30&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-02&#34;,&#34;2020-03-30&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-03-30&#34;,&#34;2020-03-30&#34;,&#34;2020-04-08&#34;,&#34;2020-04-11&#34;,&#34;2020-03-30&#34;,&#34;2020-04-06&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-03-31&#34;,&#34;2020-04-03&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-09&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-04-13&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-13&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-03-31&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-01&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-03-31&#34;,&#34;2020-04-09&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-04-10&#34;,&#34;2020-03-31&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-03-31&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-07&#34;,&#34;2020-03-31&#34;,&#34;2020-03-31&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-12&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-11&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-10&#34;,&#34;2020-04-03&#34;,&#34;2020-04-01&#34;,&#34;2020-04-14&#34;,&#34;2020-04-01&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-04&#34;,&#34;2020-04-03&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-08&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-04&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-14&#34;,&#34;2020-04-01&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-13&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-02&#34;,&#34;2020-04-01&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-01&#34;,&#34;2020-04-12&#34;,&#34;2020-04-02&#34;,&#34;2020-04-12&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-01&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-12&#34;,&#34;2020-04-02&#34;,&#34;2020-04-11&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-11&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-14&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-04-05&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-07&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-08&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-02&#34;,&#34;2020-04-03&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-14&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-04-08&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-02&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-14&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-04&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-02&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-02&#34;,&#34;2020-04-02&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-14&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-15&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-08&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-08&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-04&#34;,&#34;2020-04-14&#34;,&#34;2020-04-03&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-05&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-07&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-03&#34;,&#34;2020-04-15&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-13&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-10&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-05&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-15&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-14&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-03&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-14&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-06&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-09&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-15&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-04&#34;,&#34;2020-04-04&#34;,&#34;2020-04-07&#34;,&#34;2020-04-04&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-05&#34;,&#34;2020-04-09&#34;,&#34;2020-04-05&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-15&#34;,&#34;2020-04-05&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-05&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-05&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-05&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-05&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-15&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-13&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-14&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-09&#34;,&#34;2020-04-06&#34;,&#34;2020-04-06&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-08&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-07&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-13&#34;,&#34;2020-04-07&#34;,&#34;2020-04-15&#34;,&#34;2020-04-07&#34;,&#34;2020-04-11&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-09&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-07&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-15&#34;,&#34;2020-04-08&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-11&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-12&#34;,&#34;2020-04-11&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-13&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-08&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-14&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-10&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-09&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-09&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-14&#34;,&#34;2020-04-11&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-15&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-10&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-15&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-11&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-11&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-11&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-12&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-12&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-14&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-13&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-14&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;,&#34;2020-04-15&#34;],&#34;type&#34;:&#34;histogram&#34;,&#34;name&#34;:&#34;Daylly&lt;br /&gt;Publication&#34;,&#34;yaxis&#34;:&#34;y2&#34;,&#34;marker&#34;:{&#34;color&#34;:&#34;red&#34;,&#34;line&#34;:{&#34;color&#34;:&#34;rgba(255,127,14,1)&#34;}},&#34;opacity&#34;:0.2,&#34;error_y&#34;:{&#34;color&#34;:&#34;rgba(255,127,14,1)&#34;},&#34;error_x&#34;:{&#34;color&#34;:&#34;rgba(255,127,14,1)&#34;},&#34;xaxis&#34;:&#34;x&#34;,&#34;frame&#34;:null}],&#34;highlight&#34;:{&#34;on&#34;:&#34;plotly_click&#34;,&#34;persistent&#34;:false,&#34;dynamic&#34;:false,&#34;selectize&#34;:false,&#34;opacityDim&#34;:0.2,&#34;selected&#34;:{&#34;opacity&#34;:1},&#34;debounce&#34;:0},&#34;shinyEvents&#34;:[&#34;plotly_hover&#34;,&#34;plotly_click&#34;,&#34;plotly_selected&#34;,&#34;plotly_relayout&#34;,&#34;plotly_brushed&#34;,&#34;plotly_brushing&#34;,&#34;plotly_clickannotation&#34;,&#34;plotly_doubleclick&#34;,&#34;plotly_deselect&#34;,&#34;plotly_afterplot&#34;,&#34;plotly_sunburstclick&#34;],&#34;base_url&#34;:&#34;https://plot.ly&#34;},&#34;evals&#34;:[],&#34;jsHooks&#34;:[]}&lt;/script&gt;
&lt;p style=&#34;font-size:12px&#34;&gt;
&lt;strong&gt;Graphic 1.&lt;/strong&gt; Daylly (red) and cumulative (green) publication about COVID-19
&lt;/p&gt;
&lt;/center&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
China (32.65%), United States (14.97%), Italy (7.13%), United Kingdom (5.53%) and Canada (3.05%) were the main source of scientific literature. About 63.33% of articles analyzed came from these five countries.
&lt;/p&gt;
&lt;center&gt;
&lt;img src=&#34;/syntax/index_files/figure-html/unnamed-chunk-3-1.png&#34; width=&#34;672&#34; /&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Map 1.&lt;/strong&gt; COVID-19 literature source.
&lt;/p&gt;
&lt;hr /&gt;
&lt;/center&gt;
&lt;p align=&#34;left&#34; style=&#34;font-size:16px&#34;&gt;
PlatCOVID performed 4 descriptive syntax analysis in these abstracts:&lt;br&gt;
(1) &lt;a href=&#39;#atomization&#39;&gt;Word atomization all abstracts&lt;/a&gt;&lt;br&gt;
(2) &lt;a href=&#39;#categorization&#39;&gt;Categorization based on word atomization&lt;/a&gt;&lt;br&gt;
(3) &lt;a href=&#39;#atomization_cate&#39;&gt;Word atomization of each category&lt;/a&gt;&lt;br&gt;
(4) &lt;a href=&#39;#sentence&#39;&gt;Sentece atomization and Human Literature Curation&lt;/a&gt;
&lt;/p&gt;
&lt;hr /&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p align=&#34;center&#34; style=&#34;font-size:25px&#34;&gt;
&lt;a id=&#39;atomization&#39;&gt;
&lt;strong&gt;Word Atomization Overview&lt;/strong&gt;
&lt;/a&gt;
&lt;/p&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
Using the &lt;em&gt;atomization&lt;/em&gt; process, 22706 words/terms were found. 2061 &lt;a href=&#34;../supp/terms/global_category_words/&#34;&gt;commom words&lt;/a&gt; were execluded, remaining &lt;strong&gt;&lt;em&gt;20645&lt;/em&gt;&lt;/strong&gt; words. The table bellow shows the top 10 terms.
&lt;/p&gt;
&lt;hr /&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Box 1.&lt;/strong&gt; Top 10 Words cited in Abstracts in COVID-19 literature.
&lt;/p&gt;
&lt;div class=&#34;row&#34;&gt;
&lt;div class=&#34;col&#34;&gt;

&lt;table&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Word
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Frequency
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
disease
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1949
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
health
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1446
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
respiratory
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1380
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
clinical
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1372
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
infection
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1367
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
severe
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
1208
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
outbreak
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
958
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
novel
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
957
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
virus
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
918
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pandemic
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
892
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div class=&#34;col&#34;&gt;
&lt;br&gt;&lt;br /&gt;

&lt;p style=&#34;font-size:16px&#34; align=&#34;justify&#34;&gt;
Our analysis suggests that the scientific focus, until now, has been to summarize the main clinical symptoms of COVID-19 (terms: respiratory, clinical, severe, acute, pneumonia, syndrome and symptoms, fever, chest and lung). It is also possible to infer that many articles were driven to describe the virus spreading (terms: novel, severe, virus, outbreak epidemic and spread). The other scientific efforts discussed were about the &lt;em&gt;transmission, prevention, treatment, health care management and diagnosis&lt;/em&gt; of SARS-CoV-2 and COVID-19.
&lt;/p&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;hr /&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p align=&#34;center&#34; style=&#34;font-size:25px&#34;&gt;
&lt;a id=&#39;categorization&#39;&gt;
&lt;strong&gt;Categorization Process: The 5 classes of Science Interest&lt;/strong&gt;
&lt;/a&gt;
&lt;/p&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
Based on &lt;em&gt;global words tokenization/atomization&lt;/em&gt; from abstracts, we categorized the COVID-19 studies in five categories: (1) clinical &amp;amp; signs &amp;amp; symptoms, (2) epidemiology, (3) transmission, (4) treatment and (5) diagnosis &lt;strong&gt;(Fluxogram 1)&lt;/strong&gt;. The categorization process used the Mesh and DeCS &lt;a href=&#34;../supp/terms/term/#categoric-terms-1&#34;&gt;terms list.&lt;/a&gt;
&lt;/p&gt;
&lt;div id=&#34;htmlwidget-2&#34; style=&#34;width:672px;height:480px;&#34; class=&#34;grViz html-widget&#34;&gt;&lt;/div&gt;
&lt;script type=&#34;application/json&#34; data-for=&#34;htmlwidget-2&#34;&gt;{&#34;x&#34;:{&#34;diagram&#34;:&#34;digraph flowchart {\n\n             node [fontname = Helvetica, shape = \&#34;box\&#34;, fillcolor = \&#34;PaleGreen\&#34;, style = \&#34;filled\&#34;, color = \&#34;Honeydew\&#34;]        \n             Total [href= \&#34;./total.html\&#34;, label = \&#34;4929 \\n (Total)\&#34;]\n             \n             node [fontname = Helvetica, shape = \&#34;record\&#34;, fillcolor = \&#34;Azure\&#34;, color= \&#34;grey\&#34;]       \n             Abstract [label = \&#34;2248\\n (Abstract)\&#34;]\n             No_abst [label = \&#34;2671\\n (No Abstract)\&#34;]\n             \n             Category [label = \&#34;1733\\n (Category)\&#34;]\n             g1 [href= \&#34;../supp/terms/term/#categoric-terms-1\&#34;,label = \&#34;360\\n Diagnosis \\n (Term 1)\&#34;]\n             g2 [href= \&#34;../supp/terms/term/#categoric-terms-1\&#34;,label = \&#34;683\\n Treatment\\n (Term 2)\&#34;]\n             g3 [href= \&#34;../supp/terms/term/#categoric-terms-1\&#34;,label = \&#34;284\\n Epidemiology \\n (Term 3)\&#34;]\n             g4 [href= \&#34;../supp/terms/term/#categoric-terms-1\&#34;,label = \&#34;439\\n Transmission \\n(Term 4)\&#34;]\n             g5 [href= \&#34;../supp/terms/term/#categoric-terms-1\&#34;,label = \&#34;1346\\n Clinical, Signs and Symptoms \\n(Term 5)\&#34;]\n             not_cat [label = \&#34;516\\n (No Category)\&#34;]\n             \n             # edge definitions with the node IDs\n             Total -&gt; {Abstract No_abst}\n             Abstract -&gt; {Category not_cat}\n             Category -&gt; {g1 g2 g3 g4 g5}\n             \n             }\n             &#34;,&#34;config&#34;:{&#34;engine&#34;:&#34;dot&#34;,&#34;options&#34;:null}},&#34;evals&#34;:[],&#34;jsHooks&#34;:[]}&lt;/script&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Fluxogram 1.&lt;/strong&gt; Workflow of categorization.
&lt;/p&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
9 articles fit all categories. The articles acess on PMIDs: &lt;a href=&#39;https://pubmed.ncbi.nlm.nih.gov/32278065&#39; target=&#39;_blank&#39;&gt;32278065&lt;/a&gt;, &lt;a href=&#39;https://pubmed.ncbi.nlm.nih.gov/32112886&#39; target=&#39;_blank&#39;&gt;32112886&lt;/a&gt;, &lt;a href=&#39;https://pubmed.ncbi.nlm.nih.gov/32271601&#39; target=&#39;_blank&#39;&gt;32271601&lt;/a&gt;, &lt;a href=&#39;https://pubmed.ncbi.nlm.nih.gov/32228809&#39; target=&#39;_blank&#39;&gt;32228809&lt;/a&gt;, &lt;a href=&#39;https://pubmed.ncbi.nlm.nih.gov/32220177&#39; target=&#39;_blank&#39;&gt;32220177&lt;/a&gt;, &lt;a href=&#39;https://pubmed.ncbi.nlm.nih.gov/32185921&#39; target=&#39;_blank&#39;&gt;32185921&lt;/a&gt;, &lt;a href=&#39;https://pubmed.ncbi.nlm.nih.gov/32183901&#39; target=&#39;_blank&#39;&gt;32183901&lt;/a&gt;, &lt;a href=&#39;https://pubmed.ncbi.nlm.nih.gov/32145185&#39; target=&#39;_blank&#39;&gt;32145185&lt;/a&gt;, &lt;a href=&#39;https://pubmed.ncbi.nlm.nih.gov/32086938&#39; target=&#39;_blank&#39;&gt;32086938&lt;/a&gt;.
&lt;/p&gt;
&lt;img src=&#34;/syntax/index_files/figure-html/unnamed-chunk-6-1.png&#34; width=&#34;672&#34; style=&#34;display: block; margin: auto;&#34; /&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Venn 1.&lt;/strong&gt; Categorizations of abstracts.
&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;hr /&gt;
&lt;center&gt;
&lt;a id=&#39;atomization_cate&#39;&gt;
&lt;strong&gt;Word Atomization of Categories&lt;/strong&gt;
&lt;/a&gt;
&lt;/center&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
Then, we peformed the &lt;em&gt;words atomization&lt;/em&gt; from abstracts of each categories. &lt;a href=&#34;../supp/terms/global_category_words/#categoric-words-syntax-analysis&#34;&gt;Acess&lt;/a&gt; to view all words atomization report in each category.
&lt;/p&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Box 2.&lt;/strong&gt; Top 10 Words/terms atomization of each category.
&lt;/p&gt;
&lt;table&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Diagnose
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Treatment
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Epidemiology
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Transmission
&lt;/th&gt;
&lt;th style=&#34;text-align:center;&#34;&gt;
Sings
&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
disease (402)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
treatment (882)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
disease (302)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
transmission (710)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
clinical (1372)
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
clinical (386)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
disease (728)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
clinical (297)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
disease (439)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
disease (1353)
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
diagnosis (368)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
clinical (656)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epidemiological (247)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
infection (394)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
respiratory (999)
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
infection (293)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
infection (555)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
infection (217)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
respiratory (375)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
infection (968)
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
respiratory (283)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
respiratory (549)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
health (200)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
health (339)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
severe (884)
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
treatment (269)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
severe (527)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
respiratory (195)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
virus (291)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
health (883)
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
severe (245)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
health (414)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
epidemic (179)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
outbreak (274)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
treatment (660)
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
health (244)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
virus (340)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
confirmed (173)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
severe (254)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
novel (633)
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
novel (207)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
novel (333)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
novel (164)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
novel (234)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
symptoms (614)
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
pneumonia (193)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
acute (331)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
outbreak (159)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
clinical (229)
&lt;/td&gt;
&lt;td style=&#34;text-align:center;&#34;&gt;
virus (591)
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr /&gt;
&lt;center&gt;
&lt;a id=&#39;sentence&#39;&gt;
&lt;strong&gt;Sentece Tokenization&lt;/strong&gt;
&lt;/a&gt;
&lt;/center&gt;
&lt;br&gt;
&lt;p align=&#34;justify&#34; style=&#34;font-size:16px&#34;&gt;
Finally, we peformed the &lt;em&gt;tokenization&lt;/em&gt; sentece process from abstracts of each categories. &lt;br&gt;&lt;em&gt;Frist&lt;/em&gt;, we colect the last 4 sentence of each abstract, assumed as the conclusion of the work, using &lt;a href=&#34;../supp/methodology/#pubmed.mineR&#34;&gt;pubmed.mineR&lt;/a&gt;. Around 8992 conclusion sentences were achivied &lt;br&gt; &lt;em&gt;Second&lt;/em&gt;, we extract the sentece context of each category term, previously used, by &lt;a href=&#34;../supp/methodology/#tokenizers&#34;&gt;tokenizer&lt;/a&gt;. 340, 629, 99, 432 and 914 senteces were retrivied, about diagnosis, treatment, epidemiology, transmission and clinical, sings and symptoms, respectivelly. Articles with no context sentence were excluded. &lt;br&gt; &lt;em&gt;Third&lt;/em&gt;, we began the human curation process (Fluxogram 2):
&lt;div id=&#34;htmlwidget-3&#34; style=&#34;width:672px;height:480px;&#34; class=&#34;grViz html-widget&#34;&gt;&lt;/div&gt;
&lt;script type=&#34;application/json&#34; data-for=&#34;htmlwidget-3&#34;&gt;{&#34;x&#34;:{&#34;diagram&#34;:&#34;digraph flowchart {\n\n             node [fontname = Helvetica, shape = \&#34;box\&#34;, fillcolor = \&#34;Gold\&#34;, style = \&#34;filled\&#34;, color = \&#34;Honeydew\&#34;]        \n             g1 [label = \&#34;360\\n Diagnosis\&#34;]\n             g1_sel [label = \&#34;314\\n Selected\&#34;]\n             g1_cur [href= \&#34;../category/diagnosis/\&#34;,label = \&#34;163\\n Curated\&#34;]\n             \n             node [fontname = Helvetica, shape = \&#34;box\&#34;, fillcolor = \&#34;MediumOrchid\&#34;, style = \&#34;filled\&#34;, color = \&#34;Honeydew\&#34;]        \n             g2 [label = \&#34;683\\n Treatment\&#34;]\n             g2_sel [label = \&#34;577\\n Selected\&#34;]\n             g2_cur [href= \&#34;../category/treatament/\&#34;,label = \&#34;265\\n Curated\&#34;]\n             \n             node [fontname = Helvetica, shape = \&#34;box\&#34;, fillcolor = \&#34;PaleGreen\&#34;, style = \&#34;filled\&#34;, color = \&#34;Honeydew\&#34;]        \n             g3 [label = \&#34;284\\n Epidemiology\&#34;]\n             g3_sel [label = \&#34;87\\n Selected\&#34;]\n             g3_cur [href= \&#34;../category/epidemiology/\&#34;,label = \&#34;56\\n Curated\&#34;]\n             \n             node [fontname = Helvetica, shape = \&#34;box\&#34;, fillcolor = \&#34;RoyalBlue\&#34;, style = \&#34;filled\&#34;, color = \&#34;Honeydew\&#34;]        \n             g4 [label = \&#34;439\\n Transmission\&#34;]\n             g4_sel [label = \&#34;177\\n Selected\&#34;]\n             g4_cur [href= \&#34;../category/transmission/\&#34;,label = \&#34;61\\n Curated\&#34;]\n             \n             node [fontname = Helvetica, shape = \&#34;box\&#34;, fillcolor = \&#34;Orange\&#34;, style = \&#34;filled\&#34;, color = \&#34;Honeydew\&#34;]        \n             g5 [label = \&#34;1346\\n Symptoms\&#34;]\n             g5_sel [label = \&#34;851\\n Selected\&#34;]\n             g5_cur [href= \&#34;../category/signs/\&#34;,label = \&#34;293\\n Curated\&#34;]\n             \n             \n             # edge definitions with the node IDs\n             g1 -&gt; g1_sel g1_sel -&gt; g1_cur\n             g2 -&gt; g2_sel g2_sel -&gt; g2_cur\n             g3 -&gt; g3_sel g3_sel -&gt; g3_cur\n             g4 -&gt; g4_sel g4_sel -&gt; g4_cur\n             g5 -&gt; g5_sel g5_sel -&gt; g5_cur\n             }\n             &#34;,&#34;config&#34;:{&#34;engine&#34;:&#34;dot&#34;,&#34;options&#34;:null}},&#34;evals&#34;:[],&#34;jsHooks&#34;:[]}&lt;/script&gt;
&lt;p style=&#34;font-size:12px&#34; align=&#34;center&#34;&gt;
&lt;strong&gt;Fluxogram 2.&lt;/strong&gt; Human curation process from PlatCOVID based on 5 categories.
&lt;/p&gt;
&lt;hr /&gt;
</description>
    </item>
    
  </channel>
</rss>
